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Women on opioid substitution treatment (WOST) are a group at risk for sexually transmitted 
infections (STIs) and blood-borne viruses (BBVs). This study aimed to explore the factors that are 
associated with sexual health risks among WOST, and the sexual transmission of STIs and BBVs. 
Also, to explore the opportunities for developing a sexual health service in community pharmacies in 
England. The design of this research was informed by the Intervention Mapping approach to design 
health promotion programmes. For this qualitative study, 20 WOST and 14 community pharmacists 
(CPs) were interviewed between October 2015 and April 2017. Four WOST and three CPs took part 
in focus groups that took place in September 2017. Recruitment for WOST took place in drug services 
and a service for sex workers. CPs were recruited through community pharmacies. Data were 
collected in Bath, Bristol and Midsomer Norton (South West of England). Qualitative data was 
analysed using Framework Analysis and Content Analysis. Findings indicated that there are multiple 
factors associated with STI/BBV risk among WOST. A Social-Ecological Model was developed 
including factors at the intrapersonal level – e.g., worthlessness – interpersonal level – e.g., trust in 
health professionals – organisational level – e.g., availability of sexual health services – community 
level – e.g., intersectional stigma – and public policy – e.g., current health policies. Using 
Intersectionality Theory, this research highlighted that social inequities of health are at the core of 
sexual health risks among WOST. Multiple public health strategies at different ecological levels need 
to be designed and implemented to reduce these inequities and prevent STIs and BBVs among 
WOST. Community pharmacy could play a key role in delivering sexual health services, providing 
equity and protecting the human rights of WOST. Suggestions for service design in community 















List of Abbreviations 
 
AIDS – Acquired Immunodeficiency Syndrome 
AWP – Avon and Wiltshire Mental Health Partnership 
BBV(s) – Blood-Borne Virus(es) 
CCG – Clinical Commissioning Groups 
CP(s) – Community Pharmacist(s) 
FA – Framework Analysis 
GBV – Gender-based Violence 
GP(s) – General Practitioner(s) 
HBV – Hepatitis B Virus 
HCV – Hepatitis C Virus 
HIV – Human Immunodeficiency Virus 
HPV – Human Papillomavirus 
IM – Intervention Mapping 
IPV – Intimate Partner Violence 
LHT – Learned Helplessness Theory 
NEP – Needle Exchange Programme 
NHS – National Health Service 
OST – Opioid Substitution Treatment 
PI – Principal Investigator 
PLHIV – People who live with HIV 
PrEP – Pre-Exposure Prophylaxis 
PWID – People who Inject Drugs  
PWUD – People who Use Drugs 
QCA – Qualitative Content Analysis 
QoL – Quality of Life  
STI(s) – Sexually Transmitted Infection(s) 
WHOD – Women using Heroin and Other Drugs 





CHAPTER 1. Introduction 
This chapter provides an introduction to the context of this PhD. It includes a review of the 
literature and the aims and objectives. 
1.1. The Case for Preventing Sexually Transmitted Infections and Blood-Borne Viruses 
According to the last world estimates, there are 357 million new sexually transmitted 
infections (STI) cases every year worldwide (World Health Organization, 2016f). STIs are associated 
with more than 30 sexually transmissible bacteria, viruses and parasites (World Health Organization, 
2016c, 2016f) and are primarily transmitted via sexual contact. The most prevalent worldwide are 
herpes simplex virus type 2 (417 million people), human papillomavirus (HPV) (291 million people), 
trichomoniasis (142 million people), chlamydia (131 million people), gonorrhoea (78 million people), 
and syphilis (6 million people) (World Health Organization, 2016c, 2016f). The most prevalent 
curable STIs
1
 in the European Region by 2012 were chlamydia [women 3.9%, men 3.8%], 
trichomoniasis [women 5.8%, men 0.6%], gonorrhoea [women 0.6%, men 0.2%] and syphilis [women 
0.1%, men 0.1%] (World Health Organization, 2012). Although most STIs are curable, they can lead 
to the development of serious health conditions and have a profound impact on sexual and 
reproductive health (World Health Organization, 2016f). STIs are linked to negative pregnancy 
outcomes (e.g. neonatal deaths) (CDC, 2016; Johnson, Ghanem, Zenilman, & Erbelding, 2011), 
increased human immunodeficiency virus (HIV) risk (ECDC, 2015; Seeman, Leinhos, & Neumann, 
2013; World Health Organization, 2016c, 2016f), and low quality of life (Aral, Over, Manhart, & 
Holmes, 2006; World Health Organization, 2016c). When untreated, curable STIs such as chlamydia 
and gonorrhoea are major causes of pelvic inflammatory disease and infertility in both women 
(ECDC, 2015; World Health Organization, 2016c, 2016f) and men (Ochsendorf, 2011). Cervical 
cancer and other anogenital cancers are associated with HPV, which is the second most prevalent STI 
worldwide (de Martel, Plummer, Vignat, & Franceschi, 2017; World Health Organization, 2016c, 
2016f, 2018c). Antibiotic resistant STIs, especially gonorrhoea, are also a growing concern worldwide 
as they may become untreatable (Unemo & Nicholas, 2012). 
HIV is also sexually transmitted. It affects an estimated 33.3 million (range of 30.9 million – 
36.1 million) people around the world. In 2015, new annual cases of HIV infection were estimated to 
range between 1.8 million to 2.4 million, and there were 1.1 million estimated HIV-related deaths 
(World Health Organization, 2016b). HIV infection may result in developing Acquired 
Immunodeficiency Syndrome (AIDS) over time, a disease that weakens the immune system and 
increases the risk of opportunistic infections and other health conditions such as cancerous tumours 
                                                             





(CDC, 2016; World Health Organization, 2016e). The annual incidence of HIV (UNAIDS, 2015) and 
HIV-related deaths (World Health Organization, 2016b) have significantly dropped in the last 15 
years due to the advances in HIV prevention and HIV/AIDS treatment. 
Despite the risk is low, other blood-borne viruses (BBVs) such as Hepatitis B virus (HBV) 
and Hepatitis C virus (HCV) can also be transmitted through sex, thus this research also focused on 
the prevention of HBV and HCV. It is however important to acknowledge the potential limitations 
and negative outcomes of this inclusion (Harris & Rhodes, 2013). This point will be further expanded 
as a limitation of this study (see Discussion, page 233). Global estimates suggest that 257 million and 
71 million people are living with chronic HBV and HCV respectively in 2015 (World Health 
Organization, 2017). Viral hepatitis is a leading cause of death and can cause cirrhosis, liver failure 
and liver cancer (NHS, 2016, 2018; Stanaway et al., 2016). HIV co-infection is high – 2.6 million 
HIV-positive individuals are also living with HBV, and 2.9 million with HCV –, which increases 
mortality risk (World Health Organization, 2016d). At the end of 2013, there were 658,000 and 
672,000 HBV- and HCV-related deaths respectively (World Health Organization, 2016a, 2016d). 
Despite the efforts made over the last few years, HCV cases and HCV-related deaths continue to rise. 
Furthermore, the incidence of HBV is projected to remain unchanged for the next 40-50 years (World 
Health Organization, 2016d).  
The UK has been identified as one of the European countries with the highest rates of STIs 
(Department of Health, 2010; ECDC, 2015). In 2017, there were 625,925 new STI diagnoses in 
England, including HIV (Public Health England, 2018a). By the end of 2016, there were 89,400 
people living with HIV in the UK (Public Health England, 2017c). Heterosexual sex was the second 
most probable route for acquiring HIV in the UK by 2016 (Public Health England, 2017d). In the 
same year in England, there were 11,901 confirmed acute cases of HBV (Public Health England, 
2017a) and approximately 160,000 people were estimated to be living with chronic HCV (Public 
Health England, 2018b). Individuals of socially excluded groups, such as drug-using populations, 
were disproportionately represented in these figures. Despite a seeming drop in HCV-related deaths in 
the UK in the last year, more efforts are needed to decrease the incidence and prevalence of HCV 
(Public Health England, 2018b) particularly amongst vulnerable populations. 
1.1.1. An Overview of Public Health Strategies to Prevent STIs and BBVs 
The global burden of disease of STIs and BBVs is high and represents a major public health 
concern worldwide and in the UK. Advances in prevention, diagnosis and treatment have had a 
significant impact on the incidence, prevalence, management and outcomes of STIs and BBVs (Aral, 
Padian, & Holmes, 2005; Eaton & Kalichman, 2014; G. Hughes & Field, 2015; World Health 





treatment. The present study aims at addressing some of these gaps and contributing to the body of 
research on the prevention of STIs and BBVs. 
Since the first cases of HIV in the early 1980s (CDC, 1981), the prevention of HIV and other 
BBVs has been at the core of public health and human development strategies worldwide (Mayer & 
Pizer, 2008; United Nations, 2015a, 2015b). Most efforts to prevent STIs and BBVs among people 
who use drugs (PWUD) have focused on preventing HIV transmission (and more recently viral 
hepatitis), overlooking sexual contact as a main vector of BBV transmission (Des Jarlais et al., 2007; 
Hagan, Perlman, & Des Jarlais, 2011; Kral et al., 2001; Steen, Elvira Wi, Kamali, & Ndowa, 2009; 
Strathdee & Sherman, 2003). On the other hand, the prevention of STIs has been largely linked to 
HIV prevention (Aral et al., 2006; Steen et al., 2009; WHO/UNAIDS, 2008).  
HIV can be transmitted sexually, perinatally and parenterally. There are several behavioural 
and biomedical strategies for the prevention of HIV (Barré-Sinoussi, Ross, & Delfraissy, 2013). These 
mainly focus on: 1) promoting condom use (Charania et al., 2011; Mason-Jones et al., 2016; Moreno 
et al., 2014; Weller & Davis, 2002); 2) reducing sexual risk behaviours (e.g., condomless sex) (Del 
Rio, 2014; Hogben, Ford, Becasen, & Brown, 2015; Mason-Jones et al., 2016; Ross, 2010); 3) 
promoting the uptake of pre-exposure prophylaxis (PrEP) (Baeten et al., 2012; Baker, 2013; 
Choopanya et al., 2013; Del Rio, 2014; Grant et al., 2010; McCormack et al., 2016; Okwundu, 
Uthman, & Okoromah, 2012); 4) promoting the uptake of post-exposure prophylaxis (Del Rio, 2014); 
5) antiretroviral therapy initiation and adherence among people living with HIV (PLHIV) (Attia, 
Egger, Müller, Zwahlen, & Low, 2009; Baker, 2013; Del Rio, 2014); 6) prevention of mother-to-child 
transmission (De Cock, Jaffe, & Curran, 2012; Novitsky & Essex, 2012; Rakhmanina & van den 
Anker, 2014; Teasdale, Marais, & Abrams, 2011); 7) promoting male circumcision (De Cock et al., 
2012); 8) ensuring HIV screening of donated blood (De Cock et al., 2012); 9) encouraging HIV 
testing (Del Rio, 2014; R. Lee, Cui, Muessig, Thirumurthy, & Tucker, 2014); 10) developing vaccines 
(Baker, 2013); 11) preventing gender-based violence (GBV) (Heintz & Melendez, 2006; Stockman, 
Lucea, & Campbell, 2013); and 12) implementing opioid substitution treatment (OST) (Gowing, 
Farrell, Bornemann, Sullivan, & Ali, 2011) and needle exchange programmes (NEP) (Vlahov & 
Junge, 1998) for people who inject drugs (PWID). However, the cost-effectiveness of HIV prevention 
interventions still remains unclear (Galárraga, Colchero, Wamai, & Bertozzi, 2009; Jacobsen & 
Walensky, 2016). It is also crucial to consider the combination of biomedical approaches and 
strategies to address social, cultural and political factors associated with HIV transmission (Atujuna et 
al., 2018; Bekker, Beyrer, & Quinn, 2012; Coates, Richter, & Caceres, 2008; Kippax, 2012).   
The development of vaccines (for HBV and Hepatitis A only) (Ansaldi, Orsi, Sticchi, 
Bruzzone, & Icardi, 2014; Aspinall, Hawkins, Fraser, Hutchinson, & Goldberg, 2011; Trepo, 2014) 





Gentile, Zappulo, Buonomo, & Borgia, 2014) have led to the prevention of viral hepatitis. Other 
approaches are: 1) the screening of blood and blood products – including among organ and tissue 
donors – (Aspinall et al., 2011); 2) the promotion of condom use (Aspinall et al., 2011); 3) the 
implementation of OST and needle exchange programmes (NEP) for PWID (Aspinall et al., 2011; 
Platt et al., 2017); and 4) testing for viral hepatitis (L. Jones et al., 2014). The evidence on the cost-
effectiveness of hepatitis prevention strategies among the general and key populations (e.g., PWID) is 
mixed (Hahné et al., 2013; Krahn et al., 2005; Wright & Tompkins, 2006). Also, despite hepatitis 
vaccinations are highly effective (Børresen et al., 2012), vaccination uptake is still low among key 
populations (Public Health England, 2017f). Further efforts are needed to decrease the incidence and 
mortality associated with HBV and HCV (World Health Organization, 2016d).  
On the other hand, the prevention of STIs has been dominated by the promotion of condom 
use (Charania et al., 2011; Holmes, Levine, & Weaver, 2004; Inman, van Bakergem, LaRosa, & Garr, 
2011; Mason-Jones et al., 2016; Moreno et al., 2014; K. Wang, Brown, Shen, & Tucker, 2011). Other 
strategies include: 1) the reduction of sexual risk behaviours (e.g., having multiple sexual partners) 
(Coakley et al., 2017; Inman et al., 2011); 2) the promotion of STI testing (R. Lee et al., 2014); 3) 
encouraging the delay of sex initiation (Aarons et al., 2000; Inman et al., 2011); 4) vaccination for 
HPV (Kahn, 2005); and 5) the prevention GBV (Heintz & Melendez, 2006; Stockman et al., 2013). 
Although some strategies may be effective (Wilton et al., 2009; World Health Organization, 2016c), 
the evidence available remains unclear (Berg, 2009; Minnis & Padian, 2005; Shahmanesh, Patel, 
Mabey, & Cowan, 2008). As for the prevention of HIV, the combination of strategies seems to be 
most promising (World Health Organization, 2016c; Zimet, Mays, & Fortenberry, 2000). 
Apart from the specific strategies for prevention, the need to maintain the focus on addressing 
social and health inequities, and advocate for human rights in STI/BBV prevention should not be 
forgotten. Thus, the needs of populations most at risk for STIs and BBVs should be considered to 
design effective and comprehensive health programmes.  
1.2. Women Using Drugs: A Priority Group for STI/BBV Prevention 
Social and health inequities, such as gender inequities, are barriers for disease prevention and 
access to social and health services. These inequities disproportionally affect key populations, such as 
PWUD (UNAIDS, 2014b). Social and health inequities are violations of human rights, as they involve 
an unequal access to civil, political, economic, social, health and cultural rights (Krieger, 2014; 
United Nations, 2015b; World Health Organization, 2018b; World Health Organization Regional 
Office for Europe, 2013, 2016). Stigma, discrimination and violence are often rooted in social 
inequities, and are powerful barriers to health promotion. Punitive laws, policies and practices 
violating human rights (e.g., deportation of HIV-positive individuals and ban the entry of PLHIV 





some PWUD) experience constant stigma, discrimination and violence at an individual and socio-
structural level. This has a negative impact on preventive strategies and raises the question of how 
human rights are protected in UK and other developed countries. Debates on sex work are an 
example. On one hand, the criminalisation of sex work has been identified by some to be a powerful 
measure that diminishes public health efforts and increases individual and social harm (Kalichman, 
2017; UNAIDS, 2014a, 2015). This has led to social movements and advocacy research to claim for 
the decriminalisation of sex work, to ensure the rights of sex workers, and improve their physical 
safety, health and wellbeing (Decker et al., 2015; Morton et al., 2002; Weitzer, 2009). On the other 
hand, feminist movements have advocated for the eradication of sex work as part of the fight against 
patriarchy
2
. This is to ensure gender equity through tackling the sexualisation and objectification of 
women GBV (Walby, 1990).  
PWUD are a group that experience stigma, discrimination and violence at the individual (e.g., 
interpersonal aggression) and socio-structural level (e.g., health policies not addressing the sexual 
health needs of PWUD). They are also one of the population groups most at risk for STIs and BBVs 
(Cavanaugh, Hedden, & Latimer, 2010; Des Jarlais et al., 2011; Hwang, Zack, Rickman, & Holleman, 
2000; Kuyper et al., 2005; Public Health England, 2018b; UNAIDS, 2014a, 2015, 2016a; World 
Health Organization, 2016a, 2016b, 2016c, 2016d), and one of the priority populations for the 
prevention of STIs and BBVs worldwide. This heightened risk among drug users is mainly related to 
sharing needles and paraphernalia, engaging in sexual risk behaviours (e.g., condomless sex) and 
experiencing sexual violence (Alves, Goulart, Lara, Lucchese, & Vera, 2016; Booth, Kwiatkowski, & 
Chitwood, 2000; Branson & Clemmey, 2008; Des Jarlais et al., 2011; N. L.   Edelman, Patel, Glasper, 
& Bogen-Johnston, 2014; Elifson, Klein, & Sterk, 2006; Guimaraes et al., 2018; Hagan et al., 2011; 
Kuyper et al., 2005; T. S. Lee, Chen, & Chang, 2011; Strathdee & Stockman, 2010).  
The most prevalent BBV among drug users is HCV (Public Health England, 2017f; United 
Nations Office on Drug and Crime, 2017), with 6.1 million PWID living with HCV and high 
mortality rates (United Nations Office on Drug and Crime, 2017). In the UK, two of every five PWID 
has HCV (Public Health England, 2017f, 2018b). Although most transmissions are parenteral, the 
transmission of HCV through sexual contact is still possible and should also be a target of preventive 
programmes (Public Health England, 2017f, 2018b).  
PWUD are 28 times more likely to be living with HIV, compared to adults in the general 
population worldwide, and one in 10 PWID globally are positive for HIV (UNAIDS, 2016b). It is 
estimated that 1.6 million PWID worldwide are living with HIV (United Nations Office on Drug and 
Crime, 2017). In the UK, HIV is low among injecting drug users (0.9%) although the prevalence is 
                                                             





still higher than in the general population (0.16%) (Public Health England, 2017f). There have been 
recent outbreaks of HIV among PWID in Glasgow and South West England, which highlight the 
ongoing risk of transmission and the need for early detection of HIV. This is also especially critical as 
late HIV diagnoses among PWUD are still a concern in the UK (Public Health England, 2017f). 
Drug-using populations, and especially PWID are one of the key populations at higher risk for 
HBV (World Health Organization, 2017). The prevalence of HBV is low among drug users in the UK, 
with an estimate of 1 out of 200 PWID currently living with HBV. Among PWUD, the risk of sexual 
transmission of HBV is increased due to the higher rates of HBV and HCV among PWID and their 
sexual networks, due to injecting risks (e.g., sharing needles) (World Health Organization, 2016d). 
Despite being a vulnerable group for HBV, only one quarter of PWID in the UK are vaccinated for 
HBV. Current recommendations advise that vaccination uptake should be maintained and improved 
among PWID (Public Health England, 2017f).  
Drug users have also been globally identified as a group with an increased vulnerability to 
STIs (World Health Organization, 2016c). In spite of this, there are no official reports of the 
prevalence of STIs among PWUD worldwide or in the UK. Some efforts have been made to research 
the epidemiology of STIs amongst drug-using populations. These studies have found significantly 
higher rates of STI prevalence among PWUD, compared to rates among the general population. These 
studies suggest a 24-38% of lifetime STI prevalence (Guimaraes et al., 2018; Hwang et al., 2000), and 
a 6% (Khan, Berger, Hemberg, O’Neill, Penniman Dyer, et al., 2013) and 8% (Bradshaw, Pierce, 
Tabrizi, Fairley, & Garland, 2005) prevalence at the time of the research. Other studies have explored 
the lifetime prevalence of syphilis among drug users and reported a prevalence of 5.7% (López-Zetina 
et al., 2000) and 7.78% (B. X. Wang et al., 2013). Overall, there is a lack of epidemiological data on 
STIs among PWUD. This may suggest a lack of attention and surveillance of STIs among this 
population group. Further efforts need to be placed on determining the epidemiology of STIs among 
PWUD, to better understand the extent of STI among this population group.  
Women using drugs are particularly vulnerable to STIs and BBVs. This heightened 
vulnerability is mostly rooted in social and gender inequities, including GBV (Blankenship, Reinhard, 
Sherman, & El-Bassel, 2015; Bourgois, Prince & Moss, 2004; N. L. Edelman et al., 2014; El-Bassel, 
Gilbert, & Rajah, 2003; El-Bassel, Gilbert, Witte, Wu, & Chang, 2011; El-Bassel, Gilbert, Wu, Go, & 
Hill, 2005; Iversen, Dolan, Ezard, & Maher, 2015; Kilpatrick, Acierno, Resnick, Saunders, & Best, 
1997; Kulesza et al., 2016; UNAIDS, 2015, 2016b). Social inequities (e.g., poverty) are recognised to 
be associated with poorer general health and increased mortality (Dahlgren & Whitehead, 1991; 
Mackenbach et al., 2008; D. S. Morrison, 2009; Pampel, Krueger, & Denney, 2010; Schanzer, 
Dominguez, Shrout, & Caton, 2007; World Health Organization, 2014). Gender inequities refer to the 





power (UN General Assembly, 1948). Women worldwide are the ones most affected by gender 
inequities and GBV. Gender inequities and GBV are known to have a significant negative impact on 
women’s health (Annandale & Hunt, 2000; Sen & Östlin, 2008). For drug-using women, the 
engagement in transactional sex
3
 increases the risk for STIs and BBVs (Brooks et al., 2010; Duff et 
al., 2013; Folch et al., 2013; Mitchell & Latimer, 2009) and inconsistent use of condoms (N. L. 
Edelman et al., 2014; T. S. Lee et al., 2011). Women are also disproportionally affected by 
asymptomatic STIs, compared to men (World Health Organization, 2016c). This factor is important to 
consider as women may delay help-seeking behaviours and therefore timely screening, diagnosis and 
treatment. Furthermore, uptake of sexual health services among women using drugs seems to be poor 
(N. L. Edelman, Patel, Glasper, & Bogen-Johnston, 2013; C. L. Morrison, Ruben, & Beeching, 1995).  
The ongoing neglect of STI prevention and sexual transmission of BBVs also applies to 
STI/BBV prevention among drug-using populations (Des Jarlais, Feelemyer, Modi, Arasteh, & 
Hagan, 2012; Khan, Berger, Hemberg, O’Neill, Dyer, et al., 2013; Kral et al., 2001; Liu, Li, & Li, 
2012; Strathdee, 2003; Strathdee et al., 2001; Strathdee & Sherman, 2003). In fact, current sexual 
health strategies addressing the sexual and reproductive health needs of PWUD in the UK are still 
almost exclusively centred in preventing the parenteral transmission of HIV and HCV (Public Health 
England, 2015). Despite the efforts in preventing HIV and HCV among drug-using populations, there 
are still significant gaps in research and practice to promote the sexual health and wellbeing of this 
group (Mathers et al., 2010; Meader, Li, Des Jarlais, & Pilling, 2010; Petersen, Myers, van Hout, 
Plüddemann, & Parry, 2013; Vanthuyne, Mundt-Leach, Boyd, Broughton, & Pittrof, 2016). 
This study aims at better understanding how to prevent the sexual transmission of STIs and 
BBVs among a group of women who use drugs. This stems from the need to tackle the unique social 
and (sexual) health inequities experienced by women using drugs. The study focuses on women who 
are on OST, a form of treatment that aims at replacing the use of illegal opioids (e.g., heroin) for 
medical treatment with opioids (e.g., methadone) (Dole & Nyswander, 1965). Evidence suggests that 
OST is effective in reducing drug-seeking and drug-using behaviours, drug-related mortality, criminal 
behaviour, increased adherence to antiretroviral treatment for HIV, and HIV/BBV risk (Alto & 
O'Connor, 2011; Cornish, Macleod, Strang, Vickerman, & Hickman, 2010; Degenhardt et al., 2011; 
Gowing et al., 2011; Lawrinson et al., 2008; MacArthur et al., 2012; Malta, Strathdee, Magnanini, & 
Bastos, 2008; Manhapra, Rosenheck, & Fiellin, 2017; Marsch, 2002). Psychosocial approaches have 
been recommended by clinical guidelines for drug misuse and dependence (Clinical Guidelines on 
Drug Misuse and Dependence Update 2017 Independent Expert Working Group, 2017), however the 
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of sex for money or goods, framed as a job rather than a necessity. Using transactional sex was more appropriate to refer to 





evidence on the benefits of psychosocial services alongside OST is still conflicting (Amato, Minozzi, 
Davoli, & Vecchi, 2011; Day & Mitcheson, 2017; Dugosh et al., 2016).  
There are two main reasons to focus this research on WOST in particular. First, drug-using 
women are a hard-to-reach population. Accessing women who are already accessing health services 
was considered a first step to reach other drug-using women who are not engaging in services in 
future research. Second, WOST collect their OST in community pharmacies
4
 at least a few days per 
week as, in the UK, OST is first delivered daily and is supervised by community pharmacists (CPs). 
As clients progress, the frequency of collection lowers and some clients may be allowed to take their 
medication outside pharmacy premises. Regardless of the actual frequency, the regular access to 
health services and engagement with CPs may be a unique opportunity to prevent STIs and BBVs in 
this group of women.  
1.3. Community Pharmacy and Health Promotion: Missed Opportunities 
Over the last few years, CPs have increasingly incorporated health promotion as one of their 
roles. Even though CPs have been identified as key deliverers of public health interventions (C. 
Anderson, 2000; S. Anderson, 2007; S. Brown, Henderson, & Sullivan, 2014; T. J. Brown et al., 
2016; Todd et al., 2014), stronger evidence is required on effective implementation of health 
promotion programmes (Department of Health, 2008; Eades, Ferguson, & O'Carroll, 2011; Public 
Health England, 2017e). Community pharmacies in the UK dispense the majority of OST, which is 
often delivered on a daily basis. Providing OST presents an opportunity to promote sexual health 
among clients accessing this service as brief interventions.  
CPs have been recognised as potential deliverers of sexual health promotion services to the 
general population (Public Health England, 2017e; G. Thomas et al., 2010), and drug-using groups 
(Robertson, Bond, & Matheson, 2015). Nevertheless, their role in STI prevention for PWUD has been 
limited compared to BBVs and other health services (e.g., emergency hormonal contraception) 
(Robertson, Bond, & Matheson, 2015). Community pharmacy-based services for drug-using 
populations have been limited to harm-reduction strategies to prevent BBVs, such as NEP (T. Watson 
& Hughes, 2012). Although OST clients can access sexual health services that are open to the general 
population, there are no specific sexual health services addressing the sexual health needs of this 
group. Sexual health services available in community pharmacies are chlamydia screening, HIV 
testing, free condom distribution, sale of condoms and STI treatment. There are also reproductive 
health services offered, such as contraception, emergency hormonal contraception, and pregnancy 
tests (Public Health England, 2017e). Some services are only available to people between 15 and 24 
years old (Public Health England, 2017e). It has been argued that specific services should be offered 
                                                             





to OST clients due to the special needs of this group and the barriers that they may encounter 
accessing services, in comparison to other pharmacy clients (E. J. Edelman et al., 2014; N. L. 
Edelman et al., 2014). In addition, there are no clear referral pathways between sexual health and drug 
use services. These links would be very beneficial because of the association between drug use and 
sexual health. 
Previous research suggests that CPs seem to hold positive views on promoting health in the 
community pharmacy setting (Chaar et al., 2013; Parsons et al., 2013). Certain barriers may however 
create challenges to promote health among OST clients within community pharmacies. The most 
predominant are: 1) pharmacists’ negative attitudes and stigma towards OST clients (Eades et al., 
2011; Luger, Bathua, Alcorn, & Power, 2000; Luty, Kumar, & Stagias, 2010; McLaughlin, McKenna, 
Leslie, Moore, & Robinson, 2006; Robertson et al., 2015; G. Thomas et al., 2010; van Boekel, 
Brouwers, van Weeghel, & Garretsen, 2013); 2) pharmacists’ lack of training (C. Anderson, 2000; 
Eades et al., 2011; Jaffray et al., 2014; Luger et al., 2000; Real, Gracia Vasquez, Formica, & Palma, 
2014; G. Thomas et al., 2010; T. Watson & Hughes, 2012); 3) time constraints (Real et al., 2014; G. 
Thomas et al., 2010; T. Watson & Hughes, 2012); 4) pharmacists’ fear of clients’ negative attitudes 
and disruptive behaviours (e.g. shoplifting) (Chaar et al., 2013; Luger et al., 2000; Robertson et al., 
2015; T. Watson & Hughes, 2012); 5) pharmacist-service user relationship (Luger et al., 2000); 6) 
lack of physical space and privacy (Luger et al., 2000; Real et al., 2014); and 7) lack of economic 
incentives (C. Anderson, 2000; Real et al., 2014; T. Watson & Hughes, 2012). Most OST service 
users find supervised opiate dispensing programmes to be reasonable services (Luger et al., 2000). 
However, individuals receiving OST have also reported a lack of privacy and fear negative and 
stigmatising attitudes from CPs (Luger et al., 2000). Even though several barriers have been already 
identified, further research is needed to explore service- and client-specific barriers and facilitators. 
Community pharmacies in the UK are increasingly being incorporated in public health strategies, 
partly as a way to reduce public health costs (Agomo, 2018; Oswald & Adcock, 2016; M. C. Watson 
et al., 2014). Exploring the views of WOST and CPs is crucial in order to improve and develop new 
services that address the sexual health needs of WOST within community pharmacy.  
1.4. Research Questions and Aims 
The primary research questions of this study were: 
1. What are the individual and socio-structural factors associated with STI/BBV sexual 
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2. What role could CPs play in STI/BBV prevention in community pharmacies in England? 
3. What are the barriers and facilitators of preventing STIs and BBVs in community 
pharmacies in England, according to WOST and CPs? 
4. What could the main characteristics of a sexual health service for WOST in community 
pharmacies in England be? 
 
The main aim of this PhD was to explore the opportunity of designing and implementing a 
sexual health service for WOST in community pharmacies in England.  
The objectives of this research were: 
1. To identify and explore the factors associated with the heightened risk of sexual 
transmission of STIs and BBVs among WOST (i.e., factors associated with condomless 
sex and uptake of sexual health services). 
2. To explore the needs of WOST in relation to STI and BBV prevention. 
3. To explore the potential role of CPs in preventing the sexual transmission of STIs and 
BBVs among WOST. 
4. To offer initial recommendations for the design of a sexual health service for WOST in 









CHAPTER 2. Methodology 
The main aim of this PhD was to explore the opportunity of designing and implementing a 
sexual health service for WOST in community pharmacies in England. This is to prevent the 
transmission of STIs and BBVs among WOST. This chapter describes the research philosophy and 
research design for this PhD research. It also includes a reflexivity piece that serves as an introduction 
for the following chapters of this thesis.   
2.1. Research Philosophy 
 Philosophy is embedded in research as a system of beliefs and assumptions. These can be in 
relation to human knowledge (epistemological assumptions), the nature of social realities (ontological 
assumptions), and the influence of the researchers’ values in research (axiological assumptions) 
(Saunders, Lewis, & Thornhill, 2016). Research methodology, strategies, data collection and analysis 
are dependent on philosophical positions. Research is then neither detached from the researchers’ 
views of the world nor isolated from existing social realities (Bryman, 2016).  
2.1.1. Epistemological and Ontological Considerations 
Epistemology addresses the question of what can be considered knowledge. The main 
epistemological debate in social sciences is whether the principals, procedures and ethos of research 
in natural sciences should be applied to study the social world. Positivism and realism are 
epistemological positions that advocate for the use of the natural sciences research approach to social 
sciences (Bryman, 2016). These aim at explaining human behaviour as an external reality, that is 
separate to the descriptions and interpretations that can be inferred from it. It also assumes that there 
is one reality that can be measured. On the other hand, interpretivism aims at understanding human 
behaviour through people’s constructed meanings of a “perceived reality” (Von Wright, 1971). 
Interpretivism has its roots in the hermeneutic-phenomenological approach, which appeared as a 
critique to the positivist tradition. This approach offers an empathetic understanding of the social 
world in which the meanings of experience are understood from the social actor’s perspective. 
Interpretivism assumes that our social world (and research data) are the result of interpretations. 
According to this epistemological position, there are three levels of interpretation in social research. 
The first refers to the interpretations made by the researcher in relation to a social scientific frame. 
The second are the interpretations (of interpretations) made by the researcher, often labelled the 
“double hermeneutic”. The third level of interpretation describes the researcher’s interpretations in 
relation to the concepts, theories, and literature (Bryman, 2016; Schutz, 1962; Von Wright, 1971).  
 Ontology is the philosophical study of what constitutes reality. Ontology in social research is 





entities and “reality” are of an objective nature and external to social actors (objectivism), or “reality” 
is subjective and socially constructed by social actors (constructionism) (Bryman, 2016).  
This study adopted a pragmatic approach to epistemology and ontology. Pragmatism emerged 
as an alternative to the positivism/constructivism dualism. It is concerned about practical applications 
and solutions to research, and it is a common approach in mixed-methods research (Creswell, 2014; 
Tashakkori & Teddlie, 1998). A pragmatic approach also implies acknowledging that research occurs 
within social, historical, political and cultural contexts. Pragmatism was considered to be the most 
appropriate approach for this PhD as it offered the flexibility and freedom to choose the methods and 
procedures that were most relevant for each stage of the study. Also, as its focus on context fits with 
the values and principles of this research (see Axiological Considerations section, page 13).  
On one hand, this PhD research adopted an interpretative/constructivist approach as it aimed 
to understand participants’ constructed meanings of their own experiences. It considered social 
“reality” to be dynamic, in constant change, and shaped by the interpretations and constructed 
meanings of social actors. This study took an interpretivist approach as an acknowledgment of the 
need for interpretation (or hermeneutics) in research, especially when using qualitative methods 
(Willig, 2017). Interpretation does not only allow to give meaning to research data. Interpretation is 
also a means to “give voice” to those in situations of social and research exclusion, such as WOST. 
For this PhD, it was vital that WOST and CPs were main drivers of the research so that the research 
findings reflected the participants’ subjective realities. This was thought to lead to a fairer 
representation of the needs and experiences of WOST and CPs. 
On the other hand, this PhD research included a systematic literature review and the use of 
systematic and “directed” methods of qualitative analysis – Qualitative Content Analysis (QCA) (H. 
F. Hsieh & Shannon, 2005) –. Conducting a systematic literature review involved reporting quality in 
terms of inter-rater reliability to validate the screening process for the inclusion and exclusion of 
publications. It also comprised a series of systematic steps that were based on a set of inclusion and 
exclusion criteria (see page 19). This is rather a positivist/objectivist perspective to research, as it 
considers that knowledge and reality are objective and measurable. Using QCA (see page 28) was 
rather a deductive approach to qualitative data analysis, which fits more with positivism and 
objectivism. 
2.1.2. Axiological Considerations 
 Axiology refers to the influence of the researchers’ values in the research process. This 
involves research design, data collection, data analysis (and interpretation), and write-up and 
presentation of the data (Bryman, 2016). All human beings hold values, and researchers are not an 





Reflexivity was an important part of this research and serves as an exercise to recognise the impact of 
the researchers’ values throughout the research process (see Reflexivity section, page 42). The core 
values that shaped this study were feminism, equity and human rights. Despite being distinct values, 
these intersect with each other. These values became essential to this research through periods of 
reflexivity and the researcher’s personal values and experiences. 
2.1.2.1. Feminism and Feminist Research 
Feminism is not just about women. Feminism is about humanity and human rights. In her 
essay “Men Explain Things to Me”, Rebecca Solnit recalls Marie Sheer’s bold definition of feminism: 
“feminism is the radical notion that women are people” (Solnit, 2014). Feminism is a social, political 
and economic movement rooted in the belief that all human beings should be treated with equity, and 
the same freedom and justice. Thus, feminism concerns both women and men, and should not be 
understood as a fight against men, but instead a fight for equity, freedom and justice. Feminist 
research follows three main principles: (1) opposition to dualist thinking, (2) embracing process 
thinking, and (3) a focus on promoting and studying change (Ferguson, 2017; C. Hughes, 2002).  
According to feminist thinking, dualism is a simplification of the complexity of humans and 
the world, and leads to the development of hierarchies and power imbalances (e.g., between women 
and men). Thus, feminist research rejects the idea of constructing dualist conceptualisations of 
“reality”. Instead, it encourages the study of complexity and invites researchers to interpretivism 
(Ferguson, 2017; C. Hughes, 2002).  
Process thinking recognises the social world as dynamic and ever changing. Process thinking 
is concerned about the influence of historical processes and relationships between social elements into 
constructing “reality”. This links with the refusal of essentialism – a philosophical concept that 
ascribes the innate existence of realities and universal validity of essence – as it limits gender 
differences as innate (and unchangeable) (Ferguson, 2017; Sayer, 1997). Thus, instead of taking a 
determinist and biological reductionist perspective, feminist research embraces constructionism. 
Lastly, feminist research is activist research. Alongside feminist movements, feminist 
research takes action to reach equity, freedom and justice. This principle is essentially a fight for 
equity and human rights, which are the other core values of this research.  
2.1.2.2. Equity and Human Rights 
Equity is an ethical concept rooted in distributive justice (Braveman & Gruskin, 2003b). 
Inequity results from disparities in political, social and economic power experienced by different 





are grounded in inequalities associated with gender, ethnicity or race, disability, health status, poverty, 
and other factors associated with a lack of social power. Health equity is a human rights issue 
(Braveman & Gruskin, 2003b; Castillo, Garrafa, Cunha, & Hellmann, 2017; Fox & Meier, 2009; 
Friedman & Lawrence; United Nations, 1948). As stated in the Universal Declaration of Human 
Rights (United Nations, 1948), “Everyone has the right to a standard of living adequate for the health 
and well-being of himself (or herself) and of his (or her) family, including food, clothing, housing and 
medical care and necessary social services, and the right to security in the event of unemployment, 
sickness, disability, widowhood, old age or other lack of livelihood in circumstances beyond his (or 
her) control” (Article 25). This right, as all others in this declaration, are entitled to anyone “(…) 
without distinction of any kind, such as race, colour, sex, language, religion, political or other 
opinion, national or social origin, property, birth or other status” (Article 2). It is however unclear 
what the definition of “circumstances beyond his (or her) control” refers to in Article 25 of this 
declaration. This is a grey area as, following these premises, it is unclear whether behaviourally 
preventable health conditions (e.g., HIV) may be accounted for as situations “under” or “beyond” the 
individual’s control. Also, there are some aspects of a person’s identity that are not considered in 
Article 2, such as gender, sexual orientation and occupation. There is then a lack of clarity and even a 
gap in how universal human rights to health are defined. This research recognises the existing gaps in 
how health equity is defined, and the realities of the perpetuation of health inequities. It is an 
aspiration of this thesis to highlight existing health inequities and offer guidance to address them, to 
reach equity and ensure fundamental human rights.  
2.1.3. Research Approach and Theory Development 
This study mostly followed an inductive approach to the relationship between theory and 
research, as generating knowledge and theory development were the intended outcomes of the 
research. Inductivism differs from a deductive approach, which seeks to conduct research based on 
theory and the hypotheses deduced from it (Bryman, 2016). The ability and validity of inductive 
research to generate theory has been criticised, especially as inductivism assumes that theoretical 
statements can be inferred from singular “observational statements” (Bendassolli, 2013). However, 
inductive and deductive approaches should be understood as tendencies rather than opposed and 
distinct strategies. This research also included a certain degree of deduction, as previous theory and 
knowledge informed the research design. Understanding inductive and deductive research within a 
continuum, this study was centred in a more inductive style of thinking. This was because of the 
explorative nature of this study, which aimed at generating conclusions and contributing to theory 
building. Besides, taking an inductive approach facilitated a more open analysis and interpretation of 
the data whilst still considering the epistemological, ontological and axiological facets of this piece of 





based on the needs for the research and the nature of the data. This allowed for a more structured 
analysis that complemented other data from this research.  
2.2. Research Design 
This PhD is composed of two different studies to inform the development of a sexual health 
service in community pharmacies for WOST. Study 1 aimed to review the literature to identify 
factors associated with the risk of STIs and BBVs among women using heroin and other drugs 
(WHOD) (see page 19). Study 2 was a qualitative study that aimed to 1) explore the factors 
associated with the risk of STIs and BBVs among WOST, 2) explore the needs of WOST in relation 
to STI/BBV prevention, 3) explore the role of CP preventing STIs and BBVs among WOST, and 4) 
offer initial suggestions for the design of a pharmacy-based sexual health service for WOST (see page 
22).  
2.2.1. Service Design: an Intervention Mapping Approach  
To date, public health strategies to prevent STIs and BBVs among WOST and other PWUD 
have primarily taken an expert-led approach, which have not included the participation of community 
members in the programme planning process. They have often perpetuated the “blame culture” 
towards PWUD (Pickard, 2017). Participatory action and partnership with the potential service users 
and deliverers of a health service can facilitate and benefit the development of health promotion 
programmes (Israel, Schulz, Parker, & Becker, 1998; Israel et al., 2008). Involving service users and 
deliverers may also help address blame and stigma towards PWUD, as a participatory design would 
involve developing health services that are more committed to their needs (rather than focus on health 
promoters’ needs).  
Given that complex phenomena requires from complex action, it seems relevant to adopt a 
Social-Ecological Framework (Bronfenbrenner, 1979, 1994; McLeroy, Bibeau, Steckler, & Glanz, 
1988; Stokols, 1992, 2003), to capture psychosocial and socio-structural factors associated with 
STI/BBV risk and promoting sexual health among WOST (Baral, Logie, Grosso, Wirtz, & Beyrer, 
2013; Degenhardt et al., 2010; El-Bassel, Terlikbaeva, & Pinkham, 2010; Wellings et al., 2006).  
Intervention Mapping (IM) is an approach to the planning of health promotion programmes 
(Bartholomew Eldredge et al., 2016) that has informed the research design and process of this PhD. 
This approach is a systematic tool that has been widely used worldwide. It is founded on four main 
principles: 1) theory and evidence as crucial to service development, 2) ecological models and 
systems thinking (Simons-Morton, Simons-Morton, Parcel, & Bunker, 1988), 3) participation in 
health promotion planning (i.e., it advocates for a participatory-based design), and 4) ethical practice 





main reason to use IM over other frameworks, such as the Behaviour Change Wheel (S. Michie, 
Atkins, & West, 2014; S. Michie, van Stralen, & West, 2011). As with any other approach, IM has 
limitations: IM is a complex, time consuming and expensive process (Kok, Lo, Peters, & Ruiter, 
2011; G. Kok et al., 2011; Lloyd, Logan, Greaves, & Wyatt, 2011; Oosterom-Calo, Te Velde, Stut, & 
Brug, 2015).  
Table 1 












Step I. Logic Model of the Problem 
 Establish and work with a planning group 
 Conduct a needs assessment and create a 
Logic Model of the Problem 
 Describe the context for the programme 
 State the programme goals 
Step II. Programme Outcomes and 
Objectives – Logic Model of 
Change 
 State expected outcomes  
 Specify performance objectives 
 Select determinants for outcomes 
 Construct matrices of change objectives 
 Create a Logic Model of Change 
Step III. Programme Design  Generate themes, components, scope and 
sequence of the programme 
 Choose theory- and evidence-based 
change methods 
 Select or design practical applications to 
deliver change methods 
Step IV. Programme Production 
 Refine the structure and organisation of 
the programme 
 Prepare plans for programme materials 
 Draft messages, materials and protocols 
 Pre-test, refine and produce materials 
Step V. Programme 
Implementation Plan 
 Identify potential programme users 
 State outcomes and performance 
objectives for using the programme 
 Construct matrices of change objectives 
for using the programme 
 Design implementation interventions 
Step VI. Evaluation Plan  
 Write effect and process evaluation 
questions 
 Develop indicators and measures for 
assessment 
 Specify the evaluation design 






Note. From Planning Health Promotion Programs: An Intervention Mapping Approach (p. 13), by 
Bartholomew Eldredge et al., 2016, San Francisco, California: Jossey-Bass. Copyright [2016] by John Wiley & 
Sons, Inc. Adapted with permission (see Appendix 1). 
The IM approach provides a step-by-step guide on developing health promotion programmes 
that consists of six steps. Each step includes several tasks (see Table 1). The general aims of each step 
are summarized below: 
1. To conduct a needs assessment or problem analysis, identifying what, if anything, needs to be 
changed and for whom (Step I). 
2. To create matrices of change objectives by combining (sub-)behaviours (performance 
objectives) with determinants, identifying which beliefs should be targeted by the intervention 
(Step II). 
3. To select theory-based intervention methods that match the determinants into which the 
identified beliefs aggregate, and translate these into practical applications that satisfy the 
parameters for effectiveness of the selected methods (Step III). 
4. To integrate methods and the practical applications into an organized program (Step IV). 
5. To plan for adoption, implementation and sustainability of the program in real-life contexts 
(Step V). 
6. To generate an evaluation plan to conduct effect and process evaluations (Step VI). 
Due to the time constraints and financial limitations, this PhD includes Step I and Step II of 
the IM approach (see Table 1). Recommendations for the future design of the service are available in 
Chapter 9.   
2.2.1.1. Step I. Conducting a Needs Assessment: a Logic Model of the Problem 
 Following the IM approach, the main aim of Step I was to develop a Logic Model of the 
Problem (see Figure 1). This model included the factors associated with the risk of sexual 
transmission of STIs and BBVs among WOST, and their impact on health outcomes and quality of 
life (see Chapter 6). Step I consisted of four tasks. These are detailed below: 
2.2.1.1.1. Task I. Establishing and working with a planning group. A team of 
researchers was involved in this study. The principal investigator (PI) (LMP) was supervised by the 
other researchers in the team (HF, CD, JS, SC, JB). Both WOST and CPs were involved in the needs 
assessment and the development of initial ideas for the design of the sexual health service. 
Stakeholders, mental health professionals, nurses, social workers, and feedback from other researchers 





involved in designing the materials for the study (e.g., interview topic guides), and acted as 
gatekeepers to recruiting WOST and CPs. Meetings with an advisory group in London, composed by 
ex- and current alcohol and drug users informed the design and materials for Study 2.  
2.2.1.1.2. Task II. Planning and conducting the needs assessment. As already 
mentioned, one of the main aims of Step I was to plan the needs assessment and to develop a Logic 
Model of the Problem (see Figure 1) (Bartholomew Eldredge et al., 2016; Gilmore & Campbell, 
2005). The Logic Model of the Problem is a conceptual model that includes the factors associated 
with the risk of sexual transmission of STIs and BBVs among WOST. The PRECEDE model (Green 
& Kreuter, 1991, 1999, 2005) was used as a framework to develop the Logic Model of the Problem. 
The PRECEDE model identifies the factors associated with a health problem at multiple ecological 
levels, accounting for determinants of health, individual and socio-structural factors, the definition 
and characteristics of health outcomes, and the impact on quality of life. This involves identifying and 
exploring the factors associated with a health problem (e.g., incidence of STIs and BBVs), often 
among a certain population group (e.g., WOST). These are then related to quality of life. The Logic 
Model of the Problem for this study was developed using the data from Study 1, Study 2 and previous 




Figure 1. Logic Model of the Problem. From Planning Health Promotion Programs: An Intervention 
Mapping Approach (p. 227), by Bartholomew Eldredge et al., 2016, San Francisco, California: 
Jossey-Bass. Copyright [2016] by John Wiley & Sons, Inc. Adapted with permission (see Appendix 
1).  
2.2.1.1.2.1. Study 1. Factors associated with sexual risks and risk of STIs, HIV and other 
blood-borne viruses among women using heroin and other drugs: A systematic literature 
review 
Study 1 was a systematic literature review that aimed to review the literature on the risks of 
sexual transmission of STIs and BBVs among WHOD. This study was carried out from May 2016 
until July 2017. Several sources were used to design this study (Centre for Review and Dissemination, 
2016; Denyer & Tranfield, 2009; Lacey, Jesson, & Matheson, 2011; Moher, Liberati, Tetzlaff, 
Individual 













Altman, & The PRISMA Group, 2009; Torgerson, 2003), including meetings with librarians at the 
University of Bath, academics and other PhD students with experience conducting systematic 
literature reviews. A set of criteria was developed to guide the screening and include/exclude 
publications (see Table 2).  
Table 2  
Inclusion and Exclusion Criteria of Publications 
Inclusion Criteria Exclusion Criteria 
1. English language 
 
1. Other language than English 
2. Published between 1995 and end of June 
2016 
 
2. Reviews (including books) 
3. Including female participants 
 
3. Including male participants only 
4. Heterosexual or women who have sex with 
women participants 
 
4. Including non-heroin drug use only 
5. Participants are at least 18 years old 
 
5. Focusing on the consequences of sexual risks 
only 
6. Including heroin use, or heroin use in 
combination with other drugs 
 
6. Focusing on the physiology, chemistry, 
pharmacology or biology of sexually 
transmitted infections or blood-borne viruses 
7. Qualitative or quantitative studies 
 
7. Studies including epidemiological data only 
8. Including factors associated with sexual risks 
 
8. Studies evaluating a service only (e.g. harm 
reduction services, needle exchange 
programmes) 
 9. Focusing on the effectiveness of an 
intervention/treatment only 
 10. Focusing on drug needle (or paraphernalia) 
sharing, or harm reduction strategies only 







Study 1 was divided in six phases: 
Phase I. Data searches (May 2016 – June 2016). Systematic searches were carried out in five 
databases: PubMed, EMBASE, PsycNET, Web of Science and Scopus. PsycEXTRA (within 
PsycNET) was used to search for grey literature. Search terms included were “women”, “sexual 
behavior*”, “heroin use*” and “HIV”. Publications had to be written in English and dated from 1995 
until the end of June of 2016. All publications were saved in an EndNote file. The number of records 
identified was 12,135. 
Phase II. Title screening (July 2016). The titles of all publications were screened based on 
the inclusion/exclusion criteria (see Table 2). Titles of 11,923 publications were screened.   
Phase III. Abstract Screening (July 2016 – August 2016). The abstracts of all titles included 
after Phase II were screened based on the inclusion/exclusion criteria (see Table 2). The abstracts of 
971 records were screened. 
Phase IV. Full-text screening (August – October 2016). Full-text screening was conducted 
for all titles included after Phase III, using the inclusion/exclusion criteria (see Table 2). Publications 
included after Step IV were as well screened. A total of 321 publications were screened in Phase IV. 
All references of included publications were screened. One publication was added at this stage. Thirty 
publications were included in this systematic literature review after full-text screening. 
Phase V. Quality assessment (November 2016 – December 2016). The quality of all 
included titles were assessed using the Standard Quality Assessment Criteria for Evaluating Primary 
Research Papers from a Variety of Fields (Kmet, Lee, & Cook, 2004). PRISMA 2009 guidelines 
(Moher et al., 2009) were used to assess the quality of the systematic literature review. No 
publications were excluded for quality reasons. This systematic literature review was registered with 
PROSPERO International prospective register of systematic reviews (PROSPERO 2016: 
CRD42016039842). 
Phase VI. Data extraction & analysis (January 2017 – July 2017). Data from the 30 
publications were extracted and analysed according to the aims of this study and the 
inclusion/exclusion criteria (see Table 2).  
Searches, screening of all titles, qualitative assessment, data extraction and analysis, and 
research dissemination were carried out by the PI (LMP). Two supervisors (CD, HF) screened 10% of 





discussed. Cohen’s Kappa calculations indicated a moderate and acceptable degree of agreement (k = 
.5) (Altman, 1991).  
This study was published online in the peer-reviewed journal AIDS & Behavior on 2
nd
 of 
August 2018. See publication in Chapter 3. 
2.2.1.1.2.2. Study 2. Design of a sexual health service for women on opioid substitution 
treatment in community pharmacy 
Study 2 was a qualitative cross-sectional study, comprised by two phases. In Phase I, semi-
structured face-to-face interviews were conducted with 20 WOST and 14 CPs. In Phase II, three focus 
groups were organised: two with WOST (N=4) and another one with CPs (N=3). Data on 
demographics, drug use and sexual health were collected from all participants using a non-
standardised questionnaire. This study was conducted in the areas of Bath, Midsomer Norton and 
Bristol (England, United Kingdom). Recruitment for Study 2 started on the 18
th
 of August of 2016. 
Data analyses finalised in April 2018. The PI designed this study, supervised by the research team. 
She also recruited, collected and analysed all data. 
Participant recruitment 
Two groups of participants were recruited for Study 2: WOST and CPs. In the first stage of 
the study, participants were recruited to take part in semi-structured face-to-face interviews with the 
PI. In the second stage, participants were asked to take part in a focus group. The inclusion and 
exclusion criteria for WOST and CPs are presented in Table 3 and Table 4 respectively.  
Table 3  
Inclusion and Exclusion Criteria of Women on Opioid Substitution Treatment 
Inclusion criteria Exclusion criteria 
Female sex Male sex 
Be at least 18 years old or older Be under 18 years old 
Be currently receiving, or have previously 
received, opioid substitution treatment 
Not having received opioid substitution treatment 





Be able to communicate fluently in English 
Not being able to communicate fluently in 
English 
Table 4  
Inclusion and Exclusion Criteria of Community Pharmacists 
Inclusion criteria Exclusion criteria 
Be a community pharmacist and have worked in 
community pharmacy 
Be a trainee pharmacist 
To be currently providing, or have previously 
provided, opioid substitution treatment 
Not having delivered (ever) opioid substitution 
treatment 
Be able to provide consent Not able to provide consent 
Be able to communicate fluently in English Not able to communicate fluently in English 
After the interviews, all participants were asked whether they would like to be contacted in 
the future to know more about the study and potentially take part in the focus groups. Contact details 
(phone numbers and email addresses) were retained for all CP. Only a few WOST gave their contact 
details (phone numbers). This made it challenging to contact WOST directly.  
Recruitment strategies were different for the two groups of participants. Oral and written 
information (see Appendices 2 and 3) about the study was provided to all potential participants, to 
introduce the study and allow participants to make an informed decision on whether they wanted to 
participate in the study. All potential participants were given the space and time to ask questions and 
express concerns regarding their participation. Oral and written consent was requested from all 
participants before taking part in the study (see Appendices 4 and 5).  
Recruiting WOST. Recruitment was venue-based, a useful sampling method for recruiting 
hard-to-reach populations (Muhib et al., 2001; Raymond et al., 2010; C. Thomas & Freisthler, 2016; 
Weir et al., 2012). Recruitment was mostly opportunistic, although services’ staff helped identifying 
women for the study. Recruitment of WOST was carried out in four drug services and a service for 
sex workers. Two drug services were located in Bath, one in Midsomer Norton and the forth one in 
Bristol. The service for sex workers was located in Bristol. Recruitment efforts were also placed in 





Once ethical approvals were received (see Ethical Considerations, page 37; see Appendices 6 
and 7), Clinical Commissioning Groups (CCG) in Bath and Bristol were contacted. Also, the Avon 
and Wiltshire Mental Health Partnership (AWP) was approached to assist with recruitment 
procedures. Commissioners at the local CCGs provided the contact details of the main sexual health 
services and drug services in the area, and also of a service for sex workers
6
. Meetings with drug 
services’ teams and commissioning groups were organised to give information about the study. Once 
drug services gave their approval to recruit participants and run the study in their premises, participant 
recruitment started. Communication with the service for sex workers and sexual health services was 
over email and phone calls. Recruitment posters (see Appendix 8) were placed in sexual health 
services and follow-up calls were made to get feedback about the recruitment progress. No 
participants were recruited in sexual health services due to the challenges to identify WOST in 
services for the general population. One participant was recruited at the service for sex workers.  
An application was made to use the “Everyone included” method by AWP. Through using 
this system, AWP service users got routinely informed about relevant research opportunities by post, 
unless an individual expresses a preference not to receive information in this way. When using this 
method, the recruitment process was slightly different. First, AWP identified potential participants 
from drug and sexual health services and sent an introduction letter. If the service user was interested 
in obtaining more information about the study, AWP sent a “Research Opportunity Letter” to invite 
them into the study. Those service users still interested in participating then contacted the PI, in order 
to obtain further information about the study and potentially participating. No participants were 
recruited using this method.  
Drug services in Bath and Midsomer Norton. Drug services’ staff served as gatekeepers to 
recruiting participants. On some occasions, staff identified eligible women for the study and gave 
information to them. If women expressed interest in the study, staff would inform the PI. She then 
attended the drug service on the day and time that the potential participant had her next appointment 
at the drug service. On other occasions, the PI spent entire days in the drug services. First, staff 
identified WOST. Then the PI introduced the study to women. Recruitment posters (see Appendix 8) 
and participant information sheets (see Appendix 2) were available at waiting and consultation rooms 
in the drug services.  
Service for sex workers. After receiving approval from the service, the PI attended the 
service’s drop-in three times. During these visits the PI interacted with service users attending the 
drop-in and gave information about the study to some of them. One woman agreed to take part in the 
                                                             
6 Even though the term “transactional sex” is used in this thesis (see Chapter 1, page 7), this service was for any 






study. The interview took part in the service. After the third visit to the drop-in, the PI considered that 
it was too intrusive for women attending the service to be given information and asked to take part in 
the study. This service was the only place where women attending felt safe, so it seemed unethical to 
“ask for omething” from them in that context. Participants were no longer recruited from this service. 
The research team and service’ staff agreed with this decision.  
Drug service in Bristol. Recruitment for the focus groups took place in a drug service in 
Bristol. The service staff disseminated information (oral and written) about the study (see Appendix 
2) to potential participants. Three sessions for the focus groups were arranged at the drug service right 
after a women group session. No participants took part in the first session. One participant attended 
the second session. Despite not being a focus group per se, data were still retained. The reasons for 
this were: ethical considerations and the value of the data. The third session was successful as three 
women attended, so a focus group was run. 
Overall, recruiting WOST was a challenge. An approximate of 75 WOST were approached to 
participate in the study by the PI. It is unknown the exact number of women who were informed about 
the study by the services’ staff and AWP. Even just considering the 75 women directly approached by 
the PI, nearly ¾ of women declined (N = 55; 73,3%). The number of women who refused to take in 
the study is however considerably higher. The potential barriers to recruitment identified were: (1) 
lack of time and other priorities; (2) unwillingness to discuss sexual health-related topics (e.g., 
violence); (3) fear of stigma; (4) chaotic lifestyle; (5) being intoxicated at the time of recruitment; (6) 
feeling physically and/or emotionally unwell at the time of recruitment; and (5) distrust in the 
research/researcher and/or services’ staff (e.g., breach of confidentiality or anonymity).  
 
Recruiting CPs. First, invitation letters (see Appendix 9) were sent to superintendent 
pharmacists, pharmacy owners and/or pharmacy managers of community pharmacies in the areas of 
Bath and North East Somerset and Bristol. The purpose of these letters was to give information about 
the study and to request permission to contacting and recruiting CPs working in their pharmacies. 
Where permission was not granted by pharmacy leaders, CPs were still allowed to participate outside 
of working hours and in an individual capacity. Pharmacy leaders did not help to identify individual 
CPs eligible for the study. Platforms such as Local Pharmaceutical Committees, the Western 
Pharmacy Forum, the Pharmaceutical Services Negotiating Committee, and Twitter were used to 
advertise the study and recruit CPs (see Appendix 10). No participants were recruited through these 
platforms. 
As with recruiting WOST, the CCGs facilitated the contact with community pharmacies. Staff 
at drug services were also useful in providing the contacts of CPs. On the other hand, the PI searched 





recruitment. Recruitment packs were posted by mail to the community pharmacies identified. These 
packs contained an invitation letter (see Appendix 9), the participant information sheet (see Appendix 
3) and contact details of the research team. No CPs responded to these letters. Follow-up phone calls 
were made to contact CPs directly. Further follow-up calls and emails were sent to those CPs who 
expressed interest in the study. If still interested in taking part, a suitable time and place was agreed to 
carry out the interview. All participants were asked whether they would like to be contacted to take 
part in the focus group. Those interested were reached via email and phone to take part in the focus 
group.  
 
Recruiting CPs was not as challenging as for WOST. The PI contacted 94 community 
pharmacies. Fourteen CPs agreed to the interviews (refusal rate 85,1%). Even though the refusal rate 
was still high among CPs, the time invested in recruiting CPs was considerably lower compared to the 
recruitment of WOST. Three CPs who had already taken part in the individual interviews participated 
in the focus group. Barriers to recruiting CPs identified were: 1) lack of time and other priorities; and 
2) lack of interest in the study/research. 
Procedure and data collection 
Data collection methods for this study were semi-structured interviews (Phase I) and focus 
groups (Phase II). All participants were asked to complete a brief non-validated questionnaire after 
taking part in an interview (Phase I) or focus group (Phase II). There were two versions of the 
questionnaire, one for WOST (see Appendix 11) and a second one for CPs (see Appendix 12). The 
questionnaire for WOST included questions on demographics, drug use (and opioid treatment), and 
sexual and reproductive health history. The version for CPs included questions on demographics, the 
community pharmacy they worked at, and their job role as providers of opioid treatment. These data 
were collected to describe the sample for Study 2. The design of the questionnaire was based on 
previous literature, and inputs from the research team and other researchers that were external to this 
study.  
Oral and written consent (see Appendices 4 and 5) was required from all participants before 
taking part in the study. The PI made sure that all participants made informed decisions by providing 
oral and written information about the study timely. The opportunity to ask questions and express 
concerns was given to all participants before they agreed to take part in the study. The interviews and 
focus groups were audio recorded, with the consent of the participants. Twenty-eight interviews were 
transcribed verbatim by the PI, and six interviews by employed transcribers at the University of Bath. 
Focus groups were transcribed by student volunteers and employed transcribers at the University of 





all participants after taking part in the study. Refreshments were available during the interviews and 
focus groups. 
Phase I. Semi-structured interviews. Thirty-four individual face-to-face semi-structured 
interviews were conducted [(N=20); CP (N=14)] by the PI. Two different topic guides (one for 
WOST, and another for CPs) were developed for the purposes of this study. Previous literature, the 
research team’s expertise in the area, and inputs from an advisory group, stakeholders, and drug 
services’ staff (mental health professionals, nurses, social workers) informed the development of the 
topic guide for WOST. The topic guide for CPs was devised based on previous literature, inputs from 
the research team and feedback from other researchers in the area. See Appendices 16 and 17 for 
interview topic guides.  
Interviews with WOST. The aims of the interviews with WOST (N=20) were to explore and 
understand 1) the factors associated with the risk of sexual transmission of STIs and BBVs; 2) 
women’s knowledge, risk perceptions, beliefs and attitudes towards STIs and BBVs; 3) women’s 
experiences in community pharmacy in relation to their opioid substitution treatment; 4) women’s 
relationships and attitudes towards CPs; 5) women’s acceptability and views on a sexual health 
service in community pharmacy alongside their opioid treatment; and 6) women’s ideas for the sexual 
health service.  
 The interviews were conducted by the PI over a period of seven months (October 2016 – 
April 2017). The interviews with WOST lasted between 25 and 80 minutes. Nineteen interviews took 
place in drug services and one in the service for sex workers.  
 Interviews with CPs. The aims of the interviews with CPs (N=14) were to explore and 
understand 1) pharmacists’ experiences providing opioid treatment; 2) pharmacists’ relationships and 
attitudes towards WOST; 3) pharmacists’ views on the provision of health promotion services; 4) 
pharmacists’ perceived factors associated with the risk of sexual transmission of STIs and BBVs 
among WOST; 5) pharmacists’ acceptability and views on a sexual health service in community 
pharmacy for WOST; 6) pharmacists’ ideas for the sexual health service; and 7) pharmacists’ training.  
 The PI conducted the interviews with CPs during a period of seven months (September 2016 
– March 2017). The duration of the interviews with CPs ranged between 30 and 90 minutes. Seven 
interviews were conducted at the University of Bath, six at the community pharmacy where the 
participant worked, and one at a café.  
  Phase II. Focus groups. The main aims of running the focus groups was to further explore 
and understand 1) the factors associated with the risk of sexual transmission of STIs and BBVs among 





barriers for the design and implementation of the sexual health service; and 4) ideas for the service 
design. Also, focus groups were a method for respondent validation (see page 35). The discussion was 
initiated with both groups by informally presenting the data from the interviews of WOST (in focus 
groups with WOST) and CPs (in focus groups with CPs), using power point presentations. Topic 
guides were devised based on the data from the interviews (see Appendices 18 and 19). 
Separate focus groups with WOST and CPs were run. Two focus groups were run with 
WOST. Only one participant attended the first session; data were still retained. Three WOST took part 
in a second session. One focus group was run with CPs (N=3). These CPs had already participated in 






 of September 
2017, and the focus group with CPs was on the 21
st
 of September 2018. They took place in a drug 
service in Bristol and at the University of Bath, respectively. 
Data Analyses 
Semi-structured interviews. The interviews’ data were analysed using Framework Analysis 
(FA) (Barnard, 2010; Ritchie, Lewis, McNaughton Nicholls, & Ormston, 2014; Ritchie & Spencer, 
1994) by the PI and managed using NVivo 10 software. The FA method was developed by the UK 
National Centre for Social Research and aims to classify and organise data according to key themes, 
to develop a hierarchical thematic framework (Ritchie & Spencer, 1994). FA is a case and theme-
based approach as it creates matrices combining data from individual participants and themes across 
participants. In addition, it identifies main themes and themes subdivided by related subtopics in order 
to offer an explanatory analysis (Barnard, 2010). Contrarily to other methodological approaches, FA 
manages summarised data rather than “raw” or original data. However, each summary retains the link 
to the original data, and the language used by the participants.  
The key features of FA are 1) grounded or generative, as it is driven by the original views and 
interpretations of the participants; 2) dynamic, as it is a flexible and iterative process; 3) systematic, as 
it is a methodical method of analysis; 4) comprehensive, as it provides a full review of the data; 5) 
enables easy retrieval, as it allows researchers to retrieve and access the original textual data; 6) 
allows between- and within-case analysis, as it enables an analysis of the data for each participant and 
across participants; and 7) accessible to others, as the analysis is transparent enough so that it can be 
revised by other researchers (Ritchie & Spencer, 1994).  
As with all qualitative analysis methods, FA has advantages and disadvantages. FA is a 
systematic, comprehensive and transparent method that focuses on ordering data aiding question-
focussed analyses. It also provides the opportunity to identify relevant data from each participant, and 





display of diversity and avoidance of bias. Among the limitations, using FA is a highly time 
consuming and a laborious task. Moreover, it is important to take a critical and reflexive perspective 
in order to focus on the outcome instead of the process of FA (Barnard, 2010; Ritchie et al., 2014; 
Ritchie & Spencer, 1994). FA was used because it is a structured, but dynamic and flexible method. 
FA is not aligned with a particular theoretical and/or epistemological approach, which allows for a 
bottom-up (although deductive) analysis of the data, and potentially a more in-depth and unbiased 
data analysis (Gale, Heath, Cameron, Rashid, & Redwood, 2013).  
Other methods of analysis were considered, such as or interpretative phenomenological 
analysis (IPA) (J. A. Smith, 1996) or thematic analysis (TA) (Braun & Clarke, 2006). IPA was 
considered as it could offer a deep exploration of the experiences of both WOST and CP, based on the 
participants’ particular experiences and interpretation. Despite using IPA could have been an option 
for this study, FA was deemed more suitable due to its focus on intervention development. Also, IPA 
is commonly used in a homogeneous sample (Shinebourne, 2011; J. A. Smith, 1996; J. A. Smith, 
Flowers, & Larkin, 2009; Willig, 2013). Even though participants in this study pertained to specific 
groups (e.g., WOST) and had common experiences, there were still a heterogeneous group (e.g., some 
women engaged in transactional sex while others did not). Also, IPA has been criticised for being 
ambiguous and lacking standardisation (Tuffour, 2017), which may compromise transparency in the 
analysis process. In contrast, FA offers clarity and is a systematic but flexible method of analysis 
(Barnard, 2010; Ritchie et al., 2014; Ritchie & Spencer, 1994). On the other hand, TA is one of the 
most used methods for analysing qualitative data (Braun & Clarke, 2006). It is a useful approach to 
identify patterns (themes) within a dataset in order to describe experience. TA is a flexible and easy-
to-grasp method. However, it does not provide the in-depth analysis that was required for this piece of 
research. Besides and as for IPA, there have been concerns about the transparency and rigour of TA 
(Holloway & Todres, 2003; Nowell, Norris, White, & Moules, 2017). For the reasons stated, FA was 
chosen over other methods as the approach to analyse the semi-structured interviews in this PhD 
research.  
There are five stages to FA (Gale et al., 2013; Parkinson, Eatough, Holmes, Stapley, & 
Midgley, 2015; Ritchie & Spencer, 1994; J. Smith & Firth, 2011; Srivastava & Thomson, 2009): 
Stage 1. Familiarisation with the data. During and after the transcription process, the PI was 
familiarised with the content of the data, and gained an overview of the variety of views from the 
participants. Familiarisation with the data involved listening to the audio recordings, and writing and 
reading transcripts and research notes. Key ideas and recurrent themes were listed as part of Stage 1.  
Stage 2. Identifying a thematic framework. The data from all interviews was coded by the 





coding). Codes led to creating initial themes and subthemes to develop a thematic framework. 
Identifying this framework was also driven by the study aims and research questions. Stage 2 was not 
a mechanical or automatic procedure. Instead, it was an iterative process involving critical, analytical 
and holistic thinking. The thematic framework was modified several times, based on discussions with 
the supervisory team and after re-visiting the data. The process of refining the thematic framework 
ended when no more codes of themes/subthemes were generated or merged. The final thematic 
framework of WOST’s interviews included seven themes and 35 subthemes. The thematic framework 
of CPs’ interviews was comprised by eight themes and 21 subthemes.  
Stage 3. Indexing. Codes were “indexed” within themes and subthemes of the thematic 
framework. This process was done offline as it was more manageable given the high number of codes 
(see Figure 3). Original data was already linked to each code on the NVivo 10 software, so that 
original quotes from participants could be easily accessed in relation to codes and eventually themes 
and subthemes. 
Stage 4. Charting. Data were organised in charts, according to the themes and subthemes of 
the thematic framework. Seven charts were created for the women data, and eight for the pharmacists’ 
data. Charts were developed to include the original data (quotes) and the analysis/interpretation of the 
data (summary) for each and all participants. The interpretation of the data at this stage was focused 
on each participant and subtheme. As for previous stages of FA, charts were refined based on 
discussions with the supervisory team and after re-visiting interview data. See Figure 4 for an 
example of charting. 
Stage 5. Mapping and interpretation. Once all data was chartered, key characteristics of the 
data were mapped and interpreted across participants. Summarised data from each participant was 
revised and merged into a document, to synthesise and then interpret the data across participants for 
each theme and subtheme. Links to participants were maintained so that original data could be easily 
accessed. See Figure 5 for an example of this process. A final framework of themes and sub-themes 






Figure 2. Example of Interview Coding using NVivo 10 Software. 






Figure 4. Sample Chart using Framework Analysis.   





Focus groups. Data from the focus groups was analysed using QCA (H. F. Hsieh & Shannon, 
2005; S. Wilkinson, 2015). QCA can be defined as a method for subjectively interpreting the content 
of text through systematically classifying codes, themes and patterns (Downe-Wamboldt, 1992). The 
reason to use QCA to analyse the focus groups was because these data were collected to inform the 
analysis of the interviews, and to explore the emergence of new ideas from participants and guide 
Step II. Thus, it was decided that a more in-depth qualitative analysis was not required. The method 
used was a directed content analysis (H. F. Hsieh & Shannon, 2005), a deductive approach to 
conceptually extend the findings from the interviews. First, the transcripts were read and initial notes 
and impressions were made. Based on the data from the interviews and the topic guides for the focus 
groups, frameworks of codes were developed for each participant group (see Figures 6 and 7). These 
frameworks were used to code the focus groups transcripts. Codes were grouped into categories, and 
themes were identified based on the interpretation of the data. 
The directed content approach was adapted to allow for new themes to emerge from the data, 
and avoid restricting the findings to what was already originated from the interviews. Flexibility was 
also sought so that the use of QCA was suitable within the philosophy of research and approach to 
assessing quality already discussed in this chapter. Limitations to QCA were considered (H. F. Hsieh 
& Shannon, 2005; S. Wilkinson, 2015). The most significant limitation was related to the fact that 
data collection and analyses of the focus groups were based on the interviews’ data. This may lead to 
bias, as the data from the focus groups may have been shaped by what was already presented to the 
participants. Bias may then be more likely, as the data from the focus groups may be more aligned to 
the interview data and may miss capturing other relevant data. Other methods of qualitative analysis 
such as FA or IPA were discarded as a more in-depth analysis and inductive was not sought for the 
analysis of the focus groups. This was as the focus groups aimed to complement interview findings. 
Non-validated questionnaires. Data from the questionnaires was analysed using SPSS 
software. Descriptive statistics were used to describe the main characteristics of the research 





















Assessing the quality of qualitative research 
Research quality has traditionally been measured in terms of reliability and validity. 
Reliability refers to the consistency in the measurement. Validity serves as an indicator that the 
concept that wants to be measured is indeed measured (Bryman, 2016). Whereas measuring validity 
may be acceptable for quantitative research, some qualitative researchers have challenged the idea 
that the quality of qualitative research should be assessed in the same terms (Bryman, 2016; Guba, 
1985; Guba & Lincoln, 1994; Yardley, 2000, 2015, 2017). Alternative criteria for assessing quality in 
qualitative research have been proposed (Yardley, 2000, 2015, 2017). Sensitivity to context, 
commitment and rigour, coherence and transparency, and impact and importance are the core values 
for evaluating the quality of qualitative research according to this approach. 
Sensitivity to context. Being sensitive to the context refers to understanding previous 
literature and theoretical approaches to designing and conducting qualitative research. This also 
allows to consider the socio-cultural context, participants’ perspectives and ethical issues. This PhD 
research was sensitive to the context as it was supported by evidence and theory. It also emphasised 
the participants’ contributions by formulating open-ended questions and adapting the research to each 
individual participant. Considering the socio-cultural context was also key in this study. There were 
numerous ethical implications that were carefully considered, not only to ensure the quality of the 
research but to protect the participants’ wellbeing and rights (see page 37).  
Commitment and rigour. Using appropriate and solid theoretical and methodological 
approaches (thorough data collection procedures and in-depth analyses) and staying up-to-date with 
relevant literature were ways to ensure commitment and rigour in this research. The commitment and 
rigour of this research can be reviewed throughout this thesis and publications from this research (see 
Appendix 20).  
Coherence and transparency. Coherency refers to the consistency of the research as a 
whole. This was ensured by guaranteeing a good fit between the aims, methodology, theoretical 
approaches, data analyses and reporting of the findings. Transparency relates to the clarity and level 
of detail provided when describing research methods and presenting research findings. Transparency 
was attained by providing clear arguments and a detailed presentation of the methods and findings of 
this research. Reflexivity was also a key element for transparency as it allowed the PI to reflect on her 
experiences, especially of data collection and analysis (see page 42).  
Impact and importance. Qualitative research should promote change and increase 
understandings of phenomena. It was expected that this study could identify research gaps and inform 





attention towards social and health inequities experienced by a vulnerable group of women. Also, to 
highlight the limitations in accessing healthcare and lack of health services addressing the needs of 
this group of the population. This research was then set to have an impact and importance for 
research, policy and practice. To ensure impact and importance, the findings from this research have 
been presented at international and multidisciplinary conferences, and written for publication in peer-
reviewed journals (see Appendix 20).  
Triangulation, participant feedback, disconfirming case analysis, and paper trail were other 
main procedures to ensure the quality of qualitative research in this study (Yardley, 2000, 2015, 
2017).  
Triangulation. This PhD research used different methods for data collection (e.g. systematic 
literature review, semi-structured interviews and focus groups) and qualitative analysis (e.g. FA and 
directed QCA). This allowed different and more enriching perspectives to this research.  
Participant feedback. Using participant feedback on the research was ensured by engaging 
participants in focus groups to comment on the analysis of the interviews. Running these focus groups 
offered the opportunity to explore potential contradictions or variances in the perspectives of different 
participants.  
Disconfirming case analysis. Qualitative analyses involve finding patterns and themes in the 
data. However, it was also important to identify those cases that “did not fit” with these patterns and 
themes. Doing this broadened the scope of the analysis and offered a more consistent picture of the 
data. Disconfirming cases were acknowledged and reported where found in this PhD research. 
Paper trail. A paper trail is available for this study. This means that there are clear links 
between final reports, data analyses and raw data. All the stages of this PhD research have been 
documented, including field notes and diagrams that have informed the decision-making processes.  
Ethical Considerations 
This study required ethical approvals from the National Health Service (NHS) in England 
(UK). Ethical approval was received on 17
th
 of August 2016 (NHS Ethics: IRAS Id. 20570, REC 
16/NW/0432) (see Appendices 6 and 7). The University of Bath sponsored the NHS ethics 
application. Two substantial (see Appendices 21 and 22) and two non-substantial (see Appendices 23 
and 24) ethical amendments were submitted and approved throughout the research. 
Informed consent. Informed consent was required from all participants. This was requested 





Appendices 2 and 3) and fully understood what the research involved. The PI made sure that all 
participants were able to consent, and they understood the potential risks and benefits related to 
consenting to participating in the study.  
Oral and written consent was required and obtained from all participants in the study (see 
Appendices 4 and 5). Consent to audio record the interviews and focus groups was a requirement to 
participating in the study. Two participants requested assistance to read the research documents. 
These included the consent form and demographics questionnaire. In these cases, the PI read all 
research documents out loud while pointing out what she was reading. The PI then made sure that 
participants understood each statement and question.  
Risk and harm assessment. Taking part in the study involved the discussion of sensitive 
topics (i.e., sexual health, drug use, transactional sex, homelessness, experiences of violence, and 
other related topics), and involved the inclusion of a vulnerable group (i.e., WOST). Discussing 
sensitive topics and the inclusion of WOST were necessary for the purposes of this research. In order 
to minimise these issues, information about the content of the interviews and focus groups, as well as 
the nature of the study, were provided prior to seeking consent and before starting the interviews and 
focus groups. These were run sensitively at all times.  
There were no risks to confidentiality, no change of relationship with the healthcare 
professionals, and support was provided when needed. A protocol was prepared in case the PI had 
immediate concerns of harm, or a participant got distressed during their participation in the study. For 
WOST, the protocol included the PI seeking the participant's permission to contact their key worker 
and/or the service from which they were recruited from, if the PI had any immediate concerns that the 
participant may be at risk of harming herself or someone else. There were a few occasions in which 
the PI was concerned that the participant was being in a situation of GBV. In these cases, the PI asked 
participants whether they were getting support from their key workers or other professionals. All 
WOST who disclosed potential situations of GBV mentioned that they were already receiving 
support. Some WOST got distressed during their participation in the study. On such occasions, the PI 
gave participants the option to stop the interview or focus group. Even when participants agreed to 
continue, the interview and focus groups were stopped until the participant was ready to continue. 
External support was offered to all participants during their participation when appropriate (e.g., when 
disclosing experiences of GBV) and after their participation through debriefing forms (see 
Appendices 13-15) and verbal debriefs. Written debriefs included a list of local and free services for 
advice and support (e.g., for domestic violence and sexual health screening). This was particularly 






All participants were made aware of their right to withhold information that they were not 
willing to share, as well as withdrawing from the study or removing their data from the study at any 
time, prior to data analyses. Participants were given the opportunity to review the transcripts of their 
interviews and focus groups in which they participated, in order to improve the accuracy of the 
information given. None of the participants did however revise any of the transcripts. This was 
highlighted in the participant information sheet, and verbally explained before starting the interviews 
and focus groups.  
All participants received a £10 Love-to-Shop voucher for every time that they participated in 
the study as a token of thanks. Refreshments were provided in all research sessions. 
There were also risks of discussing sensitive topics for the PI. Appropriate support was made 
available when needed, though supervisory meetings and counselling services. Lone Working Policies 
from the University of Bath were applied when the PI collected data outside of the University 
premises and out of working hours.  
Confidentiality and anonymity. Data confidentiality was carefully ensured. Contact details 
were only requested to those participants who were interested in participating in succeeding steps of 
the study. Physical identifiable data was securely stored at the University of Bath in a locked cabinet. 
Digital information was securely stored at the University of Bath Unidesk portal (X drive). Only the 
research team had access to the data.  
Anonymised data were presented at seminars at the University of Bath, national and 
international conferences, and written in peer-reviewed journals and other reports (see Appendix 20). 
All data presented in this thesis has also been anonymised. Names used to refer to the participants are 
not the participants’ real names.  
2.2.1.1.2. Task III. Describing the context for the sexual health service. Step I of 
IM also includes an assessment of the community’s assets, capacities and abilities (i.e., of the 
geographic, social and organisational groups of individuals who may participate in, or benefit from, 
the programme), to describe the context for the service. IM identifies four components to assess the 
context: 1) social environment, 2) information environment, 3) policy/practice environment, and 4) 
physical environment.  
Assessing the social environment. The first component refers to factors that could support a 
health service (e.g., individual capacities, personal income, identity), and identifying the organisations 
and groups that could support the development and/or implementation of the service (e.g., social and 





Assessing the information environment. Assessing the information environment includes 
identifying the communication channels that could assist the development and/or implementation of a 
health service (e.g., community newspapers, television channels, radio stations, or social media).  
Assessing the policy/practice environment. This component includes the assessment of 
policies and practices that could support or present barriers to the development and/or implementation 
of a health service. Policies and practices can be at different levels (i.e., national, state, community, 
organisation, home-based). 
Assessing the physical environment. The assessment of the physical environment includes 
the aspects of the natural or built environment that could support or present barriers to the 
development and/or implementation of a health service (e.g., location of the community pharmacies 
within the community).  
 
The assessment of the context for the sexual health service was driven by the data from Study 
1 and Study 2 (evidence-based), and theory and previous literature (theory-based). It was also 
informed by informal meetings with professionals working in the areas of drug use and sexual health 
(e.g., health professionals or stakeholders). Not all components of the assessment were evaluated at 
the same level. The social environment was explored in Study 1 and Study 2. The policy/practice and 
physical environments were examined using previous evidence, meetings with professionals, and 
through the narratives of participants in Study 2. The informational environment was partially 
evaluated through mentions by participants in Study 2.  
2.2.1.1.3. Task IV. Stating the goals of the sexual health service. Defining the 
priorities and goals of the sexual health service was the main aim of Task IV. The goals for the 
service are ‘changes in health, quality of life and factors from the needs assessment’, usually being 
health or quality of life the ultimate goals (Bartholomew Eldredge et al., 2016). Following the IM 
approach, these goals should include what will change, for whom, by how much, and over what time. 
However, because the philosophical and methodological nature of this study, some features of the 
sexual health service could not be determined in detail yet (e.g., by how much will the changes in 
behaviour and/or environment will be attained). Instead, the goals for the sexual health service were 
stated more generally with data available from Study 1, Study 2 and previous evidence. Stating the 
goals for the sexual health service was the starting point for Step II. See Chapter 8 for more details. 
2.2.1.2. Step II. Programme Outcomes and Objectives  
The main aim of Step II was to determine the programme outcomes and objectives. The 





2003) was still at the core of Step II, as for Step I. Matrices of Change Objectives – a representation 
of the changes needed to influence changes in health outcomes – and a Logic Model of Change – a 
conceptual model representing the required changes to attain the goals of a health service – were 
developed at this stage. These specified the required changes at the individual and socio-structural 
levels.  
Step II is comprised of five tasks:  
2.2.1.2.1. Task I. Stating the outcomes at the individual and socio-structural 
levels. In the first task of Step II, outcomes at the individual and socio-structural levels were 
identified. These refer to the individual-level actions and socio-structural conditions that need to be 
attained to, ultimately, promote changes in health. Individual-level outcomes are often translated into 
behavioural terms such as risk reduction, health promotion, screening and early detection, adherence, 
and self-management actions. Socio-structural-level outcomes relate to interpersonal (e.g., social 
support), organisational (e.g., health care policies), community (e.g., health care accessibility), and 
societal (e.g., legislation) conditions (Bartholomew Eldredge et al., 2016). 
 
Outcomes were selected based on findings from Study 1 and Study 2. Outcomes informed the 
identification of performance objectives, the selection of determinants of health, and the development 
of Matrices of Change Objectives and the Logic Model of Change.  
2.2.1.2.2. Task II. Specifying performance objectives. Performance objectives were 
defined for each outcome identified in Task I (Step II). These were a more detailed description of 
individual-level and socio-structural components. Performance objectives were specified using data 
from Study 1 and Study 2, and based on previous literature.  
2.2.1.2.3. Task III. Selecting determinants of health. Determinants at the individual 
level reside within the individuals. These usually include cognitive factors (e.g., knowledge, attitudes, 
beliefs, values, self-efficacy, and expectations) and capabilities (e.g., skills). Determinants at the 
socio-structural level refer to situations that are external to the individual, at the social (e.g., 
interpersonal violence) and structural level (e.g., policies). The IM approach exclusively focuses on 
selecting and changing personal determinants (individual-level). This is because it is considered that 
these determinants are the only ones that the individual (and health promotion programmes) have 
power or influence over to change (Bartholomew Eldredge et al., 2016). Environmental conditions 
(socio-structural-level) (e.g., social norms) are then considered outcomes rather than determinants. 
According to the IM approach, individual decisions and actions are at the core of changes at the socio-





For this research, social and structural changes were considered as the result of collective and 
not just individual behaviour. For instance, feminist movements have influenced changes in policy 
and human rights law worldwide (Carney, 2002; J. S. Peters & Wolper, 1995). This influence in 
global politics required from a cohesive social movement and would have not been possible through 
individual actions (Moscovici, 1976; Turner, 1991). Following the philosophical underpinnings and 
values of this research and the argument in this sub-section, determinants at the both the individual 
and socio-structural levels were considered equally for the development of the sexual health services. 
Determinants were identified based on the needs assessment (Step I). This was based on the 
data of Study 1, Study 2, and evidence from the research literature. Once determinants were identified 
and selected, these were rated by their importance, in the context of the sexual health service. This is 
in terms of importance – the strength of association between the determinant and the behaviour – and 
changeability – how likely it is that the health programme will have an influence on changing the 
determinant. The rating of the determinants was mainly based on data from this PhD study.  
2.2.1.2.4. Task IV. Constructing matrices of change objectives. Matrices of Change 
Objectives were developed (see Chapter 8) by cross-referencing performance objectives with 
determinants, and identifying change objectives. There were separate matrices for each participant 
group and intervention level (individual and socio-structural). The final step of Task IV consisted of 
writing change objectives in the matrices cells, according to the data already obtained and previous 
literature.  
 
2.2.1.2.5. Task V. Creating a Logic Model of Change. The Logic Model of Change 
incorporates the pathways of the programmes potential impact. This model was constructed using the 
data from the needs assessment (Step I), as well as service outcomes, performance objectives, 




Figure 8. Logic Model of Change. From Planning Health Promotion Programs: An Intervention 
Mapping Approach (p. 285), by Bartholomew Eldredge et al., 2016, San Francisco, California: 




























More details on the development of the sexual health service are provided through this thesis 
and particularly in Chapters 7-9. The following chapters will include the findings from Study 1 
(Chapter 3) and Study 2 (Chapters 4-8). The last chapter presents a general discussion of this PhD 
thesis (Chapter 9). See Appendix 20 for details on publications, conferences and bursaries of this PhD 
research. 
2.3. Reflexivity 
 Reflexivity is key to ensure transparency and coherence in qualitative research (Yardley, 
2000). It involves a self-critical introspective journey to better understand and disseminate research. 
For these reasons, a piece of reflexivity has been included in this research. This section has been 
written based on notes of reflections made by the PI throughout the research, especially during data 
collection.  
Conducting this research has been tough, and it has led to a breaking point in my life. It 
has been a journey into understanding the complexity of drug use, sexual health and 
women’s issues. It has allowed me to develop my critical thinking and to see the world 
from a different lens. It has also meant a journey inwards, to explore my own personal 
past experiences in relation to the topics of this PhD. I have got to better understand the 
realities of social and health inequities. Particularly on gender inequities and gender-
based violence, the impact of stigma in health, the social and cultural perspectives on sex 
and sexual health (…). This has an add-on to realising about the difficulties promoting 
health and preventing disease, as it is never just about health but social and structural 
issues.   
This PhD started becoming particularly challenging once I started interviewing women. 
Their narratives of violence, isolation, fear and anger had a great impact on me, and have 
had a great impact on my research as a result. I realised about the power of sharing 
emotionally painful experiences, and I felt (and feel) a great responsibility in being loyal 
to these narratives. The interviews were loaded with emotion, and reflected the great 
social and health inequities experienced by the women that I interviewed. This was even 
more apparent through the interviews with community pharmacists, as the social 
inequities, exclusion and invisibility of drug-using women became even more obvious. 
And so this is what my research has become: a means for letting women speak up about 
their experiences of drug use, violence, transactional sex, homelessness, stigma, sexual 
health, and more. It has become an attempt for feminist and human rights advocacy, a 





For the last three and a half years I have learned to cope better with my emotions, even 
though it is still an everyday challenge. I have felt more empowered, partly because the 
dissemination of my findings allowed me to advocate for women. I could give them 
voice. In this process I have also worried about missing the aim of my research, which 
was developing a sexual health service in community pharmacies. I have had to revisit 
and shape my aims throughout the study, so that these reflected my data instead of 
limiting their potential. I have also revisited and considered my methodology several 
times. Especially because of the (mostly) exploratory and inductive nature of my PhD, I 
was worried about not having a strong consideration on theory. This, however, changed 
over time. I became more flexible in my thinking and allowed myself to explore (with 
rigour). Despite the initial anxiety, I also decided to shape my methodology to be truthful 
to my data and, most importantly, to my participants. I have also learned about the 
intricacies of qualitative data analysis and the importance of rigour and transparency in 
qualitative research.  
At times throughout the development of my PhD I felt that the aims and objectives that I 
had set at the beginning, and some elements of the methodology (the use of Intervention 
Mapping and Framework Analysis in particular) were feeling like a straitjacket. I felt that 
the perspective that I had taken on the research was too short-sighted and it needed to be 
expanded. I felt naïve to think that it was all so simple that my research could be 
developed in a straight line. I learned from it as I did not allow my initial perspective to 
restrain my thinking and analysis. I realised that using approaches such as Intervention 
Mapping and Framework Analysis can be deceiving. I realised that they were tools that 
gave me some sense of control when I started navigating in doing research. It was scary 
and having a step-by-step approach to “tell me what to do” was very reassuring. These 
approaches soon became somehow limiting when I wanted to explore and expand my 
research beyond the limits that I had set at the beginning. I started to feel uncomfortable 
as they felt restricting and too prescriptive. This is definitely something to learn from, 
one of the many lessons of this PhD that I have taken on board for my future research. 
“Logic models”, are they so “logic”? What is “logic” anyway? What is it not? Is 
experience and “logic” not subjective and individual to each of us? How can we then 
have a model that is “logic” and applicable to a group of people?  
There have been some tensions, not only in my thinking but in this PhD thesis. One of 
them is related to focusing the research in community pharmacy, when I soon realised 
that the STI/BBV prevention priorities for WOST were not within the pharmacy setting. 





is so much more that I have been sceptical at times in relation to my research. I had to go 
from the “daydreaming” state at the start of the PhD, thinking that your research can 
change the world, to the more realistic “this-is-just-a-contribution” state. And that was 
fine but frustrating too.  
I can also see now how sexual health goes beyond STI/BBV-related outcomes, I can see 
how a focus on disease is just incomplete and reductionist. When thinking of disease 
prevention and health promotion I got caught up in those negative aspects that needed to 
be changed and improved. At the same time, I forgot about all those positive things that 
can come with sex. Is sex not also an act of desire, of trust and intimacy, of love of 
another being? What about that feeling of deep connection with another human? Some of 
these elements appeared in my research (trust and love). I could see that they were 
crucial to understand sexual practices (and to understand risk). There needs to be more of 
a positive approach to sex. Public health strategies need to move beyond framing sex as a 
risk (for unplanned/unwanted pregnancies, for STIs, for HIV,…) towards the potential 
pleasure and magic of it. The same way that I realised that we might need to frame sex 
differently, we also need to do this with sexual health. And that is where another tension 
in my research has resided. I had aimed at developing a service to prevent STIs and 
BBVs. Ok. Was that all that was needed? No, not at all. There is so much more that we 
need to focus on, especially social and health inequities. Sexual health is also about 
equity and human rights, it is also about the right for having non-coerced and pleasurable 
sex. This is something that I would definitely explore and include in the aims and 
objectives of my research if I was starting it again. Even if I could not re-frame my aims 
and objectives completely I made sure that these reflections were included in the 
discussion of my research. 
I constantly have discussions around my work, and even these have taught me a lot and 
have been reflected in my research. Overall, I have encountered people who embody the 
social realities of patriarchy and misogyny, the taboo of sex, the intersectionality of 
stigmas (towards women, drug use, sex, sexual health, transactional sex, homosexuality, 
homelessness, and the list goes on), the blame culture and existing social discrimination 
and violence. But I have also had conversations with “those who get it”, which gives me 
hope that the voices of women will be listened.  
Giving meaning to the social issues that I am presenting in my thesis has been at the core 
of my thinking about promoting sexual health. And this is because I came to realise how 
social and structural matters are at the core of what we call health. I strongly believe that 





social, cultural, political, and economic factors. Public health and health promotion 
should serve as a call for social justice and as a means for social change. Today, I am 
hopeful that my research can modestly contribute to fight the challenges that we are 
facing today. I am hopeful that the stories in this thesis will serve as a reflection of what 
really matters, not just for promoting health but for humanity to progress. We are living a 
moment of social, political, cultural and environmental change. Let’s embrace it and 












CHAPTER 3. A Systematic Literature Review on the Risk of STIs and 
BBVs among Women Using Heroin and Other Drugs 
3.1. Overview 
There is a lack of understanding about the factors associated with the sexual risks that women 
using opioids experience, and the association with the risk of sexual transmission of STIs and BBVs. 
This chapter includes a publication of a systematic literature review (Study 1). Although this PhD is 
focusing on the experiences of WOST, the systematic literature review aimed to be more 
comprehensive and include other women who may not be accessing drug treatment (WHOD). This 
offered the opportunity to explore and recognize the issues that women using drugs – and not only 
those accessing treatment – may face. This was as it is likely that accessing treatments such as OST 
could reduce the challenges that women may endure. Recruiting WOST only could be an anchor on 
which to involve other women using drugs in future research and practice. The systematic literature 
review then aimed to identify the factors associated with the risk of STIs and BBVs among WHOD 
(see page 19 for details on methodology). This related to the first objective of this research, that was 
“to identify and explore the factors associated with the heightened risk of sexual transmission of STIs 
and BBVs among WOST” (see page 10).  
The findings from the systematic literature review were orally presented at the STI & HIV 
World Congress in Rio de Janeiro (Brazil) in July 2017 (see Appendices 20 and 25). A poster 
presentation was given at the Society for the Study of Addiction (SSA) Conference in Newcastle 
(UK) in November 2017 (see Appendices 20 and 26). The findings from this study were written in a 
journal format and submitted for publication to the peer-reviewed journal AIDS & Behavior on 9
th
 of 
October 2017. The paper was accepted on 22
nd
 of July 2018, and published online on 2
nd
 of August 
2018. 
3.2. Publication 
Reference: Medina-Perucha, L., Family, H., Scott, J., Chapman, S. & Dack, C. (2018). 
Factors associated with sexual risks and risk of STIs, HIV and other blood-borne viruses among 
women using heroin and other drugs: A Systematic Literature Review. AIDS and Behavior. 
https://doi.org/10.1007/s10461-018-2238-7. 




































































































































 This systematic literature review highlighted the complex interrelations of factors associated 
with STI and BBV risk among WHOD. This systematic literature review provided a wider picture of 
the factors associated with STI/BBV sexual transmission among WHOD: 1) socio-demographics; 2) 
gender roles and violence against women; 3) substance use; 4) transactional sex; 5) partners’ 
characteristics, partners’ drug use, and context of sex; 6) preferences, negotiation and availability of 
condoms; 7) HIV status and STIs; 8) number of sexual partners; 9) love and trust; 10) reproductive 
health and motherhood; and 11) risk awareness and perception of control. Undertaking this systematic 
literature review also revealed the methodological and theoretical limitations of previous research, as 
well as the research agenda over the last two decades. As the paper highlights, the focus of previous 
research has been on individual-level factors, whilst other important socio-structural determinants of 
health have been neglected. These are the prevalence of social and health inequities, GBV, stigma and 
discrimination, social neglect and structural violence. Also, the role of culture and the human need for 
intimacy and love. Human and health rights need to be at the core of any research in social sciences, 
especially when working with vulnerable populations that have been long neglected. Health 
promotion strategies seemed to have followed the same pattern and have taken an individual-level 
perspective to public health. This study, and the rest of this thesis, provides evidence on the 
importance of incorporating social-ecological frameworks in health promotion and public health. This 
would provide a broader understanding of the determinants of health and could address the social and 
health inequities that maintain poor health outcomes among those groups and individuals with less 
social power. These arguments are further developed in Chapter 9. 
This study was part of a needs assessment to provide explanations for the heightened risk of STIs 
and BBVs among WOST. The findings from the systematic literature review contributed to the 
development of the Logic Model of the Problem (see Figure 9, page 151).  
3.4. Statement of Authorship 
The planning, searches and screening for the systematic literature review were led by the author 
of this thesis (LMP). Dr Hannah Family and Dr Charlotte Dack supervised and contributed to 
planning the study and screened ten percent of the publications for each screening stage (see page 19). 
This publication was written by LMP. The PhD supervisors and co-authors, Dr Hannah Family, Dr 
Jenny Scott, Dr Sarah Chapman and Dr Charlotte Dack read, gave feedback and contributed to all 
drafts. Prof Julie Barnett contributed to the development of this paper although could not provide 






Permissions to include the publication in this PhD thesis were obtained from Springer Nature (see 
Appendix 27) on 31
st
 of July 2018.  
3.6. Data Access Statement 
Data supporting this publication are available upon request to the main author of the paper and 











CHAPTER 4. The Views of Women on Opioid Substitution Treatment 
 The findings from the semi-structured interviews and focus groups with WOST are presented 
in this chapter. These findings relate to the study aims and objectives of this PhD research (see page 
10). 
4.1. Participant Characteristics 
4.1.1 Semi-structured interviews 
 Table 5 reports sociodemographic characteristics of interview participants. WOST were 
between 27 and 56 years old (M=39.5; SD=9.65). They were mostly British (n=18, 90%), and all 
spoke English as their first language. Most participants had either no academic qualifications (n=8, 
40%), or had completed secondary education (n=7, 35%). Three women had been homeless in their 
past (15%) and another three women were homeless at the time of the research (15%). Most women 
were unemployed when they were interviewed (n=16, 80%), and 16 lived off an annual income below 
£10,000 (80%). All participants smoked tobacco (n=20). Most were using other substances, including 
heroin (n=18, 90%). All WOST were on OST, of which 70% were prescribed methadone (n=14). 
Most had had sex with men only (n=14, 70%) and almost half had engaged in transactional sex (n=8, 
40%). Seventeen women reported having experienced sexual abuse in their lifetime (89.5%); one 
participant abstained from answering this question. It is important to note that over half of WOST 
were not having sex at the time of the research (n=11, 55%). There were different explanations for 
this that are outlined in this chapter. Only four reported using condoms at the time of the interview 
(20%). A large percentage of participants had been screened for BBVs and/or STIs at some point 
(n=17, 94.4%) and some had been diagnosed with an STI or a BBV (see Table 5).  
Table 5 
Demographics, drug use, opioid substitution treatment and sexual health-related data. 
Participant characteristics (N=20) n (%) 


















No academic qualifications 
0 Level/Scottish Higher or equivalent (NVQ/SVQ Level 2) 





























































Transactional sex (lifetime) 8 (40) 
Sexual abuse (N=19)* 17 (89.5) 
Sexual health  









Male condom use 
STI/BBV screening (at least once) (N=18) 
STI/BBV diagnoses 



















* = data missing from one participant; ** = OST dosage was not requested. 
 
4.1.2. Focus groups 
There were two focus group sessions conducted. Only one WOST attended the first session. 
Three WOST attended the second session. Data from both focus groups were merged and analysed 
together as for one focus group session only one participant attended. The age of WOST taking part in 
the focus groups was between 35 and 48 years (M=40.25, SD=5.74). All women spoke English as 
their first language. Most were British (n=3, 75%) and one was Caribbean (n=1, 25%). Three WOST 
(75%) had no academic qualifications and two (50%) were unemployed. The annual income of all 
WOST taking part in focus groups was of a maximum of £9,999. There was no data on homelessness 
for this group of participants. All women were using other substances apart from the opioid 
substitution treatment. Two women gave details on the STI/BBV preventive methods that they used. 
One participant used male and female condoms. Another participant did not use any barrier methods 
(i.e., male and female condom, and dental dam). WOST taking part in the focus groups reported 
diagnoses of chlamydia, scabies, gonorrhoea and another non-specified STI. All had had a sexual 
health screen at least once in their lifetime. Two women reported having experienced sexual violence 










Demographics, drug use, opioid substitution treatment and sexual health-related data of women on 
opioid substitution treatment taking part in the focus groups. 
Participant characteristics (N=4) n (%) 












No academic qualifications 






Working 16 hours or more a week 















































Transactional sex (lifetime) 2 (50) 
Sexual abuse (N=3)* 2 (66.6) 
Sexual health  
STI/BBV preventive methods (N=2) 
Male condom use 
Female condom use 
None 

















* = data missing from one participant. 
4.2. Main Findings 
 Interviews with WOST aimed at exploring 1) the factors that may be associated with WOST’s 
risk for the sexual transmission of STIs and BBVs, 2) WOST’s sexual health needs, 3) WOST’s 
perceptions on the role that CPs promoting sexual health, and 4) WOST’s views on a pharmacy-based 
sexual health service. Data were analysed using FA (semi-structured interviews) and QCA (focus 
groups) (see page 28).  Seven themes and associated subthemes were identified, based on the data 
from the semi-structured interviews and the focus groups (see Table 7).  
Table 7 
Analytic framework: women on opioid substitution treatment.  
 Themes Subthemes 
1 Beliefs, knowledge and education Definitions of “safe sex” 
Beliefs about condoms 
STI and BBV knowledge 
Sex and sexual health education 
2 Lifestyle and risk Prioritising drug use 





3 Power and emotion Disempowerment and helplessness 
Love, trust and self-worth 
4 Intersectional stigma (publication) Gender-related stigma 
Drug-use related stigma 
Transactional sex-related stigma 
Homelessness-related stigma 
STI/BBV status-related stigma 
5 Gender-based violence The context and nature of GBV  
The impact of GBV 
Social and professional support for GBV 
6 Views and experiences with the health system 
and community pharmacy 
(Sexual) health services and the health system  
Services in community pharmacy 
Interactions in community pharmacy 
7 A sexual health service in community 
pharmacy 
Acceptability and positive aspects 
Perceived barriers 
Ideas for the service 
 
4.2.1. Beliefs, knowledge and education 
One of the themes identified was around WOST’s beliefs, knowledge and education on sex 
and sexual health. The subthemes were 1) definitions of “safe sex”, 2) beliefs about condoms, 3) STI 
and BBV knowledge, and 4) sex and sexual health education. 
4.2.1.1. Definitions of “safe sex” 
WOST were asked what “being safe” in sex meant for them. Safe sex was defined as using 
condoms
7
 by most women. A few others thought of safe sex as using condoms and contraceptives, to 
prevent both STI/BBV transmission and pregnancy. This could be related to the fact that WOST’s 
concerns were more focused on pregnancy prevention than STI/BBV sexual transmission. Having 
                                                             
7 The term “condoms” is used to refer to “male condoms”, unless specified differently. This is because 






multiple and casual sexual partners, and having high sexual activity were seen as not safe. Having 
long-term stable sexual partners was generally perceived as safe and women were not likely to use 
condoms with these partners. This was associated with feelings of trust and love (see page 93).  
“So they [men] would say “Go on the pill!” or, you know what I mean, thinking that it’s safe 
sex when it isn’t. It isn’t safe, you know what I mean, it’s not going to stop the transmitted disease and 
things like that” (Teresa, 34 years old; interview). 
Abstinence was mentioned by one participant as a way to be safe (Emmeline, 35 years old). 
Another WOST thought that rather than speaking about safe sex it should be called safer sex (Amelia, 
52 years old). Regarding reproductive health, all participants had been pregnant at some point in their 
lives. Most pregnancies seemed to be unplanned as women reported not using contraceptives or 
condoms consistently. Participants generally thought that long-lasting methods (e.g., coil) were the 
best option for them but they normally did not access these services. This seemed to be due to 
different factors that are discussed throughout this chapter and PhD thesis. Also, when using drugs, it 
was difficult for WOST to think of adhering to other types of contraceptives that needed to be taken 
regularly (e.g., contraceptive pill). 
“I think long-term approaches are useful like contraceptive injections, make sure if they 
[WOST] have a coil, because it’s a back-up for, that is the way that I look at it” (Rosa, 40 years old; 
interview). 
4.2.1.1. Beliefs about condoms 
Participants’ narratives were mostly around the use of male condoms. Several WOST 
mentioned female condoms, although these were rarely used. There were however barriers to using 
female condoms. These were perceived as embarrassing to carry as they are big and then “too 
visible”. Women were also uncertain about their effectiveness, as they could not be certain about 
whether they were well-placed or not, especially compared with male condoms. Participants also 
mentioned men’s generally negative views about female condoms. 
“Women don’t carry things like that [male condoms] do they? There should be something for 
women… I know you’ve got Femidom [female condom], women ain’t gonna go and carry that [female 
condom] out, ain’t they? (…) I think it’s more of a… embarrassment for a woman, like they go out 
and they’ve got a Femidom in their purse… you know? For a woman it’s a little bit different I feel…” 
(Eleanor, 38 years old; interview). 
There were also barriers to using male condoms. These were not always perceived as reliable 
(e.g., they could break), they made sex less intimate and unnatural and limited the pleasure for some 





women were also embarrassed about getting, carrying and negotiating condom use which hindered 
their use.  
“I mean I have used condoms in the past, you know, and it does feel weird and it doesn’t feel 
right you know… it doesn’t feel natural if you know what I mean. So you want it to feel natural, you 
know what I mean. If you want to have sex you wanna it to feel natural, skin to skin basically you 
know what I mean… but having something rubber it’s not very nice” (Teresa, 34 years old; 
interview). 
The belief of condoms being “the man’s responsibility” and women’s disempowerment in 
negotiating condom use were other barriers mentioned. Men’s general reluctance to use condoms was 
a barrier for using both female and male condoms. Believing that carrying and negotiating condom 
use was “a man’s job” seemed to enhance women’s feelings of disempowerment and lack of control 
over their sexual health.  
“It’s all quite tough on us women, you know, so it’s you know, when it comes to condoms 
women go get the pill, or get the bar [contraceptive implant] or get the injection so when it gets to the 
condoms they are not so, you know, they think they’ve done the rest of the things although they would 
do the rest of the things then the condoms is kind of down to the man (Lily, 36 years old; interview). 
4.2.1.2. STI and BBV knowledge 
The levels and nature of knowledge on sexual health varied from each participant. Most 
participants acknowledged they did not have enough information about STIs and BBVs, although 
some WOST appeared to have sufficient STI/BBV knowledge. Overall, women seemed to have a 
limited understanding about routes of transmission and symptomatology of STIs and BBVs, 
preventive methods and STI/BBV treatment. For instance, most women did not consider oral 
transmission of STIs or BBVs and were not aware of asymptomatic STIs. They also expressed not 
having heard about many STIs. Only two women had heard of HPV. Viral hepatitis, HIV, chlamydia, 
gonorrhoea and genital herpes were the main STIs and BBVs that women discussed. WOST generally 
knew more about BBVs than STIs. Despite all women being familiar with HIV, a few WOST held 
important misconceptions about HIV transmission (e.g., HIV can be acquired through saliva). These 
were related to the stigma and discrimination attached to HIV (see page 97). 
“Cause, as I said, it worries me if you use the toilet or… For instance I know this bloke, but 
we had a friend that had HIV and he came around to the house and he used one of my glasses to have 
a drink and that… I know it sounds cruel but when he left I threw the glass away, because I thought, I 
didn’t know if you could catch it through… even if I washed the glass I didn’t know if… I guess it is in 
my mind cause otherwise I wouldn’t have thought of chucking it like that, you know, just washed and 





On the other hand, participants often did not know about sexual health services in the area, 
even despite there being a sexual health clinic located in the same building as where most of the 
interviews were conducted. The screening sites that the WOST in this study visited were mostly drug 
services. Most health services that women knew about had been offered when accessing drug 
services. These were mainly screening and vaccinations for hepatitis A and B in drug services. Some 
WOST mentioned that free condoms could be obtained through NEP packs, drug services, and 
services for sex workers.  
“Yeah, I mean when I first signed up to [drug service] one of the first things that I was offered 
was a… a test for Hep C cause, you know, in the past I had used needles so I think when you’re 
getting new clients signing up for treatment I think that’s the perfect opportunity to introduce the 
whole subject, because I didn’t know that they offered all these extra things and, as soon as I did 
know yeah I took them up on it” (Rosa, 40 years old; interview). 
Sources of information, from most to least used, were: the internet, television, magazines, life 
experiences, peers, school, visual ads of sexual health services, health assessments in drug services, 
books, health professionals, and newspapers (e.g., to know about a HIV/AIDS outbreak). When 
WOST were young, getting information from parents was uncommon. This appeared to be associated 
with sex and sexual health being taboo and stigmatised topics. In some cases, women also explained 
that their parents had disregarded their sexual and reproductive health needs when they were younger. 
This had had a negative impact on their health and wellbeing, and in their relationship with their 
parents.  
“Back when, back when I asked my mum if I could go to the doctors and get the pill she said 
“No, you have to leave the home if you do that. You are a little whore if you do that”. And I had been 
with my boyfriend for over a year and I was quite young, sixteen and that, and I had been with him for 
over a year and she wouldn’t let me go to the doctors and that and I ended up pregnant” (Sarah, 53 
years old; interview). 
Being focused on drug using had prevented a few women from seeking information on 
potential health concerns, including sexual health-related issues. Drug use was also a barrier for 
accessing (sexual) health services (see page 88). On the other hand, participants felt that the 
knowledge of health professionals and people who do not use drugs around drug use and WOST’s 
realities was very restricted and superficial. 
4.2.1.3. Sex and sexual health education 
Several women talked about sex and sexual health education. Overall, participants said they 
had not had enough sex and sexual health education. Some of them remembered having some at 





about sex and sexual health themselves, which reinforced the taboo and stigma of sex. Some 
participants mentioned how they wanted a better sex and sexual health education for their children 
and grandchildren. Several women provided condoms and contraceptives to their children, and a few 
had had conversations around sex and sexual health with them. It was still challenging for WOST to 
approach the topic, as it was an uncomfortable conversation because of the taboo attached to it. 
Communicating about sex and sexual health was however key to prevention, as a few participants 
discussed. 
“In England we have this really big problem of stiff upper lip and things are taboo. We need 
to get over that. The reason it’s a taboo it’s cause nobody would talk about it. It needs to be discussed 
to prevent it happening… (…) British are so up themselves, they don’t talk about things that need to 
be discussed. And swipe it under the carpet and forget it, it doesn’t exist. And it’s the wrong attitude 
to have” (Joan, 27 years old; interview). 
Most women claimed that sex and sexual health education should be more accessible. 
Participants thought that schools should educate more on sexual health (and also other issues such as 
drug use and homelessness). They thought that the UK government should be involved in improving 
the educational system. A few women acknowledged that it was a controversial topic though, due to 
the taboo and stigma attached to sex. Some participants expressed being eager to learn more around 
sex and sexual health, and engage in communicating knowledge to others. 
“Yeah, a lot of people want to have their children learning sex education in school and they 
learn from four and it’s not that they go into details but they say about animals and plants from a very 
young age. And a lot of parents wouldn’t let their children learn… But if they don’t learn they are 
going to learn it from somewhere else” (Emmeline, 35 years old; interview). 
A few participants suggested that there should be more information available in public spaces, 
and taboo and stigma towards sex and sexual health should be challenged to allow this. One WOST 
also pointed out that there was a misrepresentation of the uses of condoms in the media, as condoms 
are almost exclusively advertised for vaginal intercourse. According to her, that needed to change in 
order to provide a more comprehensive understanding of the reasons and ways of using condoms 
(Rosa, 40 years old; interview). Some participants were teenagers and young adults during the HIV 
outbreak in the 80s and 90s. They explained how the media had a powerful role in disseminating fear 
and stigma. Participants thought that misconceptions about HIV and HIV-related stigma had 
decreased, but they were still prevalent. Pornography was also discussed to have a negative impact on 
people’s expectations of sex and sexual health.  
I remember growing up, I am 41, so that was about the time I was a teenager, I think it was 
quite terrifying the way it was broadcast, and now, literally it’s basically HIV is not the same death 





really. I have a few friends with HIV, and I have one friend, a close friend, that doesn’t want anyone 
to know really, because people are still close minded, and another service we use, once we found a 
few girls were aware, they wouldn’t use the same cup as her, they refused to use the same toilet, I 
mean in 2016-17 its almost embarrassing the way she was treated. I have another friend that has HIV, 
she’s a street sex worker, she’s very open about her status and I really respect her, but she gets such 
yeah, you know, yeah they just freak out about it. Yeah but I really respect that the fact that she’s 
quite open it” (Virginia, 41 years old; focus group). 
4.2.2. Lifestyle and risk 
 Women discussed their lifestyle and how that was related to engaging in health risks, 
including sexual health risks. This theme is divided into two subthemes: 1) prioritising drug use, and 
2) risk awareness and sexual health.  
4.2.2.1. Prioritising drug use 
Drug-seeking and drug-using behaviours were generally prioritised over any other behaviour 
or concern when women were heavily using drugs. As participants explained, taking health and 
personal risks was part of this lifestyle, as they were constantly exposed to high risks (e.g., death from 
overdose). Even if WOST expressed being aware of these risks and frightened of even losing their 
lives, using drugs outweighed their need to protect themselves. Also, compared with the risk of death, 
getting an STI or a BBV was perceived by most participants as barely harmful. WOST would 
sometimes engage in risk behaviours if these would allow them to use drugs (e.g., sharing needles or 
having condomless sex in exchange for drugs). One participant stated that, even if PWUD have a 
lifestyle that entails taking many risks, all human beings make risky choices at times. She also called 
for personal freedom to make ones’ own choices, even if these included taking risks (e.g., sexual 
health risks), and relating this to the negative views that people hold of PWUD (Joan, 27 years old; 
interview). 
“Cause that’s always what you are told about, injecting. And if you share with someone else 
it’s never safe. But you don’t really care about that. If you don’t have clean works and it’s the middle 
of the night or first thing in the morning, you can’t get any and you need it. You just grab on anything 
then (…) When you’re using, if you’re using an illicit drug you don’t care. It doesn’t really matter at 
that point, nothing really matters…” (Emmeline, 35 years old; interview). 
“Don’t think about none of that, don’t think about getting pregnant, it’s just part of your 






4.2.2.2. Risk awareness and sexual health 
Most women appeared to be aware of some sexual health risks and the potential repercussions 
on their health. Most also thought that increasing people’s awareness was important to prevent STIs 
and BBVs. According to a few participants, risk awareness increased with age, life experience and if 
diagnosed with an STI or a BBV. All participants were aware of the need to use condoms in order to 
prevent STI/BBV sexual transmission. As some participants stated, WOST needed to consider the 
risks of STI/BBV transmission as much as pregnancy. Some participants thought that most people 
were not aware of the health consequences of having an STI/BBV and did not perceive themselves at 
risk. Most participants expressed being aware of the severity of contracting HIV or viral hepatitis, but 
this was lower for STIs. A few women mentioned infertility as a concern when having an untreated 
STI, and health consequences on a foetus if getting an STI while pregnant. Some participants were not 
aware of the risks of oral transmission, nor transmission through anal sex. However, it did not seem 
that women’s awareness of risk translated into engaging in protective behaviours (e.g., using condoms 
correctly in all sexual encounters). A few participants talked about this openly.  
“Like if you’re having sex you know you’re going to have a chance of getting pregnant you’re 
going to get a chance of maybe getting any other sexual health diseases or HIV that was always in my 
head that I could get HIV, but you still do it, and I still done it. I had 10 pregnancies altogether 6 of 
those were live births that was the first one all the way through addiction and I still fucking got 
pregnant over and over again because I didn’t use condoms because there was never no condoms 
there and I weren’t going to go to the shop and buy ‘em because I need my money for drugs” (Ingrid, 
48 years old; focus group). 
Overall, women seemed to know the risks of engaging in condomless sex. Some advocated 
for the use of condoms and empowerment of women in using them. However, risk awareness was 
generally low with steady partners
8
. This was attributed to trust and love between women and their 
partners (see page 93). A few WOST however highlighted that partners could be unfaithful or be 
unaware of their own sexual health status. Women were not always aware of the heightened risks in 
these cases with steady partners. Woman-woman sex was also perceived as low risk for all 
participants, even though they recognised that there was still risk. A few participants mentioned men’s 
good hygiene, youth and physical attractiveness as factors that decreased their perception of STI/BBV 
risk. Having a low sexual desire or having few sexual encounters seemed to lower women’s 
perception of risk. However, sex was often unplanned and occurred when women were under the 
influence of drugs and/or alcohol. As participants explained, using substances decreased women’s risk 
awareness and ability to think rationally. Thus, in their words, even having no desire or few sexual 
encounters could not be translated into “being safe”.  
                                                             





“I went through a stage while being really dependent on alcohol and drinking four bottles of 
wine a day and I would wake up with people and know that I had sex with them but not remembered. 
Not wanting to. And that was just a pattern, I just let it happen. And you need help with that and I 
wasn’t on contraception because I didn’t have a partner and I didn’t want to have sex with anybody 
but you get so drunk that you find yourself in that situation” (Emma, 27 years old; interview). 
The risk of STIs and BBVs was perceived to be higher in casual sexual encounters and when 
having multiple sexual partners, especially if these were strangers. Risk was perceived to be higher 
when having sex with PWUD (and particularly with PWID), PLHIV, partners that had multiple sexual 
partners, and homeless people.  
“But when you’re having a one night stands, you know, it’s best to use them [condoms] (…) 
cause you’re sleeping with different people and all that (…) If you are in a committed relationship 
then it’s okay, you don’t have to use condoms” (Margaret, 45 years old; interview). 
Transactional sex workers were perceived to be at higher risk, compared with women that did 
not sell sex. This was considered by both women who had engaged in transactional sex and those who 
had not. This was not just in relation to their sexual health, but also because workers were more 
exposed to experiencing violence (see page 106). At the same time, women engaging in transactional 
sex seemed to be more aware of the risks of engaging in condomless sex. Workers seemed to practice 
condomless sex with clients consistently in most encounters, unless they were in immediate need for 
money or drugs and clients offered more money to have sex without using condoms. This often 
happened when WOST were experiencing withdrawal symptoms, and also when women were feeling 
most worthless (see page 93).  
“Not like you ain’t got to be a prostitute to, but it’s about all of us we all put ourselves at risk, 
don’t we” (Elizabeth, 37 years old; focus group). 
“I would never put myself through that [transactional sex] again… never put myself through 
that again, it was horrible… but at the time you don’t care, you just… all that’s on your mind is the 
drugs, and the money and that’s what your life is about, when... it’s not life living… When I was using 
it was wake up, go to [street name], get the money, go score, go back out, it’s horrendous… and it’s so 
hard to just… let go of it because it’s always there” (Marie, 29 years old; interview). 
Some women thought that most people were unaware of their own sexual health status. 
Despite most participants having undergone STI/BBV screening in the past, they were often unaware 
of which STIs and BBVs they had been screened for. A few participants got concerned about not 





after taking part in the study
9
. WOST mentioned that most of the times that they had been screened 
was because they were experiencing symptoms. Participants thought that low risk awareness and not 
having (or not noticing) signs and symptoms of infection were barriers to sexual health screening.  
“But when I found I had it [Hepatitis C] I obviously had had it for years and didn’t know I 
had it, you know what I mean? So yeah… you know, you think that you keep everything clean and I 
haven’t shared a needle in my life and still managed to catch it somehow. So…” (Sojourner, 27 years 
old; interview). 
4.2.3. Power and emotion 
 Women’s narratives were full of emotion. Power was also an important element in WOST’ 
stories and discussions. Emotions and women’s lack of control over their own lives seemed to be 
important factors associated with WOST’ sexual health. The subthemes identified were: 1) 
disempowerment and helplessness, and 2) love, trust and self-worth. 
4.2.3.1. Disempowerment and helplessness 
Overall, women expressed feeling powerless and helpless. They felt a lack of control of 
themselves and their lives, as they felt unable to make and follow through informed and conscious 
decisions. This seemed to be related to their lifestyle. WOST dealt with uncertainty and risk on a daily 
basis, some not even knowing whether they would still be alive on the same day. Women were in a 
situation in which they felt powerless over their own health, life decisions, finances, housing, and 
social relationships. Besides, living in situations of poverty and homelessness was common. In most 
cases WOST were responsible for supporting their partners and children financially. In this context, it 
was difficult for them to sustain their drug-using habits. This appeared to be the main reason why 
women initiated transactional sex or engaged in other criminalised activities (e.g., shoplifting). 
Reasons for not getting into transactional sex were mostly situational, such as having a steady partner 
or not being in withdrawal when offered to sell sex. It then seemed that not engaging in transactional 
sex was a matter of “luck” and not something that WOST had much control over. It was a vicious 
cycle in which women felt powerless. They also felt socially isolated and marginalised, and helpless 
even when accessing social care services.   
“I suppose a lot of us would do [engage in transactional sex] because we find ourselves in a 
crappy situation (pause). But from everything that’s going on [unintelligible] and probably there’s no 
one else like to help. That’s why like I would say I find it like I haven’t, but that could be me in that 
situation but I’ve been lucky. I’m having a script that doesn’t make me have to be like that” (Sylvia, 
27 years old; interview). 
                                                             





 As explained by participants, having sex was not usually in their minds. Women thought that 
their sexual drive was low due to the use of opioids, and women “just did not need it”. Participants 
thought that sex was not for them, but was a way to please men. Sex often happened in the context of 
sexual abuse or assault, transactional sex or intoxication with drugs and/or alcohol.  
“My bloke used to say when I used to wake up in the morning and I wanted a pipe it used to 
be unless I have sex he wouldn’t let me have the pipe unless you keep me happy I’m not letting you” 
(Emilie, 36 years old; focus group). 
Some women, and especially transactional sex workers, explained how they needed to use 
drugs or alcohol in order to be able to have sex. These were situations in which women felt a lack of 
control over their own bodies and sexual health.  
“I don’t know if I could have sex with people all week without doing drugs they do it for 
money I don’t think I could do that man” (Elizabeth, 37 years old; focus group). 
As one may expect, when sex was forced on women they did not have any control over 
protecting their sexual health (and lives). WOST expressed feeling powerless over experiencing 
violence. Several had experienced violence throughout their lives, in different forms and perpetrated 
by different people (see page 106). They felt unable to stop this from happening to them as they felt it 
was not dependent on them but their life situation. In most cases, they felt powerless and helpless over 
changing this. One participant explained how she had “learnt” to dissociate her body and her mind 
once she had been sexually assaulted. This was her only and last resource in a situation that was 
imposed upon her and in which she only expected to survive.  
“After that [sexual assault initiated] it’s too late and you’re just thinking ‘Fuck. Let me live 
through this. Whatever happens to me in… whatever happens to me now, let me survive it’. That’s all 
that’s going through your head. That and like ‘Blank your body from your mind, blank your body 
from your mind. This isn’t happening to you, it’s only happening to the body. Blank your body from 
your mind’” (Amelia, 52 years old; interview). 
Negotiating condom use was challenging for some women as they generally felt 
disempowered when discussing sex and sexual health, and discussing condom use. Some WOST 
believed that condoms had been produced for men and there was a lack of methods oriented to 
women. Thus, using male condoms gave men more control in sexual relationships and on women’s 
bodies and sexual health. Female condoms were seen as a method that could actually give women 
more control, although these were not widely used. A few participants called for the development of 





“A bit difficult initially [using female condoms], I mean certainly it’s quite strange, you have 
to get in a strange position but once, yeah I think, I think they’re [female condoms] good because it 
puts it more in your house, you’re in control then, you know” (Virginia, 41 years old; focus group). 
Women felt more in control in transactional sex as they felt more empowered to negotiate 
condom use with clients, compared with other sexual partners, as it was “part of the contract” of 
exchanging sex. Besides, using condoms with clients was a way for workers to gain control over their 
bodies and sexual health.  
“I also found that I acted completely, like on purpose as well, well not on purpose, completely 
opposite to what I actually, how I would actually, how I had acted like in a sexual relationship that I 
wanted to have. I would act completely opposite and I was kind of more… stronger with them [clients; 
negotiating condom use] because… it just made it all a lot easier [use condoms to cope with 
transactional sex encounters]” (Emma, 27 years old; interview). 
Some participants called for the need for women to be more empowered and encouraged to 
take control over their own bodies and lives. WOST described feeling more empowered when they 
were recovering from their drug use, and as they aged. Those that were not using “hard drugs” felt 
grateful for having got into OST and the social and professional support that they had received. 
Despite the need for support, women considered that their own willpower was key in recovering their 
lives and protecting their (sexual) health.  
“Yeah well, like I said, they [men] don’t wear it [condom] then they ain’t gonna get it [sex]. 
Simple as that. I think women, women need to put their feet down, you know, stop being soft you know 
and show them “Well if you ain’t gonna wear it we are not gonna have it”. As simple as that. “You 
put this on then we can get and do whatever… and whatever, whatever”, you know. But I think women 
need to put their feet down and be a bit stronger to be honest (…) Show them who’s boss” (Teresa, 34 
years old; interview). 
4.2.3.2. Love, trust and self-worth 
Love, trust and self-worth were key elements in WOST’s narratives. These were present in 
discussions about themselves, relationships with significant others, and health and social care 
professionals.   
 Women expressed their need for love and called for shared humanity. They explained how 
love had been one of the drivers of their behaviour, including in relation to their sexual health. The 
need for love and intimacy was mentioned as one of the barriers to condom use. Condoms were often 
perceived as a barrier for physical and emotional intimacy, as they were a physical and unnatural 





would not use condoms in steady romantic relationships. On the contrary, transactional sex workers 
would use condoms to create a physical and emotional barrier between them and their clients. Using 
condoms was somehow a way for them to cope with sex exchanges with clients. However, women 
engaging in transactional sex were more unlikely to use condoms in other sexual encounters. This was 
because they associated the use of condoms with selling sex. Using condoms with non-clients led 
them to feeling as if they were selling sex, which was emotionally challenging to cope with and 
created a barrier for love and intimacy.  
“In my conversations with other girls [transactional sex workers] they don’t really, unless it’s 
a financial transaction they will not use condoms. They don’t use them. Maybe because, yeah… 
probably actually because they don’t want to think of it as being, you know, whereas maybe a girl that 
is going to a club and has a one night stand, you know, she doesn’t all of a sudden becomes a 
prostitute when she uses a condom. Girls here [service for sex workers], I’ve just thought of it and I 
think I am probably right, hmm… if they have casual sex with a boy they like when they pull out that 
condom they are… putting on their prostitute persona” (Amelia, 52 years old; interview). 
Overall, WOST felt marginalised and dehumanised in most interactions with other people. 
This included interactions with family and friends, health and social care professionals, and society in 
general. They highlighted that getting treated in a “humane manner” was vital for WOST to engage in 
health and social care services. It also was a significant step towards self-love and self-care. It seemed 
that participants longed to feel loved and connected to other people whereas they feared getting 
emotionally and physically hurt by others. This was due to the history of violence, social isolation and 
neglect and stigma almost all of the women taking part in this research had experienced. In relation to 
this, a few participants mentioned having had “one night stands” and pleasing men despite their own 
needs, just to look for affection. 
“When I was using and I was street homeless and it was as if you didn’t exist. People 
wouldn’t even look at you cause you didn’t exist. You were the lowest, you weren’t there. I think that 
was quite, quite horrible” (Emmeline, 35 years old; interview). 
Women shared their feelings of love for their romantic partners, their children and other 
family members. Through women’s narratives, it was clear that feeling loved by significant others 
was key in their journey towards recovering from drug addiction and caring for their health. Feeling 
loved translated into feeling supported and accepted by others. This was especially important as 
WOST experienced stigma and discrimination on a daily basis (see page 97) and usually felt 
worthless. One participant also talked about support networks among transactional sex workers, and 
how these helped increase her sense of self-worth (Amelia, 52 years old; interview). Participants 





stigma, some participants did not feel worthy of love and affection. They had created emotional 
barriers that prevented them from getting affection from themselves and others. 
“We are all human and we all wanna be liked and loved and wanted and… it’s just that there 
is a lot of horrible people out there (…) People are so mean to people nowadays… there is no love in 
the world anymore I think. I think that you have to accept yourself though, but if you accept yourself 
and no one can get you… I mean, I try to put myself a star, that I’m okay, that I’m a tough person… 
(…) I put on, I try to act it cause I don’t want people to see me weak and vulnerable and down, so… I 
try to just cover it up” (Marie, 29 years old; interview). 
A few WOST explained how they had thought of pregnancy and motherhood as a means to 
stopping their addiction. However, in most cases pregnancy and motherhood did not stop their 
addiction. Some women expressed feeling guilty over not preventing pregnancy in the past, for the 
emotional pain that they had inflicted on their children (and families) due to their drug use. A few 
participants expressed guilt and sadness over their children being born with neonatal abstinence 
syndrome as women often could not stop using drugs during pregnancy. Almost all participants had 
had their children removed by social services, and these were traumatic events for them. Other women 
had terminations and miscarriages, or had given their children up for adoption. Some, were trying to 
recover their relationships with their children and families. Others had stayed away from having 
contact with them as they were ashamed of themselves and did not want to hurt their loved ones. 
Participants’ love for their children was evident. Most had come to accept that they could not care for 
them due to their drug use, or felt undeserving of them. Others were fighting to get the custody of 
their children back, although they usually felt powerless and pessimistic about it as they knew it 
depended on their drug use.  It became clear throughout the interviews that women’s self-worth was 
negatively affected by how they perceived themselves in their relationships with significant others. As 
will be further developed in this chapter, WOST’s feelings of worthlessness were related to their 
sexual health (e.g., increasing the chances of engaging in condomless sex). It is then vital to consider 
how women felt about themselves and in their relationships with significant others.  
“You think a child is going to fix you but it don’t (…) I had all [children] six of mine taken at 
one point or another cause I’ve been in prison so many times then I came back out then I pick them 
back up thinking I can put the drugs down then I put them down and pick the drugs up so it’s just 
addiction and all those things just don’t matter none of them probably an addict lies by saying they do 
matter they don’t matter for me as an addict none of those things matter” (Ingrid, 48 years old; focus 
group). 
Trust was also crucial. It was an important element in relationships with significant others 
(including romantic partners), health and social care professionals, and even transactional sex clients. 





was trust in the relationship, women could feel more certain about being in a monogamous 
relationship and thus about their sexual health being protected. On the other hand, women sometimes 
expressed feeling disempowered to suggest condom use with their steady partners. This is because 
they feared their partners might get suspicious about them being unfaithful to them, breaking their 
partners’ trust in them. Besides, suggesting using condoms in steady relationships had led to 
experiencing violence in the past among some participants (see page 106).  
“The last relationship I had, he was very controlling, he was in charge of everything and I 
would never ask him to put a condom cause he would go mad, he would think that I had done 
something dirty with someone else, yeah” (Jane, 51 years old; interview). 
Trust was also related to condomless sex with other sexual partners. For instance, if causal 
sexual partners were known (e.g., they were from the same social network), women appeared to be 
more likely to engage in condomless sex. Even with strangers, WOST could have sex without 
condoms if they trusted that the partner was not living with an STI or a BBV. Among women who 
engaged in transactional sex, trust in their clients was also relevant for them to feel safer. A few 
mentioned having regular clients that they trusted and had even helped them at a personal level (e.g., 
offering shelter). This seemed to make women’s experiences of transactional sex work less 
challenging. For some, trusting that clients did not have an STI or a BBV was a factor in having 
condomless sex with clients when offered more money. However, some participants expressed their 
general distrust in men. They thought that men were usually unconcerned and lacked awareness over 
transmitting STIs and BBVs to women. 
“Yeah… and you don’t want that [men she knows to know that she is a transactional sex 
worker], you don’t want to walk pass a group of men and… and… they all know that they can buy you 
at a drop of a hat, you know. It’s gotta be a stranger, someone that you are not gonna see them again, 
or somebody who is going to turn into a friendly, respectful [client] (…) Yeah there’s a financial 
aspect too I but that’s not the main component, you know” (Amelia, 52 years old; interview). 
Self-worth was another emotional factor that seemed to be associated with WOST’ sexual 
health. Feelings of worthlessness were present in most discussions with participants. Some women 
linked these feelings of worthlessness expressed with a lack of care for their (sexual) health and own 
life. Feeling worthless had led some women to have condomless sex, as they felt no care or love for 
themselves. In this situation, a participant explained how she even hoped to get HIV so that “it could 
take her away from it all” (Florence, 37 years old; interview). A few participants called for the need 
for women to respect and care for their lives, to love and give worthiness to themselves. They 





“I don’t even know cause you probably know the risk but you don’t give a shit how would you 
give a shit about yourself if you are using drugs I don’t worry about myself.” (Ingrid, 48 years old; 
focus group). 
“People have died in front of me and I’m… and I feel guilty saying this cause I know it 
shouldn’t be but I can’t change how I think and how I work. But I’ve seen people dying in front of me 
and I still do that thing [use drugs] that caused them to die… cause it’s not, it’s not a risk until I’ve 
gone through it. And also, with homeless people is like “What else do we have to lose?”, they’ve 
taken everything from us. By the point that I am, our lives aren’t worth that much. They might be to 
other people, to us… they’re not worth that much so the risk becomes a lot less than it would be to 
you. You would assess the risk of my life greater that I would. Does that make sense? I know that’s 
sad. Sorry… (cries)” (Joan, 27 years old; interview). 
4.2.4. Intersectional stigma 
 The intersection of different stigmatised identities of WOST was one of the main findings of 
this research. The findings in relation to intersectional stigma experienced by WOST were written and 
submitted for publication to the journal Social Science & Medicine. The first submission was on the 
13
th
 of June 2018. The manuscript went through three rounds of revisions and was accepted for 
publication on the 14
th
 of January 2019. The paper was published on 17
th
 of January 2019. The 
publication is presented below as it is published online.  
4.2.4.1. Publication 
 Reference: Medina-Perucha, Scott, J., Chapman, S., Barnett, J, Dack, C. & Family, H. 
(2019). A qualitative study on intersectional stigma and sexual health among women on opioid 
substitution treatment in England: Implications for research, policy and practice. Social Science & 
















































 This publication highlights the experiences of intersectional stigma of WOST and how 
these relate to their sexual health and general wellbeing. There was an intersection of stigmas, 
associated with women’s gender, drug use, transactional sex, homelessness and sexual health 
status. Based on women’s narratives, intersectional stigma seems to be a main factor associated 
with the risk of sexual transmission of STIs and BBVs. It also appears to be a barrier for 
accessing sexual health services. The paper highlights how having a socio-structural stance to 
sexual health promotion may be crucial to develop effective public health strategies. Data from 
the focus groups were not included in this publication as stigma was barely discussed in the 
focus groups. The mentions of stigma that were raised in the focus groups were amongst the 
views that were raised in the interviews. These are then represented in the publication, and also 
included in other themes and sections of this chapter.  
The findings in this paper were part of the needs assessment (Step I of IM), that aimed at 
exploring the factors associated with the sexual transmission of STIs and BBVs among WOST. 
The findings discussed in the paper also helped to further understand the needs of WOST in 
relation to STI and BBV prevention, what may work for a pharmacy-based sexual health 
service, and potential barriers for developing and implementing this service. This paper served 
as a publishable part of the discussion and critique of this PhD research, in relation to current 
public health approaches to sexual health among WOST. The discussion and critique were 
driven by the values of this PhD: feminism, equity and human rights. These are further 
developed throughout this thesis, and especially in Chapter 9. 
4.2.4.3. Statement of authorship 
The main author of the paper and this thesis (LMP) led this research, supervised by Dr 
Jenny Scott, Dr Charlotte Dack, Dr Hannah Family, Dr Sarah Chapman and Prof Julie Barnett. 
All members of the supervisory team supported LMP in the research planning, data collection, 
data analyses and write-up of this publication. 
4.2.4.4. Permissions 
Permissions to include the manuscript in this PhD thesis were obtained from Elsevier (see 
Appendix 28) on 29
th
 of March 2018.  
4.2.4.5. Data access statement 
Data associated with this publication can be accessed upon request to the main author of the 





4.2.5. Gender-based violence 
 GBV was a key theme identified in the semi-structured interviews and focus groups with 
WOST. There were three subthemes: 1) the context and nature of GBV, 2) the impact of GBV, and 3) 
social and professional support for GBV. 
4.2.5.1. The context and nature of GBV 
Almost all women disclosed having experienced GBV at some point in their lives. Violence 
against women was mostly perpetrated by men and took place in different periods of women’s lives. 
A few participants thought that GBV was the result of men’s need to exert power, to somehow protect 
their masculinity and social power within a “macho culture”. Some women were sexually abused 
when they were children by family members. Others had experienced intimate partner violence (IPV) 
when they were adults, some with several partners. Experiences of IPV included emotional, physical, 
financial and sexual violence by steady partners. Sexual violence in steady partnerships was difficult 
to identify by some women at the time of the abuse, but they could identify it retrospectively. Some 
women had also been physically and sexually assaulted by transactional sex clients or strangers. 
Random violence from strangers was commonly experienced by homeless women.  
“He was quite abusive anyway and yeah, he had forced himself on me a few times, yeah (…) 
That [IPV] was years ago now and to be fair at the time I didn’t really… think anything of it. It’s only 
as I got older that I realise that it was really wrong…” (Rosa, 40 years old; interview). 
It was common that men forced condomless sex on women in the context of all forms of GBV 
(i.e., IPV, sexual exploitation, violence from strangers or transactional sex clients, child sexual abuse). 
Suggesting condom use in the context of IPV could lead to an exacerbation of violence – emotional, 
physical, financial or sexual –, so women mentioned not suggesting condom use fearing an escalation 
of violence. Women were also powerless in using condoms when sexually abused, assaulted or 
exploited, as they had little or no control over their bodies. A few WOST explained having got 
pregnant from sexual violence.  
“He [ex-partner] was abusive in every way, anyway that he could possibly control me… You 
don’t really get a choice then. You can’t say “You need to use a condom” cause they are not going to. 
And if you’re being held down and it’s against your will there’s nothing that you can do…” 
(Emmeline, 35 years old; interview). 
Some WOST had reported their partners to the police and had gone through legal procedures. 
In a few cases, these partners had gone to prison and had restraining orders. Despite taking legal 
actions, a few women were still harassed, threatened and eventually assaulted by these ex-partners. 





One participant disclosed current IPV by her partner at the time of the interview. She explained how 
she tolerated occasional physical violence as it is not as severe as the violence that her previous 
partner inflicted on her
10
. 
“Hmm… no… well, yeah… well he has… [been abusive] in six years there’s been maybe 
three or four times that he’s hit me, but it’s been like a hit and then he’s been really sorry about it. I 
know it’s still wrong but I think I’m comparing it with the other one, and it’s not too bad (giggles)” 
(Sylvia, 27 years old; interview). 
Women were often forced to engage in transactional sex or shoplift to financially support 
their partner’s drug use, and their own. WOST were also initiated into transactional sex by drug 
dealers, who often coerced women into exchanging sex for money or drugs. In these situations, drug 
dealers often acted as pimps. WOST were especially vulnerable to exploitation and initiating 
transactional sex work when they were withdrawing, as already mentioned in this chapter. WOST 
then appeared to get into transactional sex in the context of GBV. Besides, working in transactional 
sex appeared to make women more vulnerable to GBV. Some clients were aggressive towards 
transactional sex workers and treated them in a disrespectful and violent manner. As a few 
participants explained, some clients acted as if they owned women’s bodies. It was again a vicious 
cycle in which violence and transactional sex went hand-by-hand. 
“My partner, ex-partner, used to take me to the places but, if he wasn’t taking me to the 
places which I suppose that was a certain element of safety there, then I would be getting taxis, men 
coming around my flat… (…) I would give the money to him” (Emma, 27 years old; interview).  
“You can’t demand anything [when working in transactional sex], you are going with guys 
[clients] that are gonna beat the shit out of you if you don’t do as you’re told essentially. You are at 
risk, you are in trouble all the time you are with a guy. Whether it’s on a doorway, getting into their 
car… you are not safe. You’ve got no one watching your back, no one knows where you are, no one 
knows who these people are, no one sees you go… That’s how girls get missing… and get murdered 
and end up in bushes, places, because they’ve just got into the car in the corner” (Joan, 27 years old; 
interview). 
4.2.5.2. The impact of GBV 
A few participants expressed self-blame for having experienced GBV. One woman (Teresa, 
34 years old) explained that she went through IPV because “she was not strong enough”. She showed 
“love and her feminine side” instead of showing her “strong side”. Based on her experience, love 
                                                             
10 This participant was offered referrals for support for GBV. The participant mentioned having discussed this 





was women’s weakest point. According to her, women needed to “stop showing her feminine side and 
show their strong side” so that men could not take advantage of them.  
“I mean I showed my feminine side when I was in a different relationship and I showed my 
love too much. And because I showed my love too much he beat me, he… I hmm had bruises on my 
face, he raped me, he hmm he… he… took control of everything, my money, my life hmm he got me 
pregnant and then I lost the babies. I wasn’t eating, I only ate when he said “You eat” hmm no 
condoms, nothing. Only because what he says goes cause I showed my weak side of myself he took 
control of that” (Teresa, 34 years old; interview). 
For another participant “IPV was good at the time” because it was a way for her to get the 
partner’s attention and “affection” (Harriet, 41 years old; interview). One woman attributed her 
inability to make “the sensible choice” of leaving her ex-partners to drug use, as there was a co-
dependency with her partner to obtain and use drugs (Emma, 27 years old; interview). Another 
WOST, who did not disclose GBV, thought that women were however responsible for their own 
decisions in the context of GBV (e.g., having condomless sex with an abusive partner) (Lucy, 56 
years old; interview).  
“With my boyfriend of ten years sometimes when we had fallen out his punishment…he sort of 
made me have sex with him and make peace afterwards but yeah… (…) For me, cause what I want is 
just affection it was good that he was doing that. I think there wasn’t much resistance (…) And he 
didn’t want me to enjoy it and if I showed that I was enjoying it he’d stop and say “This is for my 
benefit and not yours, stupid bitch”, hit me or something” (Harriet, 41 years old; interview). 
Participants expressed their anger and distrust towards men, and mentioned being emotionally 
detached from all the violence that they had experienced in their lives. They said how they “switched 
off” their emotions when they shared their experiences. Some participants expressed not wanting to 
have sex, as they associated it with negative and traumatic events in their lives.  
“And I’m gonna have to mention what happened to me cause… I have a boyfriend but I don’t, 
we don’t make love because of what happened to me as a child, you know, sexual abuse and all that. 
We are trying to build up our relationship but I’m not, I’m not up together with hmm… I don’t make 
love with my partner” (Sarah, 53 years old; interview). 
This was especially challenging for women who had sold sex. It was difficult for them to have 
sex with romantic partners after having engaged in transactional sex. 
“Again it’s a hard one for me because I don’t… I used to be a prostitute. Sex is not appealing 
to me. Happy if I never have it again, and so it’s hard for me because I just associated it all with that. 
It was work, not pleasure and so none of it is enjoyable to me. I’m quite happy if I never have it again. 





Some WOST feared being in abusive relationships with future partners. Some had avoided 
starting new relationships, and a few others were controlling and aggressive towards new partners to 
protect themselves from violence. WOST mentioned creating emotional barriers to cope with trauma 
and as a way to prevent facing violent situations again. Using drugs was a way to numb their emotions 
and prevented them from dealing with trauma. A few women acknowledged that not expressing their 
emotions was not healthy, but most were reluctant to explore their emotions and get professional 
support for GBV. One participant highlighted that she had grown stronger due to her negative life 
experiences (Emmeline, 35 years old; interview).  
“I can really go through the things [trauma] that I’ve been through like a shopping list, like 
the rape, the kids being taken off me, all of it like a shopping list cause I detach the emotion, I just cut 
the emotion now, and I flick a switch straight away, I go into business mode and I know it doesn’t 
help” (Joan, 27 years old; interview). 
4.2.5.3. Social and professional support for GBV 
There were mixed feelings and experiences regarding the support that WOST had received 
and sought for GBV. Some women had gotten social and legal support to leave, report and cope with 
situations of GBV. This came from significant others (mainly family members), and health and social 
care professionals. Some women were aware that they needed support for GBV although most did not 
seek it out or declined this support. A few women were even pressured into continuing in situations of 
GBV. Other were reluctant to access support services as they feared having to cope with their 
emotions; they would rather “forget about it”. Also, a few women thought that they did not need 
support. One participant appeared to be experiencing nightmares and flashbacks, reliving experiences 
of childhood sexual abuse. She however believed that accessing social or professional support for it 
would exacerbate these symptoms, thus she refused to do it (Anne, 50 years old; interview). 
“Not really, not really [did not get support]. Hmm cause it… cause it happened when I was 
five years old hmm and like hmm the family that I come from I… You know, you don’t really talk 
about stuff like that so I kept it secret for quite a few years and, you know, yeah… you know… It has 
come out if I’m doing hmm some counselling or some therapy but I haven’t sort of, you know, I’m... I 
don’t really wanna go there anymore cause it kind of controlled my life and for a very long time so I 
don’t want go back to it cause it just… you know…” (Marion, 37 years old; interview).  
A few participants talked about experiencing neglect and abandonment from their parents 
when they were children. Especially those that had been sexually abused during childhood felt that 
they had not received the support that they needed then, nor in their adulthood. Even when they 





identified how childhood sexual abuse was a taboo topic which made it quite challenging for them to 
disclose it to their families and get support, especially when the perpetrator was a family member.  
“Yeah, my step dad did [sexually abused her], yeah my step dad did and I got pregnant. 
And… my mum didn’t want me to have the baby and aborted, and she didn’t wanna know what colour 
it [baby] was so that she didn’t let me have it. And she knew, deep inside, that it was his (…) No, she 
[her mother] didn’t want to recognise it [abuse]. And she’s a fucking bitch anyway” (Anne, 50 years 
old; interview). 
Some women had received professional support for GBV. Participants referred to group and 
individual counselling sessions. This support was through drug services or in prison. Most women 
who received support considered that it had had positive benefits. One WOST however mentioned it 
not having been that useful as she did not engage with the counselling sessions. Two participants 
mentioned having got support for GBV from their CPs. Especially women who had received support 
expressed their willingness to help other women, as that could also help them in coping with their 
own past experiences.  
“You know, I’ve done all my, I’ve done all my courses in prison when I was raped. I’ve done 
all my work in prison, right. I know it’s not the best place to do it but I’m doin’ a lot. This is where I 
get my knowledge from. From all the courses that I’ve done, you know? (…) Yeah, I’ve done a 
women’s group and all that” (Eleanor, 38 years old; interview). 
4.2.6. Views and experiences with the health system and community pharmacy 
This theme includes the views that WOST have on 1) (sexual) health services available and 
the health system, 2) services in community pharmacy, and 2) their interactions in community 
pharmacy, with pharmacy staff and other pharmacy clients. Only quotes from the interviews were 
included in this theme as there were very few discussions about health and social care services in the 
focus groups. 
4.2.6.1. (Sexual) health services and the health system 
Participants discussed their experiences and views on the (sexual) health services that they 
accessed. The health settings that women especially referred to were general practitioner’s (GP) 
practices, drug services, community pharmacies and sexual health services. It was apparent through 
women’s narratives that there were gaps between the care that WOST were receiving and their needs. 
Participants were especially aware of services offered in drug services and those that were most 
closely related to their drug use. Most services that women engaged with were exclusively for PWUD 





consultations (e.g., in GP practices), waiting times (e.g., in sexual health clinics), and the need for 
appointments for most health services were barriers to accessing health care for most WOST. 
“Instead of seeing your doctor you could go and see your pharmacist and he [CP] should 
have more control. I think all pharmacists should have more control, you know, as much as the doctor 
and be able to prescribe the right medicines (…) Cause I mean if you want a doctor appointment 
nowadays you’ve gotta plan to be ill cause they “Sorry I don’t have an appointment in two weeks” 
“Yeah, but I need it now” […] Yeah, then I’ve got a five minute appointment and believe me when I 
say five minutes they mean five minutes, cause I know the doctor has a timer running, “ting!”, and off 
you go, it’s a five minute appointment, that’s what they keep saying to you cause when you get in 
there and suddenly you remember everything that’s wrong with you, don’t you (laughs)” (Jane, 51 
years old; interview). 
Overall, accessing sexual health services was perceived to be challenging for most WOST. 
Participants expressed that most free services had age restrictions, thus most women could not access 
them. WOST explained that free condoms were often only available in NEP packs. These were 
exclusively male condoms and only available if they were injecting drugs (or pretending to). Female 
condoms were hard to obtain and use, due to their high cost, limited availability and other barriers 
already discussed.  
“Cause they [condoms] are expensive to buy, it’s embarrassing, you can’t really access them. 
Being a drug addict you can only get condoms in the needle package but other than that…” (Jane, 51 
years old; interview).  
Most women had accessed sexual health services at some point of their lives. GPs were 
generally the first point of contact regarding general health and sexual health concerns. Screening for 
BBVs (especially for HCV) in drug services was mentioned by most participants. A couple of women 
accessed the service as there were financial incentives for screening. Some WOST referred to 
vaccinations also being offered in drug services for viral hepatitis. Most women had also screened for 
STIs at some point in their lives. A few participants mentioned not having discussed or having been 
offered sexual health services before, unless they asked or raised concerns themselves. Other women 
said that sexual health was often covered in health reviews in drug services, although the focus was 
almost exclusively on BBVs and injecting risks. The sexual transmission of STIs and BBVs was 
mostly overlooked. Women explained that staff at drug services changed often and that created 
challenges for them. This was because WOST felt more exposed to potential judgment and stigma if 
they had to explain their life story and health history to different professionals repeatedly. This was 
also seen as a barrier for building rapport and trust with health and social care professionals.  
“I also had a blood test once and my something was high on my blood and the doctor looked 





she hadn’t even noticed that my previous appointment had been for a sexual health check and that it 
was all clear. And, very judgemental, very… she just assumed (…) didn’t give me any advice on 
whether I should get tested or anything like that, she just, I just felt she was being really, really 
judgemental (…) and that was the end of the conversation, she didn’t even look into more reasons 
why these levels might have been effected…” (Rosa, 40 years old; interview). 
Attending sexual health clinics had been unpleasant for most participants, mainly due to 
anticipated and enacted stigma that often translated into negative interactions with health 
professionals (see page 97). Long waiting times and the limited opening hours of these clinics were 
also mentioned to be barriers to accessing sexual health services. Most participants were unaware of 
the location of sexual health clinics in their area. This was exemplified by their unawareness that, the 
drug service where most interviews took place was in the same building as one of these clinics. 
Having sexual health services in community pharmacy could be a way to avoid sexual health-related 
stigma and negative experiences in sexual health clinics, according to a few participants. 
“And going to the clinic [sexual health clinic], it was very embarrassing cause you see people 
and for no reason for them to go into that sort of section but, you know, but then they look at you and 
think “oh you dirty, dirty person”, you know what I mean. And “you’ve got a chlamydia disease, stay 
away sort of thing” (Teresa, 34 years old; interview). 
One participant pointed out the lack of investment in sexual health in the UK, and how the 
health care system in the UK should focus more on disease prevention rather than “just” investing in 
treatment (Joan, 27 years old; interview). Overall, participants felt socially excluded by the system 
and called for new and improved services that addressed their needs. Being able to access free sexual 
(and reproductive) health services was one of the unmet needs that participants had identified.  
“Cause it’s all about solution, like the treatment afterwards. It needs to be more about the 
prevention first in my mind. It’s the same with everything, we are all about solving the problem once 
it’s there, never about fixing it before it happens […] It’s all government workers and it’s us against 
them. We need to know someone is on our side that we can go to and know that if it goes any further it 
will do the best to help us because they’re on our side” (Joan, 27 years old; interview).  
4.2.6.2. Services in community pharmacy 
All participants taking part in the study were collecting their OST in community pharmacies. 
Most were on supervised daily treatment, and one mentioned having non-supervised treatment
11
. 
Another participant had her OST delivered at home due to mobility problems that prevented her from 
                                                             
11 Clients on non-supervised treatment collect their OST in community pharmacy but they are not required to 
take their medication in the pharmacy premises. Clients on supervised treatment are required to take their 





physically attending the pharmacy regularly (Dorothy, 48 years old; interview). Women were at 
different stages in their treatment. Some had just started whereas others had been on OST for years. 
Some women mentioned feeling embarrassed and stigmatised collecting their medication in 
community pharmacy, especially if there were other pharmacy clients around. As participants 
expressed, community pharmacy sometimes lacked the privacy needed for WOST to feel more 
comfortable and to engage in pharmacy services. As already presented in this chapter, intersectional 
stigma was an important barrier for WOST to access (sexual) health services (see page 97).  
“People look at you and you don’t want people, you don’t want people see that you’re getting 
it. But some chemist you don’t have the option to go in… but some chemists would take you to a little 
room but some chemists you don’t have that option and you just have to go to the window. So yeah it 
can be a bit difficult with someone you don’t want knowing your private business and you, you know, 
you have to take it in front of them, you have no choice”  (Sojourner, 27 years old; interview). 
A few WOST mentioned that they were unaware of the services available in community 
pharmacy, apart from the OST and NEP that were the pharmacy-based services for PWUD. Other 
participants talked about chlamydia tests offered in community pharmacy and reproductive health 
services, such as emergency hormonal contraception. However, as already mentioned, there were age 
restrictions to access these services free of cost. Women needed to book appointments with other 
health professional to access these services. Having to do this made it more unlikely for WOST to 
engage in sexual health services.  
“If there was more available to be tested I think more people would be [screening]. I think it’s 
under 23 or something that you can get the free tests kits, but over… it’s a lot more difficult and you 
have to go an book in with the doctor and then you’ve gotta go to the doctor, go to that appointment 
and it’s a bit more difficult, a more time consuming when you’ve got other things to do” (Emmeline, 
35 years old; interview). 
4.2.6.3. Interactions in community pharmacy 
Almost all participants had positive experiences with their current CPs. Positive experiences 
were defined as non-stigmatising interactions based on trust and positive rapport. Rapport and trust 
were built because of the frequent interaction (often daily) between WOST and CPs. WOST explained 
that some CPs were more approachable than others, and that created environments where women felt 
more or less comfortable to engage. According to a few participants, positive interactions also 
depended on clients’ behaviour and willingness to engage with CPs and pharmacy services. As one 
participant mentioned, pharmacists were more educated at the present time, compared to years ago. 
According to her, this translated into a better understanding of WOST’s circumstances and needs  





between women and CPs. Most conversations with CPs were casual conversations that did not get to 
be intimate or include discussions about specific health concerns. In a few occasions, participants 
explained that CPs had been an important support to get out of abusive relationships and to reduce 
their drug use. CPs were sometimes perceived to be more trusting and approachable than other health 
professionals, such as GPs or nurses.  
“I mean a pharmacist saved my life (…) You know, hmm…building a kind of, some kind of 
one-to-one relationship with, you know (…) So, you know, to build up a… my pharmacist is actively 
encouraging me with the, with the hmm you know, the detox come down of the diazepam. It’s a very 
personal thing…” (Amelia, 52 years old; interview). 
Some WOST also had negative experiences in community pharmacy, and one was not 
comfortable with her current CP (Joan, 27 years old; interview). These negative interactions had been 
with CPs, other pharmacy staff and other pharmacy clients. One participant mentioned that there was 
more stigma in small pharmacies (Sojourner, 27 years old; interview). These experiences were 
identified by participants as barriers to engage in pharmacy services. A few mentioned having 
changed pharmacists when they were not comfortable with them. Some WOST expressed not feeling 
understood by CPs and other health professionals. Women felt that health professionals such as GPs 
only knew “the theory” and lacked a comprehensive picture of drug use and WOST’ circumstances. 
Some participants claimed the need to improve the training of CPs and other health professionals, not 
only to increase their knowledge on drug use, but also to be less judgmental and stigmatising.  
“I think that some people [pharmacy staff] are more like... hmm… friendly, you don’t feel 
judged by them, but I think I’ve, certain chemists I’ve been to they just look at you all up like a drug 
user basically and they don’t have time like…. Hmm… certain chemists you are not allowed in there, 
you’ve got to be there an hour and a half before it closes, after it opens you’ve got to wait for ages 
before everyone else gets served and it’s just rude, to everyone cause they’re getting their meth, so… 
it’s just drug use… But yeah, I think that makes a difference” (Sylvia, 27 years old; interview).  
Some women mentioned feeling embarrassed and fearing stigma and discrimination when 
picking up their OST in community pharmacy (see page 97). Building positive rapport and trust was 
then a challenge for most of them. As in other services, this was particularly difficult when pharmacy 
staff changed, as the WOST felt further exposed to being stigmatised and discriminated. There were a 
couple of ideas from participants to avoid stigma and discrimination in community pharmacy. A few 
women mentioned the idea of having separate spaces in community pharmacy for OST clients and 
other pharmacy clients. Another suggestion was to have community pharmacies for PWUD only.  
“Yeah and you go again next time and there’s someone different, and that would put me off, if 
there’s someone different every time… like maybe if there was a group of people, a group of workers 





the next week its’s gonna be… but not that is someone and you’re gonna go and ‘Oh my gosh, it’s 
someone different again and I’m gonna get judged again’ or… you know? It’s the relationship the 
biggest thing” (Florence, 37 years old; interview). 
4.2.7. A sexual health service in community pharmacy 
This theme included discussions around the development and implementation of a sexual 
health service in community pharmacy, alongside OST. The subthemes were 1) acceptability and 
positive aspects, 2) potential barriers, and 3) ideas for the service. Data from focus groups have been 
included in the analysis. However as for the previous theme, quotes from focus groups are not 
included in this section due to the scarce discussions around sexual health services in community 
pharmacy in the focus groups.  
4.2.7.1. Acceptability and positive aspects 
Most participants agreed that developing and implementing a sexual health service alongside 
the OST in community pharmacy would be a good idea. The service could provide support and 
address the sexual health needs of WOST. Community pharmacy was seen as an acceptable and 
convenient setting for sexual health services. According to some participants, community pharmacy 
was a better setting than others (GP practices, drug services) as there was no need for an appointment, 
anonymity and confidentiality were typically ensured, and CPs were often more approachable than 
other professionals (e.g., GPs).  
“Sexual health, yeah… it’s good to have the option there, it needs to be. I think people find it 
hard to ask for the Hep [Hepatitis]… to do a chlamydia test or any of this and that, you know. Most of 
the signs are being there, but most people wouldn’t know that they have it there, but I think if the 
support is there, because I’ve been a working girl [transactional sex worker] before and it’s hard to… 
sometimes you feel that people judge you for doin’ it… but yeah, it’ll be good to have the option there 
instead of having to go to the doctors and…” (Marie, 29 years old; interview). 
4.2.7.2. Perceived barriers 
WOST identified several barriers to having sexual health services in community pharmacy. 
Experiences of intersectional stigma were one of the key barriers discussed by women (see page 97). 
The taboos of sex and sexual health were associated with intersectional stigma. Discussing these 
topics was, for most women, a source of embarrassment and increased the fear of being stigmatised. 
Some participants thought that some WOST could feel judged and stigmatised if offered sexual health 
services. There were individual differences about this though, as a few participants expressed being 
open and willing to discuss sexual health. Fear of a positive diagnosis was another barrier identified 





“It’s just making people aware that it’s there if they need it… (…) I mean there is screening 
for Chlamydia and all that, but all the other ones… [STIs and BBVs] I think people get so scared of it 
[HCV], they don’t wanna do it [screening], they don’t wanna know the truth if they have it or not” 
(Marie, 29 years old; interview). 
Rapport and trust with health and other professionals was crucial for most WOST in order to 
engage in services, including sexual health services. According to the participants, having good 
rapport and trust with CPs and other professionals would promote women to discuss sensitive topics. 
Having these discussions in a private space in community pharmacy was key. Still, WOST thought 
that some women might still feel stigmatised and singled out if being offered sexual health services. A 
few ideas were suggested to overcome women feeling judged. First, WOST suggested that staff in 
drug services could introduce sexual health services available in community pharmacy. Other ideas 
were that CPs gave out questionnaires to complete rather than having a one-to-one conversation to 
initiate the service, and/or having advertising materials (e.g., leaflets or posters) to help WOST ask 
about the service.  
“Yeah, yeah, it could be, it could be that ‘What are you trying to say?’ But… I mean, I 
suppose it depends on who you are, because I would think ‘Oh, you actually care and you’re 
worried’, but then… I suppose some people would feel judged. But anyway you’re not gonna win 
either way because it’s gonna be hard, but all you could do I suppose is that if that person feels 
judged it’s just that they, I don’t know… you are doing it as a survey or something so that they don’t 
feel judged, make it like a survey or… instead of coming up straight with it” (Florence, 37 years old; 
interview). 
Having had traumatic experiences (e.g., GBV), was also perceived to be a barrier for 
engaging in sexual health and other health services (see page 106). For instance, one participant talked 
about her struggles accessing sexual and reproductive services. She explained how doing so could 
trigger her feelings in relation to previous traumatic experiences, and that was something that they 
avoided: 
“Yeah… I did have a breast… done [mammogram]. It was uncomfortable but I managed 
myself to do it so that (…) it was good but I resisted that for all those years (…). It’s really hard to 
think about sexual… things. But I should have smears and things like that but I never do” (Sarah, 53 
years old; interview). 
Some women would feel especially reluctant to engage in services if the professional 
delivering them was a male. Related to this, it was important for the participants to always be given 





 “Some like talk to women, some might… this is where you might [unintelligible; have a 
challenge] a little bit cause some have got men, some have got women” (Eleanor, 38 years old; 
interview). 
Allowing enough time to deliver these services was also important for some WOST. These 
participants explained that some CPs (and other professionals) appeared to be very busy at times. This 
made them reluctant to engage in services and even share concerns about their health and treatment. 
Having to wait long to access services was another time-related constraint mentioned for most WOST.  
“Some people you think like they look busy and ‘Oh, I don’t wanna ask them’, they look 
miserable or you get some ego you know. Like at least my chemist you know that you can, you can 
approach him and he’s not gonna judge you, he’s always got time for you… you’ve got times that he’s 
on a rush and you think ‘Oh, I don’t wanna… forget it, forget it’” (Florence, 37 years old; interview). 
As women explained, their own engagement in services also depended on their drug use and 
their progress with OST. Participants thought that women who were using drugs heavily would be 
unlikely to engage in services because of the lack of prioritisation of their (sexual) health, and the 
effort that implied attending services (e.g., waiting times). If WOST were feeling unwell, for instance 
experiencing withdrawal symptoms, they would also be less likely to access services. 
“But when you’re in addiction… you’re barely able to function, you’re desperate to get better 
and then, for example, benefits… you have to like jump through all these queues and spend two hours 
on the phone to get anywhere and it’s just, it’s just not realistic” (Emma, 27 years old; interview). 
A few participants also highlighted that women using drugs who were not accessing services 
regularly could not benefit from the sexual health services in community pharmacy. There were 
suggestions to broaden the scope of the service so that it could reach and meet the needs of other 
women using drugs.   
4.2.7.3. Ideas for the service 
According to most participants, sexual health services in community pharmacy should be free 
of cost and delivered in private. A few WOST suggested offering financial incentives or vouchers to 
promote women engaging in the service. According to one participant, appointments could be 
arranged to deliver the service (Amelia, 52 years old; interview), although most women suggested that 
services should be delivered opportunistically in order for them to be successful in engaging women. 
WOST also thought that CPS and other pharmacy staff should be appropriately trained to deliver the 
service. Women should be allowed to decide whether they would like to engage in the service, so as 





“Letting people know that the information is there and if they can go to them [CPs] if they feel 
they [WOST] need to without sort of pushing too much… (laughs) So that they know that they can get 
information available there (…) so not pushing it too much so that you think that you’ve been singled 
out” (Sylvia, 27 years old; interview). 
Most WOST agreed that the service had to include the provision of information to increase 
women’s knowledge on sexual health. A few participants thought that this was especially important 
for HCV. Suggestions of the information that should be given were in relation to the routes of 
transmission and symptoms, preventive methods, how and where to screen for STIs and BBVs, and 
treatment (what, where, how). WOST suggested that this information could be provided in leaflets 
and posters in community pharmacy. However, there were women who thought that they would not 
usually look at leaflets. These were available in drug services but mostly disregarded. Apart from the 
written information, another idea for the service was to have a regular health review or assessment in 
a private consultation with their CPs. Another idea was that sexual health should just be added onto 
the general health review that women already have in drug services and community pharmacy. Also, 
one participant suggested having a free and anonymous phone line available for sexual health 
concerns and advice (Eleanor, 38 years old; interview). Increasing knowledge was seen for WOST as 
a way to also increase risk awareness and access to sexual health services (e.g., screening).  
“Yeah, I think there should be a lot more information about what, what you could catch. 
Cause people know about chlamydia, it’s the one that people always talk about. And it could be 
symptomless so you don’t know… but not really many others are talked about” (Emmeline, 35 years 
old; interview). 
A few WOST thought that the service could also include reproductive health services, such as 
contraception, emergency hormonal contraception and pregnancy tests. For a few women, there 
should be a focus on preventing unwanted/unplanned pregnancies and terminations.  
“Pregnancy test, rather than going to the doctor… cause it’s really important if you can’t get 
to the doctor for two weeks and you’re on drugs and you are pregnant, you need to get a test there 
and then. It’s really important. And if you’ve got no money, you know, I don’t think it should be like 
“Oh you haven’t got any money so you can’t have a pregnancy test”. I don’t think that’s fair” 
(Emma, 27 years old; interview). 
WOST thought that the service should also include the provision of free condoms, screening 
services and treatment. Increasing women’s confidence negotiating condom use and having trusting 
relationships was another key aspect suggested for the service. A few participants thought that the 
service could increase women’s risk awareness to promote screening and treatment. Two participants 
mentioned that this awareness raising should focus on preventing future infertility from untreated 





“But yeah I suppose it makes sense in the chemist if you could get free condoms if you needed 
them that would be of a lot of help I suppose (…) Put a little bit more awareness there for people. And 
yeah… it would make it [accessing sexual health services] less embarrassing to access things like that 
so yeah, it’s a good idea” (Sojourner, 27 years old; interview). 
Participants thought that sexual health services in community pharmacy should be advertised. 
There were different suggestions about how to advertise the service but, overall, the idea of 
advertising was to engage women in the service. A few WOST mentioned that the service could be 
first advertised in drug services so that women were aware of the services that they could access in 
community pharmacy.  
“Yeah, I mean cause I didn’t know they had service unless they gave me that information so… 
so really, you need to know everything about this. And if you don’t you will have to ring around, don’t 
you? I mean I wouldn’t know that [pharmacy chain] do a stop smoking unless they told you about it, 
and they certainly let you know about that ain’t they?” (Dorothy, 48 years old; interview). 
The use of visual materials, such as posters and leaflets in community pharmacy and other 
services such as drug services, was also discussed. A few participants mentioned the example of 
chlamydia screening being advertised in community pharmacy. Word-of-mouth was also mentioned 
as a way of spreading the word about the sexual health service within communities of PWUD. 
Advertising in other settings (e.g., homeless shelters) were other ideas to engage groups of women 
using drugs that may not be accessing drug services.  
“And the thing is that even for not all the people that don’t use, or the needle exchange or 
have a script like, the people that do have to talk to the people that don’t have about… they offer that, 
you know the word of mouth would make people realise that they offer that you know, and they would 
talk to other people about that” (Lily, 36 years old; interview). 
4.3. Summary 
 Seven themes were identified through the narratives of WOST in semi-structured interviews 
and focus groups. Data presented highlighted factors that may be associated with WOST’s higher risk 
for STIs and BBVs. These factors were at different social ecological levels, although most were socio-
structural factors (e.g., experiencing GBV). Women also discussed their views on the health and 
social care services that they access, and the opportunities for having sexual health services in 
community pharmacy.  
Experiences of intersectional stigma and violence were key themes, as well as women’s 
feelings of worthlessness, powerlessness and helplessness. WOST’s narratives were dominated by 





Using drugs had often become women’s main priority when they were heavily using and, as 
participants discussed, this took over any other area of their life (including their sexual health). 
Having enough knowledge and risk awareness were important elements to engaging in protective 
behaviours but these appeared to be insufficient for women to prevent STIs and BBVs in sexual 
interactions (i.e., by using condoms). Accessing health services was challenging as it exposed women 
to being stigmatised and discriminated. There seemed to be important gaps between the services 
available and WOST’ sexual health needs. Also, between the understandings of professionals working 
with WOST and the realities of this group of women. Overall, the acceptability for having sexual 
health services available in community pharmacy was good. However, there were important barriers 
that need to be considered for service design and that may challenge the implementation of these 
services.  
It is important to note that women discussed their experiences of sex and sexual health 
throughout their lives, and especially relating these experiences to their drug use. Although women 
often spoke about their experiences retrospectively, there was not a particular focus on how being on 
OST or accessing drug services could have improved their situation or sexual health. In fact, most 
women taking part in this research were still living in complex situations as the ones described in this 
chapter and PhD thesis. This could suggest that the issues raised by WOST may be relevant to women 
using drugs in general. Besides, some of the factors that may increase WOST’s risk for STIs and 
BBVs may be common to all women (e.g., GBV).  














CHAPTER 5. The Views of Community Pharmacists 
This chapter presents the findings from the semi-structured interviews and the focus group 
with CPs. All data collected were linked to all the aim and objectives of this PhD study (see Chapter 
1, page 10). 
5.1. Participant Characteristics 
This section contains data on the demographics, job characteristics and characteristics of the 
community pharmacies where participants worked at the time of the research. Participants taking part 
in the focus group had also been interviewed. Since these were two different stages of this research, 
data analyses for participant characteristics were performed separately. Participant characteristics are 
presented separately, for CPs that participated in semi-structured interviews and those that 
participated in the focus group. 
5.1.1. Semi-structured interviews 
 Fourteen CPs took part in individual semi-structured interviews. There were seven men (50%) 
and seven women (50%). The age range was between 25 and 57 (M=36, SD=9.46). Most were British 
(n=5, 35.7%) and white European (n=4, 28.6%), and for half English was their primary language. All 
participants had completed at least a first university degree (n=7, 50%) or a postgraduate qualification 
(n=6, 42.86%). All participants were working full-time and were responsible for delivering OST. 
Most had a job role that involved some pharmacy management responsibilities (n=11, 75.57%). See 
Table 8 for further details.  
Table 8 
Demographics and Job Characteristics of Community Pharmacists Taking Part in Semi-Structured 
Interviews 
Sample Characteristics (N=14) n (%) 

































Postgraduate certificate of education (PGCE) 








Work ≥ 16 hours /week 


















Time being a pharmacist (in months) M=145.64 (SD=124.69) 
(12.14 years) 
Responsible for OST 14 (100) 




 The type and location of community pharmacy participants worked at were mixed. Six 
worked in independent pharmacies (42.9%), four in national chains (28.6%), three in medium chains 
(21.4%), and one in a small chain (7.1%). The community pharmacies where participants worked 
were co-located with a GP surgery (n=4, 28.6%), located in a city centre (n=4, 28.6%), town centre 





participants worked offered advanced and locally commissioned services, but not all had private 
services (i.e., non-NHS services) available. See Table 9 for more details.   
Table 9 
Characteristics of Community Pharmacies Where Participants Taking Part in Semi-Structured 
Interviews Worked at the Time of the Research 
Pharmacy characteristics (N=14) n (%) 






















Prescription volume/day (n=11) M=379 (SD=217.56) 
Advanced services 
Medication use reviews 
New medicine service 
Stoma appliance customisation 








Locally commissioned services 
Alcohol screening and brief intervention 
Anticoagulant monitoring service 
Care home support and advice 
Chlamydia screening and treatment 
Vaccination services 
Domiciliary support 















Minor ailments service 
Needle and syringe programmes 
NHS health check 
Out of hours 
Sharps disposal service 
Stop smoking 
Supervised administration 













Vitality health check 














5.1.2. Focus group 
 Three CPs took part in a focus group, two women (66.7%) and one man (33.3%). The age of 
the participants was between 27 and 51 (M=35.67, SD=13.32). Participants were British (n=2, 66.7%) 
and Indian (n=1, 33.3%). All had English as their primary language. All participants had completed a 
first university degree, were working full-time, and were responsible for delivering OST. Participants’ 
job roles were superintendent pharmacist (n=1, 33.3%), pharmacy manager (n=1, 33.3%), and 
medicines inspector (n=1, 33.3%). This last participant had left community pharmacy and started her 












Demographics and Job Characteristics of Community Pharmacists Taking Part in the Focus Group 
Sample Characteristics (N=3) n (%) 

































Time being a pharmacist (in months) M=144.67 (SD=166.21) 
(12.05 years) 
Responsible for OST 3 (100) 




 CPs participating in the focus group worked in national chains (n=1, 33.3%), small chains 
(n=1, 33.3%), and independent community pharmacies (n=1, 33.3%). Community pharmacies were 
located in a health and beauty store (n=1, 33.3%), the centre of a village (n=1, 33.3%), and the centre 
of a city (n=1, 33.3%). They all delivered advanced and locally commissioned services. None of the 






Characteristics of Community Pharmacies Where Participants Taking Part in the Focus Group 
Worked at the Time of the Research 
Pharmacy characteristics (N=3) n (%) 
Type of pharmacy 
National chain 
Small chain 













Prescription volume/day (n=11) M=373 (SD=141.89) 
Advanced services 
Medication use reviews 
New medicine service 
Stoma appliance customisation 








Locally commissioned services 
Alcohol screening and brief intervention 
Anticoagulant monitoring service 
Care home support and advice 
Chlamydia screening and treatment 
Vaccination services 
Domiciliary support 
Emergency hormonal contraception 
Emergency supply 
Minor ailments service 
Needle and syringe programmes 
NHS health check 
Out of hours 






























5.2. Main Findings 
The aims of the interviews with CPs were to explore 1) the role of CPs promoting sexual 
health among WOST, 2) their experiences working with WOST, 3) their understanding of the factors 
associated with sexual health risks among WOST, and 4) their views on a sexual health service for 
WOST in community pharmacy. Following the semi-structured interviews a focus group was 
conducted to obtain feedback from participants on the findings from the interviews. This was an 
opportunity to clarify findings and gain new insights on the same issues using a different research 
method. Data were analysed using FA (semi-structured interviews) and QCA (focus groups) (see page 
28). An analytic framework was developed and included six themes and related subthemes (see Table 
12).  
Table 12 
Analytic framework: community pharmacists 
 Themes Subthemes 
1 Stigma and discrimination Pharmacy staff 
Other pharmacy clients 
2 Humanity Trust and rapport 
Empathy and compassion 
3 Communication Taboo of sex and sensitive topics 
Managing conflict 









Sexual (and reproductive) health 
Skills and training 
6 A sexual health service for WOST Acceptability 
Components of the service  
Potential barriers 
 
5.2.1. Stigma and discrimination  
Discussions around stigma and discrimination towards WOST were prevalent in the 
narratives of CPs. Stigmatising attitudes and discriminatory behaviours involved CPs themselves and 
other pharmacy clients. 
5.2.1.1. Pharmacy staff 
Discussions around stigma and discrimination towards WOST were present in most 
conversations with CPs. WOST were seen as a challenging group of clients, and data suggested that 
some CPs behaved in a discriminatory way towards them. Some even refused to provide OST in their 
community pharmacies. Power imbalances between pharmacy staff and WOST were mentioned, and 
participants referred to WOST and other PWUD as having a lower social status compared to people 
who did not use drugs. According to one participant, these power inequities “were generated by 
clients themselves” (Peter, 25 years old; interview). A few participants mentioned that CPs and other 
pharmacy staff should undertake training in stigma and discrimination, to deliver services and work 
with clients in community pharmacy. 
“People should not be in the job if they don’t treat people, everyone as humans basically, so 
manage to sort of don’t know, teach non-judgemental at pharmacy school” (Matthew, 51 years old; 
focus group). 
Based on the narratives of CPs, pharmacy clients (and people in general) seemed to be 
dichotomised into “normal” and “not normal”. Participants referred to WOST as “not normal” as 
they did not conform to a socially acceptable lifestyle, compared to other people in the community. At 
the same time, CPs seemed to place themselves within the “normal people” group. This appeared to 
create a divide between CPs and WOST that may hinder good communication and positive 
interactions. Clients were sometimes blamed for their drug use and lack of progress, and there was a 
general lack of empathy and compassion towards WOST. Nonetheless, CPs verbalised their 
willingness to support WOST in their progression. The type and level of commitment to providing 





“Hmm… I don’t know if we can change something… anyways I think it’s depending on the 
person you are talking to… if they want to give up at some point and they want to be normal (laughs) 
like the rest of us but… I don’t know… as a pharmacist if I can change something… as a person I 
don’t think… maybe something like a programme or I don’t know, something more…” (Susan, 35 
years old; interview). 
Most stigmatising attitudes towards WOST appeared to be associated with women’s drug use. 
A few participants believed that WOST and other PWUD initiated disease outbreaks within the 
general population and they were considered to be a “public hazard”. The intersections of drug use-
related stigma with transactional sex-related stigma and HIV-related stigma were also identified.  
“At some point you are… exposed to a risk as well, dealing with them [OST clients], dealing 
with an HIV positive… means that you are exposed to a problem and you, we have to be very careful” 
(Fred, 36 years old; interview). 
The stigmatising attitudes of a few CPs also highlighted the lack of understanding and 
empathy towards WOST and their circumstances. For instance, one participant stated that “OST 
clients have the aggressive behaviour in themselves” (Peter, 25 years old; interview). This may be a 
rather simplistic explanation for clients’ anger and hostility but also highlights the misconceptions 
held about the nature and context of drug use. It also implies that CPs may be expecting WOST and 
other OST clients to behave aggressively. Another participant stated that she only wanted to serve 
“the happy OST clients” (Susan, 35 years old; interview), referring to those that were trying to stop 
using drugs as opposed to those that were not planning (or were not ready) to quit. Cultural 
differences could partly explain these attitudes and behaviours among a few participants. This was 
clear for one particular CPs that was not familiar with OST provision before moving to the UK and 
explained how she could not understand at first “why the government would give free drugs to those 
people” (Susan, 35 years old; interview). 
Some participants explicitly expressed not holding stigmatising attitudes towards WOST, 
while a few held stigmatising views and used stigmatising and dehumanising terms such as “blue 
scripts”, “junkies” or “drunks”. Others seemed to be aware of their own attitudes and tried to 
challenge them (e.g., trying to avoid using the term “not normal” to refer to WOST). According to a 
number of CPs, other pharmacy staff (e.g., counter assistants) might hold more stigmatising views 
towards WOST due to the lack of training. Some CPs also mentioned that WOST may fear being 
stigmatised and discriminated in community pharmacy because of their drug use. Also, they may feel 
“singled out” if being offered sexual health services as drug use is stereotypically associated with 
sexual promiscuity and disease (e.g., HIV/AIDS). WOST may anticipate and fear being stigmatised, 





“I’ve got a good rapport with them I’m not uncomfortable asking those questions and they 
would.  But on the other hand I can understand somebody coming in as a locum or maybe a male or 
somebody who they [WOST] think is going to be judgemental then yes it would [be uncomfortable to 
discuss sexual health]” (Martha, 57 years old; interview). 
5.2.1.2. Other pharmacy clients 
Community pharmacies offer services for the general public and specific populations such as 
WOST. On rare occasions, non-OST pharmacy clients were stigmatising and openly discriminatory 
towards WOST. Non-OST pharmacy clients sometimes commented on WOST’s drug use and OST. 
These comments were mostly made to pharmacy staff but also directly to WOST. The ways CPs dealt 
with these situations varied. In some circumstances, CPs had intervened and supported WOST. Other 
CPs were reluctant to intervene for fear of losing pharmacy clients and risk affecting “the image of 
the pharmacy”. This was another example of stigmatising attitudes held by CPs themselves. Some 
CPs commented on how some pharmacies with a high number of OST clients had significantly lost 
other types of clientele, supposedly due to OST provision. One participant called for the need to 
educate non-OST pharmacy clients about the experiences of WOST to promote empathy and 
compassion, and as a way to decrease stigma and discrimination.  
“Hmm it’s not a strict relation between the, like how their physical appearance is to the drug 
misuse but they do happen sometimes that people can see, they can feel that you might be that kind of 
patient and they have that in mind. And, for them, the image of the pharmacy might be affected, ‘Oh, 
it’s always full of this kind of people in this pharmacy so I will go to another pharmacy’” (David, 25 
years old; interview).  
5.2.2. Humanity 
This theme referred to providing a humane treatment to WOST and attitudes that somehow 
attempted to lessen the impact of stigma and discrimination towards this group of women. This 
humane treatment implied thinking of WOST as human beings (and like any other women) and 
providing a treatment that was not based on women’s drug use but rather one that any woman might 
need. There were two subthemes identified: 1) trust and rapport, and 2) empathy and compassion.  
5.2.2.1. Trust and rapport 
There was a contradiction on how CPs viewed their interactions with WOST. Participants 
defined these as generally positive, while they were also stigmatising (see previous theme) and all 
reported several negative encounters. Participants identified trust and rapport as key aspects for 
having positive interactions with WOST. Building trust and rapport was facilitated by the frequent 





participants mentioned how trust and rapport were dependent on both the attitudes and behaviour of 
clients, and their own: “If the patient is friendly they will be a little bit more personal relationship, I 
mean as a rapport yeah…” (Peter, 25 years old; interview).  
CPs’ stigmatising attitudes and discriminatory behaviours towards WOST were important 
barriers for developing trust and positive rapport with clients. For instance, part of the role of 
delivering OST involved ensuring that clients had swallowed the medication. There were different 
approaches to doing this that had an influence in the trust and rapport with clients. A few CPs 
mentioned that they asked clients to open their mouths after administering the OST, and how this had 
led to arguments with some clients that refused to do so. Other CPs would use other strategies to make 
sure that clients had indeed taken their medication, such as simply having a conversation with their 
clients. In this second example, CPs paid attention to protecting trust and rapport with their clients. 
Similarly, a few CPs expressed threatening clients “if they do not behave well”, which could again be 
damaging trust and rapport. On the other hand, some CPs also explained how they would express their 
concern to clients if clients were feeling unwell, or would remind clients to pick up their medication 
so that their script was not cancelled
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. CPs explained that these actions increased trust and rapport 
with clients that could help engaging clients into services and continuing attending that particular 
pharmacy.  
“When you’re getting trust and again it’s about being open with them hmm back treating 
them like a human being rather than… a piece of filth hmm and when you gain that trust, when you 
gain that relationship with them, that’s when they start opening up” (William, 42 years old; 
interview). 
Trust and rapport were crucial to engage WOST in services and have conversations beyond 
their OST and their drug use. This also applied to delivering a sexual health service, for which trust 
and rapport were identified as important factors that could avoid WOST feeling judged and 
stigmatised. CPs felt rapport was also required for them to feel comfortable having these discussions 
and delivering services to WOST. A few participants expressed how they generally distrusted WOST 
and deemed them as “lost causes”. This seemed to be related to the stigma associated with WOST and 
other PWUD, as presented in the previous theme. Most CPs found it rewarding to work with this 
group of clients and oversee their progress in decreasing OST. At the same time, some clients never 
progressed, or their progress was erratic. This was frustrating for most CPs, especially for those that 
seemed to be more involved in accompanying and motivating clients with their treatment progression. 
These participants linked their commitment with more humane interactions and trusting relationships 
with their clients, although they also called for the need of setting professional boundaries and “not 
                                                             





getting too involved”. Trust and rapport were more difficult to build with unstable clients, as was 
engaging them in services. One participant also said that clients might be reluctant to have discussions 
around sexual health as it would be shameful and might damage the rapport with the CPs (Peter, 25 
years old; interview).  
“It all depends on the rapport you have got with them if you know them relatively well and 
you get on with them well and there are no negative issues between you, starting the conversation 
might okay, we don’t like talking about it anyway. But starting the conversation would be a hell of a 
lot easier than if you had that sort of, that sort of barrier and you didn’t know them well enough, or 
well at all to sort of do it” (Olivia, 27 years old; focus group). 
Trust and rapport were sometimes damaged when there were incidents with clients in the 
pharmacy. Although these were more commonly involving men on OST, there were also incidents 
involving WOST. Whilst CPs explained these incidents were not common, they were mentioned by 
all CPs as a negative and challenging side of delivering services to WOST. These incidents included 
arguments between clients (on OST and other pharmacy clients) and between clients and pharmacy 
staff. Shoplifting and trying to divert OST to other PWUD were other types of incidents. When these 
incidents occurred, it posed a challenge to the relationship between CPs and WOST. In cases where 
clients were banned from the pharmacy, the trust and rapport were broken. According to the 
participants, this had a negative impact on clients’ future engagement in services and CPs’s lack of 
willingness to deliver services. Anger and blame towards WOST were common in the narratives of 
CPs when discussing these incidents, and a few participants even mentioned their reluctance to work 
with WOST as a result of these negative events. Some of their narratives also reflected stigmatising 
attitudes: 
“They are people, we have to treat them as people so… they look okay, until they are stealing 
something for example (laughs). Then you start asking ‘okay… so I shouldn´t trust in this one…’” 
(Susan, 35 years old; interview). 
According to the participants, locum pharmacists
13
 were less trusted as it was more difficult 
for them to build rapport with WOST due to the less frequent contact. Based on the CPs’s narratives, 
WOST did not like change and preferred being served by their regular pharmacist rather than 
someone “new” or not “as trusted” (e.g., locum pharmacist). Clients were also more likely to 
disregard the pharmacy rules (e.g., divert OST or shoplifting) when regular pharmacists were not 
present.  
                                                             





“But in terms of arguments really, when we get the arguments really we do have some 
arguments sometimes with not regular pharmacists or the… for example I have my replacement who 
is not a regular then they might get sometimes some clashes because of the waiting time or maybe a 
bit… about different things and… so that’s why the, the kind of… that rapport is very, that rapport is 
very important between the client and the service provider and cause it would´ve minimised this kind 
of, this sort of incidents. So… often people kind of shoplift for example when I am not there or my… 
they might get involved in kind of arguments with the locum pharmacist for example…” (James, 32 
years old; interview).  
Time constraints were important barriers to building trust and rapport. Time was limited due 
to the workload of most CPs. At the same time, CPs expressed how clients were mostly “in and out” 
of the pharmacy and they did not seem interested or able to spend longer time in the pharmacy. Thus, 
the interactions between CPs and WOST were short and in a public space which limited the 
opportunity to build rapport and trust. Despite the limited time, some CPs still had informal chats with 
clients when they were picking up their medication. Doing this was seen by participants as a way to 
then involve clients in other services and ease having conversations around sensitive topics such as 
sexual health.  
“I think, you meet clients and yeah you see them every day but they are only in your 
pharmacy for a minute two minutes you know, you don’t, you sort of say ‘hi, how’s your day’ and they 
are off out again. Sometimes they stay and chat but you don’t really get to know them” (Julia, 29 
years old; interview). 
According to a few CPs, trust and rapport were more difficult to develop in big pharmacies 
and community pharmacies in the city centre. These were considered to provide a more impersonal 
and less humane service to clients. Time was also more limited in these pharmacies as they usually 
had a higher volume of clients. Likewise, negative incidents involving WOST were more common in 
big pharmacy chains for the same reasons. Pharmacy staff changed constantly, and in some 
community pharmacies, there were security staff that both increased clients’ experiences of stigma 
and hindered trust and rapport with pharmacy staff.  
“I think a lot of them especially don’t seem to like the big stores where there is change overs 
of staff and sort of security guards staring at them that sort of thing (…) Yeah so I would say a lot of 
them prefer the sort of environment here [independent pharmacy] and the fact that almost we tend to 
go on first name terms with them whatever name they like to be known by and it’s quite relaxed which 
leads to relaxed but hopefully sort of the… (laughs) relaxed but professional that’s what I’m trying to 
say not sort of inviting them home for cups of tea or anything like that but yeah I think they feel 





5.2.2.2. Empathy and compassion 
A few CPs were particularly empathetic and compassionate towards WOST. They seemed to 
be aware of the personal problems that their clients might be experiencing or have experienced in the 
past. These CPs could also see how such experiences could be related to their drug use and 
vulnerability to sexual health risks. These participants mentioned gender inequities, GBV, poverty and 
multiple diagnoses as factors for using drugs and/or having a poorer sexual health. Also, they 
understood WOST’s involvement in transactional sex as a means for surviving and obtaining drugs. 
One participant also explained how clients’ drugs might be used to numb emotional pain, for example 
from experiencing violent situations (Martha, 57 years old; interview). Another participant claimed 
that women needed to be more empowered in their relationships with men. Empowering WOST was 
for him a key factor to boost their self-worth and self-love. This participant had identified and offered 
support to clients in situations of GBV. He however explained how it was a difficult area as often 
perpetrators attended the same pharmacy and that women might be afraid of disclosing violence to the 
CPs fearing retaliation. In these situations, communication with other professionals was crucial 
(William, 42 years old; interview). A few CPs were also aware of the need to apply safeguarding 
protocols as WOST are a particularly vulnerable and marginalised group.  
“Then you find that they are on antidepressants and they have problems with depression and 
I do see that with a lot of our clients and especially the seasonal because again they’ve never sort of 
been able to get their life together they do have this sort of let’s say not being shown boundaries when 
they were younger not know how to conform to society they are isolated they’ve never been able to 
hold down stable relationships and therefore they are unhappy. So it can come from one thing and it 
can also come with the link from the emotional pain that you’ve been trying to numb with the drugs 
so” (Martha, 57 years old; interview). 
A few CPs showed empathy and compassion towards WOST and that is worth mentioning. 
These participants expressed how some WOST lived “very normal lives” (Barbara, 38 years old; 
interview) and are “like any other woman” (William, 42 years old; interview). This perception of 
normality versus non-normality may be stigmatising per se, as already discussed. However, in this 
context it signified a way of advocating an equal treatment of different groups of clients (and social 
groups). Overall, delivering services in a non-judgmental and non-stigmatising way was seen as a way 
for engaging clients in services and their progress. This was however difficult because CPs did not 
have as much information about the clients compared to other professionals working with them (e.g., 
social workers). Empathy and open communication were also key to managing negative incidents in 





“Respect, self-respect umm a lot of women a lot of addicts don’t have any respect for 
themselves. Umm… and about trying to build them up and making them realise that human and they, 
they shouldn’t be so hard on themselves umm… and allowing them that respect. So you give them 
their respect when they walk in the door, it’s theirs to lose but you give it to them to start off with that 
is the base line” (William, 42 years old; interview).  
5.2.3. Communication 
Communication was a recurrent theme in the narratives of CPs. There were two subthemes 
identified: 1) taboo of sex and sensitive topics, and 2) managing conflict.  
5.2.3.1. Taboo of sex and sensitive topics 
Sex and sexual health were treated as taboo topics and were not generally discussed in 
community pharmacy unless in the context of delivering sexual health services (e.g., emergency 
hormonal contraception). Only a couple of CPs had talked about sexual health with WOST. These 
discussions generated feelings of shame and embarrassment among CPs and, according to CPs, 
among some WOST. A few CPs questioned the appropriateness of discussing sexual health and other 
related topics (e.g., transactional sex) in community pharmacy. Male CPs considered that it would be 
more challenging for them to have these conversations with WOST, as some women might be 
reluctant and even refuse speaking to a man about these sensitive and intimate issues. Training female 
staff to deliver sexual health services could be a way to overcome this barrier in pharmacies where the 
CP is a man, according to the participants. As they mentioned, this would be a way to offer options 
for women to engage in sexual health services. 
“Umm… with male pharmacists it may be worth training up a female technician as well just 
in case the client wanted to speak to a female instead about it (…) to give the patients the option” 
(William, 42 years old; interview). 
Some CPs were more open to deliver sexual health services than others. One participant 
mentioned that he would only speak with clients about “joyful things” and avoid sensitive topics to 
prevent loss of clients (Peter, 25 years old; interview). These difficulties in discussing sexual health 
were also associated with time constraints and the fact that most interactions with WOST were not in 
a private space. Overall, these taboos created important barriers to delivering sexual health services. 
“It’s a very sensitive topic hmm… it’s very difficult to initiate hmm… and yes so I think 
hmm… almost some people might regard that as a taboo and shouldn’t be discussing it (…) but you 
wouldn´t initiate it… Because you are a substance misuser then you have to… there is a risk 





that the time is not sufficient enough to pose this sort of questions with clients” (James, 32 years old; 
interview). 
Some CPs were hesitant about starting a conversation on sexual health with WOST, fearing 
that clients would feel stigmatised. They felt especially reluctant to discuss sexual health with women 
that were not of childbearing age, had children already, or were taking contraceptives (e.g., pill). 
Based on the participants’ narratives, not speaking about sexual health with these groups of women 
was a “sign of respect”. This was associated with the taboo of sex and the assumption that sex is only 
related to reproduction. Likewise, some CPs expressed their unwillingness to discuss sexual health 
with WOST that were in a stable relationship. This was because of fearing women feeling accused for 
cheating on their partner, or their partner being unfaithful to them.  
“Like she’s in like a different period of her life [referring to a participant that was, 
supposedly, not of childbearing age] and I know just feel bit more of a respectful thing (…) Yeah but 
obviously as a healthcare professional all of that barrier should be gone” (Barbara, 38 years old; 
interview). 
Participants were concerned about the appropriateness of starting a conversation on sexual 
health without any prompts (e.g., client expressing sexual health concerns). At the same time, they 
expressed the need to overcome these taboos and be able to discuss sexual health as it was within their 
role as a health professional. There were different suggestions on how to approach sensitive topics to 
deliver sexual health services in community pharmacy for WOST. One of them was to liaise with 
other professionals working with WOST (e.g., social workers), so that they introduced the service and 
it was therefore not unexpected for women when they attended the pharmacy. A second suggestion 
was to initiate conversations on sexual health within the context of a regular health assessment. A 
third suggestion was to request WOST to fill in a questionnaire about their health and include sexual 
health questions. Completing this questionnaire could serve as a prompt to then have a consultation on 
sexual health. Other suggestions were having a protocol on how to initiate and hold a conversation on 
sexual health, undertaking specific training, and having visual material to advertise the service (e.g., 
posters, leaflets, badges for pharmacy staff) and wait for clients to ask for information. As already 
mentioned above, building trust and having good rapport would aid starting discussions on sexual 
health. Participants also identified privacy and confidentiality as key aspects to delivering sexual 
health services.  
“I guess we could maybe have leaflets or something when we give them their methadone just 
say ‘oh this is what we’re doing here now, so if you are interested then we are doing these services 
here now so have a read and think about it and if you’ve got any questions then ask’” (Monica, 39 





The quote above also illustrates that CPs were not always motivated to deliver the service or 
that willing to overcome the potential barriers to implement it. Most CPs took a passive approach in 
delivering services and engaging with WOST, while a few expressed the importance of delivering 
services proactively to involve clients. 
5.2.3.2. Managing conflict 
Based on participants’ narratives, conflict was not common, even though all CPs discussed 
negative incidents involving OST clients as one of the most important downsides of providing OST. 
As explained above, conflict included arguments and aggression between clients and/or with 
pharmacy staff, diversion of OST and shoplifting. Arguments usually arose when there were problems 
with OST provision (e.g., their prescription got cancelled). These incidents had a negative impact on 
pharmacy staff and other pharmacy clients. They also made some CPs resentful of providing the 
service because of the challenges that it entailed, as well as the amount of time that it required.  
“Hmm negatives… I mean it’s always a… I would say there’s always a few that you can’t get 
through, there’s always a few that sort of push the boundaries with behaviour and… things such as 
shoplifting, or just general behaviour in the shop that can be off-putting to some other 
costumers”(Paul, 50 years old; interview). 
Some CPs mentioned that it was important to define boundaries and implement rules in 
community pharmacy to delimit WOST’s behaviour. This was usually the way conflict was managed. 
For most CPs, it was usually distressing having to deal with negative incidents although they gained 
confidence as they had more experience. It was clear that CPs felt threatened and feared clients’ 
reactions. At the same time, they made an effort to overcome these emotions and reaffirm the 
boundaries and pharmacy rules when these were violated. Some CPs mentioned having contracts that 
OST clients should sign at the start of their treatment. These contracts mainly stated what the expected 
and acceptable behaviour was (e.g., speak to pharmacy staff in a respectful manner).  
“Hmm so there’s more to do with the… hmm… nasty people as well maybe… obviously, you 
are not obligated to serve them. Normally when there’s a new client come with a prescription, if it’s a 
new one we would ask to sign a contract with the pharmacy saying that they’re going to behave, they 
are going to treat you respectfully and they are not going to shoplift, I think. Sometimes they hmm 
comply with that, sometimes they don’t. Most of the times, you know, they did but there’s been a few 
sometimes when people have been rude to you or… and then you proceed…” (Daniel, 41 years old; 
interview).  
Most CPs discussed such incidents with WOST. Some CPs communicated openly with clients 





apologised. Clients were usually warned at least two times before they were banned from the 
pharmacy and had to request getting their treatment from another one, although some clients were 
sometimes banned after the first incident based on the severity of the incident (e.g., verbal threats or 
physical violence). Negative incidents involving WOST were usually shared with other professionals 
working with the clients (e.g., GPs). This was commonly communicated to clients. Other CPs 
however used threatening communication to deal with conflicts or did not speak with clients at all and 
just proceeded to ban them from the pharmacy. These ways of managing incidents seemed to damage 
trust and rapport and created more conflict. 
“I was a bit nervous because they can be quite aggressive but then you need to put always 
your foot down with them as well.  You need to know what is like the… like the, how can I explain… 
you can’t be too soft and you can’t be too soft or too hard because if you are too hard they can go like 
oh why are you attacking me like that and it can be aggressive, but if you act too soft like they take 
advantage of you. So you need to keep always the distance between both” (Donna, 28 years old; 
interview). 
5.2.4. Sexual health risk factors among WOST 
CPs discussed about the factors that may be associated with higher sexual health risks among 
WOST. This theme was organised in two subthemes: 1) individual-level factors, and 2) socio-
structural factors.  
5.2.4.1. Individual-level factors 
All participants discussed individual-level factors – those within the individual – that they 
thought to be associated with WOST’s increased STI/BBV risk. Socio-structural-level factors 
presented in the next subtheme were less commonly mentioned by participants. CPs’s views on 
factors associated with sexual health risks among WOST were often restricted to women’s drug use. 
A few participants however mentioned that some of these factors might be common to the general 
population. Having a chaotic lifestyle was one of the key factors that participants thought of. This 
lifestyle was dominated by risky behaviours including drug-seeking and drug-using habits, and having 
condomless sex.  
“Hmm… I think that a lot of substance misusers probably lead a chaotic lifestyle… often 
some of them may use on top of taking their methadone for example… and so they might be 
unconscious and not aware of what they are doing… there’s a lot of factors, they are coming to… will 
involve ehh the patient to… female clients actually engage in sexual kind of contacts unprotected and 





then certain, other factors are specific to substance misusers where they are kind of a using substance 
and their judgement is impaired…” (James, 32 years old; interview). 
Some CPs believed that WOST lacked general intelligence, were not responsible enough and 
were not able to think rationally and in the long-term when using drugs. To them, this was associated 
with engaging in sexual health risks. Participants mentioned that WOST’s priorities were using drugs 
and seeking sexual pleasure, especially when intoxicated. CPs thought that clients would not use 
condoms to maximise sexual pleasure and would also be unable to think about using condoms when 
intoxicated.  
“And they are thinking only for short time, not for longer time… I don’t think they really 
care… a long term… They are thinking only about this moment. If they are using drugs… They are 
not used to thinking in the long term so what is now it’s important… I think… (laughs) (…) I don’t 
know… maybe they are thinking that the pleasure is bigger if they don’t use a condom?” (Susan, 35 
years old; interview). 
Lack of risk awareness and knowledge were other factors that CPs discussed to be associated 
with poorer sexual health outcomes. A few CPs expressed that other risks that WOST were exposed to 
were a priority (e.g., overdose) over sexual health risks. Similarly, one participant explained that the 
risk awareness was lower for STIs compared to BBVs as the former “can be treated” (David, 25 
years old; interview). Participants also thought that women in stable relationships were less aware of 
the risks of condomless sex. Some CPs thought that WOST were usually unaware of their sexual 
health status. Also, that WOST commonly accessed services such as emergency hormonal 
contraception, implying that they failed to engage in protective behaviours. This could be associated 
with what another participant said about WOST not having “as much to lose as other people” and the 
lack of care to their own bodies and health (Daniel, 41 years old; interview). One CP expressed that 
she did not believe that WOST were more at risk engaging in condomless sex if they were already 
sharing used needles with their sexual partners (Susan, 35 years old; interview). 
“Well… that they are aware of the risks that they’re… like mixing which has a higher risk of 
infections due to the injecting so… hmm you know, they are not the only people at risk but yeah. And 
when you are intoxicated whether it’s on your mind or not (laughs), I don’t know. I suppose that we 
have a part at this point, making sure that they are up-to-date of their own status, whether they’ve got 
Hep C [Hepatitis C] or any other blood-borne diseases cause that might make them more, a bit more 





5.2.4.2. Socio-structural-level factors 
Some CPs mentioned socio-structural-level factors – those outside the individual – that they 
thought to be linked to STIs and BBVs. These were gender roles (e.g., condoms are a man’s job) and 
women’s general disempowerment (e.g., to negotiate condom use). Sexual partners might refuse to 
use condoms, hindering their use. One participant explained that women would have sex with men 
just to please them rather than respecting themselves.  
“I mean the problem is with this particular population is obviously the power imbalance so if 
they have got somebody that doesn’t want to use a condom and they are saying well you have to use 
it, the bloke is going to either you know take a swipe or he is going to dump them and go and find 
someone else so they have lost that protection or their source of drug or their source of money.  
Umm… so the education [of WOST] is important” (William, 42 years old; interview). 
Experiences of GBV and the engagement in transactional sex were also mentioned in relation 
to STI/BBV risk. According to a few participants, transactional sex workers could be more at risk 
because they would engage in condomless sex if in high need for money and/or drugs. One CP also 
expressed that drug dealers often extorted women into transactional sex in exchange for drugs 
(William, 42 years old; interview). The same CP also mentioned that some WOST exchanged sex for 
protection from violence, usually from other men. Another participant however stated that 
transactional sex workers were usually more aware of the risks and used condoms more consistently, 
compared to other WOST (Peter, 25 years old; interview). Some CPs knew about transactional sex 
practices of a few of their clients, but this was never discussed. The assumptions made about the 
experiences of transactional sex added onto the stigmatising attitudes that CPs held towards WOST. 
These assumptions could also be having a negative influence on the way services are delivered to this 
group of women.  
“Yeah and then obviously they themselves if alright they’re drug dependent they’ll do 
anything if they are desperate for their fix and they need the money. And if somebody says well I want 
without a condom they’re not going to say no I don’t believe they would yeah” (Martha, 57 years old; 
interview). 
Another factor was the unavailability of condoms due to financial constraints or not having 
them available as sex was not planned. Besides, WOST’s social and sexual networks were often 
perceived as high risk populations for STIs and BBVs (e.g., PWID). 
“Hmm… they don’t want, I mean, it can be both yeah… because those patients, they don’t 





rather have it without a condom or… yeah… the other thing might be a request by the, their partner 
so yeah… so that is what I think… (laughs)” (Peter, 25 years old; interview). 
5.2.5. The role of community pharmacists 
One of the topics discussed with CPs was their role as health professionals. There were three 
subthemes identified: 1) health promotion, 2) sexual (and reproductive) health, and 3) skills and 
training.  
5.2.5.1. Health promotion 
Most participants thought that CPs had a role to play in promoting the population’s health. 
They explained how the role of CPs had developed into delivering more holistic health care rather 
than just dispensing medicines. Based on the participants’ narratives, community pharmacies are a 
good setting for health promotion due to their widespread location, opening hours and not working on 
an appointment basis.  
“We’re there for to promote good health rather than just curing it it’s about promoting 
healthy living. With our pharmacy at the moment we’ve recently signed up to become a healthy living 
pharmacy which means we can help with stop smoking, promoting healthy living, so that’s something 
we’re starting soon” (Monica, 39 years old; interview). 
Participants however mentioned that time and workload pressures were barriers to health 
promotion in community pharmacy. Health promotion also required further human resources and 
physical spaces (e.g., consultation room). Apart from the time of delivering the service, there was 
time for the paperwork associated with the services. These were tasks that only CPs could undertake, 
so they could not be delegated to other pharmacy staff. There were however some services, or parts of 
services, that could be delivered by other pharmacy staff with the appropriate training. 
“I think all this paperwork audit reports all of that sort of bureaucracy to deal with if that 
was just really cut and only the bare minimum done that would help too, but again sometimes right I 
want to get this report done or this questionnaire publication things like that done and it’s got to be 
done and I’m not going to go and say oh here we go we want 15 minutes in the consulting room I’m 
just not going to do it” (Martha, 57 years old; interview). 
Health promotion services needed to be commissioned and reports had to be sent to the 
commissioners for monitoring. As participants explained, some services were compulsory and 
regulated by the NHS. Other were optional and each community pharmacy decided whether to 
provide more services and to choose among those available. These decisions were dependent on the 





delivered). One participant explained that some health promotion services could incur in financial 
gains for the community pharmacy. For example, offering sexual health screening could lead to 
selling treatment for the person screened and possibly for the sexual partner(s). Other services were 
however not financially beneficial for the pharmacy and thus he would be less inclined to deliver 
them. For instance, free condom supply did not promote selling condoms. There were no health 
promotion services available for OST clients that were specific to the needs of this group of clients.  
“I don’t think so, because usually all the health promotion they are mostly for general public, 
yeah… like about prostate health, about blood pressure, smoking cessation, something like that. Is… I 
haven’t seen anything that is target specifically for opioid patients in the pharmacy” (Peter, 25 years 
old; interview). 
Signposting and working closely with other professionals working with WOST was part of 
promoting health and the role of CPs. 
5.2.5.2. Sexual (and reproductive) health 
Sexual health was rarely discussed with WOST in community pharmacy, unless it was within 
the context of a service already available in the pharmacy (e.g., emergency hormonal contraception). 
Some participants thought that WOST would speak with the GPs or staff in drug services about their 
sexual health. Delivering sexual health services entails having conversations around sensitive and 
intimate topics. As already discussed in this chapter, sex and sexual health are taboo topics that most 
CPs felt were difficult to discuss. According to the participants, breaking these taboos would be 
crucial to implement sexual health services. A few CPs had misconceptions about sexual health risks. 
For instance, being in stable relationships was sometimes seen as a zero-risk situation. 
“Yeah just because all of the diseases that they can get even if they are on a pill or in the coil, 
they, they should always use the, the condom. I mean if they are married already, it is different but if 
they like always with a different partners yes, it is a good thing always to remind them” (Donna, 28 
years old; interview). 
Reproductive health was also discussed with a few CPs. These participants explained how 
WOST often missed the signs of pregnancy and unplanned pregnancies were common. Also, some 
WOST did not have their period due to low weight. Participants expressed that WOST lives are very 
chaotic and they should use long-acting contraceptive methods (e.g., coil) and barrier methods (e.g., 
female condoms). This was to prevent STIs and BBVs but also unplanned pregnancies. However, 
most participants referred to the male condom only, rather than discussing female condoms as a viable 
option for WOST. One explicitly talked about the benefits of the female condom stating that “men 





(William, 42 years old; interview). Pregnancy was also a time when some WOST considered and tried 
to stop using drugs. This was mostly unsuccessful, according to most CPs. Nurses and GPs were 
identified by a few CPs to be the professionals to deliver reproductive health services.  
“And also I mean obviously condoms wouldn’t be the only [method], in terms of pregnancies 
don’t know that many of them take contraceptive pill, can’t think that they do. Again whether they 
would remember every day” (Barbara, 38 years old; interview). 
As participants said, there were no specific sexual health services for WOST in community 
pharmacy. They could however access sexual health services available for the general public. These 
were free condom supply (C-card scheme
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), chlamydia screening and emergency hormonal 
contraception. There were however age restrictions for these services as they could only be accessed 
for free by women under 25 years old. One participant had offered free condoms to opioid clients as 
part of a scheme funded by a private condom company. He expressed feeling unconfident when 
offering condoms and that most clients did not take them (Daniel, 41 years old; interview). Apart 
from that case, condoms were only offered for free in NEP packs, and hygiene packs that were 
available for OST clients in the past in some community pharmacies. There was however no 
information on sexual health in these packs, just condoms. Also, as these were only given to clients 
that were collecting needles this service was not available to all WOST.  
“Hmm [opening the needle exchange programme pack] alcohol swaps, a condom… ah right, 
that’s interesting! There should be leaflets [there aren’t any leaflets inside the pack] with some contact 
details…” (Paul, 50 years old; interview).  
5.2.5.3. Skills and training 
Staff had to undertake training to deliver each health promotion service available in their 
community pharmacy. This training was the CPs’s responsibility. Training in sexual health and drug 
use was limited and such training never overlapped. A few CPs mentioned how they had trained “on 
the job” or during their training year to qualify as a CPs. Participants explained that other staff should 
also be well-trained. This was not necessarily to be able to provide health promotion services, but to 
run the pharmacy while the CPs was delivering health promotion services to clients. 
“So for this [health promotion] you need the staff to be trained, hmm… part of my staff is very 
well-trained, part of my staff is… the other part… is not s… so well-trained (…) But, as I said, the 
qualified staff helps me very much in these situations, with the health promotion, but there’s still 
space to improve” (Fred, 36 years old; interview). 
                                                             





Some CPs recognised the need to undertake further training to work with WOST, and 
especially to deliver sexual health services. This is again related to the challenges in communicating 
openly and effectively with this group of clients and in sensitive topics. In order to deliver sexual 
health services for WOST, CPs explained that they would need to undertake specific training. 
Participants’ suggestions for this training included communication and negotiation skills, 
safeguarding, sexual health in the context of drug use, and elements for the specific components of the 
service (e.g., screening procedures). Some CPs suggested that other pharmacy staff could be involved 
in delivering sexual health services to WOST. In this case, specific training would also be required for 
other pharmacy staff. 
“Umm … I think it depends if it was anything to do with testing then might need especially if 
it was specific testing for taking blood samples (…) it would be good to know to be reassured if there 
is anything special you need to do while working this client group so probably would be helpful” 
(Paul, 50 years old; interview). 
5.2.6. A sexual health service for WOST 
The development and implementation of a sexual health service for WOST in community 
pharmacy was another theme identified. There were three subthemes: 1) acceptability, 2) potential 
barriers, and 3) components of the service.  
5.2.6.1. Acceptability 
Most CPs thought that offering sexual health services to WOST in community pharmacy was 
acceptable and potentially beneficial to the clients. Community pharmacies are well placed because of 
their location and the frequency in which CPs see WOST and the rapport and trust within most of 
these interactions. Community pharmacy was also seen as “friendly” setting for vulnerable subgroups 
of PWUD, such as people in situations of homelessness. There were mixed opinions regarding the 
benefits for the community pharmacy. Some participants thought that having these services available 
could generate additional pressure to pharmacy staff and be a barrier to run other services. Another 
point made that has been already mentioned was that sexual health services may not be acceptable in 
community pharmacy because of the mere fact of discussing sex. CPs felt that this sexual health is a 
sensitive and taboo topic that may need to be discussed in other settings. These could be drug services 
or GP practices. Besides, a few participants thought that having sexual health services for WOST only 
could alienate clients and expose pharmacy staff to “harmful situations” (i.e., conflict). A few CPs 
were also concerned that WOST could deem sexual health services in community pharmacy as not 





“I definitely think there is a market for it you know it’s, I suppose it is an area that is not 
really been looked at in pharmacy (…) I think if you, I think a pharmacy would be the perfect place 
because these kinds do come in every day, so if they weren’t available that day they could maybe see 
you the next day or you know you could pick up a lot of people with you know it is difficult to catch 
people at [place name] or you know” (Julia, 29 years old; interview). 
5.2.6.2. Components of the service 
There were several suggestions for the components of the service, and ideas on how the 
service could be implemented. All CPs agreed that the service should be delivered free of cost to the 
clients and in a private space to ensure confidentiality and anonymity. Most other suggestions were 
common amongst most participants. One of the main suggestions by CPs was delivering the service in 
the context of a health assessment, or the Medicines Use Review
15
. This could include, not only 
sexual health, but other general health questions. Thus, instead of just initiating a conversation on 
sexual health, sexual health could be embedded within a general health assessment. Some participants 
mentioned that taking this approach could decrease the reluctance around discussing sexual health 
among CPs and WOST. This assessment could comprise information provision on sexual health (e.g., 
routes of transmission) to increase knowledge and risk awareness among WOST. Almost all CPs 
thought that the assessment should be done face-to-face in a consultation room. One participant 
mentioned that clients could complete a questionnaire for an initial health assessment at home, and 
then have a consultation (Michelle, 27 years old; interview). As presented above, having this 
questionnaire could also break barriers to discuss sexual health in community pharmacy.  
“[I] quite like the idea about an assessment, like maybe sort of quarterly would be quite good 
I think, just to sort of keep on top of everything and then I suppose that would then open up if they 
want to ask you anything and things like that that they might want to ask” (Olivia, 27 years old; focus 
group). 
“You [CP] will have a chat with them, you will obviously talk about their sexual health 
history and whether they are using protection or not and when they were last, if they’ve been screened 
and if not you could maybe try and arrange a screening umm… and then sort of then give an overview 
about the dangers of unprotected sex as well” (Julia, 29 years old; interview).  
Based on the participants’ narratives, consultations should be short to be feasible. At the same 
time, enough time should be allocated to these consultations to facilitate conversations on sexual 
health and other related sensitive topics. Participants also thought that there would need to be a clear 
protocol on how to deliver the service. Some CPs believed that having this protocol could increase 
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their confidence in delivering the service and discussing sexual health with WOST. It was also 
mentioned that the service outcomes and intervention processes would need to be recorded to assess 
the quality of the service.  
“It would be easier for example, if it’s a protocol yeah… at least in your head, to know what 
would manage the discussion” (Susan, 35 years old; interview). 
Offering sexual health screening (i.e., testing for STIs and BBVs) was another main idea of 
CPs. In case of positive diagnoses, CPs could provide treatment when possible (e.g., for chlamydia) or 
refer to other health professionals (e.g., for HCV). However, a few CPs expressed concerns about 
pharmacy staff not being the appropriate professionals to deliver screening results. Participants 
thought of also providing HBV vaccines. Other participants stated that signposting to other 
professionals would be required for safeguarding concerns (e.g., GBV). Condom supply was another 
key suggestion made by the participants and could be similar to the C-card scheme offered to the 
general population.  
“Umm I suppose you’d probably want a testing some way of doing testing and some way of 
well be the main thing I suppose testing, feeding back results and then sort of ability to give them 
[WOST] advice so some training for the pharmacy to make sure they [pharmacy staff] are up to date 
on all the sort of best practices for prevention of infection. Maybe some form of condom supply cause 
at the moment the C-card is only any good if you are up to 24 I don’t know well I suppose they 
[WOST] could go to the CASH clinic [sexual health clinic] as an adult at any age to get free condoms 
but again that’s not maybe so likely for this client group so some sort of supply of condoms over and 
above the sort of one or two they stick in the needle exchange pack” (Paul, 50 years old; interview). 
A few CPs thought of offering reproductive health services alongside sexual health services, 
such as emergency hormonal contraception or signposting for contraception. Two CPs thought that 
the service could be scaled up to men on OST and not just WOST. According to these participants, 
men on OST also had sexual health needs that could be addressed in community pharmacy. Likewise, 
a couple CPs explained that other groups of PWUD attending community pharmacy could be offered 
the service (e.g., people accessing NEP). CPs however thought that these other clients would be more 
difficult to engage as they spent less time in the pharmacy.  
“Umm and it could even be a signposting call because obviously we are not able to do 
contraception per se umm but it would be a signposting would you like me to arrange an appointment 
with the nurse to see” (William, 42 years old; interview).  
Some CPs highlighted the need to actively advertise the service using written material 





services and other services that WOST attend (e.g. GP practices). As already mentioned, this could be 
a challenge for CPs that disagreed on having visual material with a sexual health-related content and 
specifically for WOST in their pharmacies. The service could be first introduced when WOST started 
their treatment. Most CPs thought that community pharmacy was ready for implementing sexual 
health services for WOST as most pharmacies already offered the same or similar services for the 
general population.  
“If pharmacies are already doing, obviously if they are already doing supervised 
consumption, and they are already doing needle exchange, and they are already doing EHC 
[emergency hormonal contraception], you just put them together. It can’t be that difficult to sort of go 
“This is a separate one but it basically pulls two serv, two services together”. It can’t be that bad. 
Places that they don’t… that they don’t needle exchange, that they don’t EHC might struggle cause 
they might not have that, that knowledge base. But… it’s not hard to get it, it’s gotta be a bit 
proactive, you’ve gotta do something outside of work (laughs)” (Michelle, 27 years old; interview). 
5.2.6.3. Potential barriers 
All participants identified challenges to implementing a sexual health service for WOST in 
community pharmacy. Some of these barriers have already been mentioned in this chapter but are 
further discussed throughout this theme. The barriers were: time and workload constraints; privacy 
and confidentiality; stigma and discrimination; communication, trust and rapport; and financial 
constraints.  
All participants identified time and workload as main challenges to deliver sexual health 
services for WOST in community pharmacy. Most however mentioned that they would be willing to 
deliver the service if it did not require much time and the volume of clients was not high. This was 
compatible with CPs believing that the service should not require much time to be feasible. Booking 
appointments was not considered feasible for most participants, due to WOST’s difficulties in 
remembering and attending appointments. Instead of having an appointment system, a few 
participants suggested setting up a walk-in clinic to deliver the sexual health service. According to 
most CPs, all pharmacy staff should be involved in delivering the service. The level of involvement 
would depend on the components of the service and the pharmacy staff’s training. Training should be 
available for CPs and other pharmacy staff to deliver the service, as already discussed.  
“So say you were doing screenings and blood samples, I don’t know how comfortable or 
confident health care assistants or dispensing assistants would feel to do that, so maybe they wouldn’t 
do that, but then if it was just giving them information and doing the condom supply, I don’t see how 





There were mixed opinions on whether WOST would engage in the service. Some CPs 
believed that it would be difficult to engage some clients. Some participants mentioned that some 
WOST may not want to engage in the service (e.g., unstable or more “aggressive” clients), think that 
they do not need it (e.g., women in stable relationships), or be reluctant to discuss sexual health with 
CPs (especially male CPs). Other CPs mentioned that WOST would be open to accessing the service. 
The limited time that most clients spent in the pharmacy were other barriers, as their chaotic lifestyle 
(e.g., to attend follow-up appointments to initiate STI treatment). A few participants mentioned that 
clients should always be given the option and freedom to make decisions over engaging in the service.  
“I think some women would be more open to it than others.  I think perhaps those women that 
like the lady I was talking about that’s been in a relationship for a long time might be less interested 
than others, she might perceive herself to be at lower risk even though she might not be (…) So they 
[women in stable relationships] might dismiss it immediately” (Barbara, 38 years old; interview).  
As already presented in this chapter, building trust and rapport, and delivering non-
stigmatising and non-discriminatory services would be key to delivering sexual health services to 
WOST. Also, to engage clients in accessing the service. Discussing sex and sensitive topics was 
found to be challenging by most participants as introduced previously in this chapter. For this reason, 
the service needed to be provided in private, so in consultation rooms to ensure confidentiality and 
anonymity. Otherwise some WOST may not be willing to engage in the service, as mentioned in the 
narratives of a few CPs.  
“[I] don’t know guess they just feel embarrassed about it [discussing sexual health] and just 
maybe because of it being in the pharmacy and lots of people could overhear even though we do have 
the option to talk in private maybe they’re not aware of that.  Even if there isn’t anyone in the 
pharmacy they are still other staff members around and they may not want to talk in front of them (…) 
They just need to have a consultation room some privacy shouldn’t be a problem” (Monica, 39 years 
old; interview). 
There were also space limitations to have written material to advertise the service, such as 
posters and leaflets: “Space restrictions as well because we don’t have as much space available, and 
you have to put posters and things or leaflets” (Daniel, 41 years old; interview). A few participants 
were somehow reluctant to have sexual health posters in community pharmacy, as they were deemed 
“inappropriate” for a setting aimed at the general population.  
“I can’t expect to see this, any advertisement about blood-borne viruses in the community 
pharmacy because we have to cater all the age groups, we have to cater all… children, elderly…” 





Most participants discussed the need for the service to be commissioned, especially those 
participants that were concerned about the financial gains for the pharmacy. Those services that were 
commissioned were the ones prioritised, especially considering the time and workload pressures. The 
sexual health service should then be commissioned so that CPs could allocate time to delivering it. 
“[The service] needs to be commissioned and the pharmacists needs to get a remuneration 
for it to allow time… for the time and efforts put into it… because… I think that everywhere you go 
nowadays is kind of pressure and kind of an obligation to… an increase workload, it’s very difficult to 
provide this kind of services in addition to what we do (…) yeah if it’s a commissioned service it is 
more likely that people would do it” (James, 32 years old; interview). 
5.3. Summary 
 There were six themes identified in the interviews and focus group with CP. These themes 
relate to their interaction with WOST and their views on the factors associated with WOST’s higher 
vulnerability to sexual health-related risks. Most of the narratives were around the provision of 
services to this group. Participants discussed the opportunities for improving health promotion 
services and implementing a sexual health service for WOST alongside the provision of OST.  
Overall, it seemed that CPs had mostly positive interactions with WOST, despite the 
embedded stigmatising attitudes and discriminatory behaviours towards this group of women. There 
seemed to be a dissonance in how CPs viewed WOST and their attitudes towards them. This was 
evident when some participants expressed understanding and empathy towards WOST, while using 
stigmatising terms to refer to them. It appeared that there was a general dissonance between how CPs 
knew that they should interact and feel about WOST, and their actual beliefs, attitudes and actions. 
Conflict with WOST and other OST clients was mentioned to be rare, but still seemed to feed into the 
stigma and discrimination towards WOST. When discussing potential STI/BBV risk factors, CPs 
seemed to take an individualistic approach that was mostly centred on women’s drug use and other 
individual-level factors. Communicating openly and effectively with WOST was a great challenge for 
most CPs, although they recognised the importance of good communication to engage WOST in 
pharmacy services. Health promotion had been incorporated in the role of CPs, which included time 
and workload pressures that limited their engagement in delivering services effectively. Liaising with 
other pharmacy staff and other professionals was thought to be key in coping with these pressures. 
Implementing sexual health services for WOST in community pharmacy was generally acceptable for 
CPs, although important challenges would need to be overcome.  






CHAPTER 6. Understanding Sexual Health Risks among Women on 
Opioid Substitution Treatment 
 This chapter presents a synthesis of findings from the systematic literature review (Chapter 
3) and data from semi-structured interviews and focus groups (Chapters 4 and 5), in relation to the 
factors associated with sexual health risks among WOST. This synthesis helps to understand why 
WOST may be vulnerable to STI/BBV sexual transmission. The synthesis addressed the first 
objective of this study, to identify and explore the factors associated with the heightened risk of sexual 
transmission of STIs and BBVs among WOST. This chapter corresponds to Step I of the service 
design, according to the IM approach (see Chapter 2, page 16). Data syntheses in relation to the role 
of CPs promoting sexual health among WOST, the acceptability for sexual health services in 
community pharmacy, suggestions for service design and potential barriers are discussed in chapters 
7-9. 
6.1. A Logic Model of Sexual Health Risks among WOST 
The Logic Model of the Problem is an adaptation of the PRECEDE model used in the IM 
approach (Bartholomew Eldredge et al., 2016) (see page 16). This conceptual model is a 
representation of the main associations between determinants, factors, health outcomes, and quality of 
life outcomes identified through this research. It is important to note here that this model does not 
represent causal relationships between elements, but associations amongst these. The model was 
developed using data from the semi-structured interviews and focus groups with WOST and CPs 
(Study 2), and findings from the systematic literature review (Study 1). The model formed the basis of 
the development of the pharmacy-based sexual health service for WOST. It particularly helped when 
stating the goals for the service and developing Step II of the service design (see Chapter 8).  
6.1.1. Description of the model 
 The model is described in this section, firstly discussing the health outcomes and related 
quality of life. Then, the factors and determinants of health that seem to be associated with these 



































Figure 9. Logic Model of the Problem on Sexual Health Risks among WOST. 
 
Individual Determinants 
- Prioritisation of drug use and lifestyle 
- Cognitive and emotional impact of drugs 
and alcohol 
- Feelings of worthlessness, powerlessness 
and helplessness 
- Sense of control  
- Love and trust 
- Internalised intersectional stigma 
- Perceived negative social identity  
- Beliefs and knowledge   
- Risk awareness 
- Sexual orientation 
 
Socio-structural Determinants 
- Taboo of sex and sexual health 
- Social inequities  
- Intersectional stigma  
- Social norms and gender roles 
- Gender-based violence  
- Engagement in transactional sex 
- Lack of social and professional support  
- Partner characteristics and preferences 
- Beliefs among CPs (and other 
professionals) 
- Lack of knowledge and training CPs (and 
other professionals) 
- Policies on sex and sexual health education  
- Policies on sexual health 
- Structural barriers to developing and 
implementing sexual health services  
- Structural neglect and structural violence 
 
Individual-level Factors 
- Lack of condom (male, female) use 
- Limited uptake of sexual health 
services 
Socio-structural Factors 
- Limited availability of sexual 
health services  
- Limited availability of free 
condoms (especially female 
condoms)  
- Trust and rapport with CPs and 
other health professionals 
- Limited communication WOST-
CPs (and other professionals)  
- Conflict WOST- CPs (and other  
professionals) 
Health Outcomes 
- Sexually transmitted 
infections and blood-borne 
viruses 
- Secondary health problems 
(e.g., infertility) 
- Mortality 
Quality of Life 
- Perpetuation of experiences of intersectional 
stigma 
- Perpetuation of experiences of  social exclusion 
and violence 
- Perpetuation of feelings of worthlessness, 
powerlessness and helplessness 
- Poor self-image and social identity 
- Continuation of drug use as coping mechanism 
- Increased welfare dependence 






6.1.1.1. Health outcomes and quality of life 
 Health outcomes refer to the health conditions that this research focuses on, and that the 
sexual health service developed aims to address. In this model, health outcomes were STIs and BBVs, 
other secondary health problems (e.g., infertility due to untreated STIs), and mortality (e.g., from 
untreated HCV).  
Quality of life (QoL) in this model refers to the potential impact of health outcomes on 
WOST’s functioning and wellbeing in physical, psychological and social areas of their life. Living 
with an STI or a BBV or other health-related conditions could have a great impact on the wellbeing 
and functioning of WOST. Based on the data presented in Chapters 3-5, STI/BBV diagnoses could be 
associated with the perpetuation of experiences of intersectional stigma, social exclusion and 
violence. They could also perpetuate women’s feelings of worthlessness, powerlessness and 
helplessness, poor self-image and negative social identity. WOST’s narratives (Chapter 4) and the 
systematic literature review (Chapter 3) suggested that a deterioration of health could also be a factor 
for the maintenance of women’s drug use, as using drugs was often a way to cope with emotional 
pain. Other social consequences of living with an STI or a BBV – and especially for chronic 
conditions such as HIV – would be the increased medical and care costs for WOST, and women’s 
dependence on social welfare.   
6.1.1.2. Determinants and factors associated with health outcomes and quality of 
life 
Data from this PhD research suggested that there are multiple complex associations between 
the determinants and factors identified, and with health outcomes and quality of life. Almost all 
elements are related to each other at some level, which creates a challenge for service design. These 
interrelations are described in this chapter, organised by the main individual-level factors: 1) lack of 
condom (male and female) use, and 2) limited uptake of sexual health services. These were the factors 
most directly associated with STIs and BBVs among WOST. 
6.1.2.2.1. Lack of condom (male and female) use. The lack of female and male condom use 
was one of the key individual-level factors that were found to be associated with STIs and BBVs 
among WOST. As represented in the conceptual model, there were socio-structural factors that were 
related to individual-level factors. Individual and socio-structural determinants were also found to be 
associated with individual-level and socio-structural factors (see Figure 9). Despite data on both 
female and male condom use being included, it is important to highlight that most data were on the 
use of male condoms.  
6.1.2.2.1.1. Individual-level determinants. As described in Chapter 4, women’s lives were 





their health, even to the point of significant risk of losing their lives. WOST explained how the 
cognitive effects of using drugs and alcohol lowered their risk awareness. Women’s perception of 
control over their lives and (sexual) health was practically non-existent, especially during periods of 
heavy drug use. This could be explained by women’s experiences of neglect, stigma and violence 
throughout their lives, as well as their lifestyle. Women often felt hopeless and powerless to change 
their situation. It is also crucial to understand that drug use was often a way for women to cope with 
the trauma. However, using drugs perpetuated experiences of stigma, violence and social exclusion. It 
was a vicious cycle in which WOST had a very limited sense of control. WOST seemed to conform to 
the health risks that their lifestyle entailed. This, aggravated by a great sense of disempowerment, was 
a factor that led women to engage in condomless sex. Women somehow perceived that having a poor 
(sexual) health was part of their fate as PWUD. Engaging in condomless sex was just something else 
that they had no control over. Transactional sex workers felt more empowered to make decisions over 
using condoms with clients. However, they still felt powerless over doing so in sexual encounters 
with non-clients, and in certain situations with clients (e.g., when withdrawing from drugs and being 
offered more money for condomless sex).  
Love and trust were other emotional components that seemed to hinder condom use. WOST 
often had a low sense of self-worth. Feeling loved and building trust with another person appeared to 
be ways for them to be emotionally connected with others, potentially increasing their feelings of 
worthiness. Condoms were perceived as a barrier for intimacy, and thus for love and trust. In this 
way, condomless sex was seen as a mechanism for WOST to seek love and trust with their sexual 
partners. In the same vein, transactional sex workers were more likely to use condoms with clients to 
create emotional barriers and cope with sex exchanges.  
WOST often expressed how they felt dehumanised and socially excluded. Their social 
identity was generally negative as they felt like undesirable outliers within their communities and 
society. Women had internalised experiences of intersectional stigma, in relation to their gender, drug 
use, engagement in transactional sex, homelessness and sexual health status. All these beliefs, 
perceptions and feelings towards themselves had a negative influence on WOST’s self-worth. Women 
did not perceive themselves worthy enough to care for their (sexual) health, and even their lives at 
times. Data from this study suggest that this could be related to engaging in condomless sex.  
Women’s knowledge, beliefs and risk awareness were other determinants identified in the 
data. WOST did not always hold positive beliefs around condom use and lacked knowledge on sex 
and sexual health. Risk awareness was often low as, even if WOST knew the risks, they would not 
personally feel at risk. However, when looking carefully at the data, it was apparent that WOST’s 
lifestyle and emotions – worthlessness, powerlessness, helplessness, love and trust – outweighed the 





suggests that, among individual-level determinants, emotions could be influencing women’s 
behaviour more than cognitive rational aspects.  
Sexual orientation was a factor identified in the systematic literature review. In this review, 
lesbian and bisexual women were identified to be more vulnerable to sexual health risks as, for 
example, they were more likely to engage in transactional sex. This was explained by the social and 
health inequities experienced by this group of women because of their sexual orientation (see Chapter 
3). Apart from a few comments in relation to same-sex sex in the interviews with WOST, data from 
the semi-structured interviews and focus groups did not reflect the potential links between sexual 
orientation and sexual health. This is worth exploring in future research. 
6.1.2.2.1.2. Socio-structural-level determinants and factors. There were important 
determinants at the socio-structural level that seemed to be associated with not using female and male 
condoms. These determinants also influenced socio-structural factors, that were then associated with 
condomless sex. 
WOST’s narratives, described the challenges they experienced in negotiating (and using) 
condoms. One of the common reasons was partner’s reluctance towards using male and female 
condoms (e.g., because it limited the partner’s pleasure). This intersected with gender roles and power 
inequities in sexual encounters. Men were often in a position of power over women in sex, which 
included men’s control of condom use practices. Despite participants’ claims for women’s 
empowerment, it seemed that most WOST took submissive roles and felt powerless over caring for 
their sexual health.  
Almost all women in this study disclosed having experienced GBV throughout their lives. 
Experiencing GBV was also associated with gender roles and power inequities between men and 
women. Violence was a main theme in the data and was clearly associated with a lack of condom use. 
Transactional sex workers and homeless women seemed to be more vulnerable to violence. In 
situations of violence, WOST were simply not in control of their bodies, health and wellbeing. Thus, 
neither could they make decisions over using condoms. Perpetrators of sexual violence would not 
normally use condoms. Interestingly, the role that WOST assumed in sexual encounters with 
transactional sex clients was different. Transactional sex workers felt more entitled to negotiate 
condom use and appeared to be less likely to engage in condomless sex with clients. In turn, engaging 
in transactional sex increased WOST’s risk of experiencing violence and forced condomless sex. Lack 
of condom use was also more likely among women in transactional sex, as already discussed.  
Experiencing intersectional stigma and other social inequities such as poverty was also part of 
WOST’s day-to-day life. Being in situations of marginalisation meant that WOST had limited access 
to social resources, such as a stable sufficient income. This also translated into financial constraints to 





women’s feelings of worthlessness, powerlessness and helplessness. The relationship between these 
and condom use was already discussed above. 
The taboo of sex and sexual health, and the lack of formal (e.g., school) and informal (e.g., 
parents) education on these topics were identified to be other potential barriers for using condoms. 
Women did not have enough knowledge and had not been encouraged, through their education, to 
share their concerns of sex and sexual health with partners, family and friends, or health and social 
health professionals. Instead, WOST were educated to repress their sex and sexual health needs. 
Educational policies and informal education appeared to be associated with women’s knowledge and 
beliefs around sex and sexual health, and risk awareness. These could be associated with a lack of 
condom use. 
There were also associations between failures in the educational, social and health systems 
and WOST’ sexual health, as the needs of this group of women did not seem to be covered by 
educational, social and health policies. WOST are a minority group of women that are highly 
stigmatised, which appears to translate into social invisibility, exclusion, and structural violence
16
. 
There were limited sexual health services that addressed the needs of WOST, and those available 
were mostly focussed on screening for BBVs. Preventive measures were also focused on BBV 
prevention and injecting risks, overlooking sexual transmission as a main vector of infection. These 
services were embedded within drug services and did not seem to address all the sexual health needs 
of WOST, nor the barriers WOST experienced accessing and engaging in services. Through 
participants’ narratives, it was also clear that most CPs had a limited understanding of WOST’s needs 
and the context of their drug use. This was also perceived by WOST, in CPs and other professionals 
working with them. Beliefs and misconceptions of health professionals could be reflected in policy 
strategies, and vice versa. Data from this study suggest that current policies and CPs (and other 
professionals) may be missing WOST’ sexual health needs, and thus restricting the availability of 
condoms (especially female condoms). Despite the links between condom availability and their use 
being unclear, limited opportunities to obtain free condoms could create barriers for condom use 
among WOST.  
On the other hand, WOST’s general lack of social and professional support (e.g., trauma 
counselling) seemed to be another factor to women’s feelings of worthlessness, powerlessness and 
helplessness. These, as discussed above, were linked to a lack of condom use.  
 6.1.2.2.2. Limited uptake sexual health services. The second individual-level factor was the 
limited uptake of sexual health services among WOST. There were several socio-structural factors 
associated with this lack of access to services. Individual and socio-structural determinants were 
identified to be related to these factors (see Figure 9). 
                                                             





6.1.2.2.1.1. Individual-level determinants. When WOST accessed sexual health services it 
was often because they were directly offered to them, and especially when they were given financial 
incentives to engage in these services (e.g., for HCV screening). Other reasons for accessing these 
services were having symptoms or knowing that a sexual partner had an STI or a BBV. Thus, WOST 
seemed to access sexual health services only when there were clear prompts for them to do so.  
As for condom use, the way that women felt and thought of themselves were key barriers to 
accessing sexual health services. Feelings of worthlessness, powerlessness and helplessness, and a 
perceived negative social identity were perpetuated by experiences of intersectional stigma and 
violence (GBV and structural). Women perceived themselves as not worthy enough to protect their 
health, thus accessing sexual health services was not usually in their minds, neither was caring for 
their health.  
There was some sense of fatalism in the narratives of some women too that suggested that 
WOST “accepted” poor health as part of their lifestyle and even their social identity. They also felt 
that they did not deserve better. Having an STI or a BBV was just another condition and problem 
added to the numerous difficulties that women encountered, and the risks that they were exposed to. 
Caring for their sexual health and attending sexual health services were again not on WOST’s 
agendas.  
Love and trust were also a barrier for WOST’s perception of risk and vulnerability to STIs 
and BBVs, as discussed previously in this chapter and Chapter 4 (see page 93). Having a low risk 
perception could also lead women to believe that they did not need sexual health services, thus not 
accessing them.  
Beliefs (e.g., sexual health services are only for young people) and lack of knowledge 
regarding sexual health services (e.g., not knowing the location of services) could also limit WOST’s 
engagement with these services. It was unclear whether other individual determinants in the Logic 
Model of the Problem were associated with the limited access to sexual health services among 
WOST.  
6.1.2.2.1.2. Socio-structural-level determinants and factors. There were several socio-
structural factors and determinants associated with WOST’s restricted access to sexual health 
services.  
Overall, there was a lack of sexual health services that addressed the specific needs of WOST. 
Structural barriers for developing and implementing sexual health services (e.g., funding restrictions) 
could be an explanation for the limited availability of sexual health services for WOST. These barriers 
are further discussed in Chapters 7 and 9. Another explanation is related to structural neglect and 





exclusion. This neglect and violence from the institutions may be reflected in the lack of attention that 
the sexual health of WOST has in educational and health policies, which then translates into a lack of 
specialist services available for this group. This lack of consideration may also be reflected in the 
training of health and social care professionals such as CPs, as well as their beliefs and understanding 
of WOST’s realities and needs. This could be reducing the quality of care that these professionals are 
providing to WOST, creating great challenges for women to engage with the services. It then appears 
to be essential to involve policymakers and professionals working with WOST in improving the 
sexual health of this group of women. Improving policy and reducing social inequities could lead to a 
step forward in providing sexual health services tailored to WOST. Training of professionals should 
be improved to reduce the gaps between the needs of WOST and the care that women receive. 
Although WOST could access services for the general population, existing sexual health 
services addressing the specific needs of WOST were only embedded within drug services. Recovery 
from drug use was the priority when engaging in drug services, while sexual health was attended to on 
a few occasions, mostly in the form of routine BBV screening and hepatitis vaccinations. As already 
mentioned above, there were three main situations in which women engaged in sexual health services. 
One of them was when services were directly offered to WOST by health and social care 
professionals. Thus, it again appeared that these professionals had a key role in women’s access to 
sexual health services. However, based on the data it was clear that poor communication and conflict 
between WOST and health/social care professionals was a significant barrier for women to engage in 
services. Building trust and positive rapport is key for professionals to promote the use of available 
services among WOST, and those that might be available in the future.  
As previously discussed, experiencing GBV and intersectional stigma seemed to be 
associated with WOST’s feelings of worthlessness, powerlessness and helplessness. This meant that 
WOST did not believe that their health was important, they felt that they had no control over it, and 
there was no one there to help them. Accessing sexual health services may then not be considered to 
be an option for them. Besides, accessing these services made them feel exposed to further 
stigmatisation and deteriorate even more their sense of self-worth and social identity. The taboo of sex 
and sexual health created an even greater challenge for WOST to attend sexual health services.  
Engaging in transactional sex increase sexual health risks. This was due to the heightened 
vulnerability to experiencing sexual violence, engaging in condomless sex with non-clients and 
having condomless sex with clients at times (especially when withdrawing from drugs). It was 
however unclear whether women who sold sex accessed services more than other WOST. As for other 
WOST, transactional sex workers had engaged in sexual health services available in drug services. 
Other women had got support from services for sex workers, which may be more tailored to their 






 This chapter included a synthesis of the data presented in Chapters 3 to 5, regarding the 
factors that are associated with the risk of sexual transmission of STIs and BBVs among WOST. This 
synthesis was presented through the development of a conceptual model. This chapter comprised the 
description of this model and included determinants, factors and health outcomes that a pharmacy-
based sexual health service for WOST could address. The service design is further developed in 
Chapters 7 and 8, and also discussed in Chapter 9. 
 It became clear throughout this chapter that there is a complex interrelation between 
determinants and factors associated with STI/BBV sexual transmission among WOST. This 
intersection of multiple elements at different ecological levels needs to be considered to understand 
the sexual health risks of this group of women. Also, to understand the gaps between what needs to be 
addressed and where the focus of policies and health services currently lies.  
 This research highlighted that WOST may have a limited use of (female and male) 
condoms, and a limited access to sexual health services. This could be partly explained by the lack of 
available sexual health services that address the specific needs of this group of women. Conflicts 
between WOST and CPs (and other professionals) were a barrier for women to engage in services. 
Understanding the relationship between WOST’s lack of self-worth and disempowerment, with their 
sexual health was key. It seemed that WOST were not caring for their sexual health, nor accessing 
services, partly because of how they felt about themselves. Experiences of intersectional stigma, 
GBV, and the permanent social invisibility and exclusion felt were at the core of WOST’s feelings of 
worthlessness, powerlessness and helplessness. These shaped women’s social identity, which was in 
itself maintained by WOST’s lifestyle. At the same time, the structural neglect and structural violence 
experienced by these women could be perpetuating the stigma, violence and social exclusion among 
WOST. Besides, experiences of GBV and intersectional stigma clearly restricted the opportunities of 
WOST to protect and care for their sexual health.  
 Overall, it was a vicious cycle over which WOST felt they had no control, nor seemed to 
have the support that they needed. It appeared that WOST felt the pressure to change their own 
personal situation, while there were important social and structural elements that need to be 
addressed. In fact, this research highlights that these are key in understanding WOST’ sexual health 
risks and need to be at the core of policies and health services for this group of women. This 





CHAPTER 7. Opportunities for Service Design 
7.1. Overview 
This chapter presents data merged from the interviews and focus groups with WOST and CPs 
in relation to developing a sexual health service for WOST in community pharmacy. See Chapter 4 
and 5 for more details on the data for each participant group. The data in this chapter were part of the 
needs assessment of Step I and informed Step II (see Chapter 8). These data were reported in the form 
of a peer-reviewed publication and addressed three objectives of this PhD study (see page 10). These 
were to explore the views of WOST and CPs on 1) the acceptability of delivering sexual health 
services in community pharmacy for WOST, and the role of CPs; 2) the potential barriers for the 
pharmacy-based services; and 3) suggestions for the service. The article was submitted for publication 
to the peer-reviewed journal BMC Public Health on 14
th
 of November 2018. The manuscript was re-
submitted to BMC Health Services Research as suggested by the editor of BMC Public Health. 
Submission was on 5
th
 of December 2018. The manuscript was not accepted due to the lack of 
reviewers available. The manuscript was then re-submitted to the European Journal of Public Health 
on the 4
th
 of July 2019. The manuscript is under review.   
7.2. Publication 
 Reference: Medina-Perucha, Scott, J., Chapman, S., Barnett, J, Dack, C. & Family, H. (under 
review). Sexual health services for women on opioid substitution treatment: The role of community 
pharmacist. European Journal of Public Health.   
Abstract 
Background. Women on opioid substitution treatment (WOST) are at heightened risk for the sexual 
transmission of sexually transmitted infections and blood-borne viruses. This study aimed to explore 
the opportunities to promote their sexual health in community pharmacies in England. Methods. 
Semi-structured interviews were conducted with 20 WOST and 14 community pharmacists (CP). A 
focus group was run with three CP. Participants were recruited in drug services and a service for sex 
workers (WOST), and in community pharmacies (CP). Data collection took place between October 
2015 and September 2017. Data were analysed using Framework Analysis and directed Content 
Analysis. Results. CPs could play a role in promoting sexual health among WOST. Sexual health 
screening, treatment, and condom supply were suggested as potential ways of delivering pharmacy-
based sexual health services. These services should be actively offered to WOST, delivered in a 
private space and free of cost. We identified several challenges to overcome in order to design and 





highlights the potentially key role CPs can have promoting sexual health and addressing health 
inequities among WOST. Improvements in pharmacists’ training are required in order to address 
stigma towards WOST, and promote trust and positive rapport. Structural changes are also needed to 
broaden the services available for this group of women and improve their access to healthcare. 
Keywords 
Women; Sexual health; Opioid substitution treatment; Qualitative research; Community pharmacy 
Introduction 
People who use drugs (PWUD) are at high risk of sexually transmitted infections (STIs) and blood-
borne viruses (BBVs) – i.e., HIV, Hepatitis B and C – (1-10). Most preventive strategies for PWUD 
have focused on the prevention of HIV and Hepatitis C, especially among people who inject drugs. 
These have generally overlooked the prevention of STIs and the sexual transmission of BBVs (11-
14). Women are especially vulnerable to STIs and BBVs. This is due to several factors at different 
social ecological levels (15). Socio-structural factors include gender inequities, gender-based 
violence, and intersectional stigma. At the individual-level, feelings of love and trust are among 
barriers for condom use.   
Amongst drug-using women, women on opioid substitution treatment (WOST) are an accessible 
group as they attend social and health services on a regular basis, most notably their community 
pharmacy where they collect their opioid substitution treatment (OST). In the United Kingdom (UK), 
WOST often collect OST from community pharmacies on a daily basis. Community pharmacists 
(CPs) in the UK are highly accessible and key in delivering public health services, with an expanding 
role in health promotion (16-17). Sexual and reproductive health services for the general population, 
including STI screening and provision of emergency hormonal contraception, are already available in 
community pharmacies across the UK. Community pharmacy services for WOST are limited to 
dispensing OST and harm reduction strategies to prevent BBVs (e.g., needle exchange programs) 
(18). There is thus an opportunity to explore whether CPs could provide more holistic care to WOST, 
including sexual health promotion. But, research is needed to design and implement sexual health 
services that meet the needs of WOST and reach this vulnerable group. Making sexual health services 
available for WOST alongside their OST presents an opportunity to improve access to healthcare and 
reduce health inequities for this group of women.   
This study explores this opportunity to promote sexual health among WOST in community pharmacy, 
considering the perspectives of this group of women and CPs. It is part of a larger project that aims to 
design a pharmacy-based sexual health service for WOST. This paper addresses three objectives of 





key components of a service in community pharmacy to promote sexual health among WOST, and 3) 
identify potential challenges.  
Methods 
Thirty-four semi-structured face-to-face interviews were conducted with WOST (N=20) and CPs 
(N=14) over seven months between October 2016 and April 2017. One focus group with CPs (N=3) 
was also run on September 21st 2017. All participants completed a non-standardized questionnaire 
after the interview or focus group (see Tables 1-3).  
Recruitment Strategy   
Recruitment of WOST was opportunistic and venue-based in drug services and a service for sex 
workers in South West England (Bath, Midsomer Norton and Bristol). Previous studies with hard-to 
reach populations have used similar recruitment strategies (19). CPs were recruited through 
community pharmacies in the same localities. A £10 LovetoShop voucher (multi-retailer gift voucher 
available in the UK) was offered to all participants. 
 
 
Data Analyses  
The interviews were analysed using Framework Analysis (20) and the focus group using Directed 
Qualitative Content Analysis (21). Data were primarily analysed by one of the researchers (LMP) 
with the support and guidance of the rest of team. NVivo software version 10 was used for the 
analysis. Descriptive statistics of the questionnaire data were undertaken, using SPSS software.   
Ethical Considerations  
This study received ethical approval from the [institution granting ethical approval] on the 17th of 
August 2016 [reference numbers ethical approvals].   
Results 
Data from semi-structured interviews and the focus group were merged for both groups of participants 
and are presented below. See Tables 1-3 for participant characteristics. Main findings are structured 
by the paper’s aims and in two sections: the role of community pharmacists, and potential challenges. 






All participants considered it acceptable that community pharmacies offered sexual health services. 
Both groups recognized that, in principle, community pharmacy was very well placed to provide these 
services. This was due to frequent contact, pharmacies’ opening hours, anonymity, lack of 
appointments, and (generally) positive rapport between WOST and CPs. However, it appeared that 
sexual health was rarely discussed. The development of a pharmacy-based sexual health service could 
then be an opportunity to improve the sexual health and access to care for WOST.   
“I think it would be more helpful cause it’s somewhere that they would be going to go and pick up 
their prescriptions and so it [sexual health service] would be there.” (Emmeline, 35 years old; 
WOST).  
Most CPs believed that, overall, they were well-prepared to deliver sexual health services to WOST 
and that community pharmacy was an appropriate setting for these services. They considered that 
with the appropriate training other pharmacy staff (i.e., technicians, dispensers and counter assistants) 
could be part of providing the service. The role of each professional would depend on the components 
of the service, and the knowledge and skills required to deliver it.   
There were several ideas for developing a sexual health service for WOST in community pharmacy. 
Suggestions for the components of the service included short consultations, condom supply, sexual 
health screening and STI/BBV treatment. Working together with other pharmacy staff, and liaising 
with other health and social care professionals would be essential, according to most participants. 
They also mentioned how referrals to appropriate professionals would need to be made available 
when appropriate (e.g., to start anti-retroviral therapy for HIV). This would not only include referrals 
for health-related issues but also safeguarding concerns (e.g., gender-based violence). In pharmacies 
with more resources and capacity, a walk-in sexual health clinic could be organized to exclusively 
deliver this service.  
“If it was a sort of health assessment that would be easier to do with your daily methadone pick-ups 
because you could, have multiple attempts to sell them the idea.” (Matthew, 51 years old; CP; focus 
group).   
Potential challenges to overcome  
Based on the participants’ narratives, we identified several challenges for promoting sexual health 
among WOST in community pharmacy. These were: 1) intersectional stigma and discrimination; 2) 
trust and humanity; 3) lack of privacy and time constraints; and 4) financial limitations.   
Intersectional stigma and discrimination: beyond drug use  
Intersectional stigma refers to a qualitatively unique experience of stigma that results from the overlap 





(23), experiences of intersectional stigma were associated with the female gender, drug use, 
transactional sex, homelessness and sexual health status. Women’s narratives also highlighted how 
OST (and especially methadone) was stigmatized because of its association with drug use.  
“It sort of it’s like everyone knows about methadone and I think that it… if I went with that I would 
think that I would be judged more.” (Marion, 37 years old; WOST).   
Women’s narratives indicated a relationship between experiencing stigma and a lack of access and 
engagement with healthcare services. They expressed how they had, at some point, felt stigmatized 
and discriminated against in community pharmacies. This was either by CPs, other pharmacy staff or 
other pharmacy clients. Facing situations of stigmatization and discrimination left WOST feeling 
ashamed, helpless and reluctant to access services in community pharmacy.   
“[I was] just treated badly because you know, I was on methadone prescription, so… you know, it 
takes, it kind of makes you want not to engage with any of them.” (Lily, 36 years old; WOST).  
It was relatively common that CPs dichotomized clients into “not normal” (WOST) and “normal” 
(any other pharmacy clients). CPs sometimes seemed to be unaware of their own stigmatizing 
attitudes towards OST clients. Other times participants were aware of their own attitudes and tried to 
amend them explicitly (“well I should not say normal”). Some CPs referred to OST clients using 
stigmatizing and dehumanizing terms such as: “these people”, “addicts”, “blue scripts” – OST clients 
have a blue script rather than green in the UK –, or “drunks”. Also, a few CPs viewed PWUD as “a 
public health and public safety issue” for the general population. Working on BBV prevention with 
OST clients was even perceived as a risk for pharmacists to contract HIV. This displays the idea of 
PWUD as carriers of disease (and especially HIV), which is another example of stigmatizing views 
and attitudes that some pharmacists may hold. Some CPs recognized that the stigma towards PWUD 
was a barrier for health promotion and engaging WOST in health services.  
“I think one barrier that you probably won’t be able to overcome easily is the negative judgmental 
attitudes towards OST.” (Olivia, 27 years old; CP; focus group).   
We identified cultural difference in how CPs viewed drug use and OST. Also, there appears to be a 
link between culture and stigmatizing attitudes towards PWUD and thus OST clients. This may have 
an impact on the quality of care and interactions between CPs and WOST.   
“When I came here [UK] it was a bit awkward. Because I couldn´t understand how the government 
can give to those people [OST clients] drugs [OST].” (Susan, 35 years old; CP; interview).   
Trust and humanity: building positive rapport and good communication  
Except for one participant, all WOST felt comfortable in their current community pharmacy and with 





that their CPs had had in their progression towards recovery from drug use. Women felt that some 
CPs cared for them as they had helped them in the past with their OST and other personal matters. 
Building a relationship of trust was important for WOST to feel comfortable in their community 
pharmacy and to be willing to engage in pharmacy services.   
“He’d [CP] sometimes ask if there are any problems, especially when I went through that stuff 
[intimate partner violence] when he [ex-partner] beat me up and that, cause he [CP] was seeing me 
every day so he [CP] was obviously seeing things (…).” (Sylvia, 27 years old; WOST).   
At the same time, WOST perceived that pharmacists and other professionals had a limited 
understanding and misconceptions about their life experiences and the context of drug use. There 
seemed to be a gap in the realities of WOST and CPs that was difficult to bridge, as pharmacists 
appeared to view drug use as an individual-level phenomena. This maintained and strengthened 
feelings of isolation and helplessness among WOST, and could hinder good communication and 
building trust and positive rapport between WOST and CPs.   
CPs thought most interactions with WOST as being positive, which diverges from WOST’s 
experiences of intersectional stigma. Some emphasized the importance of having a positive rapport 
with WOST and called for a humane treatment of WOST. Working with WOST was however seen as 
challenging. CPs experienced it as rewarding when WOST progressed in their treatment, but as 
frustrating when they were either not progressing or relapsing back to drug use. Involvement of OST 
clients in thefts or arguments damaged the rapport and hindered good communication and 
understanding between clients and pharmacists. It was explained that these incidents could sometimes 
make CPs resentful and could create an environment of distrust. When such incidents were repeated, 
CPs suspended the OST and transferred clients to another community pharmacy. They were perceived 
to be a barrier to engage WOST in pharmacy services, and limited CPs willingness to deliver services 
to WOST.   
“I’m firm with them and I threaten them and I say […] I will ring up and cancel the script and you 
can go elsewhere and that” (Martha, 57 years old; CP; interview)  
Lack of privacy and time constraints: providing a space and time to share    
Even though all community pharmacies had a private consultation room, time constraints were 
significant barriers for having private consultations. This lack of privacy in pharmacy seemed to 
exacerbate experiences of stigma and discrimination. Women felt ashamed to be identified as a 
PWUD when they were picking up their medication in community pharmacy, especially if by 
someone they knew.  
“It’s kind of quite embarrassing, you know, because you don’t really want people to know that you’ve 





Time constraints were identified as main barriers to deliver health promotion services in community 
pharmacy. WOST also mentioned that they were less likely to express health-related concerns and 
engage in services with CPs having short time for consultations. According to CPs, delivering 
additional services (e.g., a new sexual health service) within current resources would be highly 
restricted by time and workload pressures.   
“(…) but you haven’t really got the time to sit in the consulting room with them and then you face a 
pile of prescriptions to come back to, that is unfortunately how it is” (Martha, 57 years old; CP; 
interview).   
 
Financial limitations: community pharmacy as a business   
CPs explained that public health services were commissioned, usually directly by the NHS or through 
Clinical Commissioning Groups
17
 or local authorities. Several CPs highlighted that community 
pharmacies are businesses and that the services they provide need to translate into financial gains. 
Some CPs feared losing clients if they had a high volume of OST clients, therefore losing pharmacy 
income.  
“Even though we want to help them, we can’t offer them anything free unless we are commissioned by 
the commissioning body” (Peter, 25 years old; CP; interview).   
Financial constraints were not identified by WOST as they may not have been aware of the business 
and financial side of community pharmacy. 
Discussion 
Community pharmacists have been identified to have a key role in promoting health (16-18). Our 
findings suggest that there are opportunities for CPs to get involved in delivering sexual health 
services for WOST. There were several suggestions for the components of a pharmacy-based sexual 
health service: having short consultations, condom supply, sexual health screening, and STI/BBV 
treatment. Proactively advertising and providing these services in private would be key to engage 
WOST. Working with other professionals, including other pharmacy staff, would be necessary. 
Specific training for all pharmacy staff would be fundamental, especially to equip pharmacists with 
the necessary skills to initiate a discussion on sexual health and be able to deal with sensitive topics. 
Drug services’ staff and GPs may need to be involved in engaging WOST in the service, and 
communicate effectively with CPs to provide holistic, quality and person-centred care.  
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There are important barriers at the social and structural level that need to be considered and 
addressed. These seemed somehow to challenge the positive views towards having pharmacy-based 
sexual health services for WOST. Abandoning individual-level approaches and taking a social 
ecological perspective to address these challenges at other levels (i.e., social and structural) is then 
essential (24).   
Even though most interactions between WOST and CPs were deemed to be positive, women still felt 
stigmatized and discriminated by pharmacy staff (including CPs) and other clients. This is an 
important barrier to accessing pharmacy services, especially for vulnerable and marginalized 
populations such as WOST. We suspect that experiences of stigma and discrimination may have been 
under-reported by women. Despite the efforts of providing a safe space for WOST to share their 
experiences, data collection took place mostly within drug services that they attend on a regular basis. 
There is the possibility that some participants may have felt cautious to share their experiences of 
community pharmacy. Stigmatizing attitudes seemed to be embedded within most CPs, and some 
were unaware of their own attitudes towards WOST. As health professionals, most pharmacists were 
mindful of the need to deliver non-judgmental and patient-centred consultations. However, this was 
not always applied in practice. The way some pharmacists talked about WOST showed how ingrained 
stigma towards PWUD is (23, 25-28). The fact that CPs may not even be aware of their own 
stigmatizing attitudes may increase the complexity of stigma reduction strategies for community 
pharmacy. Also, CPs taking part in this study could potentially hold less negative views on OST 
clients, compared to other pharmacists who were not interested in participating. However, we did not 
interview other pharmacy staff (e.g., counter assistants) and these other professionals also interact 
daily with WOST. Future research could explore their views and attitudes towards WOST in order to 
provide a more holistic picture of stigma and discrimination in community pharmacy. Strategies to 
reduce stigma in community pharmacy should be a priority to deliver health services to WOST 
effectively. These could include training programs for pharmacy staff, patient-centred approaches for 
health services (that are applied in practice), new and/or improved policies considering and addressing 
stigma, rights-based policy approaches (29).  
The “blame culture” towards PWUD prevails. Drug use is commonly attributed to individual factors 
(e.g., personality) rather than socio-structural factors (e.g., poverty). It would be expected that health 
professionals working with PWUD (e.g., pharmacists working with WOST) would be familiar with 
the multidimensionality and complexity of drug use. Interestingly, this was not what we encountered 
in our research. A few pharmacists still viewed drug use and healthcare from a reductionist and 
biomedical perspective, which calls for a review of pharmacists’ training (30). These misconceptions 
about the realities of WOST may limit their access to healthcare and contribute to maintaining health 
inequities among this group. It is then essential to consider stigma and discrimination as main barriers 





health. This will allow us to address social-structural determinants of health, to improve health, 
protect the human and health rights of WOST, and reduce social and health inequities.   
Trust is key to delivering of pharmacy services (31-32), particularly among vulnerable and 
marginalized populations such as WOST. Our findings suggested that building a trusting relationship 
would enhance access to sexual health services among WOST. Building positive rapport would 
encourage women to express their concerns and overcome reluctance to discuss their sexual health. It 
may also have a significant role in promoting effective communication, and reducing perceived and 
enacted stigma. It is also essential that human and health rights are protected by treating WOST 
humanely, and reducing stigma and discrimination (33-36).  
Other barriers to providing sexual health services alongside OST were the pragmatic considerations of 
lack of privacy and time. The lack of time may have a negative impact on effective communication 
and limit the proactive promotion and provision of sexual health services. This could restrict the 
access to healthcare and thus be another factor that maintains health inequities for WOST. We 
therefore need to be careful that appropriate time and spaces are provided for delivering sexual health 
services. This may have implications on the funding needed for sexual health services, to ensure that 
community pharmacies have the necessary resources to implement these services. This links with 
another of the challenges identified: the need for funding. Commissioning sexual health services 
would be essential for implementing the services as community pharmacies cannot fund these 
services themselves.  
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Key points 
 There are important opportunities to expand available public health services in 
community pharmacy to promote sexual health among WOST. 
 There are opportunities to improve how pharmacy services are being delivered. 
 Barriers need to be considered when developing and implementing public health 





 Policies need to be improved to protect the health of WOST and other drug-using 
populations.  
 Improving access to healthcare services and protecting human and health rights of 
WOST should be at the core of public health services 
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Demographics, drug use, opioid substitution treatment and sexual health-related data of women on 
opioid substitution treatment taking part in the interviews. 
Participant characteristics (N=20) n (%) 














No academic qualifications 
0 Level/Scottish Higher or equivalent (NVQ/SVQ Level 2) 













































Codeine 13 (65) 
















Transactional sex (lifetime) 8 (40) 
Sexual abuse (N=19) 17 (89.5) 
Sexual health  
STI/BBV preventive methods 
No sex 
None 
Male condom use 
STI/BBV screening (at least once) (N=18) 
STI/BBV diagnoses 






















Demographics and job characteristics of community pharmacists taking part in the interviews. 
Sample Characteristics (N=14) n (%) 
































Postgraduate certificate of education (PGCE) 








Work ≥ 16 hours /week 


















Time being a pharmacist (in months) M=145.64 (SD=124.69) 
(12.14 years) 
Responsible for OST 14 (100) 
Time being a pharmacist responsible for opioid substitution 










Demographics and job characteristics of community pharmacists taking part in the focus group. 
Sample Characteristics (N=3) n (%) 

































Time being a pharmacist (in months) M=144.67 (SD=166.21) 
(12.05 years) 
Responsible for OST 3 (100) 
Time being a pharmacist responsible for opioid substitution 











 The publication in this chapter combined data from WOST and CPs in relation to developing 
a sexual health service in community pharmacy for WOST. The data and analyses presented in this 
paper are an important part of this thesis. They illustrate the gaps between the views and needs of 
WOST and CPs. Also, the opportunities to work together with both groups into developing a service 
that fits both service users and service providers. It was clear through the narratives of both groups 
that this would be a challenging undertaking due to the barriers identified by participants in this study. 
A deeper exploration into the barriers and facilitators may aid future work to design the sexual health 
service. As discussed in the publication, CPs were perceived by both groups of participants as having 
a role in promoting sexual health among WOST. At the same time, there were important aspects to 
consider in the interactions between WOST and CPs. Focusing the attention on social and structural 
factors was also key. The conclusions extracted in this publication were based on the previous 
chapters and data presented in this PhD thesis. They were also key points that were considered for the 
second stage of the service development in Chapter 8 and the overall discussion of this PhD in 
Chapter 9. 
7.4. Statement of authorship 
 The research and preparation of this publication were led by the main author of the 
manuscript and this thesis. Dr Jenny Scott, Dr Charlotte Dack, Dr Hannah Family, Dr Sarah Chapman 
and Prof Julie Barnett were the supervisors and co-authors of this research and publication. They all 
gave feedback and support in planning the research, collecting and analysing data, and writing this 
publication.  
7.5. Permissions 
 Permissions were obtained from Springer Nature to include the manuscript in this PhD thesis 
(see Appendix 29) on 20
th
 November 2018.  
7.6. Data access statement 
 Data linked to this publication are available upon request to the main author of the manuscript 





CHAPTER 8. Service Design: Developing a Sexual Health Service for 
Women on Opioid Substitution Treatment in Community Pharmacy 
This chapter includes the steps for the development of a sexual health service for WOST in 
community pharmacy, to prevent STIs and BBVs. As introduced in Chapter 2, this study followed the 
IM approach (see page 16). This chapter corresponds to the last task of Step 1 (stating the goals of the 
service) and Step 2 of IM (identifying the service outcomes and objectives). This chapter is based on 
and builds upon the work presented in previous chapters. Chapter 8 is moving on from the data 
already presented in Chapters 3-6 to provide suggestions on how could these data be used to develop 
pharmacy-based services that address the sexual health needs of WOST. 
8.1. Stating the Goals of the Service 
The main goals of the sexual health service were based on the findings from this PhD 
research (see Chapters 3-6) which were synthesised in the Logic Model of the Problem in Chapter 6 
(Figure 9, page 151). Despite the crucial importance of increasing the use of female and male 
condoms among WOST, data from this study suggested that this may not be feasible in community 
pharmacy. This was due to the barriers and capacity of community pharmacy and CPs to deliver 
sexual health services for WOST (see Chapters 4-7). Interventions at multiple ecological levels may 
be needed in order to address sexual health risks among WOST (Dahlgren & Whitehead, 1991; 
McLeroy et al., 1988). This is further discussed in Chapter 9. Participants’ narratives suggested that 
increasing the availability and uptake of sexual health services would be attainable. The goals of this 
service were therefore focused on secondary rather than primary prevention. The service goals for the 
sexual health service were: 
1. To promote the uptake of sexual health services18 among WOST. 
2. To increase the engagement of CPs in delivering sexual health services to WOST. 
Attaining these goals could reduce STI/BBV rates, associated health problems (e.g., 
infertility, cancer, AIDS) and STI/BBV-related mortality. Most importantly, it could help reduce 
health inequities among WOST and improve their QoL. 
8.2. Stating Service Outcomes 
Individual-level and socio-structural outcomes were defined, based on the data presented in 
Chapters 3-6, especially the Logic Model of Change (see Figure 9, page 151).  As explained in 
Chapter 2 (see page 40), these outcomes were the actions and conditions required to attain the goals of 
                                                             
18 Sexual health services include screening, treatment and counselling for STIs and BBVs, sessions and 





the service. The outcomes are stated below and were selected from a more extensive list of potential 
outcomes. Decisions on the final outcomes were based on what participants prioritised and thought to 
be most acceptable and feasible. Previous research also informed these decisions. Some outcomes 
could not be included within the scope of this service (e.g., develop new policies for sexual health 
education), or could not be addressed successfully in community pharmacy (e.g., increase the use of 
male and female condoms among WOST). As already discussed in Chapter 5 and 7, there were 
important perceived barriers for implementing sexual health services for WOST in community 
pharmacy. These were particularly considered to select the service outcomes. Overall, the outcomes 
of the service were those to promote the availability and uptake of sexual health services in 
community pharmacy to decrease the burden of disease.   
Through the implementation of this service, change was expected mainly from WOST and 
CPs. However, other health professionals could also have a role in promoting sexual health among 
WOST (e.g., social workers or GPs in case of referrals from CPs). Details on the role of each 
professional would be detailed in subsequent stages of the service design that are not part of this PhD 
research (see pages 196 and 237).  
8.2.1. Individual-level Outcomes  
Outcomes at the individual level were the behaviours that WOST would be expected to 
perform and accomplish as a result of the sexual health service: 
1. Access and engage in sexual health services: sexual health screening, initiation and 
adherence to treatment for STI/BBV, sexual health advice and counselling, and free 
supply of barrier methods (male condom, female condom).  
8.2.2. Socio-structural level Outcomes 
Socio-structural outcomes that could be included in the intervention were identified at the 
interpersonal and organisational level. Outcomes at the community level (e.g., to develop community 
interventions to address GBV) and societal levels (e.g., changes in the educational system) were 
identified but were not within the scope of this service. 
8.2.2.1. Interpersonal-level outcomes 
Interpersonal-level outcomes relate to one-to-one interactions between WOST and other 
individuals in their interpersonal environment (e.g., family, health professionals). Interpersonal-level 
outcomes may include processes of social influence and interpersonal elements of social capital, such 
as building trust (Abbott & Freeth, 2008; Bartholomew Eldredge et al., 2016; Eriksson, 2011; Reblin 





scope to consider the interactions between service users (i.e., WOST) and service providers (i.e., 
CPs). The outcomes presented below would need to be performed by CPs: 
2. Actively address stigma towards WOST in community pharmacy.  
3. Actively identify situations of GBV among WOST and make appropriate referrals. 
8.2.2.2. Organisational-level outcomes  
Outcomes at the organisational level are norms, policies, practice and facilities (Bartholomew 
Eldredge et al., 2016; Schulz & Northridge, 2004). Organisational-level outcomes in the development 
of this service were associated with health and social services for WOST, related to the service goals. 
These outcomes would need to be performed by CPs: 
4. Actively provide information and guidance on sexual health to WOST.  
5. Actively deliver free supplies of barrier methods (male and female condoms), STI/BBV 
screening, STI/BBV treatment and counselling, and appropriate referrals to other 
professionals and health/social services.  
8.3. Specifying Performance Objectives 
Performance objectives are sub-components of the outcomes outlined in the previous section, 
as they provide specific details about how to achieve these outcomes (Bartholomew Eldredge et al., 
2016). Performance objectives need to be realistic and practical in terms of the priority group (i.e., 
WOST). For instance, making and maintaining an appointment might be a great challenge for WOST. 
These practicalities were considered when selecting performance objectives. The performance 
objectives are presented in Table 13 below and are mapped with individual-level and socio-structural 
level outcomes. Some outcomes were divided to match them with the performance objectives.  
Table 13 
Individual-level and socio-structural level outcomes, and related performance objectives.  
Individual-level outcomes 
WOST will: 
Associated Performance Objectives 
IO.1. Obtain free barrier methods (male and 
female condoms) by accessing pharmacy-
based sexual health services  
PO.1. Decide to obtain free barrier methods 
PO.2. Communicate with CPs about interest in 
obtaining free barrier methods 






IO.2. Screen for STIs and BBVs PO.1. Decide to get screened for STI/BBVs 
PO.2. Communicate with CPs about interest in 
STI/BBV screening and sexual health concerns 
PO.3. Screen for STIs and BBVs 
PO.4. Obtain STI/BBV screening results 
IO.3. Uptake treatment for STIs and BBVs, if 
positive result 
PO.1. Decide to get treatment 
PO.2. Communicate with CPs about treatment 
PO.3. Initiate and complete/undertake course of 
treatment 
Socio-structural level outcomes 
CPs will: 
Associated Performance Objectives 
SSO.1. Actively address stigma towards 
WOST in community pharmacy 
PO.1. Decide to actively address stigma towards 
WOST in their community pharmacy 
PO.2. Address stigma towards WOST in their 
community pharmacy  
SSO.2. Actively identify situations of GBV 
among WOST and make appropriate referrals 
PO.1. Undertake training in GBV 
PO.2. Decide to identify GBV among WOST 
PO.3. Identify situations of GBV among WOST 
PO.4. Decide to have a discussion around GBV 
with WOST (if situation of GBV identified) 
PO.5. Prepare discussion around GBV (if situation 
of GBV identified) 
PO.6. Initiate discussion around GBV (if situation 
of GBV identified) 
PO.7. Have discussion around GBV with WOST 
(if situation of GBV identified) 
PO.8. Decide to make appropriate referrals when 
identifying situations of GBV 
PO.9. Make appropriate and timely referrals 
SSO.3. Actively provide information and 
guidance for sexual health to WOST  
PO.1. Decide to have discussion around sexual 
health 





PO.3. Initiate a discussion on sexual health 
PO.4. Have discussion on sexual health 
PO.5. Answer WOST’s questions or concerns 
SSO.4. Actively offer free male and female 
condoms to WOST  
PO.1. Provide information around sexual health 
(SSO.3.) 
PO.2. Offer and provide free male and female 
condoms 
PO. 3. Answer WOST’s questions or concerns 
SSO.5. Actively deliver free STI/BBV 
screening, STI/BBV treatment and guidance, 
and/or appropriate referrals to other 
professionals/services  
PO.1. Provide information around sexual health 
(SSO.3.) and STI/BBV screening 
PO.2. Offer and provide WOST free STI/BBV 
screening 
PO.3. Provide STI/BBV screening 
PO.4. Send samples to laboratory for testing 
PO.5. Notify WOST of results in a private space 
within the pharmacy 
PO.6. If positive results, discuss treatment options  
PO.7. If positive results, initiate treatment/refer to 
appropriate professionals/services to initiate 
treatment 
PO.8. Answer WOST’s questions or concerns 
Note. IO = individual-level outcome; SSO = socio-structural level outcome; PO = performance objective. 
8.4. Selecting Determinants of Health 
 The next step of service design was selecting the determinants of health that were relevant to 
the development of the sexual health service for WOST, and in the context of community pharmacy. 
These were associated with individual-level behaviour and with the socio-structural changes required. 
A preliminary list containing 15 determinants of health was developed (see Table 14). Determinants 
of health were selected based on data generated in this PhD study and previous evidence. This list 
includes ratings on the importance and potential changeability of each determinant which were used 
to select those determinants most relevant for the service. As presented in Table 14, addressing most 
determinants was perceived to be important in order attain the outcomes of the service. At the same 
time, most were not rated as easily changeable. Decisions on the inclusion and exclusion of 
determinants to be addressed were mainly based on what was considered within the scope of this 





were based on data from this research (Chapters 3-6) and ratings of importance and changeability. See 
Table 14 for the list of determinants and explanations for the inclusion and exclusion of each 
determinant.  
There were eight determinants of health selected. Of these, there were four that were paired as 
they were closely associated with each other (beliefs and knowledge; skills and self-efficacy). There 
were then six determinants included at the last stage: 1) perceived barriers; 2) attitudes (including 
stigma); 3) habits; 4) risk awareness; 5) beliefs and knowledge; and 6) skills and self-efficacy. Four of 
these determinants were relevant to both individual-level and socio-structural level outcomes: 
attitudes; habits; beliefs and knowledge; and skills and self-efficacy. ‘Perceived barriers’ was only 
relevant to socio-structural level outcomes and ‘risk awareness’ for individual-level outcomes. See 
Table 14 for more details. 
8.5. Matrices of Change Objectives 
 Creating the Matrices of Change Objectives was the next step for service design. The purpose 
of these matrices were to identify change objectives. These were measurable changes that one would 
expect to see if the intervention was meeting the service goals. These matrices were constructed by 
mapping performance objectives and determinants of health. These were important to specify so that 
they could be measured for service evaluation (Step 6 of IM). The change objectives were included in 
the matrices’ cells. See Tables 15 to 22 for the Matrices of Change Objectives.  
8.6. The Logic Model of Change 
 The last stage of service design of Step II consisted of the development of a The Logic Model 
of Change, a conceptual model that illustrates the pathways of change that lead to attaining the service 
goals and influence health outcomes and quality of life (see Figure 10, page 215). As already 
mentioned, this model was developed based on the previous stages of service design. It includes the 
relationships between the change objectives, performance objectives, service outcomes, health 










8.7. Next Steps for Service Design 
 In terms of service design, this PhD research provided suggestions for the outcomes and goals 
of a pharmacy-based sexual health service to address the sexual health needs of WOST. Also, it set a 
pathway of individual-level and socio-structural elements that would need to be changed in order to 
attain these goals. Based on the IM approach (Bartholomew Eldredge et al., 2016), the next steps for 
service design would be to: 
1. Select theory- and evidence- based change methods, and generate practical applications and 
details of how to deliver these change methods (Step III). 
2. Refine the structure and organisation of the service, devise and pre-test materials (Step IV). 
3. Design the implementation and implement the service (Step V). 
4. Design and evaluation plan and evaluate the implementation of the service (Step VI). 
This PhD research run alongside another project aiming to develop a reproductive health 
service in community pharmacy for the same group of women. Ideas for grant applications are 
currently being generated in order to bring the findings of both studies together. Findings from this 
PhD will then inform the design, implementation and evaluation of a pharmacy-based service that 







List of determinants of health, including ratings of importance and changeability, agents of change and inclusion/exclusion of determinants. 
 Determinant Importance Changeability Agent(s) of change Inclusion (Y/N) Justification for inclusion/exclusion 
1 Social norms and social 
roles 
Social norms: collective 
representations of how 
individuals and particular 
social groups should 
behave 
Social roles: collective 
expectations of certain 
individuals, in terms of 
their rights, responsibilities 
and behaviours 
+++ + WOST, CPs 
 
N Social norms relevant to this research were mainly social norms of how WOST and CPs are expected to behave. 
These were, for instance, associated with WOST’s gender. Other social norms were related to sex and sexual health 
as taboo topics. Social roles relevant to this research are consonant with these same social norms. For example, in 
relation to the expected responsibilities of being a CPs.  
Despite the importance of changing social norms and roles, these were not considered to be the most changeable 
determinants. Even though the pharmacy-based service could focus on changing social norms and roles at the 
interpersonal level, there is the need for interventions at multiple ecological levels to attain changes in social norms 
and roles. These determinants were then excluded as, to attain the most impact, their inclusion should also require 
for a broader intervention that includes different settings (e.g., schools) and at the community and societal level.  
2 Self-concept and social 
identity 
Self-concept: the beliefs 
that someone holds about 
oneself 
Social identity: the beliefs 
that someone holds about 
oneself, in relation to their 
memberships to social 
groups 
+++ + WOST N Similarly to social norms and social roles, self-concept and social identity were out of the scope of this service. An 
intervention at multiple ecological levels may also be required to attain changes in these determinants. Addressing 
self-concept and social identity may be needed to involve other professionals and other settings for the service 
(e.g., drug services). Self-concept and social identity could however be indirectly and partly addressed through 
addressing other determinants such as stigma (attitudes). 
  
3 Sense of control and 
empowerment 
Sense of control: 
Perception that one has the 
control over oneself and 
the one around her 
Empowerment: autonomy 
and self-determination 
among people and social 
groups 
+++ + WOST N Sense of control and empowerment were out of the scope of this service. Based on the data from this study, these 
were important but not considered to be easily changeable. Interventions at multiple ecological levels may be 
required to attain change in WOST’ sense of control and empowerment. For instance, it would be essential to 
involve other professionals and include other settings for the service (e.g., drug service). Sense of control and 
empowerment could however be indirectly and partly addressed through addressing other determinants such as 
stigma (attitudes), habits and self-efficacy. 
4 Perceived barriers +++ + WOST, CPs Y (for CPs) WOST: Perceived barriers to access sexual health services (e.g., fear of stigma) were important to be addressed by 





Emotional (e.g., discomfort 
discussing sexual health) 




efficacy, and through addressing some barriers among CPs (e.g., discomfort initiating a conversation on sexual 
health). Other barriers (e.g., worthlessness and disempowerment) were not within the scope of the service, or could 
not be changed by WOST (e.g., time constraints in health care services) thus were not included either.  
CPs: Perceived barriers among CPs were important to be addressed too. Based on the data from this study, some of 
these barriers could be addressed in this service (e.g., lack of time). As already mentioned, addressing perceived 
barriers among CPs was also targeted as a means to reduce barriers among WOST. 
Addressing other system and structural barriers (e.g., change educational system) was out of the scope of this 
service. This would require for an intervention at multiple ecological levels that include changes in policy, 
organisational and societal levels. 
5 Attitudes (including 
stigma) 
A way of thinking or feeling 
about something, someone 
or a collective 
 
+++ + WOST, CPs 
 
Y WOST: Attitudes towards accessing sexual health services, CPs and pharmacy services were within the scope of 
this service. 
Other attitudes (e.g., regarding condom use) were not within the scope of the service. For instance, increasing the 
use of female and male condoms was not a service goal or outcome, thus attitudes towards condom use were not 
within the scope of the service.  
CPs: Attitudes towards WOST and delivering sexual health services could be addressed by this service. 
Addressing all dimensions of intersectional stigma and general negative attitudes towards WOST was out of the 
scope of this service. This may require a broader intervention in different settings (e.g., schools, drug services) and 
at different social-ecological levels (individual, interpersonal, organisational, community, societal). 
6 Motivation 
A drive to attain a certain 
goal or behave in a 
particular manner 
++ + WOST, CPs N Motivation was an important determinant to sexual health risks among WOST, and for CPs to deliver sexual health 
services. However, focusing on other determinants may be more urgent to promote the uptake of sexual health 
services among WOST (e.g., stigmatising attitudes towards WOST). These may be preconditions for motivation. 
Making changes in these other determinants (attitudes, perceived barriers, risk awareness, beliefs, skills, self-
efficacy and knowledge) may have an impact on motivation.  
7 Outcome expectancies 
Beliefs on anticipated 
consequences (positive or 
negative) that result from 
engaging in a particular 
behaviour 
++ + WOST, CPs N Outcome expectancies were important to be addressed as they reflect what WOST and CPs expected from the 
service and their own actions. Outcome expectancies were considered to be difficult to change and, as for 
motivation, there may be other determinants that are preconditions to outcome expectancies (e.g., perceived 
barriers or beliefs).  






acknowledgment that one is 
a at risk 
service. Other aspects of risk awareness (e.g., regarding condom use) were not within the scope of the services. 
This was because increasing female and condom use was not one of the service goals or outcomes. 
9 Emotions: love and trust 
Love: feelings of affection 
Trust: belief in the 
reliability, truth or ability 
of something or someone 
++ + WOST, CPs N WOST: Love and trust with sexual partners (and significant others) was not within the scope of this service, as it 
may require the involvement of other professionals and other settings for the service (e.g., drug services). Trust 
towards CPs was key for WOST to engage in the sexual health service. Trust was not directly targeted by the 
service as other determinants were considered to be preconditions to trust (e.g., stigma). 
CPs: Trust could be addressed in the context of community pharmacy, with CPs building trust and positive rapport 
with WOST. Attitudes and stigma seemed to be preconditions for trust, thus trust was not included as a determinant 
directly. Trust was rather a goal to attain through addressing other determinants. 
10 Habits 
Regular tendency or 
practice, usually embedded 
within one’s lifestyle and 
routines  
++ + WOST, CPs Y WOST: Habits were within the scope of this service and were an important determinant to target. Habits within the 
scope of the service were those related to accessing sexual health services only. Other habits (e.g., using 
female/male condoms consistently) were not included as the service did not aim to increase female and male 
condom use.  
CPs: Habits were important so that CPs delivered sexual health services regularly to WOST.  
11 Beliefs 
Acceptance and trust that 
something is true or exists 
without the need for proof 
++ + WOST, CPs Y WOST: Beliefs around sexual health, pharmacy services and pharmacy could be addressed in this service.  
CPs: Beliefs around sexual health, drug use and their role in the care of WOST could be addressed in this service. 
Whilst beliefs were not the most important determinant, these were thought to be a precondition for other 
determinants that may be addressed by this or other services (e.g., outcome expectancies).  
12 Skills 
The ability of performing a 
particular task well 
++ ++ WOST, CPs Y WOST: Skills to access and engage in services was included for this service. Despite its importance, skills to use 
female and male condoms correctly and consistently were not included as these were not a goal or outcome of the 
service.  
CPs: Skills in how to deliver the service and, especially, on how to communicate and interact with WOST were an 
important element of this service. 
13 Self-efficacy 
The believe in one’s ability  
++ + WOST, CPs Y WOST: Self-efficacy in accessing and engaging in services was included in this service. As for skills, self-efficacy 
in relation to other behaviours (e.g., negotiating condom use) was out of the scope of the service.  
CPs: Self-efficacy regarding the delivery of the service was important to be addressed in this service. Self-efficacy 





14 Social support 
Perceived network of 
people that could and 
would assist one if needed 
++ + WOST, CPs N WOST: Addressing social support (e.g., from significant others) was out of the scope of this service. Including 
social support could be an important element but would require for an intervention at multiple ecological levels 
(e.g., community level). Support from CPs was considered to be important. It was however not included as it was 
expected that addressing other determinants (e.g., attitudes) could increase perceived social support among WOST. 
CPs: Social support could be addressed in the context of community pharmacy, with CPs offering support to 
WOST. Addressing stigma and other negative attitudes, and building trust were however a precondition for social 
support in community pharmacy. This service focused on these other determinants, to also have an impact on social 
support.  
15 Knowledge 
The understanding of 
information 
++ ++ WOST, CPs Y WOST: Knowledge of sexual health and sexual health services could be addressed in this pharmacy-based service. 
Even if knowledge was not one of the key determinants it could be a pre-requisite to address other determinants 
(e.g., risk awareness). 
CPs: Increasing knowledge among CPs (e.g., on how to identify signs of GBV) was important for this service. As 
for WOST, knowledge was not necessarily the most crucial determinant to focus on, but was the precondition for 
other determinants (e.g., skills). 
Notes. Meaning of ratings: not very important or not easily changeable (+), important or changeable (++); very important or very changeable (+++). The list of theoretical approaches in this table is not meant to represent an exhaustive list of associated 
theoretical approaches. Those perceived to be most relevant were the ones included. From Planning Health Promotion Programs: An Intervention Mapping Approach (p. 307), by Bartholomew Eldredge et al., 2016, San Francisco, California: Jossey-Bass. 
Copyright [2016] by John Wiley & Sons, Inc. Adapted with permission (see Appendix 1). 
Table 15 
Matrix for individual-level outcome: obtain barrier methods 
Performance objective  
WOST will: 
Determinants 
Attitudes Habits Risk awareness Beliefs and knowledge Skills and self-efficacy 
PO.1. Decide to obtain free 
barrier methods 
A.1.1. Express positive feelings 
about using barrier methods 
A.1.2. Express positive feelings 
about obtaining barrier methods 
A.1.3. Express positive feelings 
about CPs  
A.1.4. Express positive feelings 
accessing pharmacy services 
 RA.1.1. Recognise the general and 
personal risk of contracting STIs 
and BBVs if not using barrier 
methods 
BK.1.1. State the potential consequences 
of not using barrier methods 
BK.1.2. Acknowledge that using barrier 
methods decreases the risk for STIs and 
BBVs 
SSE.1.1. Express confidence in own ability 
to obtain free barrier methods  
SSE.1.2. Express confidence in overcoming 
embarrassment and stigma associated with 
obtaining free barrier methods 






PO.2. Communicate with CPs 
about interest in obtaining free 
barrier methods 
A.2.1. Express positive feelings 
about communicating about 
barrier methods and sexual health 
A.2.2. Express positive feelings 
about communicating with CPs 
H.2.1. Develop a habit to 
communicate with CPs when 
deciding to obtain barrier methods 
RA.2.1. Understanding the general 
and personal risks for STIs and 
BBVs if not communicating with 
health professionals about barrier 
methods and sexual health 
BK.2.1. State that communicating with 
CPs could be positive to improve own 
sexual health 
SSE.3.1. Express confidence in 
communicating with CPs 
SSE.3.2. Express confidence in overcoming 
embarrassment and stigma when 
communicating with CPs 
PO.3. Engage in pharmacy 
services to obtain barrier 
methods 
A.3.1. Express positive feelings 
about accessing and engaging in 
pharmacy services 
A.3.1. Express positive feelings 
about CPs  
 
H.3.1. Develop a habit to engage 
in pharmacy services to obtain 
barrier methods  
RA.3.1. Recognise risks for STIs 
and BBVs if not engaging in sexual 
health services 
BK.3.1. State that engaging in pharmacy 
services could be positive to improve 
own sexual health 
SSE.3.1. Express confidence in engaging in 
pharmacy services 
SSE.3.2. Express confidence in overcoming 
embarrassment and stigma when engaging 
in pharmacy services 
Note. PO = performance objective; A = attitudes; H = habits; RA = risk awareness; BK = beliefs and knowledge; SSE = skills and self-efficacy. 
Table 16 
Matrix for individual-level outcome: screen for STIs and BBVs 
Performance objective  
WOST will: 
Determinants 
Attitudes Habits Risk awareness Beliefs and knowledge Skills and self-efficacy 
PO.1. Decide to get screened 
for STI/BBVs 
A.1.1. Express positive feelings 
about screening for STIs and 
BBVs 
A.1.2. Express positive feelings 
about CPs 
A.1.4. Express positive feelings 
accessing pharmacy services 
 RA.1.1. Recognise (sexual) health 
risks of not screening for STIs and 
BBVs 
BK.1.1. State the potential consequences 
of not screening for STIs and BBVs 
BK.1.2. Acknowledge that screening for 
STIs and BBVs helps protect sexual 
health, general health and wellbeing 
BK.1.3. Acknowledge the possibility of 
screening for STIs and BBVs in their 
local community pharmacy 
SSE.1.1. Express confidence in own ability 
to screen for STIs and BBVs  
SSE.1.2. Express confidence in overcoming 
embarrassment and stigma associated with 
screening for STIs and BBVs 
PO.2. Communicate with CPs 
about interest in STI/BBV 
A.2.1. Express positive feelings 
about communicating about sex 
H.2.1. Develop a habit to 
communicate with CPs when 
RA.2.1. Recognise risks for STIs and 
BBVs if not communicating with 
BK.2.1. State that communicating with 
CPs could be positive to protect sexual 
SSE.2.1. Express confidence in 





screening and sexual health 
concerns 
and sexual health  
A.2.2. Express positive feelings 
about communicating with CPs 
deciding to screen for STIs and 
BBVs 
health professionals about sexual 
health 
health, general health and wellbeing 
SSE.2.2. Express confidence in overcoming 
embarrassment and stigma when 
communicating with CPs 
PO.3. Perform STI/BBV 
screening 
A.3.1. Express commitment to 
perform STI/BBV screening 
H.3.1. Develop a habit to 
perform STI/BBV screening 
regularly  
RA.3.1. Recognise (sexual) health 
risks for not performing STI/BBV 
screening 
BK.3.1. Describe the procedures to 
perform STI/BBV screening 
 
SSE.3.1. Express confidence in performing 
STI/BBV screening 
SSE.3.2. Demonstrate ability to perform 
STI/BBV screening  
SSE.3.3. Express confidence in overcoming 
embarrassment and stigma when 
performing STI/BBV screening 
PO.4. Obtain STI/BBV 
screening results 
A.4.1. Express commitment to 
obtain screening results 
H.4.1. Develop a habit to obtain 
STI/BBV screening results when 
screening for STIs and BBVs 
RA.4.1. Recognise personal (sexual) 
health risks for not obtaining 
STI/BBV screening 
BK.4.1. Describe process for obtaining 
screening results 
BK. 4.2. Express understanding on how 
to interpret the results 
BK.4.1. Express confidence in ability to 
obtain screening results 
BK.4.2. Express confidence in coping with 
screening results 
BK.4.3. Express confidence in overcoming 
embarrassment and stigma when obtaining 
STI/BBV screening results 
Note. PO = performance objective; A = attitudes; H = habits; RA = risk awareness; BK = beliefs and knowledge; SSE = skills and self-efficacy. 
Table 17 
Matrix for individual-level outcome: uptake treatment for STIs and BBVs 
Performance objective  
WOST will: 
Determinants 
Attitudes Habits Risk awareness Beliefs and knowledge Skills and self-efficacy 
PO.1. Decide to get treatment A.1.1. Express positive feelings 
about STI/BBV treatment 
A.1.2. Express commitment to 
STI/BBV treatment 
A.1.3. Express positive feelings 
 RA.1.1. Recognise (sexual) health 
risks of not accessing STI/BBV 
treatment 
BK.1.1. State the potential consequences 
of not treating for STI/BBV 
BK.1.2. State the benefits of STI/BBV 
treatment 
BK.1.3. Express understanding about the 
SSE.1.1. Express confidence in own ability 
to uptake STI/BBV treatment  
SSE.1.2. Express confidence in overcoming 






about CP providing/referring for 
treatment 
A.1.4. Express positive feelings 
about accessing STI/BBV 
treatment services 
facts of STI or BBV diagnosed (i.e., 
transmission, symptomatology, 
diagnosis, treatment, comorbidity and 
mortality, professional and other 
support) 
BK. 1.4. Acknowledge that STI/BBV 
treatment helps protect sexual health, 
general health and wellbeing 
BK.1.5. Describe the health services to 
access for STI/BBV treatment 
PO.2. Communicate with CPs 
about treatment 
A.2.1. Express positive feelings 
about communicating about 
STI/BBV treatment 
A.2.2. Express positive feelings 
about communicating with CPs 
H.2.1. Develop a habit to 
communicate with CPs about 
treatment when diagnosed with 
an STI or a BBV 
RA.2.1. Recognise the (sexual) health 
risks of not discussing treatment 
options with CPs 
 
BK.2.1. State that communicating with 
CPs could be positive to protect sexual 
health, general health and wellbeing 
SSE.2.1. Express confidence in 
communicating with CPs 
SSE.2.2. Express confidence in overcoming 
embarrassment and stigma when 
communicating with CPs 
PO.3. Initiate and 
complete/undertake course of 
treatment 
A.3.1. Express commitment to go 
through course of treatment 
H.3.1. Develop a habit to initiate 
and complete/undertake course 
of treatment when diagnosed 
with an STI or a BBV 
RA.3.1. Recognise the risks for of not 
initiating STI/BBV treatment 
RA.3.2. Recognise the risks for 
delaying STI/BBV treatment 
initiation 
BK.3.1. Describe treatment procedures 
for specific diagnosis 
BK.3.2. Describe other forms of support 
available  
SSE.3.1. Express confidence in initiating 
and completing/undertaking course of 
STI/BBV treatment  
SSE.3.2. Express confidence in overcoming 
embarrassment and stigma when initiating 
treatment 
Note. PO = performance objective; A = attitudes; H = habits; RA = risk awareness; BK = beliefs and knowledge; SSE = skills and self-efficacy. 
Table 18  
Matrix for socio-structural level outcome: address stigma towards WOST in community pharmacy 
Performance objective  
CPs will: 
Determinants 
Perceived barriers Attitudes Habits Beliefs and knowledge Skills and self-efficacy 
PO.1. Decide to actively 
address stigma towards WOST 
in community pharmacy 
PSB.1.1. Identify potential barriers 
to address stigma towards WOST 
(e.g., conflict with other clients), 
A.1.1. Express positive feelings 
towards WOST (non-
stigmatising) 
 BK.1.1. Understand intersectional stigma 
towards WOST 
BK.1.2. Describe ways to address stigma 
SSE.1.1. Express confidence in their ability 






including own barriers and 
limitations (e.g., own stigmatising 
attitudes towards WOST) 
PSB.1.2. Anticipate potential 
barriers from WOST 
PSB.1.3. Identify ways to 
overcome barriers 
A.1.2. Express commitment to 
address stigma towards WOST 
in community pharmacy 
towards WOST in community pharmacy 
BK.1.3. Acknowledge that addressing 
stigma towards WOST can have a 
positive impact on women’ sexual 
health, general health and wellbeing 
BK.1.4. Understand the need to address 
stigma towards WOST in community 
pharmacy 
BK.1.5. Describe their role in addressing 
stigma towards WOST 
PO.2. Address stigma towards 
WOST in community 
pharmacy 
PSB.2.1. Identify potential barriers 
PSB.2.2. Act to overcome 
potential barriers as identified 
(PSB.1.3.) 
A.2.1. Express positive feelings 
towards WOST (non-
stigmatising) 
A.2.2. Express commitment to 
address stigma towards WOST 
in community pharmacy 
H.2.1. Develop a habit to address 
stigma towards WOST in community 
pharmacy 
BK.1.1. Understand intersectional stigma 
towards WOST 
BK.1.2. Describe ways to address stigma 
towards WOST in community pharmacy 
BK.1.3. Acknowledge that addressing 
stigma towards WOST can have a 
positive impact on women’ sexual 
health, general health and wellbeing 
BK.1.4. Understand the need to address 
stigma towards WOST in community 
pharmacy 
BK.1.5. Describe their role in addressing 
stigma towards WOST 
SSE.2.1. Express confidence in their ability 
to address stigma towards WOST 
SSE.2.2. Demonstrate skills to address 
stigma towards WOST 










Matrix for socio-structural level outcome: identify gender-based violence and make appropriate referrals 
Performance objective  
CPs will: 
Determinants 
Perceived barriers Attitudes Habits Beliefs and knowledge Skills and self-efficacy 
PO.1. Decide to identify GBV 
among WOST 
PSB.1.1. Identify potential barriers 
to identifying GBV among WOST 
(e.g., lack of time), including own 
barriers and limitations (e.g., 
views on GBV) 
PSB.1.2. Anticipate potential 
barriers from WOST (e.g., feeling 
judged) 
PSB.1.3. Identify ways to 
overcome barriers (e.g., plan time 
for private consultation) 
A.1.1. Express positive feelings 
towards WOST (non-
stigmatising) 
A.1.2. Express commitment to 
address GBV among WOST in 
community pharmacy 
 BK.1.1. Understand GBV  
BK.1.2. Describe ways to identify GBV 
(e.g., physical or behavioural signs of 
GBV) 
BK.1.3. Acknowledge that addressing 
GBV with WOST can have a positive 
impact on women’s wellbeing and health 
BK.1.4. Understand the need to address 
GBV among WOST around GBV 
BK.1.5. Describe their role in addressing 
GBV among WOST 
SSE.1.1. Express confidence in their ability 
to address GBV among WOST 
 
PO.2. Identify situations of 
GBV among WOST 
PSB.2.1. Identify potential barriers 
to identifying situations of GBV 
amongst WOST (e.g., lack of 
time) 
PSB.2.2. Act to overcome 
potential barriers as identified 
(PSB.1.3.) 
A.2.1. Express positive feelings 
towards WOST (non-
stigmatising) 
A.2.2. Express commitment to 
identify GBV among WOST in 
community pharmacy 
H.2.1. Develop a habit to identify 
GBV among WOST 
BK.2.1. Understand GBV 
BK.2.2. Describe ways to identify GBV 
(e.g., physical or behavioural signs of 
GBV)  
BK.2.3. Acknowledge that identifying 
GBV among WOST can have a positive 
impact on women’s wellbeing and health 
BK.2.4. Understand the need for 
identifying GBV among WOST 
BK.2.5. Describe their role in identifying 
GBV among WOST 
SSE.2.1. Express confidence in their ability 
to identify GBV among WOST 
SSE.2.2. Express confidence in their ability 
to overcome barriers to identifying GBV 
SSE.2.3. Demonstrate skills to identify 
situations of GBV among WOST 
SSE.2.4. Demonstrate skills to overcome 
barriers to identifying GBV among WOST 





discussion around GBV with 
WOST (if situation of GBV 
identified) 
to have discussion (e.g., lack of 
time), including own barriers and 
limitations (e.g., views on GBV) 
PSB.3.2. Anticipate potential 
barriers from WOST (e.g., feeling 
judged) 
PSB.3.3. Identify ways to 
overcome barriers (e.g., plan time 
for private consultation)  
about communicating with 
WOST (non-stigmatising) 
A.3.2. Express positive feelings 
about discussing GBV with 
WOST 
A.3.3. Express commitment to 
discussing GBV with WOST 
BK.3.2. Acknowledge that discussing 
GBV with WOST can have a positive 
impact on women’s wellbeing and health 
BK.3.3. Understand the need for having 
discussions with WOST around GBV 
BK.3.4. Describe their role in addressing 
GBV among WOST 
to discuss GBV with WOST 
PO.4. Prepare discussion 
around GBV (if situation of 
GBV identified) 
PSB.4.1. Anticipate and prepare 
for potential barriers to initiate and 
hold the discussion 
PSB.4.2. Plan the use of 
facilitators to initiate and hold the 
discussion  
A.4.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.4.2. Express commitment to 
plan the discussion 
H.4.1. Develop a habit to prepare the 
discussion on GBV 
BK.4.1. Acknowledge the benefits of 
preparing the discussion 
BK.4.2. Acknowledge that discussing 
GBV with WOST can have a positive 
impact on women’s wellbeing and health 
BK.4.3. Describe the steps to prepare the 
discussion 
BK.4.4. List the steps that need to be 
completed to initiate and maintain the 
discussion 
BK.4.5. Acknowledge their role in 
addressing GBV among WOST 
SSE.4.1. Express confidence in preparing 
the discussion 
SSE.4.2. Demonstrate skills to prepare the 
discussion 
PO.5. Initiate a discussion on 
sexual health (if situation of 
GBV identified) 
PSB.5.1. Identify potential barriers 
PSB.5.2. Act to overcome 
potential barriers as planned 
A.5.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.5.2. Express commitment to 
initiate a discussion on GBV 
with WOST 
H.5.1. Develop a habit to initiate a 
discussion on GBV with WOST 
BK.5.1. Recognise the steps to initiate 
the discussion on GBV 
BK.5.2. Acknowledge that discussing 
GBV with WOST can have a positive 
impact on women’s wellbeing and health 
BK.5.3. Acknowledge their role in 
addressing GBV among WOST 
SSE.5.1. Express confidence in their ability 
to approach WOST to discuss GBV 
SSE.5.2. Express confidence in their ability 
to overcome barriers to initiating a 
discussion on GBV 
SSE.5.3. Demonstrate skills to initiate a 
discussion on GBV 





barriers to initiating a discussion on GBV 
PO.6. Have discussion around 
GBV with WOST (if situation 
of GBV identified) 
PSB.6.1. Recognise potential 
barriers 
PSB.6.2. Act to overcome 
potential barriers as planned 
A.6.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.6.2. Express commitment to 
have a discussion on GBV with 
WOST 
H.6.1. Develop a habit to discuss 
GBV with WOST 
BK.6.1. Recognise the steps to initiate 
the discussion on GBV 
BK.6.2. Acknowledge that discussing 
GBV with WOST can have a positive 
impact on women’s wellbeing and health 
BK.6.3. Acknowledge their role in 
addressing GBV among WOST 
SSE.6.1. Express confidence in their ability 
to discuss GBV 
SSE.6.2. Express confidence in their ability 
to overcome barriers to having a discussion 
on GBV 
SSE.6.3. Demonstrate skills to have a 
discussion on GBV 
SSE.6.4. Demonstrate skills to overcome 
barriers to having a discussion on GBV 
PO.7. Decide to make 
appropriate referrals when 
identifying situations of GBV 
PSB.7.1. Identify potential barriers 
to make referrals for GBV, 
including those from WOST (e.g., 
reluctance to being referred) 
PSB.7.2. Identify ways to 
overcome barriers  
A.7.1. Express positive feelings 
towards WOST (non-
stigmatising) 
A.7.2. Express commitment to 
make referrals for GBV with 
WOST 
 BK.7.1. Acknowledge the need to 
address GBV among WOST 
BK.7.2. Acknowledge the need to make 
appropriate and timely referrals for GBV 
BK.7.3. Recognise appropriate 
professionals and services to make 
referrals for GBV 
BK.7.4. Describe ways to make referrals 
for GBV  
BK.7.5. Acknowledge that making 
referrals for GBV can have a positive 
impact on women’s wellbeing and health 
BK.7.6. Describe their role in addressing 
GBV among WOST 
SSE.1.1. Express confidence in their ability 
to make referrals for GBV among WOST 
 
PO.8. Make appropriate and 
timely referrals for GBV 
PSB.8.1. Recognise potential 
barriers 
PSB.8.2. Act to overcome 
potential barriers as planned 
A.8.1. Express positive feelings 
towards WOST (non-
stigmatising) 
A.8.2. Express commitment to 
make referrals for GBV 
H.8.1. Develop a habit to make 
appropriate referrals when identifying 
situations of GBV 
BK.8.1. Acknowledge the need to 
address GBV 
BK.8.2. Acknowledge the need to make 
appropriate and timely referrals for GBV 
SSE.8.1. Express confidence in their ability 
to make referrals for GBV among WOST 
SSE.8.2. Demonstrate skills to make 





BK.8.3. Recognise appropriate 
professionals and services to make 
referrals for GBV 
BK.8.4. Describe ways to make referrals 
for GBV  
BK.8.5. Acknowledge that making 
referrals for GBV can have a positive 
impact on women’s wellbeing and health 
BK.8.6. Describe their role in addressing 
GBV among WOST 
 
Note. PO = performance objective; PB = perceived barriers; A = attitudes; H = habits; BK = beliefs and knowledge; SSE = skills and self-efficacy. 
Table 20 
Matrix for socio-structural level outcome: provide information and guidance 
Performance objective  
CPs will: 
Determinants 
Perceived barriers Attitudes Habits Beliefs and knowledge Skills and self-efficacy 
PO.1. Decide to have 
discussion around sexual 
health 
PSB.1.1. Identify potential barriers 
to have discussion (e.g., lack of 
time), including own barriers and 
limitations (e.g., discomfort 
having a discussion on sexual 
health) 
PSB.1.2. Anticipate potential 
barriers from WOST (e.g., feeling 
judged) 
PSB.1.3. Identify ways to 
overcome barriers (e.g., plan time 
for private consultation)  
 
A.1.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.1.2. Express positive feelings 
about discussing sexual health 
with WOST 
 BK.1.1. Describe the main facts about 
STIs and BBVs (i.e., transmission, 
symptomatology, diagnosis, treatment, 
comorbidity, mortality, available 
support) 
BK.1.2. Acknowledge that discussing 
sexual health with WOST can have a 
positive impact on women’ sexual 
health, general health and wellbeing 
BK.1.3. Understand the need for having 
discussions with WOST around sexual 
health 
BK.1.4. Understand the sexual health 
needs of WOST 
SSE.1.1. Express confidence in their ability 






BK.1.5. Describe their role in promoting 
sexual health among WOST 
PO.2. Prepare discussion 
around sexual health 
PSB.2.1. Anticipate and prepare 
for potential barriers to initiate and 
hold the discussion 
PSB.2.2. Plan the use of 
facilitators to initiate and hold the 
discussion  
A.2.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.2.2. Express commitment to 
plan the discussion 
 BK.2.1. Acknowledge the benefits of 
preparing the discussion 
BK.2.2. Acknowledge that discussing 
sexual health with WOST can have a 
positive impact on their sexual health, 
general health and wellbeing 
BK.2.3. Describe the steps to prepare the 
discussion 
BK.2.4. List the steps that need to be 
completed to initiate and maintain the 
discussion 
BK.2.5. Acknowledge their role in 
promoting sexual health among WOST 
SSE.2.1. Express confidence in preparing 
the discussion 
SSE.2.2. Demonstrate skills to prepare the 
discussion 
PO.3. Initiate a discussion on 
sexual health  
PSB.3.1. Identify potential barriers 
PSB.3.2. Act to overcome 
potential barriers as planned 
A.3.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.3.2. Express commitment to 
initiate a discussion on sexual 
health 
H.3.1. Develop a habit to initiate a 
discussion on sexual health with 
WOST 
BK.3.1. Recognise the steps to initiate 
the discussion on sexual health 
BK.3.2. Acknowledge that discussing 
sexual health with WOST can have a 
positive impact on their sexual health, 
general health and wellbeing 
BK.3.3. Acknowledge their role in 
promoting sexual health among WOST 
SSE.3.1. Express confidence in their ability 
to approach WOST to discuss sexual health 
SSE.3.2. Express confidence in their ability 
to overcome barriers to initiating a 
discussion on sexual health with WOST 
SSE.3.3. Demonstrate skills to initiate a 
discussion on sexual health 
SSE.3.4. Demonstrate skills to overcome 
barriers to initiating a discussion on sexual 
health 
PO.4. Have discussion on 
sexual health 
PSB.4.1. Recognise potential 
barriers 
PSB.4.2. Act to overcome 
potential barriers as planned 
A.4.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.4.2. Express commitment to 
H.4.1. Develop a habit to discuss 
sexual health with WOST 
BK.4.1. Recognise the steps to have a 
discussion on sexual health 
BK.4.2. Acknowledge that discussing 
sexual health with WOST can have a 
SSE.4.1. Express confidence in their ability 
to discuss sexual health 
SSE.4.2. Express confidence in their ability 





have a discussion on sexual 
health 
positive impact on their sexual health, 
general health and wellbeing 
BK.4.3. Acknowledge their role in 
promoting sexual health among WOST 
on sexual health 
SSE.4.3. Demonstrate skills to have a 
discussion on sexual health 
SSE.4.4. Demonstrate skills to overcome 
barriers to having a discussion on sexual 
health 
PO.5. Answer WOST’s 













PSB.5.1. Recognise potential 
barriers 
PSB.5.2. Act to overcome 
potential barriers as planned 
A.5.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.5.2. Express positive feelings 
to answer WOST’s questions 
and concerns 
A.5.3. Express commitment to 
answer WOST’s questions and 
concerns 
H.5.1. Develop a habit to answer 
WOST’s questions and concerns 
BK.5.1. Acknowledge that answering 
WOST’s questions and concerns can 
have a positive impact on their sexual 
health, general health and wellbeing 
BK.5.2. Acknowledge their role in 
promoting sexual health among WOST 
SSE.5.1. Express confidence in their ability 
to answer clients’ questions and concerns 
SSE.5.2. Demonstrate skills to answer 
clients’ questions and concerns  
Note. PO = performance objective; PB = perceived barriers; A = attitudes; H = habits; BK = beliefs and knowledge; SSE = skills and self-efficacy. 
Table 21 
Matrix for socio-structural level outcome: offer and provide barrier methods 
Performance objective  
CPs will: 
Determinants 
Perceived barriers Attitudes Habits Beliefs and knowledge Skills and self-efficacy 
PO.1. Provide information 
around sexual health (SSO.3.)  
(see Table 20) (see Table 20) (see Table 20) (see Table 20) (see Table 20) 
PO.2. Offer free male and 
female condoms 
PSB.2.1. Recognise potential 
barriers 
PSB.2.2. Act to overcome 
potential barriers as planned 
A.2.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.2.2. Express positive feelings 
about offering condoms to 
WOST 
H.2.1. Develop a habit to offer male 
and female condoms to WOST 
 
BK.2.1. Acknowledge the benefits of 
facilitating the availability of condoms to 
WOST 
BK.2.2. Acknowledge that offering 
condoms to WOST can have a positive 
impact on their sexual health, general 
health and wellbeing  
SSE.2.1. Express confidence in their ability 
to offering condoms to WOST 
SSE.2.2. Express confidence in their ability 
to overcome barriers to offering condoms to 
WOST 





A.2.3. Express commitment to 
offer condoms to WOST 
BK.2.3. Acknowledge that availability of 
condoms does not necessarily translate 
into condom use 
BK.2.4. Understand the need for offering 
condoms to WOST  
BK.2.5. Describe their role in promoting 
sexual health among WOST 
condoms to WOST 
SSE.2.4. Demonstrate skills to overcome 
barriers to offering condoms to WOST 
PO. 3. Answer WOST’s 
questions or concerns 
PSB.3.1. Recognise potential 
barriers 
PSB.3.2. Act to overcome 
potential barriers as planned 
A.3.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.3.2. Express positive feelings 
to answer WOST’s questions 
and concerns 
A.3.3. Express commitment to 
answer WOST’s questions and 
concerns 
 H.3.1. Develop a habit to answer 
WOST’s questions and concerns 
BK.3.1. Acknowledge that answering 
WOST’s questions and concerns can 
have a positive impact on their sexual 
health, general health and wellbeing 
BK.3.2. Acknowledge their role in 
promoting sexual health among WOST 
SSE.3.1. Express confidence in their ability 
to answer clients’ questions and concerns 
SSE.3.2. Demonstrate skills to answer 
clients’ questions and concerns  
Note. PO = performance objective; PSB = perceived and structural barriers; A = attitudes; OE = outcome expectancies; BK = beliefs and knowledge; SSE = skills and self-efficacy. 
Table 22 
Matrix for socio-structural level outcome: STI/BBV screening, treatment and referrals 
Performance objective  
CPs will: 
Determinants 
Perceived barriers Attitudes Habits Beliefs and knowledge Skills and self-efficacy 
PO.1. Provide information 
around sexual health (SSO.3.)  
(see Table 20) (see Table 20) (see Table 20) (see Table 20) (see Table 20) 
PO.2. Offer WOST free 
STI/BBV screening 
PSB.2.1. Recognise potential 
barriers 
PSB.2.2. Act to overcome 
potential barriers as planned 
A.2.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.2.2. Express positive feelings 
about offering STI/BBV 
screening to WOST 
H.2.1. Develop a habit to offer free 
STI/BBV screening to WOST 
BK.2.1. Acknowledge that offering 
STI/BBV screening to WOST will a 
positive impact on their sexual health, 
general health and wellbeing  
BK.2.2. Understand the need for offering 
STI/BBV screening to WOST  
SSE.2.1. Express confidence in their ability 
to offer STI/BBV screening to WOST 
SSE.2.2. Express confidence in their ability 
to overcome barriers to offering STI/BBV 





A.2.3. Express commitment to 
offer STI/BBV screening to 
WOST 
BK.2.3. Describe their role in promoting 
sexual health among WOST 
SSE.2.3. Demonstrate skills to offer 
STI/BBV screening to WOST 
SSE.2.4. Demonstrate skills to overcome 
barriers to offering STI/BBV screening to 
WOST 
PO.3. Perform STI/BBV 
screening 
PSB.3.1. Recognise potential 
barriers 
PSB.3.2. Act to overcome 
potential barriers as planned 
A.3.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.3.2. Express positive feelings 
about performing STI/BBV 
screening 
A.3.3. Express commitment to 
perform STI/BBV screening 
 BK.3.1. Identify relevant screening 
procedures 
BK.3.2. Describe the steps to perform 
STI/BBV screening 
BK.3.3. Acknowledge that offering 
STI/BBV screening to WOST will have 
a positive impact on their sexual health, 
general health and wellbeing  
SSE.3.1. Express confidence in their ability 
to perform STI/BBV screening 
SSE.3.2. Demonstrate skills to perform 
STI/BBV screening 
PO.4. Send samples to the 
laboratory for testing 
PSB.4.1. Recognise potential 
barriers 
PSB.4.2. Act to overcome 
potential barriers as planned 
A.4.1. Express commitment to 
send samples to the laboratory 
for testing 
H.4.1. Develop a habit to send 
samples to the laboratory for testing 
BK.4.1. Describe the steps to send 
samples to the laboratory for testing 
BK.4.2. Acknowledge that sending 
samples to the laboratory will have a 
positive impact on WOST’ sexual health, 
general health and wellbeing 
SSE.4.1. Express confidence in their ability 
to send samples to the laboratory 
SSE.4.2. Demonstrate skills to send 
samples to the laboratory 
PO.5. Notify WOST of results 
in a private space within the 
pharmacy 
PSB.5.1. Recognise potential 
barriers 
PSB.5.2. Act to overcome 
potential barriers as identified 
(PSB.5.1.) 
A.5.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.5.2. Express positive feelings 
about notifying results 
A.5.3. Express commitment to 
notify results 
H.5.1. Develop a habit to notify 
STI/BBV screening results to WOST 
BK.5.1. Describe the steps to notifying 
results 
BK.5.2. Acknowledge that notifying 
results will have a positive impact on 
WOST’ sexual health, general health and 
wellbeing 
BK.5.3. Acknowledge the potential 
difficulties of notifying results (e.g., 
WOST’s reactions in relation to positive 
results) 
SSE.5.1. Express confidence in their ability 
to notify WOST of results 
SSE.5.2. Demonstrate skills to notify 





BK.5.4. Describe the main facts about 
STIs and BBVs (i.e., transmission, 
symptomatology, diagnosis, treatment, 
comorbidity, mortality, available 
support) 
PO.6. If positive results, 
discuss treatment options  
PSB.6.1. Recognise potential 
barriers 
PSB.6.2. Act to overcome 
potential barriers as planned 
A.6.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.6.2. Express positive feelings 
about discussing treatment 
options 
A.6.3. Express commitment to 
discussing treatment options 
H.6.1. Develop a habit to discuss 
treatment options with WOST, if 
positive results 
BK.6.1. Describe the steps involved in 
discussing treatment options 
BK.6.2. Acknowledge that discussing 
treatment options will a positive impact 
on WOST’ sexual health, general health 
and wellbeing 
BK.6.3. Describe the main facts about 
STIs and BBV treatment and available 
support 
SSE.6.1. Express confidence in their ability 
to discuss treatment options 
SSE.6.2. Demonstrate skills to discussing 
treatment options 
PO.7. If positive results, 




PSB.7.1. Recognise potential 
barriers 
PSB.7.2. Act to overcome 
potential barriers as planned 
A.7.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.7.2. Express positive feelings 
about initiating treatment and/or 
making referrals to relevant 
professionals/services 
 A.7.3. Express commitment to 
initiating treatment and/or 
referring WOST to relevant 
professionals/services 
H.7.1. Develop a habit to initiate 
treatment/refer to appropriate 
professionals/services, if positive 
results 
BK.7.1. Describe relevant treatment 
options for STIs and BBVs 
BK.7.2. Identify relevant professionals 
and services for people living with an 
STI or BBV 
BK.7.3. Describe the steps for referrals 
BK.7.4. Acknowledge that initiating 
treatment and/or referring to relevant 
professionals/services will have a 
positive impact on WOST’ sexual health, 
general health and wellbeing 
SSE.7.1. Express confidence in their ability 
to initiate treatment 
SSE.7.2. Express confidence in their ability 
to make relevant referrals 
SSE.7.3. Demonstrate skills to initiate 
treatment  
SSE.7.4. Demonstrate skills to make 
relevant referrals  
 
PO. 8. Answer WOST’s 
questions or concerns 
PSB.8.1. Recognise potential 
barriers 
PSB.8.2. Act to overcome 
potential barriers as planned 
A.8.1. Express positive feelings 
about communicating with 
WOST (non-stigmatising) 
A.8.2. Express positive feelings 
to answer WOST’s questions 
H.8.1. Develop a habit to answer 
WOST’s questions and concerns  
BK.8.1. Acknowledge that answering 
WOST’s questions and concerns can 
have a positive impact on their sexual 
health, general health and wellbeing 
BK.8.2. Acknowledge their role in 
SSE.8.1. Express confidence in their ability 
to answer clients’ questions and concerns 
SSE.8.2. Demonstrate skills to answer 






A.8.3. Express commitment to 
answer WOST’s questions and 
concerns 
promoting sexual health among WOST 































































- Risk awareness 
- Beliefs and knowledge 




- Perceived barriers 
- Attitudes 
- Habits 
- Beliefs and knowledge 
- Skills and self-efficacy 
 
Health Outcomes 
- Sexually transmitted 
infections and blood-borne 
viruses 
- Secondary health problems 
- Mortality 
Quality of Life 
- Reduction of experiences of 
intersectional stigma 
- Reduction of experiences of social 
exclusion and violence 
- Reduction of feelings of 
worthlessness, powerlessness and 
helplessness 
- Improvement of self-image and 
social identity 
- Reduction of drug use as coping 
mechanism 
- Decreased welfare dependence 




- Obtain barrier methods 
(male and female condoms) 
- Screen for sexually 
transmitted infections and 
blood-borne viruses 
- Uptake treatment for 






- Provide information and 
guidance 
- Offer barrier methods (male 
and female condoms) 
- Deliver screening, treatment 
and referrals for sexually 















 This chapter presented suggestions on the design of a sexual health service for WOST in 
community pharmacy. These are built from the findings presented in previous chapters of this thesis 
(see Chapters 3-6).  
The chapter contains the goals and outcomes of the service at the individual and socio-
structural levels. Determinants of health were identified. Those relevant to the service goals and 
outcomes were selected from a more extensive list, are were: perceived barriers; attitudes (including 
stigma); habits; risk awareness; beliefs and knowledge; and skills and self-efficacy. Determinants 
were then mapped with performance objectives to create matrices of change objectives. In these 
matrices, change objectives were defined.  
This PhD research, including the suggestions for service design will inform future research 
and the further development of a sexual and reproductive health service for WOST in community 
















CHAPTER 9. Discussion 
 The main aim of this PhD research was to explore the opportunities for designing and 
implementing a sexual health service for WOST in community pharmacies in England. There were 
four objectives in this PhD research (see page 10). The first was to explore the sexual health risks that 
WOST are exposed to, and how these may be associated with a higher risk for the sexual transmission 
of STIs and BBVs. The second was to understand the needs of WOST for STI/BBV prevention. The 
third objective was to explore the potential role that CPs could play in promoting sexual health 
amongst this group of women. The last objective was to provide initial suggestions for designing a 
pharmacy-based sexual health service in England that addresses the needs of WOST. An integrative 
discussion of all aims and objectives is presented in this final chapter.  
The first section of this chapter includes a critical discussion of the findings. This is followed 
by a critique on health service design, and specifically of the IM approach (Bartholomew Eldredge et 
al., 2016). The impact and future directions of this research, together with its strengths and the 
limitations are also outlined at the end of this chapter. 
9.1. Discussion of Main Findings 
This PhD research has highlighted the complex interrelation of factors that may be related to 
sexual health risks among WOST. This was already evident when conducting a systematic literature 
review for Study 1 (Chapter 3) and became even more multifaceted when conducting and analysing 
the semi-structured interviews and focus groups for Study 2 (Chapters 4-6). The intersection of factors 
at different social-ecological levels became apparent when analysing all data. In this section, data 
from this PhD research are discussed through the lens of the Social-Ecological Approach and 
Intersectionality Theory, to offer a bird’s-eye view on the complexity of the factors associated with 
sexual health risk among WOST. This corresponds with the main aim and first two objectives of this 
PhD research (see page 10). This section also offers a discussion on the design of a pharmacy-based 
sexual health service for WOST and the role that CPs could play. This is to address objectives three 
and four of this study (see page 10). The need for a Social-Ecological and Intersectionality approach 
is discussed first. 
9.1.1. A Social-Ecological and Intersectionality Approach to Sexual Health Risks among 
WOST 
Despite the calls in the last decades to challenge the predominant focus on individual-level 
approaches to behaviour change in health promotion (Davis, Campbell, Hildon, Hobbs, & Michie, 
2015; Glanz & Bishop, 2010; Link & Phelan, 1995), some research and public health strategies are 





reductionist perspective of human behaviour that appears to still be dependent on the biomedical 
approach (Kelly et al., 2010; Kelly et al., 2009). Merely focusing on individual behaviour is just not 
enough. This argument is supported by the data from this PhD research, which also suggests that 
reductionist approaches to health promotion may encourage a blaming attitude towards those who are 
most vulnerable to poorer health outcomes. This could inevitably widen social and health inequities 
among those groups already marginalised, such as WOST. The existence of social and health 
inequities is a social problem. Researchers and health promoters cannot simply expect that social 
problems can be addressed without changing the “top structures” of our societies. Social and health 
systems then need to be challenged to accommodate fundamental human rights, such as the access to 
healthcare. Changes in individual behaviours and health outcomes should then follow. As already 
stated above, promoting blame and placing full responsibility on individuals to change their behaviour 
may be detrimental to attaining positive change. In this context, individuals – and especially those 
most vulnerable – may be even more disempowered towards promoting their own health.   
Another critique of the current approaches to health promotion relates to the emphasis on 
effectiveness and cost-effectiveness. This focus co-exists in a world in which healthcare (and health 
outcomes) are ruled by economic interests. Biomedical and technological “solutions” are still 
prioritised over socio-structural approaches, by allocating more funding to research and practices that 
could lead to financial benefits (Pratt & Loff, 2012). The economic crisis in the last decade has also 
led to a decline in the quality of healthcare worldwide (Williams & Maruthappu, 2013), which 
inevitably has a negative impact on the population’s health. Despite considering the value and need 
for health economics and acknowledging the realities of modern society, limiting health costs should 
not be the focal point of public health strategies. Efforts to promote health and prevent disease need to 
ensure social justice and tackle social and health inequities. Defending human rights and advocating 
for social justice should then be a (if not the) priority, alongside reducing the incidence of health 
conditions and promoting global health. Therefore, decisions on public health strategies should not be 
driven solely by the economics of health (Dahlgren & Whitehead, 1991). 
Consistent with this argument, some academics have already advocated the use of complex 
systems approaches to public health that address factors at all ecological levels (Krieger, 1994, 2001; 
McLeroy et al., 1988; Rutter et al., 2017; Sniehotta et al., 2017). These approaches incorporate both 
individual and socio-structural factors as determinants of health. The findings from this research serve 
as evidence for the need to take a Social-Ecological Approach (Bronfenbrenner, 1979; Degenhardt et 
al., 2010; McLeroy et al., 1988; Wellings et al., 2006) to promote sexual health among WOST. The 
Social-Ecological Approach originates from the Ecological Systems Theory developed by the 
psychologist Urie Bronfenbrenner (Bronfenbrenner, 1979), who highlighted the influences of the 
environment in human development. Over a decade later, McLeroy et al. (1988) developed a Social-













abandonment of frameworks focusing on individual-level behaviour change programmes, as they fail 
to acknowledge the influences of the social, cultural, political, and economic context. Instead, the 
Social-Ecological Approach for health promotion integrates factors and processes at several 
ecological levels that then influence health behaviour: 
1. Intrapersonal factors: individual characteristics, such as beliefs, skills or attitudes. 
2. Interpersonal processes: interactions in formal and informal social networks and social 
support systems. 
3. Organisational factors: characteristics and regulations of institutions or organisations. 
4. Community factors: relationships between institutions or organisations, and other networks. 
5. Public policy: laws and policies. 
Figure 11. Social-Ecological Approach for health promotion, adapted from McLeroy et al. (1988). 
In this PhD research, factors found to be associated with sexual health risks among WOST 
were at all levels of the Social-Ecological Approach. There were individual factors (e.g., 
worthlessness and powerlessness), interpersonal processes or factors (e.g., trust and social support), 
organisational factors (e.g., availability of sexual health services), community factors (e.g., 
intersectional stigma towards WOST), and public policy-related factors (e.g., national policy on sex 
and sexual health education). Using the Social-Ecological Approach is useful to understand the 
intricate relationships between STI/BBV risk-related factors among this group of women. It is 
however important to note that some factors were present at several levels of the Social-Ecological 
Approach. Intersectional stigma was a good example of this, as experiences of stigma were found at 





professionals), organisational level (e.g., structural stigma embedded in health services), community 
level (e.g., social exclusion), and policy level (e.g., structural neglect reflected in public policy).  
Social-Ecological models have already been developed to understand substance use 
(Gruenewald, Remer, & LaScala, 2014; Matto, 2004) and HIV risk among vulnerable populations, 
including PWID (Baral et al., 2013) and sex workers (Larios et al., 2009), and substance use and 
sexual health risks (Elkington, Bauermeister, & Zimmerman, 2011). A theoretical development of this 
PhD was to create a modified Social-Ecological Model for sexual health risks in WOST (see Figure 
12). It is worth noting that this model is not exhaustive and further research should be conducted in 
order to have a wider picture on sexual health risks among WOST (see page 238). Longitudinal and 
mixed-methods studies could be valuable to identify relevant factors, and to explore the interactions 
between these. Sociological and policy research could have important contributions to this model. The 
main factors associated with sexual health risks among WOST have already been presented in 
Chapter 6.  
9.1.1.1. Intrapersonal factors 
There were several factors at the intrapersonal level identified in this study. These were 
primarily related to: 
1. Social identity: feelings of worthlessness and powerlessness, perceived negative 
social identity, and internalised intersectional stigma. 
2. Significant others: love and trust, and feelings of helplessness. 
3. Life stories and current life situations: feelings of powerlessness and helplessness, 
risk awareness, prioritisation of drug use and lifestyle. 
4. General beliefs and knowledge. 
5. Sexual orientation. 
The intrapersonal factors presented here are important to consider in order to understand 
sexual health risks among WOST. However, these must not be seen in isolation, as they are only the 
tip of the iceberg in the complexities of risk. In this thesis it is argued that these intrapersonal factors 
are mostly influenced by social and structural factors, and particularly by social inequities of health.  
9.1.1.2. Interpersonal processes 
Interpersonal processes were those associated with the type and quality of WOST’s 
interactions with others around them, including significant others and health professionals: 
1. Lack of social and professional support. 





3. Engagement in transactional sex. 
4. Intersectional stigma. 
5. Gender-based violence. 
As it is discussed later in this chapter, experiences of GBV, engagement in transactional sex 
and intersectional stigma are key in understanding sexual health risks among WOST. They are also 
crucial for STI/BBV prevention among this group of women. Building trusting relationships with 
health professionals, based on positive rapport and communication was another main factor identified 
at the interpersonal level. WOST perceived a generalised lack of social and professional support that 
had been maintained throughout their lives. This posed a greater challenge to care for their sexual 
health, as well as having implications on their drug use and general health. Interpersonal factors 
influence factors at the intrapersonal level.  
9.1.1.3. Organisational factors 
Organisational factors were mainly associated with health services and community pharmacy: 
1. Structural neglect and structural violence19: limited availability of specialised sexual 
health services. 
2. Structural barriers to developing and implementing sexual health services (e.g., time 
and finances). 
3. Intersectional stigma. 
4. Taboo of sex and sexual health. 
It became evident throughout this research that current health services for WOST were not 
addressing the sexual health needs of this population group. There seemed to be a limited availability 
of sexual health services, and none are specifically directed to WOST. Only harm reduction services 
(e.g., needle exchange) and BBV screening appeared to be made available and actively offered to 
WOST. There is however the need to develop holistic services that include all aspects of WOST 
sexual health. There were also important structural barriers to developing and implementing new 
services, such as time and financial constraints. These need to be considered when designing health 
services. These barriers need to also be considered as factors associated to sexual health risks, as they 
limit the availability and accessibility to services. Intersectional stigma was again key at the 
organisational level. It created significant barriers for implementing services and building trust, 
positive rapport and communication between CPs and WOST. It also limited the access of WOST to 
(sexual) health services. Similarly, the taboo of sex and sexual health posed a challenge for WOST to 
                                                             
19 A form of violence in which a social structure of institution fails to ensure social justice and equity, causing 





accessing (sexual) health services. Feelings of shame and embarrassment to discuss sexual health was 
a barrier for both WOST and CPs.   
9.1.1.4. Community factors 
There were several community factors identified in this PhD research: 
1. Social inequities. 
2. Intersectional stigma. 
3. Social norms and gender roles. 
4. Taboo of sex and sexual health.  
Community factors were of high importance as they may be determinants for factors at other 
ecological levels (e.g., GBV). In this chapter, the role of social inequities on sexual health risks 
among WOST is discussed in more depth. The associations between intersectional stigma and sexual 
health have already been discussed in Chapter 4 (see page 97). Social norms and gender roles are of 
high relevance too as they are at the core of other factors such as intersectional stigma and GBV. They 
are also closely related to social inequities. The taboo nature of sex and sexual health is also 
significant at the community-level. As with social norms and gender roles, these taboos are socially 
constructed and create important barriers for STI/BBV prevention. They limit sexual health education 
and communication and where and in what settings these topics can be discussed. They are also the 
root of STI/BBV- and transactional sex-related stigmas.  
9.1.1.5. Public policy  
This PhD research did not investigate policy directly, although findings suggested important 
policy implications as it seems that policies are failing to address the sexual health needs of WOST. 
As for organisational-level factors, structural neglect and structural violence were also a reality at the 
public policy level. The findings from this study made apparent that the health and educational 
systems in the UK could have been neglecting the sexual health needs of WOST. This created 
important challenges for STI/BBV prevention through the lack of specialised sexual health services 
for WOST, and limited training of CPs on drug use and sexual health. This neglect and structural 
violence was also a factor for sexual health risks among WOST as most women did not have access to 
sexual health education of quality and, as already mentioned, specialised sexual health services.  
This chapter offers a critical discussion of what seems to be at the core of the factors 






Public Policy  
  
Structural neglect and structural violence 
(health and educational systems) 
Community Factors  
 
Social inequities; Intersectional stigma; Social norms and 
gender roles; Taboo of sex and sexual health 
 
Organisational Factors  
 
Limited availability of sexual health services (structural neglect 
and violence); Structural barriers to developing and implementing 
sexual health services (e.g., time, finances); Intersectional stigma 
 
 
Interpersonal Factors     
            
Lack of social and professional support; Intersectional 
stigma; Gender-based violence; Engagement in 
transactional sex; Trust, rapport and communication 
with health professionals 
Intrapersonal Factors  
 
Prioritisation of drug use and lifestyle; 
Cognitive and emotional impact of drugs and 
alcohol; Feelings of worthlessness, 
powerlessness and helplessness; Love and 
trust; Internalised intersectional stigma; 
Perceived negative social identity; Beliefs 
and knowledge; Risk awareness; Sexual 
orientation 
 





9.1.2. Social Inequities and Health: Invisibility, Exclusion and Neglect 
Equity was one of the main values of this research (see page 13). Social inequities are 
concerned with the unjust distribution of power among different social groups and communities. 
Social inequities have a great impact on health and generating health inequities (Braveman, 2014; 
Braveman & Gruskin, 2003a, 2003b; Braveman et al., 2011; Krieger, 2014). Social inequities were 
apparent among WOST, as they were mostly seen through the lens of their belonging to stigmatised 
and socially excluded groups (i.e., women, PWUD, transactional sex workers, people living in 
situations of homelessness, and people living with an STI or a BBV) (see Chapters 3-7). Intersectional 
stigma associated with pertaining to these social groups has already been discussed in Chapter 4 (see 
page 97). Here it is argued that social inequities are behind experiences of intersectional stigma, GBV 
and other factors associated with sexual health risks among WOST. These are the ones that need to be 
primarily addressed.  
Power is key in these discussions, as it is at the core of social inequities. The sociologist Max 
Weber was one of the first to theorise about power. Based on a translation and analysis by Wallimann, 
Tatsis, and Zito (1977), Weber’s definition of power is as follows: “within a social relationship, 
power means every chance (no matter whereon this chance is based) to carry through the own will, 
even against resistance” (Wallimann et al., 1977, p. 232). Another sociologist, Michael Mann (Mann, 
1986) described social power as two-fold. First, that societies were “constituted of multiple 
overlapping and intersecting sociospatial networks of power”. Second, “a general account of 
societies, their structure, and their history can best be given in terms of the interrelations of (…) the 
four sources of social power: ideological, economic, military and political” (Go, 2013). WOST were 
not in power, neither of their lives, nor of their health. This lack of power was often attributed to the 
effects of drug use and drug-using lifestyles, by both WOST and CPs. This is however a partial 
explanation for WOST’ disempowerment. Based on the Social-Ecological Model presented in this 
chapter (see Figure 12), it is clear that this disempowerment is associated with elements at different 
ecological levels. Most are associated with social inequities, from the internalised intersectional 
stigma to the structural neglect and violence. 
Intersectionality Theory is a useful framework to explain the complexity of intersections 
between social identities, social inequities and health (Bauer, 2014; Bowleg, 2008; Crenshaw, 1989; 
S. L. Dworkin, 2005; Hancock, 2007; Hankivsky, 2012; N. Hsieh & Ruther, 2016; Kulesza et al., 
2016; Purdie-Vaughns & Eibach, 2008; Shields, 2008; Townsend, 2008; Walby, Armstrong, & Strid, 
2012; Warner, 2008). Intersectionality Theory was developed in the context of sexism and racism 
research, after the concept of ‘intersectionality’ was first introduced by Crenshaw (1989). After 
almost three decades, Intersectionality Theory is now widely used in research on minority groups such 





populations (Chambers et al., 2015; Earnshaw, Smith, Cunningham, & Copenhaver, 2015; Lacombe-
Duncan, 2016; Logie, James, Tharao, & Loutfy, 2011; Loutfy et al., 2012; Sangaramoorthy, Jamison, 
& Dyer, 2017; Wagner, Girard, McShane, Margolese, & Hart, 2017). Intersectionality is concerned 
about unique experiences of social isolation and exclusion resulting from the convergence of different 
marginalised identities (e.g., female gender and PWUD). Intersectionality does not refer to the 
quantitative “accumulation” of marginalisation. It is rather an approach to explore and understand the 
qualitatively unique experiences resulting from intersecting sources of marginalisation. Previous 
research on health promotion has been informed by Intersectionality Theory, including in the area of 
HIV prevention (Chambers et al., 2015; Earnshaw et al., 2015; Lacombe-Duncan, 2016; Logie et al., 
2011; Loutfy et al., 2012; Sangaramoorthy et al., 2017; Wagner et al., 2017) 
Intersectionality has already been discussed in this PhD thesis (see Chapter 4, page 97). In 
this chapter, this theoretical framework is taken forward into understanding sexual health risks among 
WOST more broadly and in-depth. Intersectionality helps us understand the impact of pertaining to 
social groups that are stigmatised and made invisible within society (Purdie-Vaughns & Eibach, 
2008). Also how these intersections are at the core of STI/BBV risk among WOST. A discussion on 
the main social inequities experienced by WOST – poverty and gender inequities – and sexual health 
is necessary.  
9.1.2.1. Poverty: the unequal distribution of resources 
Poverty refers to the lack of access to social, economic or political resources, or the inability 
to use available resources. Poverty is a reflection of social inequities, of the unequal distribution of 
social, economic and political power. There are certain social groups that are more likely to 
experience both social inequities and poverty. Among these groups are women (Alcock, 2006; Cohen, 
1994) and people living with a chronic condition, including HIV (Kalichman et al., 2006; McMahon, 
Wanke, Terrin, Skinner, & Knox, 2011; Probst, Parry, & Rehm, 2016; Wiewel et al., 2016; Yun, 
Govender, & Mody, 2001). There is also a well-reported link between poverty – generally framed as 
lower socio-economic status –, general health and mortality (Dahlgren & Whitehead, 1991; 
Mackenbach et al., 2008; D. S. Morrison, 2009; Pampel et al., 2010; Schanzer et al., 2007; World 
Health Organization, 2014).  
‘Aporofobia’ (aporophobia in English) was the Spanish word of the year in 2017
20
. It is a 
term introduced by the Spanish philosopher Adela Cortina Orts (Cortina, 2000, 2017). Its meaning 
represents an unavoidable reality: the invisibility, exclusion and repudiation of those who are poor. 
Something that became clear conducting this research was that aporophobia was experienced by 
WOST, especially those living in situations of homelessness. Due to WOST’s lack of social, 
                                                             
20 Words are chosen every year based on their relevance to social, cultural and political actuality and their 





economic and political resources, these women were rendered invisible within society, and most lived 
in situations of social exclusion and marginalisation. Making invisible and excluding those individuals 
in situations of poverty means that human rights and equity are not protected among those that need 
resources the most. It also creates barriers to good health and access to health care services.  
Homelessness was relatively prevalent among WOST. Many were living off benefits as few 
had permanent jobs that allowed them to sustain themselves. Other sources of income that were 
mentioned by participants included transactional sex working and shoplifting. However, poverty 
among WOST should not only be defined by their income or employment status. It also needs to be 
defined through the lack of access to social resources and social engagement in their communities and 
wider society (e.g., political decisions) (Burchardt, Le Grand, & Piachaud, 2002). Engaging in these 
activities, and especially selling sex, added an extra layer of complexity in WOST’s lives. This was 
due to the exposure to legal problems, experiences of intersectional stigma, and higher vulnerability to 
experiencing GBV (among women in transactional sex). The social exclusion and invisibility of 
WOST was even greater for women that had multiple intersecting stigmatised identities. It may be 
that intersectional stigma also increases the chances for living in poverty, as it creates greater barriers 
for accessing resources (e.g., health services).  
The relationships between social capital
21
 and health can also provide an explanation of how 
inequities in the distribution of resources are associated with health (Eriksson, 2011; Hawe & Shiell, 
2000). There has been a growing interest in social capital in health promotion in the last decades 
(Bourdieu, 1986; Coleman, 1988; Eriksson, 2011; Hawe & Shiell, 2000; Portes, 1998). Social capital 
fits well within social-ecological models of health, as the one presented in this chapter (see Figure 
12). As already mentioned, those living in situations of poverty (e.g., WOST) generally have poorer 
health. Based on the social capital approach, these differences are rooted in the breakdown of social 
cohesion and social exclusion of people living in situations of poverty (R. G. Wilkinson, 1996). This 
is not just a matter of income inequity but also of differences in power and social status (Muntaner & 
Lynch, 1999; R. G. Wilkinson, 1997, 1999). Social capital is concerned about social cohesion at 
different ecological levels, from family ties to community networks. It also highlights powerlessness 
as a key barrier for health promotion (Wallerstein, 1992). Empowerment, understood as “social 
capital” rather than an individual trait, is key to promoting health (Hawe & Shiell, 2000; Zimmerman, 
1990, 2000).  
In 2011, Malin Eriksson developed a model of individual and collective social capital that is 
useful to understand how poverty among WOST may be associated with their health (Eriksson, 2011). 
Eriksson differentiated between individual and collective social capital. While individual social 
                                                             






capital is related to social support and social norms, collective social capital is concerned about trust 
and collective action. Both individual and collective social capital influence individuals’ engagement 
in health-protective and health-risk behaviours. For instance, social support and trust have been found 
to be associated with health-protective behaviours (Campbell & Jovchelovitch, 2000; Nieminen et al., 
2013). In this PhD research, the lack of social support created barriers to STI/BBV prevention. The 
relationship between trust and sexual health outcomes was two-fold. Trust in sexual partners was 
generally linked to condomless sex to protect intimacy, even in situations of sexual health risks 
(Rhodes & Cusick, 2000). However, trust in health professionals seemed to promote WOST’s access 
to (sexual) health services. Trust within sexual relationships is key to create intimacy and enjoyment 
in sexual pleasure, as well as feelings of belonging. The sense of belonging arising from trust may as 
well be associated with perceived social support. On the other hand, maintaining an illusion of trust in 
situations of GBV was a matter of survival and coping with violent situations. For instance, breaching 
trust with sexual partners could be a trigger of GBV or could even escalate situations of violence. The 
connections between social capital and health are still to be further explored, and especially for this 
specific population. Future research could focus on providing a deeper understanding of why and how 
elements of social capital may be associated with STI/BBV risk among WOST. Also, the links 
between poverty and social capital among this group. 
Poverty is an important element of social inequities of sexual health among WOST. Thus, it 
needs to be considered within future research and public health strategies. Intersectionality approaches 
are also key to understanding the complex framework of vulnerable populations such as WOST. 
Poverty needs to be addressed, not just for health reasons but to decrease social and health inequities, 
and for social justice. 
9.1.2.2. Gender inequities and gender-based violence: a discussion on the role of 
feminism 
 Feminist theorists have developed different perspectives on patriarchy – a system of social 
structures and practices in which men dominate, oppress and exploit women (Walby, 1990) – and 
explanations for gender inequities. According to radical feminism
22
, sexuality is male-dominated 
(Coveney, Jackson, Jeffreys, Kay, & Mahoney, 1984; A. Dworkin, 1981; M. Evans, 1997; 
MacKinnon, 1982; Millet, 1977; Rich, 1977; Walby, 1990). This theoretical perspective explains how 
women are sexualised and reduced to sexual objects aimed at pleasuring men. Pornography, 
commercial sex and sexual violence result from this male-dominated sexuality. Similarly to the 
sexualisation of women, GBV in all its forms is socially constructed and based on patriarchal 
                                                             
22 Radical feminism is a movement and framework of feminism originated in the 1960s with the Women’s 
Liberation Movement. It focuses on women’s oppression through sexuality, the ideology of femininity and 





structures (Walby, 1990). Radical feminists have argued that GBV is a means for men’s control over 
women (Brownmiller, 1976). It is then essential to understand that sexual violence is not a matter of 
sex but power. Women’ subordination to men is historical and ingrained in most cultures and societies 
worldwide. Power is the main driver of these gender inequities. 
 Gender inequities and a feminist perspective are central to this study (see page 13). Gender 
inequities and GBV were part of the stories of most (if not all) WOST that participated in this 
research. WOST were dominated and oppressed by men, from abusers in their childhood to drug 
dealers and partners. WOST were powerless in situations of violence, and over changing patriarchal 
relationships. This defencelessness could be increased due to neglect from the social and health 
systems. For instance, reporting situations of violence to the authorities was commonly not enough to 
stop GBV. This seemed to perpetuate WOST’s disempowerment, and sense of worthlessness and 
helplessness. This is one the reasons why views of GBV need to shift from a view that GBV is an 
individual experience to one that also takes into account how these experiences are embedded within 
the context of patriarchal societies. It is also important to question whether WOST, and other women 
in situations of marginalisation and social exclusion, are included in feminist movements.  
Intersectionality has been an important part of third-wave feminism
23
 (E. Evans, 2015; 
McCall, 2005; Shields, 2008). It is also relevant for this PhD thesis as findings suggested the need to 
apply intersectionality approaches to explain sexual health risks among WOST. For instance, 
homeless women and women engaging in transactional sex were more vulnerable to GBV, compared 
to other WOST. This could be because of the intersection of poverty and gender inequities. Patriarchal 
views on sexuality and women lead to the objectification of women. Transactional sex workers and 
homeless WOST seemed to be deemed as the underclass. As women themselves explained, they were 
dehumanised and treated as sexual objects by most men.  
Feminist theorists have claimed the need to include gender inequities in the agendas of 
politicians and policymakers (E. Evans, 2015; M. Evans, 1997; Walby, 1990, 1997). Historically, 
feminist movements have taken actions to incorporate women within the social system. In the last 
century, these have mainly been the suffragette movement (Pankhurst, 1977) and the abortion and 
reproduction rights moment (E. Evans, 2015). Despite the advances made, feminist movements are 
still focusing on increasing women’s visibility into policies that ensure women’s rights over their 
bodies.  
                                                             
23 Feminist movements since 1990s until 2010s. First wave feminism began in the mid-19th century and 
predominantly focused on women’ suffrage. Second wave feminist began in 1960s-1970s and was centred in 
reaching gender equity through women’s social and economic participation. Third wave feminism started in the 
1990s and focused on intersectionality and challenging the concept of femininity. It also aimed at re-framing the 
ideas of second wave feminism, usually over-emphasising the experiences of white upper-middle class women 





For this PhD, the reproductive health and sexual liberation movements are the most relevant. 
Sexual and reproductive health policies appear to still be embedded within patriarchal structures of 
sexuality and they are still violating women’s human rights. For instance, despite the efforts of some 
researchers in the last few years to develop hormonal contraception for men (Behre et al., 2016; 
Nieschlag, 2005), preventing pregnancy is still a woman’s issue. This has been argued to be partly due 
to the reluctance of the pharmaceutical industry to invest in developing male hormonal contraceptives 
(Nieschlag, 2005). Sexual and reproductive health rights are still disregarded, as decisions over 
women’s bodies are mostly made by male-dominated governments. Donald Trump’s current 
government (2017 - ) in the United States is a clear example of this. Trump’s government has, for 
instance, limited the availability of contraceptives and restricted the access to abortion. Women are 
also still carrying the burden of preventing pregnancy through “family planning” methods that are 
often holding them responsible for pregnancy prevention. Even condoms are male-constructed 
technologies that prevent women, in many cases, to make decisions to protect their sexual and 
reproductive health. Female condoms have been on the market for decades now, but these are still 
under the radar (Hoffman, Mantell, Exner, & Stein, 2004; Maksut & Eaton, 2015; Marfatia, Pendya, 
& Mehta, 2015; Sakondhavat, 2002; Vijayakumar, Mabude, Smit, Beksinska, & Lurie, 2006). There 
are several barriers to using female condoms, including women perceiving them as questionably 
effective and their high economic cost compared to male condoms. Taking a wider stance, female 
condoms are rarely displayed in selling points (including community pharmacies), or advertised in 
commercial and public health campaigns. Historically, they have not been as targeted in sexual health 
promotion programmes, compared to male condoms (A. Peters, Jansen, & van Driel, 2010; Public 
Health England, 2017b). All these were evident through this research and were barriers for WOST 
taking control over their sexual health. Female condoms, together with dental dams (Ritchers & 
Clayton, 2010) and even PrEP (Baeten et al., 2012; Choopanya et al., 2013; McCormack et al., 2016) 
should be made accessible for vulnerable populations such as WOST.   
Gendered social constructions of sex and sexual health are also relevant to this discussion. As 
already discussed, women are sexualised and often given value based on the sum of their body parts. 
Women are often socially seen as male possessions for the benefit of male’s sexual pleasure and 
social status. This was not an exception for WOST. Their narratives commonly included men’s 
sexualisation and objectification of women. Sexual violence was alarmingly prevalent. Perpetrators 
were family members, friends, romantic partners, sexual partners, transactional sex clients, drug 
dealers and strangers. Equal relationships with men were scarce. Another common type of GBV was 
sexual exploitation. Based on participants’ narratives, WOST were commonly “introduced” to 
transactional sex by drug dealers or their romantic partners. This was often to pay debts to drug 
dealers, and to sustain drug use for WOST but also their romantic partner’s habit. For WOST, 





sex were often life shattering for WOST. The decriminalisation of transactional sex was advocated in 
the first publication included in this thesis (see Chapter 4 page 97). In this final chapter it is 
emphasised that decriminalisation may not an option for situations of sexual exploitation (as for 
WOST), and that decriminalising sex work (incl. transactional sex) could contribute to the 
maintenance of patriarchal social structures.  
There is much work to do for gender equity and to, for once, eliminate GBV. Part of this work 
is the need to involve politicians and policy makers, so that they shape the health and educational 
systems in a way that equity can be attained.  
9.1.2.3. Addressing social inequities of health  
Intersectionality Theory helps us understand WOST’s experiences of membership to 
stigmatised and marginalised groups. This is categorical intersectionality, commonly used by 
psychologists applying Intersectionality Theory to their work (Cole, 2008). There is also the need to 
focus on political intersectionality, an approach that addresses political and organisational aspects of 
pertaining to multiple subordinate identities (Cole, 2008). This relates to the organisation and policy 
levels, but also social movements such as the feminist movement today.  
Experiences of WOST were shaped by their membership to several marginalised and 
stigmatised groups: women, PWUD, transactional sex workers, people living in situations of 
homelessness, and people living with an STI or a BBV. Intersectional stigma has already been 
discussed as having a great influence on WOST’ social identity. In turn, the way that WOST perceive 
themselves has a significant impact on their sexual health. Experiences of social exclusion 
experienced by WOST have clear links with their feelings of worthlessness, powerlessness and 
helplessness. How can WOST perceive their worth if they feel dehumanised? How can WOST feel 
empowered to change their situation if they feel that they are not worth changing it? How can they, in 
this context, be empowered to protect their sexual health? How can WOST feel supported if the 
social, economic and political systems are rendering them invisible and neglecting their needs? This is 
a very complex cycle that has great implications for health promotion. 
It is generally assumed that people want to stay healthy, but it is also obvious that we all do 
not always protect our health. For WOST this was even more complicated as data from this study 
suggested that they often assumed illness, disability and death as part of their destiny. Most of us may 
fear illness, disability and death as these may mean the abandonment of ourselves, those that we love 
and the lives that we know. It means changing our realities to the unknown. For WOST, this unknown 
was not necessarily perceived worse than their current situation. The prospective of something better 
was just not an option in most cases. This is a sad and challenging reality that cannot (and must not) 





Learned Helplessness Theory (LHT) is useful to explain WOST’s feelings of powerlessness 
and helplessness at the individual-level. LHT was first developed based on experiments with 
laboratory animals (Overmier & Seligman, 1967; Seligman, 1972; Seligman & Maier, 1967). Since 
then, LHT has been widely used especially in experimental and clinical psychology (Maier & 
Seligman, 2016). According to LHT, individuals that are continuously exposed to unavoidable 
traumatic events become passive in making actions to prevent future trauma. This is due to the 
potential unavoidability and uncontrollability of these traumatic events (learned helplessness). Despite 
the individual-level focus and grounds on behaviourism of the LHT, it is still a valuable approach to 
explain WOST’s behaviour in the context of this research. Social inequities are again the core issue, 
as the predisposition of WOST to experiencing trauma (e.g., GBV), and the impact on sexual health, 
have their roots in the lack of social equity. In turn, experiencing social inequities is a key factor for 
experiencing intersectional stigma, one of the main determinants of health inequities (Hatzenbuehler, 
Phelan, & Link, 2013). This is where the main efforts need to be focused on, for social justice and to 
improve sexual health among WOST.  
Addressing social inequities is then key to promoting sexual health among WOST. The social 
inequities experienced by WOST suggest the need for urgent action to ensure human and health 
rights. And it seems that changes need to occur in the social, economic and political systems in order 
to ensure that the rights of WOST are being protected. This could facilitate promoting health, 
including the prevention of STIs and BBVs. Two sources of inequity, poverty and gender inequities, 
have been discussed in this PhD thesis. Other sources of inequity should be explored within this 
population in future research. Main areas that could be included in the intersection of social inequities 
are related to sexual orientation (homophobia), transsexuality (transphobia), race/ethnicity (racism), 
social class (classism) and age (ageism). 
The need to focus on social inequities of health was already highlighted decades ago 
(Dahlgren & Whitehead, 1991; McKeown, 1976). Social inequities of health are still within the public 
health’s agenda today (Arcaya, Arcaya, & Subramanian, 2015; Barreto, 2017; Braveman & Gottlieb, 
2014; Braveman et al., 2011; Mackenbach, 2012; Mackenbach et al., 2008; World Health 
Organization, 2014).  Despite the efforts and progress made, current health policies appear to be 
failing in addressing the core of the problem (i.e., lack of social and health equity). We therefore need 
equity-oriented health policies that address these pressing issues. Dahlgren and Whitehead (1991) 
proposed a model of the main determinants of health that need to be addressed by policy and public 
health strategies (see Figure 13). They stated that, despite the influence of individual-level 
determinants such as gender or age, these factors were not controllable thus should not be the focus of 
public health efforts. Each of the other layers in this model could be addressed by policy at different 






Figure 13. The Determinants of Health, adapted from (Dahlgren & Whitehead, 1991). 
1. Policy Level 1: aimed at structural changes (e.g., economic strategies). 
2. Policy Level 2: aimed at improving living and working conditions through healthy public 
or business strategies (e.g., health services). 
3. Policy Level 3: aimed at strengthening social and community support (e.g., social 
support). 
4. Policy Level 4: aimed at influencing individual lifestyles and attitudes (e.g., sexual health 
education). 
Apart from policy changes, it is important to address social inequities of health developing 
and implementing interventions at multiple social-ecological levels. This PhD research calls for public 
health strategies that incorporate multiple elements at different social-ecological levels, including 
shifts towards equity-oriented policies. These strategies need to however ensure personal freedom and 
autonomy by enabling rather than restricting choice (Barnett, Ogden, & Daniells, 2008; Department 
of Health, 2010; Nuffield Council on Bioethics, 2007). Also, interventions targeting vulnerable 
populations (e.g., WOST) need to pay careful attention not to increase stigmatisation towards these 





This PhD research presents suggestions for the design of a pharmacy-based sexual health 
service for WOST that also considers addressing social inequities of health (see Chapters 6-8). A 
discussion on the development of this service is available in the following sections of this chapter. 
9.1.3. The Design of a Sexual Health Service  
 The main aim of this research was to explore the opportunities for developing a sexual health 
service for WOST in community pharmacy. This section offers a critical review of the main findings 
in relation to this objective.  
 The question now is: What can be done in community pharmacy? What can CPs do with such 
a complex picture? As already discussed, a single public health intervention or health service cannot 
cover all aspects that need to be addressed to reduce sexual health risks among WOST. However, any 
change and development in the sexual health services available for WOST can be valuable. The 
findings from this PhD research suggest that CPs could actually have an important role in promoting 
sexual health among WOST. As highlighted in previous chapters, there are however barriers that need 
to be considered. There is still something that CPs can contribute to in promoting the sexual health of 
WOST. A discussion on these barriers has already been presented in Chapters 5-8. In this chapter, 
these barriers are framed within the Social-Ecological Approach. 
One of the most important barriers highlighted in this PhD research was the prevalence of 
negative and stigmatising attitudes towards WOST among CPs. The case for addressing intersectional 
stigma towards WOST has already been presented in this thesis. Intersectional stigma towards WOST 
is also maintained through drug use, and general social inequities experienced by this group of 
women. Despite accessing drug services appeared to be beneficial for some women taking part in this 
research, there was not a clear link between accessing services for drug use (i.e., OST) and improved 
sexual health. Future research could focus on exploring the role that accessing health services can 
have on reducing of sexual health risks among WOST and improving sexual health outcomes. 
Previous research has suggested multiple factors to be associated with drug use, from 
biological to socio-structural factors. Theoretical approaches to addiction – to a substance or a 
behaviour (e.g., gambling) – have however been dominated by behavioural and biomedical sciences. 
These explanations of addiction have been restricted to the role of impulses, motivation, lack of self-
control, and classical and operant conditioning (West, 2013). These are again reductionist approaches 
that fail to acknowledge the complexity of factors associated with drug use, and other related issues 
(e.g., sexual health risks among PWUD). What about the role of GBV? What about the day-to-day 
experiences of intersectional stigma? What about the lack of services addressing the needs of drug-





It is undeniable that there are important physiological and psychological factors to drug use. 
But widening this perspective is crucial to understanding and addressing drug use, as well as social 
and health-related harm (e.g., sexual health) effectively. Comprehensive theories of addiction, such as 
the Excessive Appetites Model, have attempted to provide a broader concept of what constituted 
addiction (Orford, 1985, 2001). However, this model still places more importance on elements of self-
control and habit formation and less on social structures and political systems. This is an example of 
theoretical approaches that have aimed at “ticking the box” of including social factors in their models. 
They still offer limited explanations by merely including opportunity (e.g., availability of heroin in a 
community) or external stimuli as environmental elements of drug use (West, 2013). There are other 
elements such as social norms, policies or the economy that should be considered. Other theoretical 
models have provided population-level explanations for addiction, such as Social Network Theories, 
Economic Models, Communication and Marketing Theories, and Organisational Systems Models. Yet 
again, not much attention has been placed on these theories in comparison to other individual-level 
theoretical frameworks (West, 2013).  
Dominant behavioural and biomedical explanations of drug use may be having a great 
negative impact on the stigmatisation, social invisibility and exclusion of WOST. These 
understandings of drug use were apparent in the narratives of most CPs. Neglecting the role of socio-
structural factors maintains the structures that sustain the social and health problems that we are 
facing today. This neglect also contributes to sustaining stigmatising attitudes towards those that are 
living in situations of marginalisation, including WOST. As already discussed in this chapter, social 
inequities are at the core of sexual health risks among WOST. Community pharmacy-delivered 
interventions could be involved in achieving health equity for WOST (T. J. Brown et al., 2016). 
Changes in the training of CPs should also be attained to promote a wider understanding of 
drug use and other related issues (e.g., STI/BBV sexual transmission) among CPs. Improvements in 
training should also aim at increasing CPs’s understanding on how their own attitudes can have a 
crucial role in (sexual) health promotion among WOST. Not accounting for the social and cultural 
conditions of WOST may actually sustain power inequities in CPs-WOST relations (Aronowitz, 
Deener, Keene, Schnittker, & Tach, 2015; Bourdieu, 1977). Based on social capital approaches, 
health professionals need to be conscious of how they work with their patients and avoid “reinforcing 
status hierarchies and the oppression of some groups by others” (Hawe & Shiell, 2000). It is then 
crucial that CPs become aware of the social inequities experienced by WOST and the dynamics of 
power that can occur in their interactions with them (McDonald, Jayasuriya, & Harris, 2012; Nimmon 
& Stenfors-Hayes, 2016).  
Although some CPs were understanding and compassionate, intersectional stigma towards 





this PhD research were already interested and involved in the care of WOST and other PWUD. 
Therefore, it may be that CPs in this research held more positive attitudes in comparison with other 
CPs that did not participate. The prevalence of CPs’ stigmatising attitudes towards WOST seems 
again to be a reflection of the social inequities that WOST experience. These negative attitudes are 
also important barriers to STI/BBV prevention. Addressing social inequities could then also shape the 
attitudes of CPs towards WOST. This is indeed a challenge but could greatly improve WOST’s access 
to pharmacy services. Also, how these services are delivered and their impact on sexual health 
outcomes, wellbeing and health equity.  
Communication on sensitive topics such as sex and sexual health is not an easy task. This was 
one of the challenges that both CPs and WOST thought that needed to be addressed in community 
pharmacy. Trust and privacy were key facilitators to engaging in discussions on sexual health due to 
the sensitivity of the topic. An important aspect to consider, again taking a social-ecological 
perspective, is the taboo of sex and sexual health. Through history, sex has been framed as dangerous 
and corruptive pleasure “that seduced one’s mind” (Dabhoiwala, 2012). Religion has had a major role 
in framing sex as an unclean and loathsome practice that was only morally allowed for reproductive 
purposes in heterosexual married couples. Throughout the centuries and even today, there have been 
punishments for socially condemnable sexual acts, from public shaming to executions. In the history 
of sex, women have always been more vulnerable to such punishments and social shaming 
(Dabhoiwala, 2012). Despite the fact that attitudes towards sex have changed, sex is still a taboo topic 
that can generate feelings of shame. It can be seen as an inhuman practice that has long been framed 
as a risk (Bauman, 2003), rather than a natural and healthy practice. The historical secrecy around sex 
is reflected in the difficulties of CPs (and also WOST) have discussing sexual health. Also, sexual 
health among WOST often implies discussing other sensitive and taboo topics such as GBV 
(including child sexual abuse), transactional sex, homelessness, STI/BBV status, and drug use.  
Changing these taboos means shifting society’s attitudes towards sex and other topics 
discussed in this PhD thesis. This is a great undertaking that again requires changes at different 
ecological levels. Suggestions may include advances in CPs-WOST communication through 
improved professional training, facilitate trusting and open environments within communities to 
promote healthy sex and relationships, and changes in educational policies that incorporate a more 
open and comprehensive sex and sexual health education for children and teenagers. Changes in how 
CPs normalise and discuss sex and sexual health would be beneficial to generate trust and openness, 
facilitating the access of WOST to pharmacy-delivered sexual health services.  
Improving drug policies can also be key to challenge societal and cultural views of drug use 





ecological levels, to promote compassionate and non-judgmental attitudes towards PWUD, and a 
holistic and socio-structural perspective on drug use, towards the de-stigmatisation of drug use. 
Improving communication in community pharmacy could also reduce time constraints (Nass, 
Banerjee, Efferth, & Wohlmann, 2016) and improve clients’ loyalty (Antunes, Gomes, & Cavaco, 
2015). Refining communication skills among CPs can be done effectively using simulated patient 
methods (Mesquita et al., 2010), and delivering communication courses using videos and offering 
constructive feedback to students (Jin, Choi, Kang, & Rhie, 2018). This would not only improve 
effective and positive communication, but also increase CPs’s confidence to discuss sensitive topics 
(Jin et al., 2018). All CPs in this study expressed that working with WOST was challenging. This was 
partly because of the gaps in communication and CPs’s lack of training and confidence in dealing 
with conflict. Improving CPs’s confidence in communicating with WOST is also important in dealing 
with potential conflicts in community pharmacy. Together with these advances, adopting a patient-
centred approach should also be a priority to improve the interactions between CPs and WOST. This 
is important in order to build trust and health-related outcomes (Beach, Keruly, & Moore, 2006). It 
could also improve access to health services by reducing health inequities (Fenton et al., 2018).  
There were important structural barriers, apart from intersectional stigma and lack of 
communication. These were time and workload constraints, privacy and confidentiality, and financial 
constraints. All of these are commonly reported barriers in community pharmacy (Arnet, Gudka, 
Salter, Hersberger, & Clifford, 2018; Donovan & Paudyal, 2016; Eades et al., 2011; Laird, Hunter, 
Sardar, Fitzgerald, & Lowrie, 2016; Laliberté, Perreault, Damestoy, & Lalonde, 2012; Luger et al., 
2000; L. Michie et al., 2016; Rose, Lutnick, & Kral, 2014; Strang & Sheridan, 2003). These barriers 
are related to how community pharmacies are structured and policed. A Social-Ecological Approach 
and suggestions from Dahlgren and Whitehead (1991) (see Figure 13) to address social inequities of 
health at the policy level offer a useful framework to addressing these barriers. These approaches 
could be useful to develop policies and guidelines in community pharmacy to overcome the structural 
challenges here discussed.  
Despite the barriers discussed, both WOST and CPs taking part in this study welcomed the 
development of new sexual health services in community pharmacy. It then seems that community 
pharmacies are well placed to deliver sexual health services to WOST and address some of the sexual 
health needs of WOST, even if not all (e.g., GBV). This is due to the limitations in community 
pharmacy (e.g., time constraints) and the role that CPs are able to undertake (e.g., due to their 
professional training). Improvements in professional training for CPs and changes in policy could 
reduce the barriers identified. As already mentioned, developing interventions at multiple ecological 
levels would be necessary to address all factors of sexual health risks among WOST identified in this 





The service goals and outcomes for the pharmacy-delivered sexual health service are 
presented in Chapter 8 (see page 190). These are focused on increasing the availability of sexual 
health services for WOST. More specifically, this service would promote sexual health screening and 
treatment uptake. Table 14 in Chapter 8 (see page 197) includes a brief justification of the reasons 
why particular determinants of health could (not) be addressed by the pharmacy-based sexual health 
service. It is important to understand that decisions on the inclusion and exclusion of determinants 
were not just based on priorities for WOST. They were also based on what was considered acceptable 
and feasible within the community pharmacy setting. It is crucial to bear in mind ethical implications 
in public health strategies (Kass, 2001). This chapter highlighted the need to address social inequities 
experienced by WOST as these are behind WOST’s vulnerability to STIs and BBVs. Even if not as a 
whole, the sexual health service designed in this PhD research would make a contribution to attaining 
equity for WOST.  
9.1.3.1. Next stages for service design 
The suggestions for service development in this PhD thesis correspond to Step I and Step II of 
IM (Bartholomew Eldredge et al., 2016). Using this approach, the next stages of service design would 
include: 
1. The design of the service (Step III) 
a. Themes, components, scope, and sequence 
b. Theory- and evidence- based change methods 
c. Design of practical implications to deliver change methods 
2. The production of the service (Step IV) 
a. Refine the structure and organisation of the service 
b. Prepare materials for the service 
c. Draft messages, materials and protocols 
d. Pretest, refine and produce materials 
3. The implementation of the service (Step V) 
a. Identify the service users (adopters, implementers and maintainers) 
b. State the outcomes and performance objectives for using the service 
c. Constructing matrices of change objectives for using the service 
d. Design the implementation of the service 
4. The evaluation plan (Step VI) 
a. Write questions for evaluating the effect and process of the service 
b. Develop indicators and measures for assessing the service 
c. Specify the design for the evaluation 





Completing the design, implementation and evaluation of the service would require a high 
amount of resources, including funding and professionals working on this project. The findings from 
this PhD will inform the design of a service aimed at improving the access of WOST to reproductive 
and sexual health services through community pharmacy. Funding applications will be submitted in 
order to undertake this research. 
9.2. Defining Sexual Health: An Equity and Human Rights Approach 
Another point worth discussing is the importance to define ‘sexual health’ within research 
more broadly. Sexual health is often exclusively associated with STIs and BBVs. Being in good 
health is however not just about ill-health, but about promoting health and wellbeing in all its 
dimensions. Defining sexual health then needs to include emotional, mental and social wellbeing in 
relation to sexual experiences, rather than the mere absence of STIs and BBVs (World Health 
Organization, 2006). Equity and human rights should also be incorporated into the definition of health 
and sexual health (International Planned Parenthood Federation, 2008; UN General Assembly, 1948; 
United Nations, 1994; World Association for Sexual Health, 2014). Sexual health involves the right to 
pleasurable and safe sexual experiences that are free of coercion, violence and discrimination (World 
Health Organization, 2006). There are several principles with regards to sexual health that are a matter 
of human and sexual rights (Miller, Kismödi, Cottingham, & Gruskin, 2015). Universality and 
inalienability are at the core of these principles. These refer to the fact that human and sexual rights 
are universal. Every single human being is born with them and these rights cannot (and should not) be 
taken away. Human and sexual rights are also indivisible and interdependent. This means that all 
rights – political, civil, social, cultural and economic – are equally important and they cannot be 
understood as separate entities; the denial of one right usually compromises another. For instance, 
denying access to sexual health education may also mean denying the right to make informed 
decisions about one’s sexual health. A third human and sexual rights principle is non-discrimination 
as a tool for reaching equity and ensuring sexual health. Any unequal treatment of certain groups or 
individuals (e.g., women) violates human rights and impairs equity, as well as it may compromise the 
access to health at its highest possible standard. Reaching for equity is a matter of social justice and a 
call for humanity. Reaching for equity concerns us all, and so it matters in health and social research, 
especially when working with socially excluded and marginalised communities, such as women on 
opioid substitution treatment (WOST) (Braveman, 2014; Braveman & Gruskin, 2003a, 2003b; 
Braveman et al., 2011).   
Despite a broader definition of sexual health was considered in this research, this 
understanding of sexual health emerged throughout the research rather than in the research design 
process. The research aims and objectives were really based on a definition of sexual health as the 





that the findings and discussions of this research were based on a broader approach to sexual health 
among WOST.  
Future research in this area should also consider framing the aims and objectives in line with 
the Millennium Development Goals (United Nations, 2015a) and the 2030 Agenda for Sustainable 
Development (United Nations, 2015b). Two of the 17 goals in this report would be especially relevant 
to this research. These are ‘ensuring healthy lives and promoting well-being for all at all ages’ (Goal 
3), and ‘achieving gender equality and empowerment of all women and girls’ (Goal 5). These goals 
have already been reflected on global strategies for STI and BBV reduction (UNAIDS, 2015, 2016a; 
World Health Organization, 2016a, 2016b, 2016c, 2016d). Also, that to offer recommendations to 
address the health inequities experienced by this group of women would be incorporated within the 
aims. It should not be just a matter of preventing disease or promoting health, but also a call for social 
justice, and human and sexual (health) rights.  
9.3. Strengths, Limitations and Future Directions 
 There were strengths and limitations to this research that need to be considered. This study 
was the first attempt to develop a sexual health service for WOST in community pharmacy. One of its 
strengths was the use of qualitative methods. These allowed for a comprehensive exploration of 
participants’ experiences from their own perspectives, which led to an in-depth understanding of 
sexual health risks among WOST. Using qualitative methods also provided an opportunity to explore 
the role of CPs promoting sexual health among WOST more broadly, and to initiate the design of the 
service. Despite being highly time consuming and complex, using FA allowed for the rich and 
extensive data analysis required for this study. The use of IM was another strength of this study, as it 
served as a useful guidance to designing the pharmacy-based sexual health service. 
Taking an equity, human rights and feminist approaches to this research was another of its 
assets. It was a goal of this research to contribute to reducing the social inequities of health 
experienced by WOST, and to focus on social justice and human rights in health. The findings from 
this study and the approach taken could inform future public health strategies. Approaching research 
from these values fitted well with a bottom-up approach that focused on what was important to 
participants, and on their constructive meanings of their own experiences. In line with this, this PhD 
study aimed at co-designing a sexual health service with its service users (i.e., WOST) and service 
providers (i.e., CPs). This could potentially improve the acceptability and effectiveness of the service 
if implemented.  
This PhD research focused on the experiences of WOST (and WHOD for Study 1), and did 
not include other women using drugs. Even if this could be seen as a limitation, some of the 





becomes a strength, as it could be that this study could inform future research and the development of 
sexual health services that include other women using drugs.  
There is the possibility of having missed other important elements associated with sexual 
health among WOST due to the exploratory nature of this PhD, especially as the aims and objectives 
were not really framed within a broader definition and understanding of sexual health. On the other 
hand, there is the possibility that participants (both WOST and CPs) had underreported some of their 
experiences or negative views (e.g., of CPs towards WOST). This research could then have lessened 
the complexity of interrelations between sexual health-related factors. At the same time, aiming to 
take a comprehensive approach has been an ambitious and challenging undertaking. This was a 
challenge for identifying patterns in the data and making decisions for service design. Future research 
should keep focusing on the complexity of sexual health risks among WOST. Also, on exploring 
particular factors highlighted in this PhD (e.g., intersectional stigma). Related to this point, it would 
be relevant to consider other social inequities in future work such as racism, homophobia, 
transphobia, classism and ageism.  
Another important limitation that should be acknowledged is related to the inclusion of HBV 
and HCV within this study. Viral hepatitis was included given the potential of the sexual transmission 
of HBV and HCV. However, previous research has reported that the evidence of the sexual 
transmission of viral hepatitis is weak (Alary, Joly, Vinceletter, Lavoie, Turmel, Remis, 2005; Azeem, 
Taqweem, Ahmed, Wakil, 2011; Neumayr, Propst, Schwaighofer, Judmaier, Vogel, 1999; Shepards, 
Finelli, Alter, 2005; Vandelli et al., 2004). Framing hepatitis transmission risk as both through 
injecting and sexual practices has also been highlighted as a factor that could perpetuate risk practices 
(Harris & Rhodes, 2013). In this study, the authors discuss that including sexual risks within public 
health strategies to prevent HCV could lead to the increase of risk practices. This is because people 
living with HCV and their sexual partners could decide to share needles if already engaging in 
condomless sex, if they perceived parenteral and sexual risk transmission to be equivalent based on 
public health messaging. It is then crucial to consider the inclusion of viral hepatitis prevention 
alongside STI/HIV prevention in future research and design of public health services. 
Mixed-methods approaches could be useful to triangulate different sources and types of data. 
Including quantitative analyses could help to further explain the nature and type of relationships 
between factors (e.g., between experiencing intersectional stigma and accessing sexual health 
services). Applying the findings of this research to WOST in other communities within the UK and 
other countries would also be valuable for future research. Also, considering community pharmacies 
in other areas of the country and community pharmacies and health systems worldwide. Other 





analysed (i.e., using QCA), as a more exploratory approach could have encouraged new and divergent 
views to arise. 
Despite the usefulness of IM, using this or other approaches to develop health promotion 
programmes critically is another take-away message. It is essential to remember that these approaches 
are designed to offer guidance to develop services, but should be able to be adapted to each particular 
case. Even though IM was a useful and systematic approach to follow, it was rather prescriptive at 
times. At the same time, it was sometimes unclear how to undertake some of the tasks or make certain 
decisions for service development (e.g., deciding on determinants of health). However, IM is an 
evidence- and theory-based approach that allows for developing evidence- and theory-based health 
services, an essential criteria to plan health services (DiClemente, Salazar, & Crosby, 2011; Glanz & 
Bishop, 2010; S. C. Jones & Donovan, 2004). On the other hand, one of the reasons for using IM was 
its focus on incorporating social-ecological approaches. However, it appeared that IM gave more 
importance to individual-level determinants and could neglect the importance of socio-structural 
elements. In this study, this was a limitation that was addressed by using IM in a flexible manner 
rather than a rigid guideline. In line with this critique, the role of culture should also be incorporated 
in future service development to address social inequities of health more broadly (Airhihenbuwa, 
Ford, & Iwelunmor, 2014; Aronowitz et al., 2015; Asad & Kay, 2015; Napier et al., 2014; Singer, 
2012; Singer, Dressler, George, & The NIH Expert Panel, 2016).  
WOST seemed open to share their life experiences and views on service development. 
However, given the nature of the data, some women may have underreported some of their 
experiences. All participants were reassured that taking part in the study would not have any impact 
on their care, and all information would be kept confidential. However, some WOST may have not 
shared some of their negative views of health services, including community pharmacy. Similarly, 
social desirability needs to be considered when interpreting the data from CPs. Mixed messages of 
CPs regarding their own attitudes towards WOST were common in participants’ narratives. This 
suggests that participants could have portrayed themselves more positively in their interactions with 
WOST, than they really were. Also, that CPs could have reported more positive views on their clients 
than they really held. It could also be that some CPs did not share more negative opinions on the 
development of the sexual health service. It could be that the responses from both groups were 
slightly biased due to the information that they had on the interviewer (e.g., if they knew that she was 
a psychologist or was a researcher at a Department of Pharmacy & Pharmacology). Future research 
should acknowledge these limitations and always explicitly ensure confidentiality and anonymity.  
Whilst there is a certain analysis of the health system and policies in this thesis, this study has 
not directly focused on these structural factors. Policy analyses and the involvement of policymakers, 





future research. As introduced in Chapter 2 (see page 13), data analyses and discussions in this PhD 
thesis have been inevitably influenced by the researchers’ values and subjective interpretation of the 
data. Despite this not being a limitation per se it is something that needs to be acknowledged in any 
research.  
Very importantly, future research should aim at addressing social inequities of health among 
WOST. Efforts to develop new strategies to prevent STIs and BBVs among this group of women 
should also consider Social-Ecological Approaches and Intersectionality Theory. Gaps between 
research, policy and practice need to be bridged so that WOST’ sexual health needs are addressed, 
and inequities are reduced.   
9.4. Research Implications 
The implications and impact of this PhD research have been illustrated in this chapter. There 
are important implications for research, policy and practice. The previous section has highlighted the 
need for continuing the research in this area and implications for future research. The focus of this 
section is on implications for policy and practice.  
There are also important implications for policy. These should consider Intersectionality 
(Crenshaw, 1989) and Social-Ecological approaches (Bronfenbrenner, 1994; Dahlgren & Whitehead, 
1991; McLeroy et al., 1988). Programmes for children may also be crucial in order to shift views on 
sex and sexual health. Improvements in these should aim at having open and honest discussions 
around sex and sexual health and tackle the taboo and stigma around these topics. The findings from 
this study also led to consider current legislation on transactional sex. Feminist discourses need to be 
incorporated to political debates around the criminalisation of transactional sex, to focus on 
eliminating GBV and gender inequities. Women are still second-class citizens and this research serves 
as a call for this to change. As this study highlighted, efforts should be made to face patriarchal 
systems and shift social and gendered norms in society. As for gender inequities and GBV, other 
important social inequities need to become a priority for the agenda of policymakers and public health 
professionals.  
This PhD research also calls for the development of community interventions that foster 
healthier environments and increase social capital (Bourdieu, 1986; Coleman, 1988; Eriksson, 2011; 
Hawe & Shiell, 2000; Portes, 1998). Community-level interventions would also be key in shaping 
attitudes and social norms in relation to the sensitive and taboo topics addressed in this PhD thesis. 
These changes could be greatly beneficial in how WOST relate to themselves and the interactions that 
they have with other people around them. They could also, in turn, promote positive changes in policy 





This research could also have an important impact on the practice of health and social care 
professionals working with WOST, including community pharmacists. As presented throughout this 
thesis, it is important that professionals working with WOST recognise the complexity of their life 
stories. Also, that this has a deep influence on their health and what seem to be “their health 
decisions”. Blaming and stigmatising attitudes need to be replaced by compassionate and empathetic 
responses.  
9.5. Conclusions 
The main aim of this study was to explore the opportunity of designing and implementing a 
sexual health service for WOST in community pharmacies in England. There were several objectives 
in order to attain this aim. These were 1) to identify and explore the factors associated with the 
heightened risk of sexual transmission of STIs and BBVs among WOST; 2) to explore the needs of 
WOST in relation to STI and BBV prevention; 3) to explore the potential role of CPs in preventing 
the sexual transmission of STIs and BBVs among WOST; and 4) to offer initial recommendations for 
the design of a sexual health service for WOST in community pharmacies in England.  
This research highlighted the complexity of factors that are associated with sexual health risks 
among WOST. A Social-Ecological model was developed and included the multiple factors that are 
associated with sexual health risks at different ecological levels. Social inequities were discussed to be 
at the core of sexual health risks among WOST. The findings from this study directed our attention 
towards prevailing social inequities and how these are a concern for health promotion and public 
health. Joint actions are needed to tackle the barriers to include social and health inequities within the 
public health agenda. Very importantly, health services and public health strategies should be 
developed for those groups that are most vulnerable, such as WOST. In the end, equity is about giving 
the necessary resources to people as they need them. Equity needs for active listening and for wide-
open eyes to the realities around us. This is what this research intended, to open ourselves to the 
realities of WOST, to bring us closer to what their needs are to promote sexual health.   
More attention needs to be drawn towards the potential of community pharmacy in promoting 
health. Despite this being in the public health’s agenda of the UK for several years now (T. J. Brown 
et al., 2016; Donovan & Paudyal, 2016; Public Health England, 2017e), there is the need for 
evidence- and theory-based services developed for community pharmacies. Barriers to promoting 
health in community pharmacy cannot however be neglected. Service development needs to aim at 
acknowledging and promoting socio-structural changes so that these barriers can be addressed. There 
also need to be changes in the education and training of CPs. These should aim at fostering non-
blaming and non-stigmatising attitudes towards PWUD. They should also focus on acknowledging 





highlighted that CPs could play a role in promoting sexual health among WOST. However, 
pharmacy-based services could only address part of the complexity of factors associated with sexual 
health risks among WOST. Interventions at multiple social-ecological levels will be required to 
address the core factors identified in this study. 
The conclusions from this PhD research all lead to the same simple idea. We need to 
remember that we are all human, despite of our biological sex, gender, use of psychoactive 
substances, sources of income, level of education, living conditions, health status, race, sexual 
orientation, place of birth (...). This research is a call for humanity, a call for equity and access to 
human rights. This will enable a move beyond current limitations of many public health strategies for 
WOST and other vulnerable populations. It will also enable us to build healthier societies that leave 
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Appendix 10. Social Media Post (CPs) 
 
Title: Community pharmacists for a study at the University of Bath 
Please note that this research has received NHS ethics approval (REC Ref. 16/NW/0432 // IRAS ID 
205701), and ethical approval from the University of Bath.  
 
Compared to the general population, the risk of sexually transmitted infections and blood-borne 
viruses is higher among individuals who use opioids (e.g. heroin), women being particularly 
vulnerable. The University of Bath has funded a PhD study to explore the role of community 
pharmacists in preventing sexually transmitted infections and blood-borne viruses 
among opioid substitution treatment female clients. This study will aim to design and pilot a 
public health service to promote safe sex among women receiving opioid substitution treatment in 
community pharmacies. This research will determine the feasibility and potential effectiveness 
of this service.  
 
For this study, we are hoping to recruit 20 community pharmacists providing opioid 
substitution treatment in the areas of Bath and Bristol. Participating will involve a one-to-one 
interview, filling in a short questionnaire, and/or participating in group discussions. All the data 
collected will be anonymized and confidential.  
 
If you have any questions or would like to take part, please contact Laura Medina-Perucha 
at l.medina.perucha@bath.ac.uk or 01225 384215 
 


















































































































Appendix 16. Interview Guide (WOST) 
 
Concept Question Prompts 
Introduction 
Safe/unsafe sex 
We all have very different opinions and views 
about what safe and unsafe sex are.  
It would be very helpful to know what you 
think about this.  
What about oral sex? 
Factors to safe/unsafe sex What do you think are the reasons for people 
to have safe sex? 
What about unsafe sex? 
Relationship type  
Do you think the type of relationship (e.g. if 
you are in a long-term relationship, or you 
have a one-night stand) is an important factor 
to have safe sex? 
What about unsafe sex?  
Sex work  
Some women have previously told me that 
they have participated in sex work. They also 
told me that, in that situation, they were a lot 
more confident telling clients to use condoms, 
compared to men they were in a relationship 
with. What are your views on this?  
 
Partner’s attitudes towards sex 
What is your opinion on the importance of a 
sexual partner’s attitudes towards sex? 







Now that we are discussing about how sex is 
different depending on your partner, some 
people also find very difficult to discuss using 
a condom or sexual health status (e.g. if they 
have been screened or diagnosed with an STI). 
What are your views on this? 
 
Sexual preferences 
We all have different preferences when it 
comes to sex. For example, people have 
different sexual orientations, or like to have 
sex in different way. 
How do you think that could be linked to 
having safe or unsafe sex? 
Anal, oral, vaginal sex  
 
BDSM (Bondage & Discipline, Domination & 
Submission, Sadism & Masochism) 
Libido 
Do you believe that have high or low libido 
has something to do with someone’s decision 
to use condoms or not? 
 
Knowledge about STIs and BBVs 
So… the two main reasons for women to have 
safe sex are to avoid pregnancy, and to avoid 
getting a sexually transmitted infection. There 
are a lot of different infections that are 
transmitted through sex (I had personally no 
idea about most of them until I started this 
project!). Would you know what these 
infections are?  
Where have you got that information from?  
 Have you ever received advice from a 
health professional (e.g. pharmacist, or 
GP) about STIs and BBV? 
 Any health campaign? 
 
History of STIs and BBVs 
Have you ever had tests or screening for any of 





Have you had the HPV vaccine?  
What do you know about it? 
Risk perceptions 
Thinking about past and current relationships, 
we all normally find it quite difficult to think 
that we will get an STI or a BBV. Have you 
ever experiences that before? 
 
How do you think people decide if they are at 
risk or not? 
(Start closing) – All the things that we have been talking about today have been really helpful so far. I would like to ask you just a few more 
questions now about the experiences with health professionals, and particularly with your community pharmacist.  
 
Health promotion in community pharmacy 
As you may know, there are different health 
professionals that we could ask for advice if 
we are concerned about sexually transmitted 
infections and contraceptive methods. 
Because there are pharmacies everywhere, and 
we do not normally need to book an 
appointment with our pharmacist, community 
pharmacists are very important in giving 
advice about safe sex practices.  
What are your views on this?  
Have you ever come across a service like that 
in your pharmacy? 
Relationship with community pharmacist 
How would you describe your relationship 
with your pharmacist? 
Why good?  
If bad – how could it be improved? 
Opportunities to obtain health advice in 
community pharmacy 
Have you had the opportunity to ask for health 
advice to your pharmacist? 





Sexual health in community pharmacy 
Have you ever received sexual health 
information in your pharmacy? 
How would you feel if you received advice on 
safe sex when you go to the pharmacy to get 
your methadone? 
And the last question – this study is looking to 
do you think that it is a good idea to develop a 
service to encourage people to have safe sex in 
community pharmacies?  
 
Do you have any ideas on what this service 
could include? 
Thank you very much for answering my questions, all the information that you have given me will be very useful indeed. Before we finish though, I 
would like to ask you if you have any questions, or you would like to make any final comments (?) 
















Appendix 17. Interview Topic Guide (CPs) 
Concept Question Prompts 
Introduction 
OST provision – experiences, positive and 
negative aspects of this service provision, 
attitudes towards providing OST and OST 
users 
Could you tell me a little bit about the OST 
services that you provide in your community 
pharmacy? 
What is your experience providing OST? 
What would you say the positive aspects of 
providing this service are (if any)? 
What are the negative aspects of it (if any)? 
Provision of health promotion services – 
knowledge, attitudes, views 
I would like to ask you now about health 
promotion services, e.g. general health checks 
or smoking cessation. What health promotion 
activities do you routinely provide? 
What other related services in community 
pharmacy do you know about? 
What about sexual health services (e.g. 
emergency hormonal contraception, 
contraception, STI screening, fertility)? 
If not at the moment, have you provided such 
services in the past? 
What are your views on providing these 
services in community pharmacy? 
Do you think there is a need for this services to 
be implemented in community pharmacies? 
Is it feasible? ((Explore this after their 
answer)) 






Do you provide any of these services to 
women receiving OST? 
Tell me a little bit more about this…  
Needs for sexual health services for WRO  
We are also interviewing women who are OST 
users, and one of the things that we are 
exploring are the factors that might lead to 
have safe or unsafe sex. It would also be very 
helpful to know the community pharmacists’ 
perspectives on this. 
What factors do you think that make people 
have safe sex? 
What about unsafe sex?  
What kind of advice do you give patients on 
safe sex? 
 
What are your experiences in this area with 
women receiving OST? 
What other forms of support do you give at the 
moment to women receiving OST? 
Sex work  
Some women receiving OST have mentioned 
that they have engaged in commercial sex at 
some point in their life, and this has been 
identified as a risk factor to contract an STI or 
BBV. 
Have you encountered this with your clients? 
 
If you know that someone is sex working, what 
would you do? 
(If there is nothing that they would o) – what 





Provision of sexual health services – 
knowledge, attitudes 
As I have mentioned before, this study is 
specifically looking at improving the sexual 
health of women who are receiving OST. 
However, it would be useful to know about 
sexual health services that you know about for 
the general population through community 
pharmacy? 
Do you provide this kind of services? 
Have you ever provided this kind of services in 
the past? 
What are your views on providing these 
services? 
Relationship with WRO – attitudes, prejudice, 
stigma 
How would you describe your interactions 
with women receiving OST? 
 
Other pharmacists have mentioned that they 
have had problems with some clients when 
they come in to get their OST (e.g. they have 
felt intimidated, they have had arguments, or 
some service users have stolen something from 
the pharmacy, etc.). 
Have you found yourself in any, or other 
similar, situations? 
 
How do you feel about working with this client 
group? 
And what about this particular topic (i.e. 
sexual health)?  
Views and attitudes towards the study/health 
programme 
So, the main aim of this study is to design a 
service in community pharmacies to promote 
safe sex among women receiving OST. 
What are your views on providing services to 
What are the positives and negatives of 







prevent STIs and BBV infections in 
community pharmacies, for women receiving 
OST? 
Should anything be done/changed in order to 
implement this service? 
(e.g. workload/time pressure, financial issues, 
training) 
Within your pharmacy, who do you think 
could provide this kind of service? 
 
 
Do you believe that service users would be 
keen on receiving sexual health information 
when coming to get their methadone? 
Design ideas for health promotion service 
Do you have any idea of the type of service 
that community pharmacists could provide 
(e.g. short consultation, referral, or information 
provision giving leaflets out)? 
 
(Start the closing) – All the things that we have been talking about today have been really helpful and interesting so far. I would like to ask you a 
few last questions now the training that community pharmacists receive and have access to. 
Training 
What are your views on the training for 
community pharmacists in relation to OST 
provision? 
What about sexual health? 
 
If you were to provide sexual health services 
for women receiving OST, would you be 
happy with the training that you have had 
already? 
 
Could you tell me a little bit about the training 
on sexual health that you have had in the past? 





Has the training that you have had included 
guidance on consultation skills to deal with 
difficult situations? (Tell me about this 
training) 
Thank you very much for answering my questions, all the information that you have given me will be very useful indeed. Before we finish though, I 
would like to ask you if you have any questions, or you would like to make any final comments (?)  







































































Appendix 20. Research Dissemination 
Data from this study has been disseminated throughout the study. This study has been 
presented at national and international conferences (see Tables A20.1 and A20.2): Society for the 
Study of Addiction, STI & HIV World Congress, European Public Health Conference, and at the 
European Health Psychology Society Conference. Oral presentations on this study have been also 
given at the University of Bath. Manuscripts have been written and sent to peer-reviewed journals.  
The outline of presentations and publications can be found below:  
Table A20.1 
Oral Presentations 
Authors Presentation title Conference details 
Medina-Perucha L., Scott J., 
Dack C., Chapman S., Family 
H. & Barnett J.  
A qualitative study on 
intersectional stigma, violence 
and STI/BBV risk among 
women on opioid substitution 
treatment in England: 
Implications for research and 
practice (under review).  
IUSTI European & World 
Congress 2018, Dublin 
(Ireland); June 2018. 
Medina- Perucha L., Dack C., 
Family H., Scott J., Chapman 
S., & Barnett J. 
Psychosocial factors of sexual 
risks among women using 
heroin and other drugs: A 
systematic literature review.  
Health & Clinical Research 
Theme Seminar, University of 
Bath (United Kingdom);  
February 2018. 
Medina-Perucha L., Dack C., 
Scott J., Family H., Chapman S. 
& Barnett J. 
Promoting sexual health among 
women on opioid treatment in 
community pharmacy: A 
qualitative study.  
Society for the Study of 
Addiction PhD Symposium 
2017, Newcastle (United 
Kingdom); November 2017. 
Medina-Perucha L., Family H., 
Dack C., Scott J. & Barnett J. 
 Promoting sexual health 
among women on opioid 
treatment in community 
pharmacy: A qualitative study.  
European Public Health 
Conference 2017, Stockholm 
(Sweden); November 2017. 
Medina-Perucha L., Family H., 
Dack C., Scott J. & Barnett J. 
Psychosocial determinants of 
sexual practices among women 
using heroin and other drugs: A 
systematic literature review.  
STI & HIV World Congress 
2017, Rio de Janeiro (Brazil); 







Authors Presentation title Conference details 
Medina-Perucha L., Scott J., 
Dack C., Chapman S., Family 
H. & Barnett J. 
 Intersectional stigma and the 
prevention of sexually 
transmitted infections and blood 
borne viruses: Implications for 
the design of a pharmacy based 
service for women on opioid 
substitution treatment. 
European Public Health 
Conference 2018, Ljubljana 
(Slovenia); November 2018. 
Medina-Perucha L., Scott J., 
Dack C., Chapman S., Family 
H. & Barnett J. 
Using Intervention Mapping to 
design a sexual health service 
for women on opioid 
substitution treatment. 
European Health Psychology 
Conference 2018, Galway 
(Ireland); August 2018. 
Medina-Perucha, L. Dack C., 
Family H., Scott J. & Barnett J. 
Psychosocial factors of sexual 
practices among women using 
heroin and other drugs: A 
systematic literature review.  
Society for the Study of 
Addiction Annual Symposium 
2017, Newcastle (United 
Kingdom); November 2017. 
Medina-Perucha L., Dack C., 
Family H., Scott J. & Barnett J. 
Study protocol: Design and 
pilot of a sexual health service 
for women receiving opioid 
substitution treatment in 
community pharmacy. 
Society for the Study of 
Addiction Annual Symposium 
2016, York (United Kingdom); 
November 2016. 
Publications 
Medina-Perucha L., Scott J., Chapman S., Barnett J., Dack C. & Family H. (under review). 
Sexual health services for women on opioid substitution treatment: The role of community 
pharmacies. European Journal of Public Health.   
Medina-Perucha L., Scott J., Chapman S., Barnett J., Dack C. & Family, H. (2019). A 
qualitative study on intersectional stigma and sexual health among women on opioid substitution 
treatment in England: Implications for research, policy and practice. Social Science & Medicine, 222, 
315-322.  
Medina-Perucha L., Family H., Scott J., Chapman S. & Dack C. (2018). Factors associated 
with sexual risks and risk of STIs, HIV and other blood-borne viruses among women using heroin and 





Medina-Perucha L., Dack C., Scott J., Family H. & Barnett J. (2017). Promoting sexual health 
among women on opioid treatment in community pharmacy: A qualitative study. The European 
Journal of Public Health, 27 (3). DOI 10.1093/eurpub/ckx187.071 
Medina-Perucha L., Family H., Dack C, Scott J. & Barnett J. (2017). Psychosocial 
determinants of sexual practices among women using heroin and other drugs: A systematic literature 
review. Sexually Transmitted Infections, 93, Suppl 2, A19 008.6. 
The dissemination of findings and research training were supported by several bursaries and 
awards to attend international conferences (see Table A20.3). 
Table A20.3 
Bursaries and awards to attend conferences and training courses 
Awarding body Amount Date Awarded for 
British Psychological Society £200 19/11/2016 
IUSTI World Congress 2016 
(Marrakech, Morocco) 
British Psychological Society £1000 22/01/2016 
Intervention Mapping (University of 
Maastricht, The Netherlands) 
Department of Pharmacy & 
Pharmacology (University of 
Bath) 
£250 05/02/2016 
IUSTI World Congress 2016 
(Marrakech, Morocco) 
Psychology Postgraduate Affairs 
Group (PsyPAG) 
£100 30/03/2016 
Intervention Mapping (University of 
Maastricht, The Netherlands) 
Alumni Fund (University of 
Bath) 
£250 15/07/2016 
Intervention Mapping Course (University 
of Maastricht, The Netherlands) 
Society for the Study of 
Addiction 
£350 29/07/2016 
Society for the Study of Addiction 2016 
annual symposium (York, United 
Kingdom) 
British Psychological Society £350 03/04/2017 
STI & HIV World Congress 2017 
(Rio de Janeiro, Brazil) 
Fran Trust £500 19/04/2017 
STI & HIV World Congress 2017 














Society for the Study of 
Addiction 
£350 03/05/2017 
Society for the Study of Addiction 2017 
annual symposium (Newcastle, United 
Kingdom) 
Department of Pharmacy & 
Pharmacology (University of 
Bath) 
£240 15/05/2017 
STI & HIV World Congress 2017 
(Rio de Janeiro, Brazil) 
British Association for Sexual 
Health and HIV (BASHH) 
£1087 18/05/2017 
STI & World Congress 2017 
(Rio de Janeiro, Brazil) 
Alumni Fund  
(University of Bath) 
£250 06/07/2017 
European Public Health Conference 2017 
(Stockholm, Sweden) 
Psychology Postgraduate Affairs 
Group (PsyPAG) 
£300 14/08/2017 
STI & HIV World Congress 2017 
(Rio de Janeiro, Brazil) 
Santander Mobility Award  
(Santander Universities) 
£1016 14/04/2018 
IUSTI European & World Congress 
2018 (Dublin, Ireland) 
Foundation for the Sociology of 
Health & Illness 
£800 18/05/2018 
IUSTI European & World Congress 
2018 (Dublin, Ireland) 
British Psychological Society £400 14/07/2018 






Appendix 21. Substantial Amendment I 
 
Dear Miss Medina-Perucha, 
Further to the below, I am pleased to confirm that HRA Approval has been issued for the referenced 
amendment, following assessment against the HRA criteria and standards.  
The sponsor should now work collaboratively with participating NHS organisations in England to 
implement the amendment as per the below categorisation information.  This email may be 
provided by the sponsor to participating organisations in England to evidence that the amendment 
has HRA Approval. 





Dr Eleanor Ashworth | HRA Assessment  
Health Research Authority 
HRA, Ground Floor, Skipton House, 80 London Road, London, SE1 6LH 
E: eleanor.ashworth@nhs.net  
www.hra.nhs.uk 
The HRA is keen to know your views on the service you received – our short feedback 
form is available here 
 
 
From: nrescommittee.northwest-preston@nhs.net [mailto:nrescommittee.northwest-preston@nhs.net]  
Sent: 24 January 2017 11:12 
To: l.medina.perucha@bath.ac.uk; pro-vc-research@bath.ac.uk 
Cc: I.Blair@bath.ac.uk 
Subject: IRAS 205701. Confirmation of REC Validation and Categorisation of Amendment 
Dear Miss Medina-Perucha, 
IRAS Project ID: 205701 
REC Reference: 16/NW/0432 
Short Study Title: 
A public health service to promote 
safe sex 
Date complete amendment submission received: 19 January 2017 
Amendment No./ Sponsor Ref: 1 





Amendment Type: Substantial 
Thank you for submitting the above referenced amendment. I am pleased to confirm that this 
amendment has been submitted to the REC for ethical review. Please find attached a copy 
of the validation letter.  
Categorisation of Amendment  
In line with the UK Process for Handling UK Study Amendments I can confirm that this 
amendment has been categorised as:  
Category A - An amendment that has implications for, or affects, ALL participating NHS 
organisations 
You should now provide this email, together with the amended documentation, to the 
research management support offices and local research teams at your participating NHS 
organisations in England.  
Subject to the three conditions below, you will be able to implement the amendment at your 
participating NHS organisations in England 35 days after you notify them of the 
amendment. A template email to notify participating NHS organisations in England is 
provided here.  
You may not implement this amendment until and unless you receive all required regulatory 
approvals, including REC favourable opinion, (for participating organisations in England, this 
includes receiving confirmation of HRA Approval for the amendment). You should provide 
regulatory approvals to the research management support offices and local research teams 
at your participating NHS organisations in England, plus to local research teams at any 
participating NHS organisations in Northern Ireland, Scotland or Wales*. 
You may not implement this amendment at any participating NHS organisations which 
inform you within the 35 day period that they require additional time to consider the 
amendment, until they notify you that the considerations have been satisfactorily completed. 
You may not implement this amendment at any participating NHS organisation that informs 
you that it is no longer able to undertake this study. 
Note: you may only implement changes described in the amendment notice or letter.  
If you receive required regulatory approvals (for participating organisations in England, this 
includes confirmation that the amendment has been granted HRA Approval) after the 35 
days have passed, you may then immediately implement this amendment at all participating 
NHS organisations that have not requested additional review time, or are no longer able to 
undertake this study.  
There is no need for you to receive a letter of confirmation from the participating organisation 
that the amendment can be implemented, as the intended date of implementation is 
communicated through the above process. However, you may be able to implement this 
amendment ahead of the 35 day deadline, if all necessary regulatory approvals are in place 
and the participating organisation has confirmed that the amendment may be implemented 
ahead of the 35 day date.  









Carol Ebenezer | REC Manager 
Health Research Authority 
3rd Floor 
Barlow House 
4 Minshull St 
Manchester 
M1 3HY 
E: nrescommittee.northwest-preston@nhs.net | T: 02071048008 | 
www.hra.nhs.uk 
The HRA is keen to know your views on the service you received – our short 
feedback form is available here 
 
IMPORTANT – Click here for the latest details of the roll-out of HRA Approval in England 
 






This message may contain confidential information. If you are not the 
intended recipient please inform the 
sender that you have received the message in error before deleting it. 
Please do not disclose, copy or distribute information in this e-mail or 
take any action in reliance on its contents: 
to do so is strictly prohibited and may be unlawful. 
 
Thank you for your co-operation. 
 
NHSmail is the secure email and directory service available for all NHS 
staff in England and Scotland 
NHSmail is approved for exchanging patient data and other sensitive 
information with NHSmail and GSi recipients 
NHSmail provides an email address for your career in the NHS and can be 
accessed anywhere 












Appendix 22. Substantial Amendment II 
 
Dear Laura, 
Many thanks for confirming this. You will hopefully have seen by now that the amendment 
has been approved. I wish you the best with the continuing research. 
Kind regards, 
Chris 
Dr Chris Kitchen 
Assessor 
Health Research Authority 
3rd Floor, Barlow House, 4 Minshull Street, Manchester, M1 3DZ  
T. 0207 104 8193 
E. hra.approval@nhs.net 
W. www.hra.nhs.uk  
Sign up to receive our newsletter HRA Latest. 
 
From: Laura Medina Perucha [mailto:L.Medina.Perucha@bath.ac.uk]  
Sent: 11 December 2017 16:11 
To: KITCHEN, Chris (HEALTH RESEARCH AUTHORITY); Pro-Vice-Chancellor for Research 
Subject: RE: IRAS 205701. Amendment confirmation of REC Validation, categorisation and 
implementation information 
Dear Dr Kitchen, 
Thank you for your email.  
Regarding the “snowballing sampling”: we are proposing to ask participants (both service users and 
pharmacists) to voluntarily inform other potential participants about the study. It would be a word-
of-mouth chain-referral sampling. None of the participants will  be informed of who has previously 
taken part in the study, so confidentiality will always be ensured throughout the recruitment. 
Please let me know if you have any further questions/concerns. 
Kind regards, 
Laura. 
From: KITCHEN, Chris (HEALTH RESEARCH AUTHORITY) [mailto:chris.kitchen@nhs.net]  
Sent: 08 December 2017 13:03 







Subject: RE: IRAS 205701. Amendment confirmation of REC Validation, categorisation and 
implementation information 
Dear Miss Medina-Perucha, 
 
Thank you for submitting the below amendment for assessment under HRA Approval. I note 
that the REC has now issued its opinion of the amendment, but from the assessment side, I 
had one query on which I would appreciate your response. 
I note that the change in recruitment strategy will involve using professional contacts and 
snowballing. Please could you clarify precisely how the snowballing aspect of this will work? 
In particular, please clarify who will be approached to provide suggestions for further 
participants in the study, and who those further participants may be (e.g. service users, 
pharmacists etc.). 





Dr Chris Kitchen 
Assessor 
Health Research Authority 
3rd Floor, Barlow House, 4 Minshull Street, Manchester, M1 3DZ  
T. 0207 104 8193 
E. hra.approval@nhs.net 
W. www.hra.nhs.uk  
Sign up to receive our newsletter HRA Latest. 
From: nrescommittee.northwest-preston@nhs.net [mailto:nrescommittee.northwest-
preston@nhs.net]  
Sent: 04 December 2017 12:17 
To: l.medina.perucha@bath.ac.uk; pro-vc-research@bath.ac.uk 
Cc: I.Blair@bath.ac.uk 












Dear Miss Medina-Perucha, 
Thank you for submitting an amendment to your project. Please find attached a copy of the 
REC validation letter for the submitted amendment. 
If you have participating NHS/HSC organisations in any other UK nations we will forward the 
information to the relevant national coordinating function(s).  
Please note that you may only implement changes described in the amendment notice. 
What Happens Next? 
When available, please forward any other regulatory approvals that are expected for this 
amendment to hra.amendments@nhs.net. However, you do not need to forward the REC 
favourable opinion as we will be able to access this through our systems. 
Information Specific to Participating NHS Organisations in England 
You should now share your notice of amendment and, if applicable, amended documents, 
together with this email, with all participating NHS organisations in England.  In doing so, you 
should include the NHS R&D Office, LCRN (where applicable) as well as the local research 
team. A template email to notify participating NHS organisations in England is provided on 
the HRA website. 
The participating NHS organisations in England should prepare to implement this 
amendment. 
Your amendment will be reviewed by the REC, as per the attached letter.  In parallel to this, 
an assessment against HRA standards will take place. 
Once the REC Favourable Opinion is issued, any other regulatory approvals are in place 
and the HRA assessment has been successfully completed, you will receive an email 
confirming that your amendment has HRA Approval. 
You may implement your amendment at all participating NHS organisations in England 35 
calendar days from the day on which you provide the organisations with this email and your 
amended documents (or as soon as the participating NHS organisation confirm that you may 
implement, if sooner), so long as you have HRA Approval for your amendment by this 
date.  NHS organisations do not have to confirm they are happy with the amendment. 
If HRA Approval is issued subsequent to this date, you may implement following HRA 
Approval. 
You may not implement the amendment at any participating NHS organisations in England 
that requests additional time to assess, until it confirms that it has concluded its 
assessment.   
You may not implement at any participating NHS organisation in England that declines to 
implement the amendment. 
IRAS Project ID: 205701 












Amendment Date: 27 November 2017 
Amendment Type: Substantial 
Outcome of HRA 
Assessment 
HRA Approval for the amendment is pending. The HRA will 
separately confirm HRA Approval for the amendment by email. 
Implementation date in 
NHS organisations in 
England  
35 days from date amendment information  together with this 
email, is supplied to participating organisations (provided HRA 
Approval for the amendment is in place and conditions above 
are met) 
For NHS/HSC R&D Office information 
Amendment Category A 
    
If you have any questions about the ethical review of this amendment, please do not hesitate 
to contact me.  
If you have any questions relating to the wider HRA approval process, please direct these 
to hra.approval@nhs.net. 
If you have any questions relating this amendment in one of the devolved administrations, 
please direct these to the relevant national coordinating function.  
Additional information on the management of amendments can be found in the IRAS 
guidance. 
Please do not hesitate to contact me if you require further information.  
Kind regards  
Mrs Carol Ebenezer  
REC Manager  
Health Research Authority  
Ground Floor | Skipton House | 80 London Road | London | SE1 6LH  
E.hra.amendments@nhs.net  
W. www.hra.nhs.uk  
 
































Appendix 24. Non-Substantial Amendment II 
 
Dear Miss Medina-Perucha 
IRAS Project ID:   205701 
Short Study Title: A public health service to promote safe sex 
Date complete amendment submission 
received: 
3 October 2016 
Amendment No./ Sponsor Ref:  Non Substantial Amendment 1 
Amendment Date:  30 September 2016 
Amendment Type: Non Substantial 
Thank you for submitting the above referenced amendment. In line with the UK Process for 
Handling UK Study Amendments I can confirm that this amendment has been categorised 
as:  
Category C - An amendment that has no implications that require management or oversight 
by the participating NHS organisations 
As such, the sponsor may implement this amendment as soon as any relevant regulatory 
approvals are in place (for participating organisations in England, please see ‘Confirmation 
of Assessment Arrangements’ below).  
As Chief Investigator/Sponsor, it remains your responsibility to ensure that the research 
management offices and local research teams (if applicable) at each of your participating 
organisations are informed of this amendment. 
Note: you may only implement changes described in the amendment notice or letter.  
Participating NHS Organisations in England – Confirmation of Assessment 
Arrangements 
Further to the details above, I can confirm that no HRA assessment of this amendment is 
needed.  
 If this study has HRA Approval, this amendment may be implemented at participating 
NHS organisations in England once the conditions detailed in the categorisation 
section above have been met 
 If this study is a pre-HRA Approval study, this amendment may be implemented at 
participating NHS organisations in England that have NHS Permission, once the 
conditions detailed in the categorisation section above have been met.  For 
participating NHS organisations in England that do not have NHS Permission, these 
sites should be covered by HRA Approval before the amendment is implemented at 





 If this study is awaiting HRA Approval, I have passed your amendment to my 
colleague in the assessment team and you should receive separate notification that 
the study has received HRA Approval, incorporating approval for this amendment. 






Kirsten Peck |  HRA Approval Amendment Co-ordinator 
Health Research Authority 
Bristol HRA Centre, Level 3, Block B, Whitefriars, Lewins Mead, Bristol, BS1 
2NT 




IMPORTANT – Click here for the latest details of the roll-out of HRA Approval 
in England 
 
The HRA is keen to know your views on the service you received – our short 






This message may contain confidential information. If you are not the 
intended recipient please inform the 
sender that you have received the message in error before deleting it. 
Please do not disclose, copy or distribute information in this e-mail or 
take any action in reliance on its contents: 
to do so is strictly prohibited and may be unlawful. 
 
Thank you for your co-operation. 
 
NHSmail is the secure email and directory service available for all NHS 
staff in England and Scotland 
NHSmail is approved for exchanging patient data and other sensitive 
information with NHSmail and GSi recipients 
NHSmail provides an email address for your career in the NHS and can be 
accessed anywhere 









Appendix 25. Abstract STI & HIV World Congress Rio de Janerio (Brazil), 
July 2017 
Psychosocial Determinants of Sexual Practices among Women Using Heroin and Other Drugs: 
















Department of Pharmacy & Pharmacology, University of Bath (United Kingdom) 
2 
Department of Psychology, University of Bath (United Kingdom) 
Introduction 
Women using heroin and other drugs (WHOD) are at high risk of sexually transmitted 
infections (STIs) and blood-borne viruses (BBVs). However, little attention has been paid to 
identify the psychosocial determinants of sexual practices among these women. An overview 
of these determinants could be key for health professionals and policy makers, to tackle STIs 
and BBVs and promote health among WHOD. The main aims of this study were to review 
the literature on the psychosocial determinants of sexual practices among WHOD, and to 
determine the nature and quality of the evidence. 
Methods 
The search strategy included five databases: PubMed, EMBASE, PsycNET, Web of Science 
and Scopus. PsycEXTRA was used for grey literature and other publications. Search terms 
included “women *”, “heroin use*”, “sexual behaviour*”, and “HIV". Only publications in 
English, and published between 1995 and June 2016 were included. The PRISMA 2009 
guidelines and the Hawken method were used for quality assessment purposes. This 
systematic review was registered with PROSPERO (Ref. CRD42016039842). 
Results 
Out of the 11,985 publications screened, 30 peer-reviewed articles were included. Most publications 
were cross-sectional (n=27) quantitative studies (n=23), amounting 10,808 women. Psychosocial 
determinants identified included socio-demographic characteristics, sexual orientation, financial 
constraints, gender roles, gender-based violence, HIV status, feelings of love and trust, and 







This systematic review provides an insight into the psychosocial determinants of sexual risk practices 
of WHOD, and highlights the importance of conducting women-only studies. It also identifies 
research gaps, such as the need to focus on protective factors, relationship dynamics, sexual risks with 
non-paying partners, and the study of the broader sociocultural context of sex and sexuality. Overall, 
these findings could be crucial for the development of preventive strategies to tackle STIs and BBVs, 
and promote the sexual health and psychosocial wellbeing of WHOD.  
Please indicate if this research is published or unpublished: 
 published 
 unpublished 
Disclosure of Interest Statement: 
























Appendix 26. Abstract Society for the Study of Addiction Symposium 
Newcastle (UK), November 2017 
 
Psychosocial Factors of Sexual Practices among Women Using Heroin and Other Drugs: A 













Department of Pharmacy & Pharmacology, University of Bath (United Kingdom) 
2 
Department of Psychology, University of Bath (United Kingdom) 
Aims 
Women using heroin and other drugs (WHOD) are at high risk of sexually transmitted infections 
(STIs) and blood-borne viruses (BBVs). However, little attention has been paid on those factors that 
have a role in the development and maintenance of women’s sexual behavior. This research aimed at 
identifying psychosocial factors of sexual practices, and providing evidence on the nature and quality 
of the available data.  
Methods 
The search strategy included five databases: PubMed, EMBASE, PsycNET, Web of Science and 
Scopus. PsycEXTRA was used for grey literature and other publications. Search terms included 
“women *”, “heroin use*”, “sexual behaviour*”, and “HIV". The PRISMA 2009 guidelines was used 
for quality assessment purposes. This systematic review was registered with PROSPERO (Ref. 
CRD42016039842). 
Results 
Out of the 12,135 publications screened, 30 peer-reviewed articles were included. Most publications 
were cross-sectional (n=25) quantitative studies (n=23), amounting 11,305 women. These were socio-
demographic characteristics; alcohol and drug using patterns; gender roles and violence against 
women; partner type, partner characteristics and context of sex; number of partners; preferences, 
negotiation and availability of condoms; sex work; HIV status and other sexually transmitted diseases; 
risk awareness and perception of control; love and trust; pregnancy, fertility and motherhood. These 
findings were however inconsistent due to the heterogeneity of the samples, the varied methodologies 






Overall, this review highlights important implications for future research and practice, such as the 
need to focus on relationship dynamics, the role of emotions, and the study of the broader 
sociocultural context of sex and sexuality. It also provides evidence for the development of STI/BBV 
preventive strategies, and promotion of sexual health and psychosocial wellbeing of WHOD.  






































































Appendix 29. Permission to Include Publication 3 
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